
<html lang="en"     class="pb-page"  data-request-id="da490e96-73a7-4f9b-8b04-b5e130edbee1"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2017.60.issue-20;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.7b00830;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis of Potent and Selective Inhibitors of Aldo-Keto Reductase 1B10 and Their Efficacy against Proliferation, Metastasis, and Cisplatin Resistance of Lung Cancer Cells" /></meta><meta name="dc.Creator" content="Satoshi  Endo" /></meta><meta name="dc.Creator" content="Shuang  Xia" /></meta><meta name="dc.Creator" content="Miho  Suyama" /></meta><meta name="dc.Creator" content="Yoshifumi  Morikawa" /></meta><meta name="dc.Creator" content="Hiroaki  Oguri" /></meta><meta name="dc.Creator" content="Dawei  Hu" /></meta><meta name="dc.Creator" content="Yoshinori  Ao" /></meta><meta name="dc.Creator" content="Satoyuki  Takahara" /></meta><meta name="dc.Creator" content="Yoshikazu  Horino" /></meta><meta name="dc.Creator" content="Yoshihiro  Hayakawa" /></meta><meta name="dc.Creator" content="Yurie  Watanabe" /></meta><meta name="dc.Creator" content="Hiroaki  Gouda" /></meta><meta name="dc.Creator" content="Akira  Hara" /></meta><meta name="dc.Creator" content="Kazuo  Kuwata" /></meta><meta name="dc.Creator" content="Naoki  Toyooka" /></meta><meta name="dc.Creator" content="Toshiyuki  Matsunaga" /></meta><meta name="dc.Creator" content="Akira  Ikari" /></meta><meta name="dc.Description" content="Aldo-keto reductase 1B10 (AKR1B10) is overexpressed in several extraintestinal cancers, particularly in non-small-cell lung cancer, where AKR1B10 is a potential diagnostic marker and therapeutic ta..." /></meta><meta name="Description" content="Aldo-keto reductase 1B10 (AKR1B10) is overexpressed in several extraintestinal cancers, particularly in non-small-cell lung cancer, where AKR1B10 is a potential diagnostic marker and therapeutic ta..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 13, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00830" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00830" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00830" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00830" /></link>
        
    
    

<title>Synthesis of Potent and Selective Inhibitors of Aldo-Keto Reductase 1B10 and Their Efficacy against Proliferation, Metastasis, and Cisplatin Resistance of Lung Cancer Cells | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00830" /></meta><meta property="og:title" content="Synthesis of Potent and Selective Inhibitors of Aldo-Keto Reductase 1B10 and Their Efficacy against Proliferation, Metastasis, and Cisplatin Resistance of Lung Cancer Cells" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0012.jpeg" /></meta><meta property="og:description" content="Aldo-keto reductase 1B10 (AKR1B10) is overexpressed in several extraintestinal cancers, particularly in non-small-cell lung cancer, where AKR1B10 is a potential diagnostic marker and therapeutic target. Selective AKR1B10 inhibitors are required because compounds should not inhibit the highly related aldose reductase that is involved in monosaccharide and prostaglandin metabolism. Currently, 7-hydroxy-2-(4-methoxyphenylimino)-2H-chromene-3-carboxylic acid benzylamide (HMPC) is known to be the most potent competitive inhibitor of AKR1B10, but it is nonselective. In this study, derivatives of HMPC were synthesized by removing the 4-methoxyphenylimino moiety and replacing the benzylamide with phenylpropylamide. Among them, 4c and 4e showed higher AKR1B10 inhibitory potency (IC50 4.2 and 3.5 nM, respectively) and selectivity than HMPC. The treatments with the two compounds significantly suppressed not only migration, proliferation, and metastasis of lung cancer A549 cells but also metastatic and invasive potentials of cisplatin-resistant A549 cells." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00830"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00830">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00830&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00830&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00830&amp;href=/doi/10.1021/acs.jmedchem.7b00830" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 8441-8455</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00854" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00847" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/acs.jmedchem.7b01911"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis of Potent and Selective Inhibitors of Aldo-Keto Reductase 1B10 and Their Efficacy against Proliferation, Metastasis, and Cisplatin Resistance of Lung Cancer Cells</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Satoshi++Endo">Satoshi Endo</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-0578-9672" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shuang++Xia">Shuang Xia</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Miho++Suyama">Miho Suyama</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yoshifumi++Morikawa">Yoshifumi Morikawa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hiroaki++Oguri">Hiroaki Oguri</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dawei++Hu">Dawei Hu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yoshinori++Ao">Yoshinori Ao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Satoyuki++Takahara">Satoyuki Takahara</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yoshikazu++Horino">Yoshikazu Horino</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-8916-6298" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yoshihiro++Hayakawa">Yoshihiro Hayakawa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yurie++Watanabe">Yurie Watanabe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hiroaki++Gouda">Hiroaki Gouda</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Akira++Hara">Akira Hara</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kazuo++Kuwata">Kazuo Kuwata</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â½</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Naoki++Toyooka">Naoki Toyooka</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Toshiyuki++Matsunaga">Toshiyuki Matsunaga</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Akira++Ikari">Akira Ikari</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">â </span> <span class="aff-text">Laboratory of Biochemistry, Gifu Pharmaceutical University, Gifu 501-1196, Japan</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">â¡</span> <span class="aff-text">Graduate School of Innovative Life Science, University of Toyama, Toyama 930-8555, Japan</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">Â§</span> <span class="aff-text">Graduate School of Science and Engineering, University of Toyama, Toyama 930-8555, Japan</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">â¥</span> <span class="aff-text">Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">â¥</span> <span class="aff-text">School of Pharmacy, Showa University, Tokyo 142-8555, Japan</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">Faculty of Engineering, Gifu University, Gifu 501-1193, Japan</span></div><div class="aff-info" id="aff7"><span class="aff-symbol">â½</span> <span class="aff-text">United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Gifu 501-1193, Japan</span></div><div class="corresp-info"><strong>*</strong>S.E.: e-mail, <a href="/cdn-cgi/l/email-protection#c8bbada6aca788afa1aebde5b8bde6a9abe6a2b8"><span class="__cf_email__" data-cfemail="97e4f2f9f3f8d7f0fef1e2bae7e2b9f6f4b9fde7">[emailÂ protected]</span></a>; phone, +81-58-230-8100; fax, +81-58-230-8105.</div><div class="corresp-info"><strong>*</strong>N.T.: e-mail, <a href="/cdn-cgi/l/email-protection#5f2b30263030343e1f3a3138712a722b30263e323e713e3c71352f"><span class="__cf_email__" data-cfemail="e0948f998f8f8b81a0858e87ce95cd948f99818d81ce8183ce8a90">[emailÂ protected]</span></a>; phone, +81-76-445-6859; fax, +81-76-445-6703.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00830&amp;href=/doi/10.1021%2Facs.jmedchem.7b00830" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 8441â8455</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 4, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 June 2017</li><li><span class="item_label"><b>Published</b> online</span>13 October 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 October 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00830" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00830</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8441%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSatoshi%2BEndo%252C%2BShuang%2BXia%252C%2BMiho%2BSuyama%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D20%26contentID%3Dacs.jmedchem.7b00830%26title%3DSynthesis%2Bof%2BPotent%2Band%2BSelective%2BInhibitors%2Bof%2BAldo-Keto%2BReductase%2B1B10%2Band%2BTheir%2BEfficacy%2Bagainst%2BProliferation%252C%2BMetastasis%252C%2Band%2BCisplatin%2BResistance%2Bof%2BLung%2BCancer%2BCells%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8455%26publicationDate%3DOctober%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00830"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2014</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00830" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis of Potent and Selective Inhibitors of Aldo-Keto Reductase 1B10 and Their Efficacy against Proliferation, Metastasis, and Cisplatin Resistance of Lung Cancer Cells&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Satoshi&quot;,&quot;last_name&quot;:&quot;Endo&quot;},{&quot;first_name&quot;:&quot;Shuang&quot;,&quot;last_name&quot;:&quot;Xia&quot;},{&quot;first_name&quot;:&quot;Miho&quot;,&quot;last_name&quot;:&quot;Suyama&quot;},{&quot;first_name&quot;:&quot;Yoshifumi&quot;,&quot;last_name&quot;:&quot;Morikawa&quot;},{&quot;first_name&quot;:&quot;Hiroaki&quot;,&quot;last_name&quot;:&quot;Oguri&quot;},{&quot;first_name&quot;:&quot;Dawei&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Yoshinori&quot;,&quot;last_name&quot;:&quot;Ao&quot;},{&quot;first_name&quot;:&quot;Satoyuki&quot;,&quot;last_name&quot;:&quot;Takahara&quot;},{&quot;first_name&quot;:&quot;Yoshikazu&quot;,&quot;last_name&quot;:&quot;Horino&quot;},{&quot;first_name&quot;:&quot;Yoshihiro&quot;,&quot;last_name&quot;:&quot;Hayakawa&quot;},{&quot;first_name&quot;:&quot;Yurie&quot;,&quot;last_name&quot;:&quot;Watanabe&quot;},{&quot;first_name&quot;:&quot;Hiroaki&quot;,&quot;last_name&quot;:&quot;Gouda&quot;},{&quot;first_name&quot;:&quot;Akira&quot;,&quot;last_name&quot;:&quot;Hara&quot;},{&quot;first_name&quot;:&quot;Kazuo&quot;,&quot;last_name&quot;:&quot;Kuwata&quot;},{&quot;first_name&quot;:&quot;Naoki&quot;,&quot;last_name&quot;:&quot;Toyooka&quot;},{&quot;first_name&quot;:&quot;Toshiyuki&quot;,&quot;last_name&quot;:&quot;Matsunaga&quot;},{&quot;first_name&quot;:&quot;Akira&quot;,&quot;last_name&quot;:&quot;Ikari&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;8441-8455&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00830&quot;},&quot;abstract&quot;:&quot;Aldo-keto reductase 1B10 (AKR1B10) is overexpressed in several extraintestinal cancers, particularly in non-small-cell lung cancer, where AKR1B10 is a potential diagnostic marker and therapeutic target. Selective AKR1B10 inhibitors are required because compounds should not inhibit the highly related aldose reductase that is involved in monosaccharide and prostaglandin metabolism. Currently, 7-hydroxy-2-(4-methoxyphenylimino)-2H-chromene-3-carboxylic acid benzylamide (HMPC) is known to be the most potent competitive inhibitor of AKR1B10, but it is nonselective. In this study, derivatives of HMPC were synthesized by removing the 4-methoxyphenylimino moiety and replacing the benzylamide with phenylpropylamide. Among them, 4c and 4e showed higher AKR1B10 inhibitory potency (IC50 4.2 and 3.5 nM, respectively) and selectivity than HMPC. The treatments with the two compounds significantly suppressed not only migration, proliferation, and metastasis of lung cancer A549 cells but also metastatic and invasive potential&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00830&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00830" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00830&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00830" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00830&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00830" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00830&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00830&amp;href=/doi/10.1021/acs.jmedchem.7b00830" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00830" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00830" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00830%26sid%3Dliteratum%253Aachs%26pmid%3D28976752%26genre%3Darticle%26aulast%3DEndo%26date%3D2017%26atitle%3DSynthesis%2Bof%2BPotent%2Band%2BSelective%2BInhibitors%2Bof%2BAldo-Keto%2BReductase%2B1B10%2Band%2BTheir%2BEfficacy%2Bagainst%2BProliferation%252C%2BMetastasis%252C%2Band%2BCisplatin%2BResistance%2Bof%2BLung%2BCancer%2BCells%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D20%26spage%3D8441%26epage%3D8455%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/jmcmar.2017.60.issue-20/20171026/jmcmar.2017.60.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/medium/jm-2017-00830q_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00830&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Aldo-keto reductase 1B10 (AKR1B10) is overexpressed in several extraintestinal cancers, particularly in non-small-cell lung cancer, where AKR1B10 is a potential diagnostic marker and therapeutic target. Selective AKR1B10 inhibitors are required because compounds should not inhibit the highly related aldose reductase that is involved in monosaccharide and prostaglandin metabolism. Currently, 7-hydroxy-2-(4-methoxyphenylimino)-2<i>H</i>-chromene-3-carboxylic acid benzylamide (HMPC) is known to be the most potent competitive inhibitor of AKR1B10, but it is nonselective. In this study, derivatives of HMPC were synthesized by removing the 4-methoxyphenylimino moiety and replacing the benzylamide with phenylpropylamide. Among them, <b>4c</b> and <b>4e</b> showed higher AKR1B10 inhibitory potency (IC<sub>50</sub> 4.2 and 3.5 nM, respectively) and selectivity than HMPC. The treatments with the two compounds significantly suppressed not only migration, proliferation, and metastasis of lung cancer A549 cells but also metastatic and invasive potentials of cisplatin-resistant A549 cells.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74085" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74085" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Lung carcinoma is a leading cause of cancer deaths in Japan and worldwide for both men and women,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> of which non-small-cell lung carcinoma (NSCLC) accounts for approximately 85% of lung cancer cases. Most patients with NSCLC are diagnosed at advanced stages with an overall five-year survival rate of only 15%.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Currently, several NSCLC markers, such as epithelial growth factor receptor (EGFR),<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> anaplastic lymphoma kinase (ALK),<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> mesenchymalâepithelial transition factor (MET)<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and KRAS,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> were identified. Molecular targeting therapies for NSCLC patients against gene mutations occurring in the genes encoding components of EGFR and the downstream mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways have been developed, but the overall prognosis remains poor.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">Fukumoto et al.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> identified a member of the aldo-keto reductase (AKR) superfamily, AKR1B10, as an overexpressing protein in NSCLC, in particular smokersâ NSCLC, and suggested that the enzyme is a potential diagnostic marker. Subsequently, many researchers also verified AKR1B10 as a lung cancer biomarker.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13">(9-13)</a> In addition, the enzyme has been reported to be overexpressed in hepatocarcinoma,<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> breast cancer,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> pancreatic carcinoma,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and oral squamous cell carcinomas.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> AKR1B10 is a monomeric cytosolic NADPH-dependent reductase that catalyzes the reduction of various carbonyl compounds including reactive aldehydes, retinoids, and isoprenoids.<a onclick="showRef(event, 'ref14 ref19'); return false;" href="javascript:void(0);" class="ref ref14 ref19">(14, 19)</a> Therefore, the enzyme has been thought to be involved in the development, progression, and survival of carcinomas through multiple mechanisms including detoxification of cytotoxic reactive carbonyls,<a onclick="showRef(event, 'ref14 ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref14 ref20 ref21 ref22 ref23">(14, 20-23)</a> modulation of retinoic acid level,<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> regulation of cellular fatty acid synthesis and lipid metabolism,<a onclick="showRef(event, 'ref21 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref21 ref26 ref27">(21, 26, 27)</a> elevation of sphingosine-1-phosphate,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and integrin Î±5/Î´-catenin mediated FAK/Src/Rac1 signaling pathways.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Furthermore, AKR1B10 is suggested to be implicated in acquiring cancer cell resistance to anticancer drugs such as mitomycin C, cisplatin (CDDP), anthracyclines (doxorubicin and idarubicin), and docetaxel.<a onclick="showRef(event, 'ref30 ref31 ref32 ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32 ref33 ref34 ref35">(30-35)</a> Thus, this enzyme has been recognized not only as a potential diagnostic or prognostic marker but also as a novel therapeutic target for the treatment of the above extraintestinal cancers and for chemoresistance.</div><div class="NLM_p">Due to its recognition as a therapeutic target, many inhibitors of AKR1B10 have been discovered in natural compounds and existing drugs, and synthesized until 2015 as described in recent reviews.<a onclick="showRef(event, 'ref33 ref36'); return false;" href="javascript:void(0);" class="ref ref33 ref36">(33, 36)</a> Subsequently, two AKR1B10 inhibitors, polyhydroxysteroid derivatives<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and 2-[5-chloro-2-[(2,3,4,5,6-pentabromophenyl)methylcarbamoyl]phenoxy]acetic acid (MK204),<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> have been reported. <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a> shows the representative potent AKR1B10 inhibitors, which are divided into two groups, nonselective and selective ones, with respect to the inhibitory selectivity to AKR1B10 over human aldose reductase (AKR1B1), which is similar to AKR1B10 in both primary and tertiary structures.<a onclick="showRef(event, 'ref14 ref24'); return false;" href="javascript:void(0);" class="ref ref14 ref24">(14, 24)</a> AKR1B1 and AKR1B10 show overlapped substrate specificity<a onclick="showRef(event, 'ref14 ref19'); return false;" href="javascript:void(0);" class="ref ref14 ref19">(14, 19)</a> but differ in high prostaglandin F<sub>2Î±</sub> synthase<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and <span class="smallcaps smallerCapital">d</span>-glucose reductase activities,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> which are exhibited only by AKR1B1. In addition, AKR1B1 has been shown to be involved in colon cancer growth,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> in contrast to a protective role of AKR1B10 in normal colon cells.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Therefore, the inhibitory selectivity to AKR1B10 over AKR1B1 is ideally required for development of drugs in the treatment of the extraintestinal cancers and chemoresistance. Among the inhibitors shown in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>, oleanolic acid<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> is the most selective, then 3-(4-hydroxy-2-methoxyphenyl)acrylic acid 3-(3-hydroxyphenyl) propyl ester (HAHE),<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> and the most potent inhibitor is 7-hydroxy-2-(4-methoxyphenylimino)-2<i>H</i>-chromene-3-carboxylic acid benzylamide (HMCB).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/medium/jm-2017-00830q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of representative AKR1B10 inhibitors and their inhibitory potency toward AKR1B10 (1B10) and its structurally similar enzyme AKR1B1 (1B1). Abbreviations: MHPC, (<i>Z</i>)-2-(4-methoxyphenylimino)-7-hydroxy-<i>N</i>-(pyridin-2-yl)-2<i>H</i>-chromene-3-carboxamide; and BDMC, bisdemethoxycurcumin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00830&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In this study, we designed and synthesized novel analogues of HMCB by referring to the structure of the selective AKR1B10 inhibitor, HAHE,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> in order to develop more potent and selective AKR1B10 inhibitors. The analogues <b>4a</b>â<b>l</b> were evaluated for inhibition of AKR1B10 and AKR1B1, and it was found that two (<b>4c</b> and <b>4e</b>) of them are more potent and selective AKR1B10 inhibitors than HMCB. The structural reason for the increase in the inhibitory potency and selectivity was examined by docking simulation of <b>4c</b> in AKR1B10. Additionally, <b>4c</b> and <b>4e</b> were evaluated in terms of inhibitory effects on migration, proliferation, and metastasis of lung cancer A549 cells, as well as ability to overcome resistance to CDDP.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33541" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33541" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Design and Synthesis of Coumarin Derivatives</h3><div class="NLM_p">The HMCB structure except for its 4-methoxyphenylimino moiety is somewhat similar to the selective AKR1B10 inhibitor HAHE, but the benzylamide moiety of HMCB is shorter than the 3-(3-hydroxyphenyl)propyl ester part of HAHE (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). To improve the poor selectivity of HMCB, its derivative (<b>3aâ²</b>) that replaced the benzylamide moiety with 3-hydroxyphenylpropylamide was designed and first synthesized (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Condensation of <b>1a</b> with cyanoacetic acid using EDC provided the amide <b>2a</b>, which was converted to <b>3a</b> via corresponding iminochromene. Deprotection of MOM group with acid afforded not desired <b>3aâ²</b> but <b>4a</b>. To avoid the acid hydrolysis of the phenyliminochromene moiety, we conducted the deprotection of the MOM group first in the amide <b>2a</b> to yield <b>2aâ²</b>, which was converted to <b>3aâ²</b> as the same procedure for <b>3a</b>. Unfortunately, the inhibitory effect of <b>3aâ²</b> was less potent and selective compared to HMCB, but very fortunately coumarin <b>4a</b> showed good selectivity against AKR1B1 with acceptable inhibitory effect on AKR1B10. The coumarin <b>4a</b> retained the inhibitory potency to AKR1B10 and showed low inhibition to AKR1B1, resulting in a 22-fold increase in the selectivity to AKR1B10 over AKR1B1. Thus, we aimed at developing the <b>4a</b>-based derivatives (<b>4b</b>â<b>l)</b> as the new candidates for AKR1B10 inhibitors. The amides <b>2a</b>â<b>i</b> were prepared by condensation with cyanoacetic acid with appropriate amines, which were prepared by hydrogenation of azides shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, using EDC. The Knoevenagel condensation of <b>2a</b>â<b>i</b> with 2-hydroxybenzaldehydes followed by treatment of the resulting iminochromenes with <i>p</i>-methoxyaniline gave rise to phenyliminochromenes <b>3a</b>â<b>k</b>. Acid-catalyzed hydrolysis of <b>3a</b>â<b>k</b> provided the coumarins <b>4a</b>â<b>l</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Among the derivatives (<b>4a</b>â<b>4c</b>) hydroxylated at different positions on the phenyl ring, <b>4c</b> with the 4â²-hydroxy group was the most potent inhibitor and was approximately 10-fold more selective toward AKR1B10 than HMCB (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Among the derivatives with fluorinated phenyl rings (<b>4d</b>â<b>4f</b>), <b>4e</b> with 4â²-F showed the highest inhibitory potency (IC<sub>50</sub> 3.5 nM) and selectivity (79-fold), which greatly exceeded that of HMCB. In contrast, the replacement of a methyl group (<b>4g</b>) and methoxy group (<b>4h</b>) instead of the 4<b>â²</b>-hydroxy group of <b>4c</b> decreased both inhibitory potency and selectivity. These results suggest that the hydroxyl group or fluorine atom at the <i>p</i>-position on the phenylpropylamide moiety is a structural requisite for the selective and strong inhibition of AKR1B10.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/medium/jm-2017-00830q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>C1</b>â<b>C9</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00830&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/medium/jm-2017-00830q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Coumarin Derivatives <b>4a</b>â<b>4l</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00830&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/medium/jm-2017-00830q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design process of selective AKR1B10 inhibitor <b>4a</b> from the lead compound HMCB.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00830&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibition of AKR1B10 and AKR1B1 by Coumarin Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/medium/jm-2017-00830q_0011.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="Â±" /></col><col align="char" char="â" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="2" align="center" char="Â±">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">Â </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>n</i></th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center" char="Â±">AKR1B10</th><th class="colsep0 rowsep0" align="center" char="â">AKR1B1</th><th class="colsep0 rowsep0" align="center" char=".">selectivity<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4a</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3â²-OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="Â±">8.3Â Â±Â 1.4</td><td class="colsep0 rowsep0" align="char" char="â">180Â Â±Â 1</td><td class="colsep0 rowsep0" align="char" char=".">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">2â²-OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="Â±">6.4Â Â±Â 0.4</td><td class="colsep0 rowsep0" align="char" char="â">220Â Â±Â 19</td><td class="colsep0 rowsep0" align="char" char=".">34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4c</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">4â²-OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="Â±">4.2Â Â±Â 0.2</td><td class="colsep0 rowsep0" align="char" char="â">204Â Â±Â 4</td><td class="colsep0 rowsep0" align="char" char=".">49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4d</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3â²-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="Â±">6.0Â Â±Â 1.4</td><td class="colsep0 rowsep0" align="char" char="â">340Â Â±Â 42</td><td class="colsep0 rowsep0" align="char" char=".">57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4e</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">4â²-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="Â±">3.5Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="char" char="â">277Â Â±Â 17</td><td class="colsep0 rowsep0" align="char" char=".">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4f</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3â²,5â²-diF</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="Â±">7.8Â Â±Â 0.3</td><td class="colsep0 rowsep0" align="char" char="â">320Â Â±Â 49</td><td class="colsep0 rowsep0" align="char" char=".">41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4g</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">4â²-Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="Â±">7.0Â Â±Â 0.6</td><td class="colsep0 rowsep0" align="char" char="â">200Â Â±Â 14</td><td class="colsep0 rowsep0" align="char" char=".">29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4h</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">4â²-OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="Â±">11Â Â±Â 0.9</td><td class="colsep0 rowsep0" align="char" char="â">390Â Â±Â 40</td><td class="colsep0 rowsep0" align="char" char=".">35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4i</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">4â²-OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="Â±">11Â Â±Â 0.2</td><td class="colsep0 rowsep0" align="char" char="â">314Â Â±Â 27</td><td class="colsep0 rowsep0" align="char" char=".">27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4j</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">4â²-OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="Â±">2700Â Â±Â 400</td><td class="colsep0 rowsep0" align="char" char="â">>10000<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">>4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4k</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">4â²-OH</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="Â±">1500Â Â±Â 70</td><td class="colsep0 rowsep0" align="char" char="â">9500Â Â±Â 750</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4l</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">4â²-OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="Â±">20Â Â±Â 1.0</td><td class="colsep0 rowsep0" align="char" char="â">98Â Â±Â 9.1</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Selectivity is expressed as a ratio of AKR1B1/AKR1B10.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Inhibition percentage was 20% at 10000 nM.</p></div></div></div><div class="NLM_p">Other derivatives having a phenethyl moiety (<b>4l</b>)<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> and a phenylbutyl moiety (<b>4i</b>) instead of the phenylpropyl moiety of <b>4c</b> showed higher IC<sub>50</sub> values and lower selectivity to AKR1B10 than those of <b>4c</b>, suggesting that the 3-carbon chain length between the amide and phenyl ring of <b>4c</b> is appropriate for fitting in the inhibitor-binding site of the enzyme. In addition, the derivatives without 7-OH (<b>4j</b>) and with 8-OH (<b>4k</b>) on the coumarin ring of <b>4c</b> markedly reduced the inhibitory potency toward both AKR1B10 and AKR1B1. In particular, the decline observed in <b>4j</b> was significant, suggesting that the 7-hydroxyl group is the most important structural prerequisite for the potent inhibition for the two enzymes.</div><div class="NLM_p">The synthetic route to <b>4a</b>â<b>l</b> shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> included the initial targets of iminochromenes <b>3a</b>â<b>k</b> and was relatively long. Next we refined the synthetic route for the most potent inhibitor <b>4e</b>. Known coumarin <b>5</b><a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> was treated with 4-fluorophenylpropylamine, prepared by reduction of corresponding amide,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> in the presence of EDC, HOBt, and <i>N</i>-methylmorpholine to afford <b>4e</b> in 78% yield (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/medium/jm-2017-00830q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Improved Synthesis of <b>4e</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00830&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">AKR1A1, AKR1C1, AKR1C2, AKR1C3, and AKR1C4 are human members of the AKR superfamily, and their substrate specificity for aldehydes overlaps with that of AKR1B10.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> In addition, human carbonyl reductase 1 (CBR1) was reported to be inhibited by des-4-methoxyphenylimino derivatives of MHPC, such as 8-hydroxy-2-imino-2<i>H</i>-chromene-3-carboxylic acid (2-chlorophenyl)amide.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Therefore, the inhibitory selectivity of <b>4c</b> and <b>4e</b> toward AKR1B10 was further examined by comparing their effects on the activities of these enzymes. Compounds <b>4c</b> and <b>4e</b> were more than 100-fold less inhibitory to these enzymes compared to AKR1B10 (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Thus, the two compounds are highly selective to this enzyme.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibitory Effects of <b>4c</b> and <b>4e</b> on AKRs and CBR1</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="Â±" /></col><col align="char" char="." /></col><col align="char" char="Â±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="2" align="center" char="Â±"><b>4c</b></th><th class="rowsep1 colsep0" colspan="2" align="center" char="Â±"><b>4e</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">enzyme</th><th class="colsep0 rowsep0" align="center">substrate<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="Â±">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">ratio<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="Â±">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">ratio<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AKR1B10</td><td class="colsep0 rowsep0" align="left">20 Î¼M P3A</td><td class="colsep0 rowsep0" align="char" char="Â±">4.1Â Â±Â 0.3</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char="Â±">3.4Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AKR1A1</td><td class="colsep0 rowsep0" align="left">2.0 mM P3A*</td><td class="colsep0 rowsep0" align="char" char="Â±">1500Â Â±Â 10</td><td class="colsep0 rowsep0" align="char" char=".">370</td><td class="colsep0 rowsep0" align="char" char="Â±">1700Â Â±Â 160</td><td class="colsep0 rowsep0" align="char" char=".">500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AKR1C1</td><td class="colsep0 rowsep0" align="left">7 Î¼M <i>S</i>-Tetralol</td><td class="colsep0 rowsep0" align="char" char="Â±">950Â Â±Â 25</td><td class="colsep0 rowsep0" align="char" char=".">230</td><td class="colsep0 rowsep0" align="char" char="Â±">12000Â Â±Â 600</td><td class="colsep0 rowsep0" align="char" char=".">3500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AKR1C2</td><td class="colsep0 rowsep0" align="left">260 Î¼M <i>S</i>-Tetralol</td><td class="colsep0 rowsep0" align="char" char="Â±">970Â Â±Â 57</td><td class="colsep0 rowsep0" align="char" char=".">240</td><td class="colsep0 rowsep0" align="char" char="Â±">610Â Â±Â 2</td><td class="colsep0 rowsep0" align="char" char=".">180</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AKR1C3</td><td class="colsep0 rowsep0" align="left">1.4 mM <i>S</i>-Tetralol</td><td class="colsep0 rowsep0" align="char" char="Â±">1600Â Â±Â 150</td><td class="colsep0 rowsep0" align="char" char=".">390</td><td class="colsep0 rowsep0" align="char" char="Â±">470Â Â±Â 19</td><td class="colsep0 rowsep0" align="char" char=".">140</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AKR1C4</td><td class="colsep0 rowsep0" align="left">110 Î¼M <i>S</i>-Tetralol</td><td class="colsep0 rowsep0" align="char" char="Â±">820Â Â±Â 31</td><td class="colsep0 rowsep0" align="char" char=".">200</td><td class="colsep0 rowsep0" align="char" char="Â±">350Â Â±Â 19</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CBR1</td><td class="colsep0 rowsep0" align="left">50 Î¼M Isatin</td><td class="colsep0 rowsep0" align="char" char="Â±">4200Â Â±Â 400</td><td class="colsep0 rowsep0" align="char" char=".">1000</td><td class="colsep0 rowsep0" align="char" char="Â±">1100Â Â±Â 140</td><td class="colsep0 rowsep0" align="char" char=".">310</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Substrate concentrations of AKRs correspond to the approximate <i>K</i><sub>m</sub> values, which were reported<a onclick="showRef(event, 'ref19 ref66'); return false;" href="javascript:void(0);" class="ref ref19 ref66">(19, 66)</a> and determined in this study (*). P3A, pyridine-3-aldehyde.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Ratio to AKR1B10.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Molecular Docking and Site-Directed Mutagenesis of Inhibitor Binding Residues</h3><div class="NLM_p">To elucidate the underlying structural reasons for the high AKR1B10-selective inhibition of the 7-hydroxycoumarin derivatives, models of docked <b>4c</b> in the AKR1B10âNADP<sup>+</sup> complex<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> were constructed. In the model with the best docking score (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A), <b>4c</b> was held in the substrate-binding site through a number of contacts including the catalytic residues, Tyr49 and His111. The 7-hydroxy group on the coumarin ring of <b>4c</b> formed H-bond interactions with His111 and the nicotinamide of NADP<sup>+</sup>. The interactions are probably important for the high inhibitory potency of <b>4c</b>, because the derivative without the 7-OH group (<b>4j</b>) showed extremely low inhibition. When this model was compared with the previously reported model with the nonselective AKR1B10 inhibitor HMCB docked<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B), the orientation of the coumarin ring of <b>4c</b> in the binding site resembled that of the chromene ring of HMCB in its docking model, but those of the 4-hydroxyphenylpropyl moiety of <b>4c</b> and the benzylamide moiety of HMCB were markedly different. While the benzylamide moiety of HMCB is close to only Gln303, the 4-hydroxyphenylpropyl moiety of <b>4c</b> was surrounded by eight residues (Phe116, Phe123, Pro124, Lys125, Ala131, Ile132, Val301, and Leu302) and its hydroxyl group formed an H-bond interaction with the main-chain carbonyl group of Pro124. These <b>4c</b>-specific interactions might contribute to the higher inhibitory potency of <b>4c</b> than HMCB, despite the lack of the 4-methoxyphenylimino moiety in its structure. Among the above eight residues, Lys125, Ala131, Ile132, and Val301 differ from the corresponding residues (Leu, Val, Val and Leu, respectively) in AKR1B1, suggesting that these residue differences are related to the high selectivity of <b>4c</b> to AKR1B10 over AKR1B1.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/medium/jm-2017-00830q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Docked models of <b>4c</b> (A) and HMCB (B) in AKR1B10âNADP<sup>+</sup> complex. The portion of NADP<sup>+</sup> (yellow) and AKR1B10 residues (light gray) within 4.0 Ã from the inhibitors are depicted with possible hydrogen bond interactions, which are shown in dotted lines with distances (Ã).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00830&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To confirm the interactions predicted by the molecular docking of <b>4c</b>, we prepared mutant AKR1B10s, in which Lys125, Val301, and Gln303 were replaced with the corresponding residues (Leu, Leu, and Ser, respectively) in AKR1B1. In addition, Trp220 was replaced by a smaller aromatic residue, Tyr, in order to evaluate the role of its hydrophobic interaction with <b>4c</b>. Since <b>4c</b> was a competitive inhibitor with respect to the alcohol substrate in the NADP<sup>+</sup>-linked geraniol oxidation, the effects of the mutations on the <i>K</i><sub>i</sub> value for <b>4c</b> were determined (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). The Lys125Leu, Trp220Tyr, and Val301Leu mutant enzymes showed more than 3-fold higher <i>K</i><sub>i</sub> values than the wild-type enzyme. In contrast, the Gln303Ser mutation had no influence on the <i>K</i><sub>i</sub> value, probably because Gln303 is involved in the binding of HMCB, but not <b>4c</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). The results support the <b>4c</b>-binding mode shown in its docking model.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effects of Mutations of AKR1B10 on <i>K</i><sub>i</sub> Value for <b>4c</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="Â±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">enzyme</th><th class="colsep0 rowsep0" align="center" char="Â±"><i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">ratio<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">wild-type</td><td class="colsep0 rowsep0" align="char" char="Â±">2.3Â Â±Â 0.3</td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Lys125Leu</td><td class="colsep0 rowsep0" align="char" char="Â±">6.9Â Â±Â 0.4</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Trp220Tyr</td><td class="colsep0 rowsep0" align="char" char="Â±">14Â Â±Â 0.2</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Val301Leu</td><td class="colsep0 rowsep0" align="char" char="Â±">9.8Â Â±Â 0.6</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Gln303Ser</td><td class="colsep0 rowsep0" align="char" char="Â±">2.5Â Â±Â 0.4</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Ratio of mutant/wild type.</p></div></div></div><div class="NLM_p">In order to investigate the selectivity of <b>4c</b>, we compared AKR1B10 and AKR1B1 from the structural and energetic points of view. We assumed that <b>4c</b> could bind to AKR1B1 in a manner similar to the binding mode of <b>4c</b> with AKR1B10, because the binding site of AKR1B1 shows significant homology to that of AKR1B10. The structure of AKR1B1 docked with <b>4c</b> was first generated by homology modeling method using the docking model of AKR1B10 with <b>4c</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A) as the template. All calculations for homology modeling were conducted using the SchrÃ¶dinger suite 2015-4 (SchrÃ¶dinger, LLC, New York, NY, USA). The interaction modes of <b>4c</b> with residues of AKR1B10 and AKR1B1 were shown as a superimposed figure (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00830/suppl_file/jm7b00830_si_001.pdf" class="ext-link">Figure S1</a>). Among residues near <b>4c</b>, two residues different between AKR1B10 (Lys125 and Val301) and AKR1B1 (Leu125 and Leu301) were considered to cause the selectivity of <b>4c</b> for AKR1B10. This is supported by the mutagenesis of the two residues (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).</div><div class="NLM_p last">We next performed binding free energy (Î<i>G</i><sub>bind</sub>) calculations based on molecular mechanics PoissonâBoltzmann surface area (MM-PBSA) methods, in order to investigate the selectivity of <b>4c</b> from the energetic point of view. These calculations were conducted using the AMBER14 package,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.7b00830/suppl_file/jm7b00830_si_001.pdf" class="ext-link">Table S1</a> shows the resulting Î<i>G</i><sub>bind</sub> values calculated by MM-PBSA calculations. The Î<i>G</i><sub>bind</sub> (â42.95 kcal/mol) of <b>4c</b> with AKR1B10 was more favorable than that of <b>4c</b> with AKR1B1 (â41.25 kcal/mol), suggesting that the binding affinity of <b>4c</b> was greater in AKR1B10 complex. This was consistent with the difference in IC<sub>50</sub> values between the two enzymes, indicating that the MM-PBSA method could provide reliable Î<i>G</i><sub>bind</sub> values. Moreover, the contributions of Lys125 (Leu125) and Val301 (Leu301) of AKR1B10 (AKR1B1) to Î<i>G</i><sub>bind</sub> were estimated by the alanine scanning analysis, where the 125th or 301st residue was substituted by alanine in the computer. The Î<i>G</i><sub>bind</sub> values of <b>4c</b> with the alanine-substituted AKR1B10s and AKR1B1s were calculated using the MM-PBSA python script within the AMBER14 package (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00830/suppl_file/jm7b00830_si_001.pdf" class="ext-link">Table S1</a>). The Î<i>G</i><sub>bind</sub> values of Lys125Ala and Val301Ala mutants of AKR1B10 with <b>4c</b> were â41.69 and â41.32 kcal/mol, respectively, and the respective binding free-energy changes (ÎÎ<i>G</i><sub>bind</sub>) were 1.26 and 1.62 kcal/mol. This suggested that Lys125 and Val301 of AKR1B10 contribute largely to the binding affinity for <b>4c</b>. In contrast, the ÎÎ<i>G</i><sub>bind</sub> values for Leu125Ala and Leu301Ala mutants of AKR1B1 were â0.08 and 1.28 kcal/mol, respectively, suggesting that Leu301, but not Leu125, of AKR1B1 contributes largely to the binding affinity for <b>4c</b>. In the superimposed <b>4c</b>-docked models of AKR1B10 and AKR1B1 (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00830/suppl_file/jm7b00830_si_001.pdf" class="ext-link">Figure S1</a>), the alkyl side chain of AKR1B10 Lys125 was in contact with <b>4c</b>, but that of AKR1B1 Leu125 was away from <b>4c</b>. Therefore, the hydrophobic interaction of the alkyl side chain of Lys125 with 4-hydroxyphenylpropyl moiety of <b>4c</b> might mainly cause the selectivity of <b>4c</b> for AKR1B10.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Effects of <b>4c</b> and <b>4e</b> on Migration and Proliferation of Lung Cancer A549 Cells</h3><div class="NLM_p">The efficacies of <b>4c</b> and <b>4e</b> as AKR1B10 inhibitors were investigated by analyzing their effects on the migration and proliferation of A549 cells, since AKR1B10 was reported to enhance migratory and proliferative potentials of cancer cells through induction of matrix metalloproteinase 2 and regulation of isoprenoid homeostasis, respectively.<a onclick="showRef(event, 'ref32 ref52'); return false;" href="javascript:void(0);" class="ref ref32 ref52">(32, 52)</a> When the effects of <b>4c</b> and <b>4e</b> on the migration of A549 cells were first examined in a wound-healing assay, the cells treated for 24 h with <b>4c</b> or <b>4e</b> showed significantly lower migration compared to the control group treated with vehicle alone (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A). Next, the effects of <b>4c</b> and <b>4e</b> on the cell growth were examined using previously established AKR1B10-stably overexpressing A549 cells (A549/1B10 cells)<a onclick="showRef(event, 'ref32 ref52'); return false;" href="javascript:void(0);" class="ref ref32 ref52">(32, 52)</a> and the parental A549 cells (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B). The cell number of the 96 h cultured A549/1B10 cells was significantly greater than that of the parent A549 cells. Compounds <b>4c</b> and <b>4e</b> dose-dependently suppressed the growth of both A549 and A549/1B10 cells, and their suppressive effects were statistically significant at 20 Î¼M. As the cell numbers of A549/1B10 cells treated with 20 Î¼M inhibitors were the same as those of A549 cells under the same conditions, it is suggested that the inhibitors almost completely suppressed increased cell proliferation by the overexpressing AKR1B10 as well as the endogenous protein. In order to evaluate the significance of <b>4c</b> and <b>4e</b> as AKR1B10 inhibitors, their inhibitory effects on the metastatic potential of A549 cells were investigated by using an experimental lung metastasis model of A549-Luc2 cells (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). Compared to a group injected with the A549-Luc2 cells treated with vehicle alone, the groups injected with the <b>4c</b>- and <b>4e</b>-treated A549-Luc2 cells exhibited markedly reduced <i>in vivo</i> metastatic potential to the lung, indicating that <b>4c</b> and <b>4e</b> affect the behavior of lung cancer A549 cells not only <i>in vitro</i> but also <i>in vivo</i>. The results suggest that catalytic activity of AKR1B10 is related to the metastasis of A549 cells. These selective inhibitors would be useful in future studies that elucidate how AKR1B10-mediated metabolism or pathways are responsible for the metastatic potential of A549 cells.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/medium/jm-2017-00830q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of invasive and proliferative potential of A549 cells by <b>4c</b> and <b>4e</b>. (A) Wound-healing assay. The cells were scratched and then treated for 24 h with vehicle dimethyl sulfoxide (DMSO), 20 Î¼M <b>4c</b>, or 20 Î¼M <b>4e</b>. As representative photographs at 0 h and 24 h culture are shown, the cells migrated into the scratch wounds (two dotted lines). The migration distance of the inhibitor-treated cells is expressed as the percentage to that of the DMSO-treated control cells in the bar graph. Significant difference from the control cells, *<i>p</i> < 0.05 (<i>n</i> = 3). (B) Proliferative assay. A549 cells (left) and A549/1B10 cells (right) were cultured in the absence or presence of the indicated concentrations of <b>4c</b> and <b>4e</b>, and the viable cell numbers were estimated at 96 h. Significant differences (<i>p</i> < 0.05) from the inhibitor-free A549 cells and A549/1B10 cells are shown with * and <sup>#</sup>, respectively (<i>n</i> = 4).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00830&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/medium/jm-2017-00830q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibition of A549 cells metastasis into mouse lung by <b>4c</b> and <b>4e</b>. Cultured A549âLuc2 cells were treated with 20 Î¼M <b>4c</b> or <b>4e</b> or vehicle DMSO (as a control) for 48 h and then injected into the tail vein of BALB/c nude mice (<i>n</i> = 5). After 4 days, luciferase luminescence in the lungs was evaluated. Significant difference from the control, *<i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00830&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Effects of <b>4c</b> and <b>4e</b> on CDDP-Resistant A549 Cells</h3><div class="NLM_p">AKR1B10 was reported to be involved in CDDP-resistance of A549 cells through its up-regulation.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The CDDP-resistant A549 (CDDP-R-A549) cells were less sensitive to CDDP, as shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A, where almost all CDDP-R-A549 cells were viable after 24 h treatment with 40 Î¼M CDDP in contrast to 36% viability of the parental A549 cells. Cotreatment with <b>4c</b> or <b>4e</b> and 40 Î¼M CDDP decreased the cell viability of CDDP-R-A549 cells in a dose-dependent manner, and this action was most obvious in the treatment of 40 Î¼M <b>4e</b>, which resulted in almost the same CDDP sensitivity as that of the parent A549 cells. Next, in order to reflect conditions of practical medical treatment, the effects of <b>4c</b> or <b>4e</b> on sensitivity of the CDDP-R-A549 cells to a low concentration (0.5 Î¼M) of CDDP were examined. Under the conditions, CDDP-R-A549 cells exponentially grew during 96 h culture in contrast to little growth of the parental A549 cells (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B) and were made CDDP-sensitive by treatment with <b>4c</b> or <b>4e</b> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>C). Furthermore, we examined effects of <b>4c</b> or <b>4e</b> on metastatic and invasive potentials of CDDP-R-A549 cells (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). When the two potentials were analyzed by the Boyden chamber assays, the CDDP-R-A549 cells showed higher potentials than the parental A549 cells (data not shown). Compound <b>4e</b> significantly inhibited the metastasis and invasion of the CDDP-resistant cells, although <b>4c</b> was less effective. AKR1B10 was suggested to be implicated in acquiring cancer cell resistance to several anticancer drugs and enhancing metastatic and invasive potentials of doxorubicin-resistant gastric cancer cells<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> through its ability to detoxify lipid peroxidation-derived aldehydes.<a onclick="showRef(event, 'ref30 ref31 ref32 ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32 ref33 ref34 ref35">(30-35)</a> The present results not only support the above roles of AKR1B10 in resistance to anticancer drugs but also demonstrate that <b>4c</b> and <b>4e</b> are effective agents for overcoming CDDP resistance of lung cancer cells.</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/medium/jm-2017-00830q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Overcoming CDDP resistance of A549 cells by treatments with <b>4c</b> and <b>4e</b>. (A) Effects of <b>4c</b> and <b>4e</b> on CDDP sensitivity of CDDP-R-A549 cells. The CDDP-R-A549 cells and parental A549 cells were pretreated for 2 h without or with the indicated concentrations of <b>4c</b> or <b>4e</b>, and then treated for 24 h with 40 Î¼M CDDP. The viability values are expressed as percentages to that of the parental cells treated without inhibitor. (B) Growth curves of A549 and CDDP-R-A549 cells in medium containing 0.5 Î¼M CDDP (<i>n</i> = 3). (C) Effects of <b>4c</b> and <b>4e</b> on the growth of CDDP-R-A549 cells in the presence of 0.5 Î¼M CDDP. The cells were cultured for 96 h in the absence or presence of <b>4c</b> or <b>4e</b>. The viable cell numbers are expressed as percentages to that of the parental A549 cells treated without inhibitor. Significant difference from CDDP-R-A549 cells treated without inhibitor, *<i>p</i> < 0.05 (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00830&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/medium/jm-2017-00830q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of <b>4c</b> and <b>4e</b> on metastatic and invasive potentials of CDDP-R-A549 cells. The cells were seeded on a polycarbonate membrane and Type I collagen-coated polycarbonate membrane in Boyden chambers for analyzing the metastatic (white bar) and invasive potentials (black bar), respectively, and then treated for 48 h without or with the indicated concentrations of <b>4c</b> or <b>4e</b>. The cells passed through pores of the membrane were counted microscopically, and their numbers are expressed as the percentages to those of the control cells treated without inhibitor. Significant difference from the control cells, *<i>p</i> < 0.05 (<i>n</i> â¥ 4).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00830&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85778" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85778" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Using HMCB as the lead, we newly synthesized its derivatives, <b>4c</b> and <b>4e</b>, that are currently the most potent AKR1B10 inhibitors with high selectivity to this enzyme over AKR1B1. The high selectivity was suggested to be brought about by interactions of the 4-hydroxyphenylpropyl moiety of <b>4c</b> with the substrate-binding residues including Lys125 and Val301 that differ from the corresponding ones in AKR1B1. The two inhibitors significantly suppressed not only migration and proliferation of lung cancer A549 cells but also metastasis of the cells into mouse lung. Moreover, they increased CDDP sensitivity of CDDP-resistant A549 cells and inhibited the metastatic and invasive potentials of the CDDP-resistant cells. Accordingly, these <i>ex vivo</i> results suggest the effectiveness of the inhibitors as antiproliferative agents against AKR1B10-overexpressing cancers and adjuvant drugs for overcoming CDDP resistance of lung cancer.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57064" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57064" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Chemistry: General</h3><div class="NLM_p last">Melting points were determined with an AS ONE micro melting point apparatus and are uncorrected. Flash chromatography was performed with Kanto Kagaku silica gel 60N (63â210 mm). NMR spectra were recorded on a JEOL JNM-A 400, JEOL JNM-ECX 500 spectrometer in the solvent indicated. Chemical shifts (Î´) are given in ppm downfield from TMS and referenced with CHCl<sub>3</sub> (7.26 ppm) or DMSO (2.49 ppm) as an internal standard. Peak multiplicities are designated by the following abbreviations: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad. Coupling constants (<i>J</i>) are given in hertz. Infrared spectra were obtained with a SHIMADZU FTIR-8400 spectrometer using film KBr pellet technique. High resolution mass spectral data was obtained on a JEOL MStation JMS-700. All commercial reagents were used as received unless otherwise noted. The purities (91 to >98%) of compounds <b>3aâ²</b> and <b>4a</b>â<b>l</b> were analyzed by HPLC analysis. Analytical HPLC performed on JASCO PU-2082 plus intelligent HPLC pump with GL Science InertSustainC18 (5 Î¼L, 4.6 mm Ã 250 mm) column and 100% MeCN as mobile phase with flow rate of 1â3 mL/min at 35â50 Â°C.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General Procedure for the Preparation of Methanesulfonic Acid Ester (<b>B</b>)</h3><div class="NLM_p">To a stirred solution of the alcohol (<b>A1</b>,<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a><b>A2</b>,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a><b>A3</b>,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a><b>A4</b>,<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> or <b>A5</b>,<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> 1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) were added MsCl (1.2 mmol) and Et<sub>3</sub>N (1.5 mmol) at 0 Â°C, and the resulting mixture was stirred for 2 h at room temperature. The reaction was quenched by satd. NH<sub>4</sub>Cl (aq), and the organic layer was separated. The aqueous mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (5 mL Ã 3), and the organic layer and extracts were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. The residue was chromatographed on silica gel (15 g, hexane/ethyl acetate = 4:1) to give the corresponding methanesulfonic acid ester <b>B</b>, which was used in the next step immediately.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Methanesulfonic Acid 3-(3-Methoxymethoxyphenyl)propyl Ester (<b>B1</b>)</h4><div class="NLM_p last">Yield 96%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 2.08 (2H, quint, <i>J</i> = 7.5 Hz), 2.73 (2H, t, <i>J</i> = 7.5 Hz), 3.00 (3H, s), 3.48 (3H, s), 4.23 (2H, t, <i>J</i> = 7.5 Hz), 5.17 (2H, s), 6.83â6.91 (3H, m), 7.21 (1H, t, <i>J</i> = 8.0 Hz); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 30.2, 31.3, 37.0, 55.8, 69.0, 94.2, 113.8, 116.2, 121.8, 129.4, 141.8, 157.2.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Methanesulfonic Acid 3-(2-Methoxymethoxyphenyl)propyl Ester (<b>B2</b>)</h4><div class="NLM_p last">Yield 94%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 1.82 (2H, quin, <i>J</i> = 7.5 Hz), 2.71 (2H, t, <i>J</i> = 7.5 Hz), 3.15 (2H, t, <i>J</i> = 7.5 Hz), 3.49 (3H, s), 5.21 (2H, s), 6.84 (1H, t, <i>J</i> = 8.0 Hz), 7.08 (1H,d, <i>J</i> = 8.0 Hz), 7.10â7.17 (1H, m); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 30.4, 31.9, 38.2, 55.8, 94.1, 113.5, 121.2, 127.3, 129.8, 123.1, 156.3.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Methanesulfonic Acid 3-(4-Methoxymethoxyphenyl)propyl Ester (<b>B3</b>)</h4><div class="NLM_p last">Yield 96%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 1.88 (2H, quint, <i>J</i> = 7.3 Hz), 2.65 (2H, t, <i>J</i> = 7.3 Hz), 3.28 (2H, t, <i>J</i> = 7.3 Hz), 3.48 (3H, s), 5.18 (2H, s), 6.97 (2H, d, <i>J</i> = 8.0 Hz), 7.09(2H, d, <i>J</i> = 8.0 Hz); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 30.6, 30.7, 30.9, 37.3, 55.9, 69.1, 94.5, 116.4, 129.3, 133.6, 155.7.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Methanesulfonic Acid 4-(4-Methoxymethoxyphenyl)butyl ester (<b>B4</b>)</h4><div class="NLM_p last">Yield 96%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 1.69â1.78 (4H, m), 2.60 (2H, t, <i>J</i> = 7.5 Hz), 2.98 (3H, s), 3.48 (3H, s), 4.23 (2H, t, <i>J</i> = 7.5 Hz), 5.15 (2H, s), 6.96 (2H, d, <i>J</i> = 8.5 Hz), 7.08 (2H, d, <i>J</i> = 8.5 Hz); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 27.1, 28.3, 34.0, 36.9, 55.6, 69.8, 94.3, 116.0, 129.1, 134.7, 155.3.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Methanesulfonic Acid 3-(3-Fluorophenyl)propyl Ester (<b>B5</b>)</h4><div class="NLM_p last">Yield 78%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 2.89 (2H, quint, <i>J</i> = 7.5 Hz), 3.11 (2H, t, <i>J</i> = 7.5 Hz), 3.35 (3H, s), 4.58 (2H, t, <i>J</i> = 7.5 Hz), 7.11â7.25 (3H, m), 7.61 (2H,d, <i>J</i> = 7.5 Hz); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 29.7, 30.5, 68.8, 112.31 (d, <i>J</i> = 19.4 Hz), 114.6 (d, <i>J</i> = 18.3 Hz), 123.7, 129.5 (d, <i>J</i> = 7.3 Hz), 142.5 (d, <i>J</i> = 9.6 Hz), 162.2 (d, <i>J</i> = 241.7 Hz).</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure for the Preparation of Azide (<b>C</b>)</h3><div class="NLM_p">To a stirred solution of methanesulfonic acid ester (<b>B1</b>, <b>B2</b>, <b>B3</b>, <b>B4</b>, <b>B5</b>, or <b>B6</b>,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> 1 mmol) in DMF/H<sub>2</sub>O (2:1) was added NaN<sub>3</sub> (2 mmol), and then the reaction mixture was heated to 60 Â°C for 20 h. After cooling, the reaction was quenched by H<sub>2</sub>O. The aqueous mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (5 mL Ã 3). The organic extracts were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. The residue was chromatographed on silica gel (15 g, hexane/acetone = 100:1) to give the corresponding azide <b>C</b>, which was used in the next step immediately.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 1-(3-Azidopropyl)-3-methoxymethoxybenzene (<b>C1</b>)</h4><div class="NLM_p last">Yield 78%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 1.92 (2H, quint, <i>J</i> = 7.5 Hz), 2.68 (2H, t, <i>J</i> = 7.5 Hz), 3.29 (2H, t, <i>J</i> = 7.5 Hz), 3.49 (3H, s), 5.17 (2H, s), 6.83â6.90 (3H, m), 7.21 (1H, t, <i>J</i> = 8.0 Hz); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 30.2, 32.6, 50.5, 55.9, 94.3, 113.8, 116.3, 121.9, 129.4, 142.4, 157.3; IR (neat) 2422, 1652, 1634 cm<sup>â1</sup>.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 1-(3-Azidopropyl)-2-methoxymethoxybenzene (<b>C2</b>)</h4><div class="NLM_p last">Yield 89%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 1.91 (2H, quint, <i>J</i> = 7.5 Hz), 2.73 (2H, t, <i>J</i> = 7.5 Hz), 3.29 (2H, t, <i>J</i> = 7.5 Hz), 3.49 (3H, s), 5.21 (2H, s), 6.94 (1H, t, <i>J</i> = 8.0 Hz), 7.09 (1H,d, <i>J</i> = 8.0 Hz), 7.13â7.18 (1H, m); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 27.4, 28.9, 50.7, 55.8, 94.1, 113.7, 121.48, 127.3, 129.7, 123.0, 155.0; IR (neat) 2421, 1652, 1634 cm<sup>â1</sup>.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 1-(3-Azidopropyl)-4-methoxymethoxybenzene (<b>C3</b>)</h4><div class="NLM_p last">Yield 94%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 1.91 (2H, quint, <i>J</i> = 7.3 Hz), 2.73 (2H, t, <i>J</i> = 7.3 Hz), 3.29 (2H, t, <i>J</i> = 7.3 Hz), 3.49 (3H, s), 5.21 (2H, s), 6.94 (1H, t, <i>J</i> = 8.0 Hz), 7.09 (1H,d, <i>J</i> = 8.0 Hz), 7.10â7.18 (1H, m); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 30.3, 31.6, 50.3, 55.6, 94.3, 116.1, 129.13, 133.9, 155.5; IR (neat) 2422, 1652, 1635 cm<sup>â1</sup>.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 1-(4-Azidobutyl)-4-methoxymethoxybenzene (<b>C4</b>)</h4><div class="NLM_p last">Yield 81%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 1.62â1.68 (4H, m), 2.59 (2H, t, <i>J</i> = 7.5 Hz), 3.28 (2H, t, <i>J</i> = 7.5 Hz), 3.48 (3H, s), 5.15 (2H, s), 6.96 (2H, dd, <i>J</i> = 4.5, 2.0 Hz), 7.08 (2H, dd, <i>J</i> = 4.5, 2.0 Hz); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 28.4, 28.6, 34.5, 51.3, 55.9, 94.6, 116.3, 129.3, 135.2, 155.5; IR (neat) 2384, 1652, 1635 cm<sup>â1</sup>.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 1-(3-Azidopropyl)-3-fluorobenzene (<b>C5</b>)</h4><div class="NLM_p last">Yield 72%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 1.90 (2H, quint, <i>J</i> = 7.5 Hz), 2.71 (2H, t, <i>J</i> = 7.5 Hz), 3.29 (2H, t, <i>J</i> = 7.5 Hz), 6.82â6.95 (3H, m), 7.25 (2H, q, <i>J</i> = 7.0 Hz); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 29.9, 32.2, 50.2, 112.8 (d, <i>J</i> = 20.6 Hz), 115.0 (d, <i>J</i> = 20.75 Hz), 123.9, 129.7 (d, <i>J</i> = 7.4 Hz), 143.3 (d, <i>J</i> = 7.3 Hz), 162.8 (d, <i>J</i> = 244.3 Hz); IR (neat) 2424, 1654, 1635 cm<sup>â1</sup>.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 1-(3-Azidopropyl)-4-methylbenzene (<b>C6</b>)</h4><div class="NLM_p last">Yield 75%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 1.90 (2H, quint, <i>J</i> = 7.5 Hz), 2.33 (3H, s), 2.67 (2H, t, <i>J</i> = 7.5 Hz), 3.28 (2H, t, <i>J</i> = 7.5 Hz), 7.09 (2H, d, <i>J</i> = 8.7 Hz); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´20.5, 30.2, 31.9, 50.1, 127.9, 128.8, 135.0, 137.4; IR (neat) 2385, 1652, 1635 cm<sup>â1</sup>.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Procedure for the Preparation of Amide (<b>2a</b>â<b>i</b>)</h3><div class="NLM_p">A stirred suspension of <b>C1</b>, <b>C2</b>, <b>C3</b>, <b>C4</b>, <b>C5</b>, <b>C6</b>, <b>C7</b>,<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a><b>C8</b>,<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> or <b>C9</b><a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> (1 mmol) and 10% PdâC (3 mg) in MeOH (5 mL) was hydrogenated under hydrogen atmosphere (1 atm.) for 12 h. The catalyst was removed, and the filtrate was evaporated to give the corresponding amine (<b>1a</b>â<b>i</b>), which was used directly in the next step. To a stirred solution of cyanoacetic acid (1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) were added the corresponding amine (<b>1a</b>â<b>i</b>, 1 mmol), EDC (2 mmol), and DMAP (0.2 mmol), and the resulting mixture was stirred at room temperature for 20 h. The reaction mixture was evaporated, and the residue was chromatographed on silica gel (15 g, hexane/acetone = 5:1) to give the corresponding amide (<b>2</b>).</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2-Cyano-<i>N</i>-[3-(3-methoxymethoxyphenyl)propyl]acetamide (<b>2a</b>)</h4><div class="NLM_p last">Yield 54%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 1.90 (2H, quint, <i>J</i> = 7.5 Hz), 2.65 (2H, t, <i>J</i> = 7.5 Hz), 3.32 (2H, s), 3.34 (2H, q, <i>J</i> = 7.5 Hz), 3.48 (3H, s), 5.17 (2H, s), 6.82â6.90 (3H, m), 7.22 (1H, t, <i>J</i> = 8.0 Hz); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 25.7, 30.3, 33.0, 39.9, 55.9, 94.3, 113.9, 114.8, 116.2, 121.8, 129.5, 142.6, 157.3, 161.2; IR (neat) 3421, 1652, 1635 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 262 (M<sup>+</sup>); HRMS Calcd for C<sub>14</sub>H<sub>18</sub>N<sub>2</sub>O<sub>3</sub> 262.1317, Found 262.1315.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-Cyano-<i>N</i>-[3-(2-methoxymethoxyphenyl)propyl]acetamide (<b>2b</b>)</h4><div class="NLM_p last">Yield 70%; mp 80â83 Â°C; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 1.86 (2H, quint, <i>J</i> = 7.0 Hz), 2.72 (2H, t, <i>J</i> = 7.0 Hz), 3.33 (4H, q, <i>J</i> = 7.0 Hz), 3.49 (3H, s), 5.25 (2H, s), 6.39 (1H, br), 6.96 (1H, t, <i>J</i> = 8.0 Hz), 7.09(2H,d, <i>J</i> = 8.0 Hz), 7.14â7.18(2H,m); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 25.6, 27.1, 29.2, 30.8, 56.0, 94.4, 113.9, 114.8, 121.7, 127.3, 129.9, 129.9, 154.8, 161.2; IR (KBr) 3294, 1653, 1559 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 262 (M<sup>+</sup>); HRMS Calcd for C<sub>14</sub>H<sub>18</sub>N<sub>2</sub>O<sub>3</sub> 262.1317, Found 262.1314.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2-Cyano-<i>N</i>-[3-(4-methoxymethoxylphenyl)propyl]acetamide (<b>2c</b>)</h4><div class="NLM_p last">Yield 49%; mp 78â81 Â°C; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 1.86 (2H, quint, <i>J</i> = 7.3 Hz), 2.62 (2H, t, <i>J</i> = 7.3 Hz), 3.32 (4H, q, <i>J</i> = 7.3 Hz), 3.47 (3H, s), 5.15 (2H, s), 6.03 (1H, br), 6.97 (2H, d, <i>J</i> = 8.5 Hz), 7.09 (2H,d, <i>J</i> = 8.5 Hz); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 25.7, 30.6, 32.1, 39.8, 55.8, 94.4, 114.8, 116.3, 129.1, 134.3, 155.4, 161.3; IR (KBr) 3420, 1652, 1558 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 262 (M<sup>+</sup>); HRMS Calcd for C<sub>14</sub>H<sub>18</sub>N<sub>2</sub>O<sub>3</sub> 262.1317, Found 262.1314.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-Cyano-<i>N</i>-[3-(3-fluorophenyl)propyl]acetamide (<b>2d</b>)</h4><div class="NLM_p last">Yield 58%; mp 68â69 Â°C; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 1.89 (2H, quint, <i>J</i> = 7.5 Hz), 2.67 (2H, t, <i>J</i> = 7.5 Hz), 3.32â3.36 (4H, m), 6.10 (1H, br), 6.90â6.96 (3H, m), 7.26 (1H, m); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 25.7, 30.0, 32.4, 39.4, 112.6 (d, <i>J</i> = 20.6 Hz), 114.8 (d, <i>J</i> = 20.8 Hz), 123.8 (d, <i>J</i> = 2.5 Hz), 129.6 (d, <i>J</i> = 8.5 Hz), 143.5 (d, <i>J</i> = 7.3 Hz), 161.2 (d, <i>J</i> = 6.1 Hz), 162.5 (d, <i>J</i> = 243.0 Hz); IR (KBr) 3328, 1661, 1554 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 220 (M<sup>+</sup>); HRMS Calcd for C<sub>12</sub>H<sub>13</sub>FN<sub>2</sub>O 220.1012, Found 220.1013.</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-Cyano-<i>N</i>-[3-(4-fluorophenyl)propyl]acetamide (<b>2e</b>)</h4><div class="NLM_p last">Yield 42%; mp 73â75 Â°C; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 1.87 (2H, quit, <i>J</i> = 7.5 Hz), 2.64 (2H, t, <i>J</i> = 7.5 Hz), 3.30â3.36 (4H, m), 6.96â7.00 (2H, m), 7.12â7.15 (2H, m); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 25.7, 30.5, 30.7, 32.8, 39.6, 114.8 (d, <i>J</i> = 3.6 Hz), 115.0, 128.2 (d, <i>J</i> = 19.5 Hz), 129.4 (d, <i>J</i> = 7.3 Hz Hz), 136.6 (d, <i>J</i> = 2.5 Hz), 161.0 (d, <i>J</i> = 242.0 Hz), 161.7; IR (KBr) 3323, 1660, 1587, 1554 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 220 (M<sup>+</sup>); HRMS Calcd for 220.1012, Found 220.1013.</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2-Cyano-<i>N</i>-[3-(3,5-difluorophenyl)propyl]acetamide (<b>2f</b>)</h4><div class="NLM_p last">Yield 48%; mp 100â102 Â°C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.70 (2H, quint, <i>J</i> = 7.5 Hz), 2.60 (2H, t, <i>J</i> = 7.5 Hz), 3.60 (2H, q, <i>J</i> = 7.5 Hz), 3.60 (2H, s), 6.94â7.03 (3H, m), 8.24 (1H, br); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 26.0, 30.3, 32.9, 39.8, 101.7 (t, <i>J</i> = 25.5 Hz), 111.1 (d, <i>J</i> = 4.8 Hz), 111.2 (d, <i>J</i> = 4.8 Hz), 115.0, 145.0 (t, <i>J</i> = 8.5 Hz), 162.3, 163.1 (d, <i>J</i> = 248 Hz), 163.2 (d, <i>J</i> = 247.0 Hz); IR (KBr) 3301, 1647, 1599 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 238 (M<sup>+</sup>); HRMS Calcd for C<sub>12</sub>H<sub>13</sub>F<sub>2</sub>N<sub>2</sub>O 238.0918, Found 238.0918.</div></div><div id="sec4_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-Cyano-<i>N</i>-(3-p-tolylpropyl)acetamide (<b>2g</b>)</h4><div class="NLM_p last">Yield 66%; mp 69â71 Â°C; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 1.88 (2H, quint, <i>J</i> = 7.5 Hz), 2.32 (3H, s), 2.64 (2H, t, <i>J</i> = 7.5 Hz), 3.34(4H, q, <i>J</i> = 7.5 Hz), 7.11 (2H, q, <i>J</i> = 7.83 Hz); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 20.6, 25.6, 30.3, 32.2, 39.6, 115.0, 127.9, 128.8, 135.2, 137.7, 161.9; IR (KBr) 3295, 1652, 1558 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 216 (M<sup>+</sup>); HRMS Calcd for C<sub>13</sub>H<sub>16</sub>N<sub>2</sub>O 216.1263, Found 216.1264.</div></div><div id="sec4_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-Cyano-<i>N</i>-[3-(4-methoxyphenyl)propyl]acetamide (<b>2h</b>)</h4><div class="NLM_p last">Yield 45%; mp 61â62 Â°C; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 1.88 (2H, quint, <i>J</i> = 7.5 Hz), 2.62 (2H, t, <i>J</i> = 7.5 Hz), 3.31 (2H, s), 3.33 (2H, q, <i>J</i> = 7.5 Hz), 3.80 (3H, s), 5.99 (1H, br), 6.84 (2H, d, <i>J</i> = 9.0 Hz), 7.10 (2H, d, <i>J</i> = 9.0 Hz); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 25.7, 30.6, 31.9, 39.7, 55.0, 113.7, 114.9, 129.0, 132.9, 157.7, 161.6; IR (KBr) 3355, 1655, 1559, 1516 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 232 (M<sup>+</sup>); HRMS Calcd for C<sub>13</sub>H<sub>16</sub>N<sub>2</sub>O<sub>2</sub> 232.1212, Found 232.1218.</div></div><div id="sec4_4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2-Cyano-<i>N</i>-[4-(4-methoxymethoxyphenyl)butyl]acetamide (<b>2i</b>)</h4><div class="NLM_p last">Yield 49%; mp 59â60 Â°C; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 1.56â1.65 (4H, m), 2.59 (2H, t, <i>J</i> = 7.5 Hz), 3.32 (2H, q, <i>J</i> = 7.5 Hz), 3.35 (2H, s), 3.45 (3H, s), 5.15 (2H, s), 6.05 (1H, br), 6.97 (2H, d, <i>J</i> = 8.5 Hz), 7.07 (2H, d, <i>J</i> = 8.5 Hz); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 25.7, 28.47, 28.50, 34.3, 40.0, 55.7, 94.4, 114.8, 116.1, 129.1, 135.2, 155.2, 161.3; IR (KBr) 3448, 1653, 1558, 1507 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 276 (M<sup>+</sup>); HRMS Calcd for C<sub>14</sub>H<sub>18</sub>N<sub>2</sub>O<sub>3</sub> 276.1474, Found 276.1474.</div></div><div id="sec4_4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 2-Cyano-<i>N</i>-[3-(3-hydroxyphenyl)propyl]acetamide (<b>2aâ²</b>)</h4><div class="NLM_p last">To a stirred solution of <b>2a</b> (262 mg, 1 mmol) in THF (5 mL) was added 10% HCl (5 drops), and the resulting mixture was heated at 40 Â°C for 12 h. After cooling, H<sub>2</sub>O was added to the reaction mixture, and the aqueous mixture was extracted with EtOAc (5 mL Ã 3). The organic extracts were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. The residue was chromatographed on silica gel (15 g, CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 100:1) to give <b>2aâ²</b> (174 mg, 81%) as a colorless oil. mp 100â101 Â°C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 1.89 (2H, q, <i>J</i> = 7.7 Hz), 2.63 (2H, t, <i>J</i> = 7.7 Hz), 3.32 (2H, s), 3.34 (2H, t, <i>J</i> = 7.7 Hz), 6.09 (1H, br), 6.68 (1H, s), 6.69 (1H, d, <i>J</i> = 7.3 Hz), 6.75 (1H, d, <i>J</i> = 7.3 Hz), 7.16 (1H, t, <i>J</i> = 7.3 Hz); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 25.3, 30.4, 32.4, 38.7, 112.8, 115.2, 116.3, 118.9, 129.2, 142.9, 157.3, 162.0; IR (KBr) 3387, 1649, 1556 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 218 (M<sup>+</sup>); HRMS Calcd for C<sub>12</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub> 218.1055, Found 218.1050.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> General Procedure for the Preparation of Amide (<b>3a</b>â<b>k</b>)</h3><div class="NLM_p">To a stirred solution of amide (<b>2a</b>â<b>i</b>, 1 mmol) in EtOH (3 mL) were added catalytic amount of piperidine (2 drops) and benzaldehyde (1 mmol), and the reaction mixture was stirred at room temperature for 12 h. The suspension was filtered to give iminochromene, which was used directly in the next step. To a stirred solution of the iminochromene obtained above in acetic acid (2 mL) was added <i>p</i>-methoxyaniline (1 mmol), and the resulting mixture was stirred at room temperature for 12 h. The solvent was removed under reduced pressure, and the residue was chromatographed on silica gel (15 g, CH<sub>2</sub>Cl<sub>2</sub>) to give the corresponding phenyliminochromene (<b>3a</b>â<b>k</b>) as the yellow solid.</div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 7-Hydroxy-2-(4-methoxyphenylimino)-2<i>H</i>-chromene-3-carboxylic Acid [3-(3-Methoxymethoxyphenyl)propyl]amide (<b>3a</b>)</h4><div class="NLM_p last">Yield 67%; mp 144â146 Â°C; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 1.96 (2H, quint, <i>J</i> = 7.5 Hz), 2.70 (2H, t, <i>J</i> = 7.5 Hz), 3.45â3.50 (5H, m), 3.82 (3H, s), 5.13 (2H, s), 6.65 (1H, s), 6.75 (1H, d, <i>J</i> = 7.5 Hz), 6.82â6.94 (4H, m), 7.14â7.18 (1H, m), 7.25â7.27 (3H, m), 7.30 (1H, d, <i>J</i> = 7.5 Hz), 8.42 (1H, s), 10.75 (1H, br); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 30.9, 33.4, 39.6, 55.5, 56.1, 94.5, 102.4, 111.8, 113.4, 113.8, 114.1, 116.5, 122.2, 124.8, 129.5, 130.8, 137.3, 141.4, 143.1, 148.8, 155.3, 156.8, 157.4, 161.8, 162.5, 163.8, 171.8; IR (KBr) 3442, 1653, 1559, 1506 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 488 (M<sup>+</sup>); HRMS Calcd for C<sub>28</sub>H<sub>28</sub>N<sub>2</sub>O<sub>6</sub> 488.1947, Found 488.1943.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 7-Hydroxy-2-(4-methoxyphenylimino)-2<i>H</i>-chromene-3-carboxylic Acid [3-(3-Hydroxyphenyl)propyl]amide (<b>3aâ²</b>)</h4><div class="NLM_p last">Yield 65%; mp 235â236 Â°C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.80 (2H, quint, <i>J</i> = 7.6 Hz), 2.57 (2H, t, <i>J</i> = 7.6 Hz), 3.29â3.30 (2H, m), 3.77 (3H, s), 6.53 (1H, d, <i>J</i> = 2.3 Hz), 6.56 (1H, dd, <i>J</i> = 8.3, 2.3 Hz), 6.59 (1H, s), 6.60 (1H, d, <i>J</i> = 8.9 Hz), 6.72 (1H, dd, <i>J</i> = 8.3, 2.3 Hz), 6.95 (2H, d, <i>J</i> = 8.6 Hz), 7.04 (1H, t, <i>J</i> = 8.3 Hz), 7.32 (2H, d, <i>J</i> = 8.6 Hz), 7.60 (1H, d, <i>J</i> = 8.9 Hz), 8.39 (1H, s), 9.24 (1H, br), 10.22 (1H, t, <i>J</i> = 5.6 Hz); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 31.1, 33.2, 39.0, 55.7, 101.8, 111.5, 113.3, 113.5, 114.5, 115.7, 117.5, 119.5, 125.3, 129.8, 131.7, 137.5, 141.1, 143.3, 148.9, 155.1, 156.8, 157.9, 162.2, 162.9; IR (KBr) 3190, 1666, 1566, 1448 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 444 (M<sup>+</sup>); HRMS calcd for C<sub>26</sub>H<sub>24</sub>N<sub>2</sub>O<sub>5</sub> 444.1685, found 444.1689; Purity 97% (HPLC).</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 7-Hydroxy-2-(4-methoxyphenylimino)-2<i>H</i>-chromene-3-carboxylic Acid [3-(2-Methoxymethoxyphenyl)propyl]amide (<b>3b</b>)</h4><div class="NLM_p last">Yield 63%; mp 198â199 Â°C; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 1.95 (2H, quint, <i>J</i> = 7.5 Hz), 2.77 (2H, t, <i>J</i> = 7.5 Hz), 3.41 (3H, s), 3.50 (2H, q, <i>J</i> = 7.5 Hz), 3.83 (3H, s), 5.13 (2H, s), 6.65 (1H, d, <i>J</i> = 2.5 Hz), 6.74 (1H, dd, <i>J</i> = 6.0, 2.5 Hz), 6.89â6.92 (3H, m), 7.05 (1H, d, <i>J</i> = 8.0 Hz), 7.12â7.16 (2H, m), 7.26â7.29 (3H, m), 7.33 (1H, d, <i>J</i> = 8.5 Hz), 8.44 (1H, s), 10.68 (1H, t, <i>J</i> = 5.5 Hz); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 27.9, 29.5, 39.6, 55.4, 55.9, 56.0, 94.2, 102.3, 107.1, 111.8, 113.2, 113.8, 114.0, 121.7, 124.7, 127.3, 129.6, 130.1, 130.3, 130.6, 137.2, 141.2, 155.09, 155.12, 156.7, 163.5; IR (KBr) 3348, 1652, 1558, 1506 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 488 (M<sup>+</sup>); HRMS Calcd for C<sub>28</sub>H<sub>28</sub>N<sub>2</sub>O<sub>6</sub> 488.1947, Found 488.1943.</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 7-Hydroxy-2-(4-methoxyphenylimino)-2<i>H</i>-chromene-3-carboxylic Acid [3-(4-Methoxymethoxyphenyl)propyl]amide (<b>3c</b>)</h4><div class="NLM_p last">Yield 76%; mp 100â103 Â°C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.93 (2H, quint, <i>J</i> = 7.5 Hz), 2.68 (2H, t, <i>J</i> = 7.5 Hz), 3.35â3.46 (5H,m), 3.84 (3H, s), 5.13 (2H, s), 6.61 (1H, s), 6.70 (2H, d, <i>J</i> = 8.5 Hz), 6.93 (4H, t, <i>J</i> = 8.5 Hz), 7.11 (2H, d, <i>J</i> = 8.5 Hz), 7.37 (1H, d, <i>J</i> = 8.5 Hz), 7.62 (1H, d, <i>J</i> = 8.5 Hz), 8.42â8.50 (1H, m), 10.50 (1H, t, <i>J</i> = 4.75 Hz); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) Î´; 31.0, 32.4, 39.3, 55.4, 55.9, 88.6, 94.5, 102.3, 113.2, 114.0, 116.3, 124.6, 129.4, 130.7, 134.7, 141.2, 148.6, 155.2, 155.5, 156.7, 161.9, 163.6, 177.9; IR (KBr) 3443, 1653, 1559, 1507 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 488 (M<sup>+</sup>); HRMS Calcd for C<sub>28</sub>H<sub>28</sub>N<sub>2</sub>O<sub>6</sub> 488.1947, Found 488.1943.</div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 7-Hydroxy-2-(4-methoxyphenylimino)-2<i>H</i>-chromene-3-carboxylic Acid [3-(3-Fluorophenyl)propyl]amide (<b>3d</b>)</h4><div class="NLM_p last">Yield 75%; mp 208â210 Â°C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.85 (2H, quint, <i>J</i> = 7.5 Hz), 2.68 (2H, t, <i>J</i> = 7.5 Hz), 3.17â3.29 (2H, m), 3.77 (3H, s), 6.53 (1H, s), 6.72 (1H, dd, <i>J</i> = 2.0, 8.5 Hz), 6.84â6.97 (3H, m), 7.05 (2H, d, <i>J</i> = 8.5 Hz), 7.30 (3H, d, <i>J</i> = 8.5 Hz), 7.60 (1H, d, <i>J</i> = 8.5 Hz), 8.38 (1H, s), 10.21 (1H, t, <i>J</i> = 5.5 Hz); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 30.9. 32.8, 38.9, 55.8, 101.9, 111.5, 113.1 (d, <i>J</i> = 20.6 Hz), 113.5, 114.5, 115.5, 115.6, 117.5, 125.0 (d, <i>J</i> = 2.5 Hz), 125.2, 130.7 (d, <i>J</i> = 8.5 Hz), 131.7, 137.5, 141.1, 145.0 (d, <i>J</i> = 7.38 Hz), 148.9, 155.1, 156.8, 162.3, 162.9, 162.8 (d, <i>J</i> = 241.75 Hz); IR (KBr) 3447, 1662, 1559, 1506 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 446 (M<sup>+</sup>); HRMS Calcd for C<sub>26</sub>H<sub>23</sub>FN<sub>2</sub>O<sub>4</sub> 446.1642, Found 446.1641.</div></div><div id="sec4_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 7-Hydroxy-2-(4-methoxyphenylimino)-2<i>H</i>-chromene-3-carboxylic Acid [3-(4-Fluorophenyl)propyl]amide (<b>3e</b>)</h4><div class="NLM_p last">Yield 68%; mp 207â209 Â°C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.94 (2H, quint, <i>J</i> = 7.5 Hz), 2.70 (2H, t, <i>J</i> = 7.5 Hz), 3.46 (2H, t, <i>J</i> = 7.5 Hz), 3.84 (3H, s), 6.62 (1H, s), 6.71 (1H, d, <i>J</i> = 8.5 Hz), 6.93 (4H, t, <i>J</i> = 8.5 Hz), 7.13 (2H, t, <i>J</i> = 8.5 Hz), 7.24 (1H, s), (1H, d, <i>J</i> = 8.5 Hz), 8.452 (1H, s), 10.54 (1H, s); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 35.2, 36.2, 42.9, 59.7, 105.8, 115.5, 117.5, 118.5, 119.4 (d, <i>J</i> = 21.9 Hz), 121.4, 129.2, 132.8 (d, <i>J</i> = 3.8 Hz), 134.9 (d, <i>J</i> = 8.5 Hz), 135.8, 141.5, 142.0 (d, <i>J</i> = 2.4 Hz), 145.1, 152.8, 165.1 (d, <i>J</i> = 240.6 Hz), 166.2, 166.8; IR (KBr) 3447, 1653, 1559, 1506 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 446 (M<sup>+</sup>); HRMS Calcd for C<sub>26</sub>H<sub>23</sub>FN<sub>2</sub>O<sub>4</sub> 446.1642, Found 446.1641.</div></div><div id="sec4_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 7-Hydroxy-2-(4-methoxyphenylimino)-2<i>H</i>-chromene-3-carboxylic Acid [3-(3,5-Difluorophenyl)propyl]amide (<b>3f</b>)</h4><div class="NLM_p last">Yield 85%; mp 230â232 Â°C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.86 (2H, quint, <i>J</i> = 7.5 Hz), 2.68 (2H, t, <i>J</i> = 7.5 Hz), 3.29â3.56 (2H, m), 3.77 (3H, s), 6.52 (1H, d, <i>J</i> = 2.0 Hz), 6.71 (1H, dd, <i>J</i> = 6.5, 2.0 Hz), 6.94â7.02 (5H, m), 7.30 (2H, d, <i>J</i> = 9.0 Hz), 7.61 (1H, d, <i>J</i> = 8.5 Hz), 8.39 (1H, s), 10.18 (1H, t, <i>J</i> = 5.5 Hz), 10.65 (1H, br); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) Î´; 30.6, 32.8, 38.6, 55.7, 101.8 (t, <i>J</i> = 25.5 Hz), 111.5, 111.9 (dd, <i>J</i> = 24.3, 4.9 Hz), 113. 5, 114.5, 117.4, 125.3, 131.6, 137.5, 141.1, 146.7 (t, <i>J</i> = 9.8 Hz), 148.8, 155.1, 162.8 (d, <i>J</i> = 244.3 Hz), 156.3 (d, <i>J</i> = 237.0 Hz), 163.0, 169.3; IR (KBr) 3458, 1652, 1558, 1506 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 464 (M<sup>+</sup>); HRMS Calcd for C<sub>26</sub>H<sub>22</sub>F<sub>2</sub>N<sub>2</sub>O<sub>4</sub> 464.1548, Found; 464.1552.</div></div><div id="sec4_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 7-Hydroxy-2-(4-methoxyphenylimino)-2<i>H</i>-chromene-3-carboxylic Acid (3-<i>p</i>-Tolylpropyl)amide (<b>3g</b>)</h4><div class="NLM_p last">Yield 82%; mp 220â222 Â°C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.81 (2H, quint, <i>J</i> = 7.3 Hz), 2.28 (3H, s), 2.49 (2H, t, <i>J</i> = 7.3 Hz), 3.25â3.39 (2H, m), 3.76 (3H, s), 6.52 (1H, s), 6.73 (1H, dd, <i>J</i> = 2.0, 8.5 Hz), 6.49 (2H, d, <i>J</i> = 8.5 Hz), 7.06 (4H, q, <i>J</i> = 8.5 Hz), 7.30 (2H, d, <i>J</i> = 8.5 Hz), 7.59 (1H, d, <i>J</i> = 8.5 Hz), 8.38 (1H, s), 10.20 (1H, t, <i>J</i> = 5.5 Hz); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 58.9, 68.2, 69.7, 75.8, 92.7, 138.8, 150.5, 151.5, 162.2, 165.7, 166.4, 168.6, 172.2, 175.7, 178.1, 185.9, 192.1, 192.1, 193.8, 199.2; IR (KBr) 3227 1662, 1559, 1504 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 442 (M<sup>+</sup>); HRMS Calcd for C<sub>27</sub>H<sub>26</sub>N<sub>2</sub>O<sub>4</sub> 442.1893, Found 442.1888.</div></div><div id="sec4_5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 7-Hydroxy-2-(4-methoxyphenylimino)-2<i>H</i>-chromene-3-carboxylic Acid [3-(4-Methoxyphenyl)propyl]amide (<b>3h</b>)</h4><div class="NLM_p last">Yield 87%; mp 198â200 Â°C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.92 (2H, quint, <i>J</i> = 7.5 Hz), 2.67 (2H, t, <i>J</i> = 7.5 Hz), 3.45 (2H, q, <i>J</i> = 7.5 Hz), 3.75 (3H, s), 3.82 (3H, s), 6.64 (1H, s), 6.73 (1H, d, <i>J</i> = 8.3 Hz), 6.78 (2H, d, <i>J</i> = 8.5 Hz), 6.90 (2H, d, <i>J</i> = 9.0 Hz), 7.08 (2H, d, <i>J</i> = 8.5 Hz), 7.24â7.27 (3H, m), 7.32 (1H, d, <i>J</i> = 8.3 Hz), 8.43 (1H, s), 10.65 (1H, br); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) Î´; 31.3, 32.2, 38.9, 55.4, 55.7, 101.8, 111.5, 113.5, 114.2, 114.5, 117.4, 125.2, 129.7, 131.6, 133.7, 137.5, 141.1, 148.8, 155.1, 156.8, 157.9, 162.2, 162.8; IR (KBr) 3441, 1652, 1558, 1506 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 458 (M<sup>+</sup>); HRMS Calcd for C<sub>27</sub>H<sub>26</sub>N<sub>2</sub>O<sub>5</sub> 458.1842, Found 458.1843.</div></div><div id="sec4_5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 7-Hydroxy-2-(4-methoxyphenylimino)-2<i>H</i>-chromene-3-carboxylic Acid [4-(4-Methoxymethoxyphenyl)butyl]amide (<b>3i</b>)</h4><div class="NLM_p last">Yield 83%; mp 179â181 Â°C; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 1.62â1.75 (4H, m), 2.60 (2H, t, <i>J</i> = 7.5 Hz), 3.46â3.49 (5H, m), 3.83 (3H, s), 5.14 (2H, s), 6.63 (1H, s), 6.72 (1H, d, <i>J</i> = 8.5 Hz), 6.89â6.93 (4H, m), 7.06 (2H, d, <i>J</i> = 8.5 Hz), 7.22 (2H, d, <i>J</i> = 8.5 Hz), 7.32 (1H, d, <i>J</i> = 8.5 Hz), 8.42 (1H, s), 10.59 (1H, t, <i>J</i> = 5.0 Hz); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 28.9, 29.2, 34.7, 35.0, 39.9, 55.5, 56.0, 78.5, 94.7, 102.5, 112.0, 114.1, 116.3, 124.8, 129.4, 130.8, 135.7, 137.2, 141.2, 155.2, 155.4, 156.8, 162.0, 163.6, 185.7; IR (KBr) 3442, 1652, 1558, 1506 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 502 (M<sup>+</sup>); HRMS Calcd for C<sub>29</sub>H<sub>30</sub>N<sub>2</sub>O<sub>6</sub> 502.2104, Found 502.2099.</div></div><div id="sec4_5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 2-(4-Methoxyphenylimino)-2<i>H</i>-chromene-3-carboxylic Acid [3-(4-Methoxymethoxyphenyl)propyl]amide (<b>3j</b>)</h4><div class="NLM_p last">Yield 94%; mp 110â112 Â°C; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 1.94 (2H, quint, <i>J</i> = 7.5 Hz), 2.70 (2H, t, <i>J</i> = 7.5 Hz), 3.46â3.50 (5H, m), 3.85 (3H, s), 5.14 (2H, s), 6.94 (4H, d, <i>J</i> = 8.5 Hz), 7.12 (3H, d, <i>J</i> = 8.5 Hz), 7.20 (1H, t, <i>J</i> = 8.5, Hz), 7.30 (2H, t, <i>J</i> = 8.5 Hz), 7.44 (1H, t, <i>J</i> = 8.5 Hz), 7.51 (1H, dd, <i>J</i> = 2.0, 8.5 Hz), 8.52 (1H, s), 10.52 (1H, t, <i>J</i> = 5.5 Hz); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 32.8, 32.2, 28.8, 55.1, 55.5, 94.2, 113.7, 114.4, 114.9, 116.0, 118.8, 121.2, 124.0, 124.6, 128.9, 129.1, 132.0, 134.5, 134.0, 147.9, 153.0, 155.2, 156.6, 161.8; IR (KBr) 3447, 1653, 1558, 1506 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 472 (M<sup>+</sup>); HRMS Calcd for C<sub>28</sub>H<sub>28</sub>N<sub>2</sub>O<sub>5</sub> 472.1998, Found 472.2006.</div></div><div id="sec4_5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 8-Hydroxy-2-(4-methoxyphenylimino)-2<i>H</i>-chromene-3-carboxylic Acid [3-(4-Methoxymethoxyphenyl)propyl]amide (<b>3k</b>)</h4><div class="NLM_p last">Yield 89%; mp 192â194 Â°C; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 1.94 (2H, quint, <i>J</i> = 7.5 Hz), 2.68 (2H, t, <i>J</i> = 7.5 Hz), 3.45â3.84 (5H, m), 3.85 (3H, s), 5.15 (2H, s), 6.93â6.97 (5H, m), 7.06â7.13 (5H, m), 7.20â7.23 (2H, m), 8.53 (1H, s), 10.33 (1H, br); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) Î´ 20.7, 31.0, 32.4, 39.3, 55.4, 55.9, 94.5, 114.2, 116.3, 119.2, 119.4, 120.6, 121.0, 124.4, 129.3, 134.7, 136.9, 138.8, 141.0, 143.0, 147.6, 155.4, 156.9, 162.4; IR (KBr) 6424, 1662, 1558, 1506 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 488 (M<sup>+</sup>); HRMS Calcd for C<sub>28</sub>H<sub>28</sub>N<sub>2</sub>O<sub>6</sub> 488.1947, Found 488.1952.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> General Procedure for the Synthesis of Coumarin (<b>4a</b>â<b>l</b>)</h3><div class="NLM_p">To a stirred solution of phenyliminochromene (<b>3a</b>â<b>k</b>, 1 mmol) in THF (5 mL) was added 10% HCl (5 drops), and the resulting mixture was heated at 40 Â°C for 12 h. After cooling, H<sub>2</sub>O was added to the reaction mixture, and the aqueous mixture was extracted with EtOAc (5 mL Ã 3). The organic extracts were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. The residue was chromatographed on silica gel (15 g, CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 100:1) to give the corresponding coumarin (<b>4a</b>â<b>l</b>) as solid. The compounds for the measurement of mp, HPLC analysis, and biological tests were used after recrystallization from MeOH or EtOH, which is indicated after mp.</div><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 7-Hydroxy-2-oxo-2<i>H</i>-chromene-3-carboxylic Acid [3-(3-Hydroxyphenyl)propyl]amide (<b>4a</b>)</h4><div class="NLM_p last">Yield 71%; mp 243â245 Â°C (MeOH); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.91 (2H, quint, <i>J</i> = 7.5 Hz), 2.64 (2H, t, <i>J</i> = 7.5 Hz), 3.44 (2H, q, <i>J</i> = 7.5 Hz), 6.65â6.66 (1H, m), 6.71â6.74 (2H, m), 6.85 (1H, d, <i>J</i> = 2.5 Hz), 6.97 (1H, dd, <i>J</i> = 6.0, 2.5), 7.09 (1H, t, <i>J</i> = 8.0 Hz), 7.79 (1H, d, <i>J</i> = 8.5 Hz), 8.74 (1H, br), 8.80 (1H, s); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 31.1, 33.0, 102.3, 111.6, 113.3, 114.3, 114.9, 115.7, 119.4, 129.8, 132.5, 143.4, 148.4, 156.8, 157.8, 161.6, 164.2; IR (KBr) 3340, 1700, 1545 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 339 (M<sup>+</sup>); HRMS Calcd for C<sub>19</sub>H<sub>17</sub>NO<sub>5</sub> 339.3420, Found 339.1106; Purity >98% (HPLC).</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 7-Hydroxy-2-oxo-2<i>H</i>-chromene-3-carboxylic Acid [3-(2-Hydroxyphenyl)propyl]amide (<b>4b</b>)</h4><div class="NLM_p last">Yield 64%; mp 220â222 Â°C (MeOH); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.92 (2H, quint, <i>J</i> = 7.5 Hz), 2.72 (2H, t, <i>J</i> = 7.5 Hz), 3.44 (2H, q, <i>J</i> = 7.5 Hz), 6.83â6.85 (2H, m), 6.96â7.03 (2H, m), 7.14 (1H, d, <i>J</i> = 7.5 Hz), 8.80 (1H, s), 8.81 (1H, br); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 27.5, 29.8, 39.2, 102.3, 111.7, 114.3, 114.8, 115.4, 119.4, 127.4, 128.1, 130.3, 132.4, 148.4, 155.6, 156.8, 161.6, 162.0, 164.1; IR (KBr) 3420, 1700, 1540, 1227 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 339 (M<sup>+</sup>); HRMS Calcd for C<sub>19</sub>H<sub>17</sub>NO<sub>5</sub> 339.3420, Found 339.1106; Purity 97% (HPLC).</div></div><div id="sec4_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 7-Hydroxy-2-oxo-2<i>H</i>-chromene-3-carboxylic Acid [3-(4-Hydroxyphenyl)propyl]amide (<b>4c</b>)</h4><div class="NLM_p last">Yield 95%; mp 220â222 Â°C (MeOH); <sup>1</sup>H NMR (500 MHz, acetone-<i>d</i><sub>6</sub>) Î´ 1.84 (2H, quint, <i>J</i> = 7.5 Hz), 2.58 (2H, t, <i>J</i> = 7.5 Hz), 3.38 (2H, q, <i>J</i> = 7.5 Hz), 6.72 (2H, d, <i>J</i> = 8.5 Hz), 6.82 (1H, d, <i>J</i> = 2.0 Hz), 6.94 (1H, dd, <i>J</i> = 6.5, 2.0 Hz), 6.04 (2H, d, <i>J</i> = 8.5 Hz), 7.76 (1H, d, <i>J</i> = 8.5 Hz), 8.69 (1H, br), 8.77 (1H, s); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 31.5, 32.2, 39.1, 102.3, 111.6, 114.3, 114.9, 115.6, 129.6, 132.0, 132.5, 148.4, 155.9, 156.8, 161.6, 162.1, 164.1; IR (KBr) 3442, 1734, cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 339 (M<sup>+</sup>); HRMS Calcd for C<sub>19</sub>H<sub>17</sub>NO<sub>5</sub> 339.3420, Found 339.1106; Purity >98% (HPLC).</div></div><div id="sec4_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 7-Hydroxy-2-oxo-2<i>H</i>-chromene-3-carboxylic Acid [3-(3-Fluorophenyl)propyl]amide (<b>4d</b>)</h4><div class="NLM_p last">Yield 90%; mp 209â210 Â°C (MeOH); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.83 (2H, quint, <i>J</i> = 7.5 Hz), 2.64 (2H, t, <i>J</i> = 7.5 Hz), 3.21â3.35 (2H, m), 6.79 (1H, s), 6.86 (1H, dd, <i>J</i> = 2.0, 8.5 Hz), 6.98 (1H, t, <i>J</i> = 8.5 Hz), 7.05 (2H, d, <i>J</i> = 8.5 Hz), 7.30 (1H, q, <i>J</i> = 8.5 Hz), 7.80 (2H, d, <i>J</i> = 8.5 Hz), 8.66 (1H, t, <i>J</i> = 5.8 Hz), 8.75 (1H, s); <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ â113.67; <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 30.9, 32.7, 39.0, 102.3, 111.7, 113.1(d, <i>J</i> = 20.63 Hz), 114.4, 114.9, 115.5 (d, <i>J</i> = 20.6 Hz), 125.0 (d, <i>J</i> = 2.5 Hz), 125.3, 130.7 (d, <i>J</i> = 8.6 Hz), 125.3, 130.7 (d, <i>J</i> = 10.7 Hz), 132.5, 145.1 (d, <i>J</i> = 6.0 Hz), 148.4, 156.8, 161.6, 163.1 (d, <i>J</i> = 246.8 Hz), 163.8; IR (KBr) 3562, 1705, 1550, 1226 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 341 (M<sup>+</sup>); HRMS Calcd for C<sub>19</sub>H<sub>16</sub>FNO<sub>4</sub> 341.1063, Found 341.1067; Purity 98% (HPLC).</div></div><div id="sec4_6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 7-Hydroxy-2-oxo-2<i>H</i>-chromene-3-carboxylic Acid [3-(4-Fluorophenyl)propyl]amide (<b>4e</b>)</h4><div class="NLM_p last">Yield 96%; mp 207â209 Â°C (EtOH); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.95 (2H, quint, <i>J</i> = 7.5 Hz), 2.70 (2H, t, <i>J</i> = 7.5 Hz), 3.49 (2H, q, <i>J</i> = 7.5 Hz), 6.88â6.91 (2H, m), 6.94â6.98 (2H, m), 7.14â7.18 (2H, m), 7.20â7.23 (1H, m), 7.57 (1H, d, <i>J</i> = 8.5 Hz), 8.83 (1H, s), 8.87 (1H, br); <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ â117.54; <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) Î´; 31.3, 32.1, 39.0, 102.3, 111.6, 114.3, 114.8, 115.4 (d, <i>J</i> = 20.6 Hz), 128.8 (d, <i>J</i> = 3.6 Hz), 130.5 (d, <i>J</i> = 8.6 Hz), 132.4, 138.1, 148.4, 156.7, 156.7, 161.1 (d, <i>J</i> = 239.9 Hz), 164.6, IR (KBr) 3572, 1717, 1558, 1267 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 341 (M<sup>+</sup>); HRMS Calcd for C<sub>19</sub>H<sub>16</sub>FNO<sub>4</sub> 341.1063, Found 341.1065; Purity >98% (HPLC).</div></div><div id="sec4_6_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 7-Hydroxy-2-oxo-2<i>H</i>-chromene-3-carboxylic Acid [3-(3,5-Difluorophenyl)propyl]amide (<b>4f</b>)</h4><div class="NLM_p last">Yield 92%; mp 213-214 Â°C (MeOH); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.85 (2H, quint, <i>J</i> = 7.5 Hz), 2.67 (2H, t, <i>J</i> = 7.5 Hz), 3.27â3.41 (2H, m), 6.81 (1H, s), 6.88 (2H, d, <i>J</i> = 8.5 Hz), 6.99â7.02 (3H, m), 7.82 (1H, d, <i>J</i> = 8.5 Hz), 8.67 (1H, t, <i>J</i> = 5.5 Hz), 8.78 (1H, s); <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ â110.54; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 30.5, 32.6, 38.9, 101.7 (t, <i>J</i> = 28.3 Hz), 102.3, 111.6, 111.9 (dd, <i>J</i> = 4.9, 19.4 Hz), 114.2, 114.8, 132.4, 146.8 (t, <i>J</i> = 9.1 Hz), 148.4, 156.7, 161.5, 162.8 (d, <i>J</i> = 244.3 Hz), 162.1, 162.9 (d, <i>J</i> = 244.3 Hz), 164.1; IR (KBr) 3227, 1718, 1549, 1226 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 359 (M<sup>+</sup>); HRMS Calcd for C<sub>19</sub>H<sub>15</sub>F<sub>2</sub>NO<sub>4</sub> 359.0969, Found 359.0968; Purity 95% (HPLC).</div></div><div id="sec4_6_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 7-Hydroxy-2-oxo-2<i>H</i>-chromene-3-carboxylic Acid (3-<i>p</i>-Tolylpropyl)amide (<b>4g</b>)</h4><div class="NLM_p last">Yield 90%; mp 220â222 Â°C (MeOH); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.79 (2H, quint, <i>J</i> = 7.5 Hz), 2.23 (3H, s), 2.56 (2H, t, <i>J</i> = 7.5 Hz), 3.25â7.37 (2H, m), 6.78 (1H, s), 6.80 (1H, dd, <i>J</i> = 2.0, 8.5 Hz), 7.05 (4H, q, <i>J</i> = 8.5 Hz), 7.79 (1H, d, <i>J</i> = 8.5 Hz), 8.64 (1H, t, <i>J</i> = 5.8 Hz), 8.74 (1H, s); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 21.1, 31.3, 32.6, 39.1, 102.3, 111.7, 114.4, 114.8, 128.7, 129.4, 132.5, 135.1, 138.9, 148.4, 156.8, 161.6, 162.0, 164.1; IR (KBr) 3214, 1715, 1549 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 337 (M<sup>+</sup>); HRMS Calcd for C<sub>20</sub>H<sub>19</sub>NO<sub>4</sub> 337.1314, Found 337.1311; Purity >98% (HPLC).</div></div><div id="sec4_6_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 7-Hydroxy-2-oxo-2<i>H</i>-chromene-3-carboxylic Acid [3-(4-Methoxyphenyl)propyl]amide (<b>4h</b>)</h4><div class="NLM_p last">Yield 95%; mp 205â207 Â°C (MeOH); <sup>1</sup>H NMR (500 MHz, acetone-<i>d</i><sub>6</sub>) Î´ 1.95 (2H, quint, <i>J</i> = 7.5 Hz), 2.69 (2H, t, <i>J</i> = 7.5 Hz), 3.47 (2H, q, <i>J</i> = 7.5 Hz), 3.79 (3H, s), 6.87â6.89 (3H, m), 7.02 (1H, dd, <i>J</i> = 6.0, 2.5 Hz), 7.21 (2H, d, <i>J</i> = 6.5 Hz), 7.84 (1H, d, <i>J</i> = 8.5 Hz), 8.76 (1H, br), 8.84 (1H, s); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 31.4, 32.1, 39.1, 55.4, 102.3, 111.6, 114.2, 114.3, 114.8, 129.7, 132.4, 133.8, 148.4, 156.7, 157.9, 161.6, 162.0, 164.1; IR (KBr) 3318, 1706, 1540 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 353 (M<sup>+</sup>); HRMS Calcd for C<sub>20</sub>H<sub>19</sub>NO<sub>5</sub> 353.1263, Found 353.1262; Purity 95% (HPLC).</div></div><div id="sec4_6_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 7-Hydroxy-2-oxo-2<i>H</i>-chromene-3-carboxylic Acid [4-(4-Hydroxyphenyl)butyl]amide (<b>4i</b>)</h4><div class="NLM_p last">Yield 66%; mp 225â226 Â°C (MeOH); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.59â1.63 (4H, m), 2.55 (2H, t, <i>J</i> = 7.5 Hz), 3.45 (2H, q, <i>J</i> = 7.5 Hz), 6.75 (2H, d, <i>J</i> = 8.5 Hz), 6.82 (1H, d, <i>J</i> = 2.0 Hz), 6.95 (1H, dd, <i>J</i> = 6.5, 2.0 Hz), 7.01 (2H, d, <i>J</i> = 8.5 Hz), 7.76 (1H, d, <i>J</i> = 8.5 Hz), 8.10 (1H, br), 8.76 (1H, s); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 29.2, 29.2, 34.4, 39.3, 102.3, 111.6, 114.2, 114.8, 115.5, 129.6, 132.4, 132.6, 148.4, 155.8, 156.7, 161.6, 161.9; IR (KBr) 3312, 1707, 1550 1227 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 353 (M<sup>+</sup>); HRMS Calcd for C<sub>20</sub>H<sub>19</sub>NO<sub>5</sub> 353.1263, Found 353.1262; Purity >98% (HPLC).</div></div><div id="sec4_6_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 2-Oxo-2<i>H</i>-chromene-3-carboxylic Acid [3-(4-Hydroxyphenyl)propyl]amide (<b>4j</b>)</h4><div class="NLM_p last">Yield 67%; mp 194â196 Â°C (MeOH); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.92 (2H, quint, <i>J</i> = 7.5 Hz), 2.65 (2H, t, <i>J</i> = 7.5 Hz), 3.27â3.41 (2H, m), 6.76 (2H, d, <i>J</i> = 8.5 Hz), 7.06 (2H, d, <i>J</i> = 8.5 Hz), 7.37â7.42 (2H, m), 7.67 (2H, m), 8.92 (1H, s); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 31.4, 32.1, 39.8, 115.6, 116.6, 119.0, 119.7, 125.6, 129.6, 130.7, 131.9, 134.5, 147.7, 154.3, 155.9, 160.9, 161.6; IR (KBr) 3345, 1717, 1608, 1569 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 323 (M<sup>+</sup>); HRMS Calcd for C<sub>19</sub>H<sub>17</sub>NO<sub>4</sub> 23.1158, Found 323.1156; Purity >98% (HPLC).</div></div><div id="sec4_6_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 8-Hydroxy-2-oxo-2<i>H</i>-chromene-3-carboxylic Acid [3-(4-Hydroxyphenyl)propyl]amide (<b>4k</b>)</h4><div class="NLM_p last">Yield 86%; mp 225â227 Â°C (MeOH); <sup>1</sup>H NMR (500 MHz, acetone-<i>d</i><sub>6</sub>) Î´ 1.93 (2H, quint, <i>J</i> = 7.5 Hz), 2.67 (2H, t, <i>J</i> = 7.5 Hz), 3.45 (2H, q, <i>J</i> = 7.5 Hz), 6.80 (2H, d, <i>J</i> = 8.5 Hz), 7.12 (2H, d, <i>J</i> = 8.5 Hz), 7.29â7.41 (2H, m), 7.45 (1H, t, <i>J</i> = 5.0 Hz), 8.14 (1H, s), 8.82 (1H, br), 8.89 (1H, s); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 31.4, 32.1, 39.2, 115.6, 119.5, 119.9, 120.5, 125.6, 129.6, 131.9, 143.0, 144.9, 148.1, 155.8, 160.8, 161.7; IR (KBr) 3390, 1718, 1610 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 339 (M<sup>+</sup>); HRMS Calcd for C<sub>19</sub>H<sub>17</sub>NO<sub>5</sub> 339.1107, Found 339.1108; Purity >98% (HPLC).</div></div><div id="sec4_6_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 7-Hydroxy-2-oxo-2<i>H</i>-chromene-3-carboxylic Acid [2-(4-Hydroxyphenyl)ethyl]amide (<b>4l</b>).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></h4><div class="NLM_p last">Yield 65%; mp 271â273 Â°C (MeOH); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 2.81 (2H, t, <i>J</i> = 7.5 Hz), 3.61 (2H, q, <i>J</i> = 7.5 Hz), 6.78 (2H, dd, <i>J</i> = 4.5, 2.0 Hz), 7.11 (2H, dd, <i>J</i> = 4.5, 2.0 Hz), 7.79 (1H, d, <i>J</i> = 8.5 Hz), 8.73 (1H, br), 8.80 (1H, s); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 34.7, 41.4, 102.3, 111.6, 114.0, 114.9, 115.7, 129.7, 130.0, 132.5, 148.5, 156.2, 161.5, 161.9, 164.2; IR (KBr) 3313, 1709, 1539 cm<sup>â1</sup>; MS (EI) <i>m</i>/<i>z</i> 325 (M<sup>+</sup>); HRMS Calcd for C<sub>19</sub>H<sub>17</sub>NO<sub>5</sub> 325.3154, Found 325.0947; Purity 96% (HPLC).</div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Improved Synthesis of <b>4e</b> from <b>5</b></h3><div class="NLM_p last">To a stirred solution of <i>p</i>-fluorobenzenepropanamide<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> (200 mg, 1.2 mmol) in THF (10 mL) was added LiAlH<sub>4</sub> (136 mg, 3.6 mmol), and the resulting suspension was refluxed for 18 h. After cooling, the reaction mixture was diluted with AcOEt (10 mL) and then quenched with 10% NaOH aq. at 0 Â°C. The insoluble materials were filtered off using Celite, and the filtrate was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated <i>in vacuo</i> to yield corresponding amine, which was used for the next reaction without further purification. To a stirred solution of the amine obtained above in THF (6 mL) were added 7-hydroxycoumarin-3-carboxylic acid (190 mg, 0.9 mmol)<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> and EDC (265 mg, 1.4 mmol) at room temperature, and the resulting mixture was stirred at room temperature for 1 h. To the reaction mixture was added <i>N</i>-methylmorpholine (0.2 mL, 1.8 mmol), and the reaction mixture was stirred at room temperature for 18 h. The reaction mixture was diluted with AcOEt (10 mL) and 10% HCl aq., and the organic phase was separated; the aqueous mixture was extracted with AcOEt (5 mL Ã 3). The organic phase and extracts were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i>. The residue was chromatographed on SiO<sub>2</sub> (20 g, CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 100:1) to give <b>4e</b> (314 mg, 78%) as a yellow solid.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Enzyme Purification</h3><div class="NLM_p last">Homogenous recombinant AKR1B10,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> AKR1B1,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> AKR1A1,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> AKR1C isoforms (1C1â1C4),<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62, 63)</a> CBR1,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> and mutant enzymes of AKR1B10 (K125L, W220Y, V301L, and Q303S)<a onclick="showRef(event, 'ref43 ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref43 ref65 ref66">(43, 65, 66)</a> were prepared and purified to homogeneity as previously described. All enzymes were stored at â20 Â°C in 10 mM potassium phosphate buffer, pH 7.0, containing 20% glycerol, 1 mM EDTA, and 5 mM 2-mercaptoethanol.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Enzyme Activity Assay</h3><div class="NLM_p">The potency of the compounds was determined by measuring their ability to inhibit the reductase or dehydrogenase activities of the enzymes, which were assayed at 25 Â°C by measuring the rate of change in NADPH absorbance at 340 nm. The reaction mixture (total volume of 2.0 mL) consisted of 0.1 M potassium phosphate, pH 7.4, coenzyme (0.1 mM NADPH or 0.25 mM NADP<sup>+</sup>), substrate, enzyme, and inhibitor.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The inhibitors were dissolved in methanol and added to the reaction mixture, not to exceed 2% methanol concentration. The reaction was started by the addition of the enzyme. The enzyme concentrations of AKR1B10 and AKR1B1 were 3â6 Î¼g/mL. The IC<sub>50</sub> values for inhibitors were determined in the NADPH-linked reductase activities toward 0.2 mM pyridine-3-aldehyde (for AKR1B10 and AKR1B1),<a onclick="showRef(event, 'ref19 ref44'); return false;" href="javascript:void(0);" class="ref ref19 ref44">(19, 44)</a> 2 mM pyridine-3-aldehyde (for AKR1A1), and 50 Î¼M isatin (for CBR1).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> In the IC<sub>50</sub> determination of AKR1C1â1C4, their NADP<sup>+</sup>-linked dehydrogenase activities were assayed using (<i>S</i>)-(+)-1,2,3,4-tetrahydro-1-naphthol (<i>S</i>-tetralol) as the substrate.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div><div class="NLM_p last">Kinetic studies of AKR1B10 and its mutant enzymes in the presence of inhibitors were carried out in NADP<sup>+</sup>-linked geraniol oxidation over a range of five substrate concentrations [(0.5â5) Ã <i>K</i><sub>m</sub>] at a saturating concentration (0.25 mM) of the coenzyme.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The inhibition patterns were analyzed from the LineweaverâBurk plots (double reciprocal plots of the initial velocities versus concentrations of substrate), and <i>K</i><sub>i</sub> (inhibition constant) for the competitive inhibitor was estimated from replots of the slopes of the LineweaverâBurk plots versus inhibitor concentrations as described previously.<a onclick="showRef(event, 'ref19 ref44'); return false;" href="javascript:void(0);" class="ref ref19 ref44">(19, 44)</a></div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Molecular Modeling</h3><div class="NLM_p last">The modeling of binding mode of <b>4c</b> with AKR1B10 was performed using the SchrÃ¶dinger suite 2013-2 (SchrÃ¶dinger, LLC, New York, NY, 2013). The 3D structure of <b>4c</b> was first generated using the LigPrep 2.7 program. The conformational search of <b>4c</b> was then performed using the ConfGen 2.5 program, and the resulting conformers were used in the following docking calculations. The X-ray structure of the AKR1B10 in complex with caffeic acid phenethyl ester (CAPE) (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GQ0">4GQ0</a>) was used as a receptor for docking. Because CAPE possesses a similar chemical structure to <b>4c</b>, it would be more adequate to use the receptor structure derived from the CAPEâAKR1B10 complex. The X-ray structure was minimized using force-field OPLS 2005 through the Protein Preparation Wizard in Maestro 9.5. We removed H<sub>2</sub>O molecules before docking calculations. The docking calculation of <b>4c</b> against AKR1B10 was performed using the Glide 6.0 SP mode. Box center for the âReceptor Grid Generationâ protocol was set to a centroid of CAPE binding to AKR1B10. The van der Waal radius scaling of 1.0 was used for both protein and ligand, and the maximum number of poses per conformer was set to 2. The generated poses were ranked according to docking score, and we finally selected a docked complex with the lowest docking score as the interaction model. In order to test the docking procedure, we applied it for the CAPEâAKR1B10 complex. The positional and conformational root-mean-square deviations between X-ray and docked poses were 0.34 and 0.17 Ã, respectively. This result suggested that the procedure is adequate for producing a reliable binding model between CAPE and AKR1B10.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Cell Culture</h3><div class="NLM_p last">Lung cancer A549 cells were obtained from American Type Culture Collection (Manassas, VA, USA) and grown in Dulbeccoâs modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, penicillin (100 U/mL), and streptomycin (100 Î¼g/mL) at 37 Â°C in a humidified incubator containing 5% CO<sub>2</sub>. The A549/1B10 cells<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68, 69)</a> and CDDP-R-A549 cells<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> were established as reported previously. For establishment of the subpopulation resistant to CDDP, the A549 cells were continuously treated in the growth medium supplemented with CDDR whose concentration was increased in a stepwise manner (0.05â5 Î¼M).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Measurement of Metastatic and Invasive Potential</h3><div class="NLM_p last">Migrating potential of the cells was determined by wound-healing and Boyden chamber assays as described previously.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Briefly, the cells were seeded into a 6-well culture plate at a density of 3 Ã 10<sup>5</sup> cells/well. After reaching a 90% confluence of the cells, the cell monolayer was scratched with a 10-Î¼L pipet tip, washed twice with the growth medium, and then incubated for 24-h  in serum-free DMEM supplemented with AKR1B10 inhibitors or the vehicle DMSO, in order to allow the cells to migrate from the wound surface to the cell-free area. The migrating potential was evaluated by microscopically measuring the width of the cell-free area. In case of the Boyden chamber assay, the cells were seeded on a polycarbonate membrane (8-Î¼m pore) at a density of 1 Ã 10<sup>4</sup> cells/well and cultured for 36 h. After medium in the upper layer of the membrane was replaced with fresh growth medium, the cells were incubated for 48 h in serum-free DMEM supplemented with AKR1B10 inhibitors or the vehicle DMSO. The cells that migrated to the underside of the membrane were fixed with methanol and stained with Giemsa solution, and their number was counted microscopically. Invasive activity of cells was similarly analyzed using the polycarbonate membrane coated with type-I collagen (Nitta Gelatin, Osaka, Japan).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Measurement of Proliferation Rate and CDDP Sensitivity</h3><div class="NLM_p last">In proliferation assay, A549 cells and CDDP-R-A549 cells were seeded into a 48-well multiplate at a density of 2 Ã 10<sup>4</sup> cells/well, and then treated for 24 or 96 h with AKR1B10 inhibitors. To evaluate CDDP sensitivity of A549 cells and CDDP-R-A549 cells, the cells were seeded into a 96-well multiplate at a density of 2 Ã 10<sup>4</sup> cells/well, and then treated for 24 h with AKR1B10 inhibitors in the presence or absence of 0.5 or 40 Î¼M CDDP. Proliferation rate and drug sensitivity of the cells were estimated by monitoring the cell viability, which was evaluated by tetrazolium dye-based cytotoxicity assay using 2-(4-iodophenyl)-3-(4-nitro-phenyl)-5-(2,4-disulfophenyl)-2<i>H</i>-tetrazolium.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Experimental Metastasis Assay by iv Inoculation</h3><div class="NLM_p last">Female 6-week-old C.B-17/lcrHsd-Prkdc<sup>scid</sup> (SCID) mice were purchased from Japan SLC (Hamamatsu, Japan). All experiments were approved and carried out according to the guidelines of the Care and Use of Laboratory Animals of University of Toyama (Toyama, Japan). The experimental lung metastasis of A549/Luc2 cells was performed as previously described.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Briefly, A549/Luc2 were precultured in the absence or presence of 20 Î¼M <b>4c</b> or <b>4e</b> for 48 h and inoculated intravenously (2 Ã 10<sup>6</sup> cells/200 Î¼L PBS/mouse) into mice. Four days after the tumor inoculation, mice were intraperitoneally injected with 200 Î¼L of 1.5 mg/mL luciferin (VivoGlo; Promega, Madison, WI, USA) 10 min prior to removal of the lungs for bioluminescent assay using an <i>in vivo</i> imaging system (IVIS Lumina II, Caliper Life Sciences, Hopkinton, MA, USA).</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Statistical Analysis</h3><div class="NLM_p last">Data are expressed as the means Â± SD of at least three independent experiments, unless otherwise noted. Statistical evaluation of the data was performed by using the unpaired Studentâs <i>t</i> test and ANOVA followed by Fisherâs test.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i75"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00830">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02803" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02803" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00830" class="ext-link">10.1021/acs.jmedchem.7b00830</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Data of <b>4c</b>-binding modes in AKR1B10 and AKR1B1 and effect of alanine scanning on binding free energy for <b>4c</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00830/suppl_file/jm7b00830_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00830/suppl_file/jm7b00830_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00830/suppl_file/jm7b00830_si_001.pdf">jm7b00830_si_001.pdf (185.55 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00830/suppl_file/jm7b00830_si_002.csv">jm7b00830_si_002.csv (1.41 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00830" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34316" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34316" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Satoshi Endo</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Biochemistry, Gifu Pharmaceutical University, Gifu 501-1196, Japan</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0578-9672" title="Orcid link">http://orcid.org/0000-0003-0578-9672</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f88b9d969c97b89f919e8dd5888dd6999bd69288"><span class="__cf_email__" data-cfemail="d6a5b3b8b2b996b1bfb0a3fba6a3f8b7b5f8bca6">[emailÂ protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Naoki Toyooka</span> - <span class="hlFld-Affiliation affiliation">Graduate
School of Innovative Life Science, University
of Toyama, Toyama 930-8555, Japan</span>;Â 
    <span class="hlFld-Affiliation affiliation">Graduate
School of Science and Engineering, University
of Toyama, Toyama 930-8555, Japan</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8ffbe0f6e0e0e4eecfeae1e8a1faa2fbe0f6eee2eea1eeeca1e5ff"><span class="__cf_email__" data-cfemail="4632293f29292d270623282168336b32293f272b27682725682c36">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuang Xia</span> - <span class="hlFld-Affiliation affiliation">Graduate
School of Innovative Life Science, University
of Toyama, Toyama 930-8555, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Miho Suyama</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Biochemistry, Gifu Pharmaceutical University, Gifu 501-1196, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yoshifumi Morikawa</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Biochemistry, Gifu Pharmaceutical University, Gifu 501-1196, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hiroaki Oguri</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Biochemistry, Gifu Pharmaceutical University, Gifu 501-1196, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dawei Hu</span> - <span class="hlFld-Affiliation affiliation">Graduate
School of Innovative Life Science, University
of Toyama, Toyama 930-8555, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yoshinori Ao</span> - <span class="hlFld-Affiliation affiliation">Graduate
School of Science and Engineering, University
of Toyama, Toyama 930-8555, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Satoyuki Takahara</span> - <span class="hlFld-Affiliation affiliation">Graduate
School of Innovative Life Science, University
of Toyama, Toyama 930-8555, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yoshikazu Horino</span> - <span class="hlFld-Affiliation affiliation">Graduate
School of Science and Engineering, University
of Toyama, Toyama 930-8555, Japan</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8916-6298" title="Orcid link">http://orcid.org/0000-0002-8916-6298</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yoshihiro Hayakawa</span> - <span class="hlFld-Affiliation affiliation">Division
of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yurie Watanabe</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Showa University, Tokyo 142-8555, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hiroaki Gouda</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Showa University, Tokyo 142-8555, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Akira Hara</span> - <span class="hlFld-Affiliation affiliation">Faculty of
Engineering, Gifu University, Gifu 501-1193, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kazuo Kuwata</span> - <span class="hlFld-Affiliation affiliation">United
Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Gifu 501-1193, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Toshiyuki Matsunaga</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Biochemistry, Gifu Pharmaceutical University, Gifu 501-1196, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Akira Ikari</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Biochemistry, Gifu Pharmaceutical University, Gifu 501-1196, Japan</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>S.E. and N.T. participated in research design and mainly contributed to writing the paper. S.X., D.H., Y.A., S.T., and Y.H. synthesized novel compounds. M.S., Y.M., H.O., and T.M. performed the biological analyses. Y.H. performed the in vivo study. Y.W. and H.G. contributed to the molecular docking. H.G., A.H, K.K., T.M., and A.I. contributed to the experiment plan and discussion of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d959e5771-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i77">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80081" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80081" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This study was partially supported by JSPS Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (MEXT KAKENHI Grant Number JP26460149).</p></div><div class="postAsapNotesSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="postAsapNotesSection">Note Added After ASAP Publication</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84538" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84538" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="first last">After this paper was published ASAP on October 13, 2017, Scheme 2 was corrected. The revised version was reposted October 17, 2017.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i78" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i78"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i79" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i79"> Abbreviations Used</h2><tr><td class="NLM_term">AKR</td><td class="NLM_def"><p class="first last">aldo-keto reductase</p></td></tr><tr><td class="NLM_term">AKR1B1</td><td class="NLM_def"><p class="first last">human aldose reductase</p></td></tr><tr><td class="NLM_term">A549/1B10 cells</td><td class="NLM_def"><p class="first last">A549 cells stably overexpressing AKR1B10</p></td></tr><tr><td class="NLM_term">BDMC</td><td class="NLM_def"><p class="first last">bisdemethoxycurcumin</p></td></tr><tr><td class="NLM_term">CAPE</td><td class="NLM_def"><p class="first last">caffeic acid phenethyl ester</p></td></tr><tr><td class="NLM_term">CBR1</td><td class="NLM_def"><p class="first last">carbonyl reductase 1</p></td></tr><tr><td class="NLM_term">CDDP</td><td class="NLM_def"><p class="first last">cisplatin</p></td></tr><tr><td class="NLM_term">CDDP-R-A549 cells</td><td class="NLM_def"><p class="first last">CDDP-resistant A549 cells</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbeccoâs modified Eagle medium</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylaminopropyl)carbodiimide</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epithelial growth factor receptor</p></td></tr><tr><td class="NLM_term">HAHE</td><td class="NLM_def"><p class="first last">3-(4-hydroxy-2-methoxyphenyl)acrylic acid 3-(3-hydroxyphenyl) propyl ester</p></td></tr><tr><td class="NLM_term">HMCB</td><td class="NLM_def"><p class="first last">7-hydroxy-2-(4-methoxyphenylimino)-2<i>H</i>-chromene-3-carboxylic acid benzylamide</p></td></tr><tr><td class="NLM_term">MHPC</td><td class="NLM_def"><p class="first last">(<i>Z</i>)-2-(4-methoxyphenylimino)-7-hydroxy-<i>N</i>-(pyridin-2-yl)-2<i>H</i>-chromene-3-carboxamide</p></td></tr><tr><td class="NLM_term">MM-PBSA</td><td class="NLM_def"><p class="first last">molecular mechanics PoissonâBoltzmann surface area</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">non-small-cell lung carcinoma</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11331" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11331" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 71 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Jemal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiwari, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghafoor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuels, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feuer, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thun, M. J.</span><span> </span><span class="NLM_article-title">American Cancer Society. Cancer Statistics, 2004</span> <span class="citation_source-journal">Ca-Cancer J. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">â</span> <span class="NLM_lpage">29</span><span class="refDoi">Â DOI: 10.3322/canjclin.54.1.8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.3322%2Fcanjclin.54.1.8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=14974761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A280%3ADC%252BD2c%252FosFaluw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2004&pages=8-29&author=A.+Jemalauthor=R.+C.+Tiwariauthor=T.+Murrayauthor=A.+Ghafoorauthor=A.+Samuelsauthor=E.+Wardauthor=E.+J.+Feuerauthor=M.+J.+Thun&title=American+Cancer+Society.+Cancer+Statistics%2C+2004&doi=10.3322%2Fcanjclin.54.1.8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2004</span></div><div class="casAuthors">Jemal Ahmedin; Tiwari Ram C; Murray Taylor; Ghafoor Asma; Samuels Alicia; Ward Elizabeth; Feuer Eric J; Thun Michael J</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-29</span>
        ISSN:<span class="NLM_cas:issn">0007-9235</span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival rates based on incidence data from the National Cancer Institute and mortality data from the National Center for Health Statistics.  Incidence and mortality rates are age standardized to the 2000 US standard million population.  A total of 1,368,030 new cancer cases and 563,700 deaths are expected in the United States in 2004.  Incidence rates stabilized among men from 1995 through 2000 but continued to increase among females by 0.4% per year from 1987 through 2000.  Mortality rates have decreased by 1.5% per year since 1992 among men, but have stabilized from 1998 through 2000 among women.  Cancer death rates continued to decrease from the three major cancer sites in men (lung and bronchus, colon and rectum, and prostate) and from female breast and colorectal cancers in women.  In analyses by race and ethnicity, African-American men and women have 40% and 20% higher death rates from all cancers combined compared with White men and women, respectively.  Cancer incidence and mortality rates are lower in other racial and ethnic groups than in Whites and African Americans for all sites combined and for the four major cancer sites.  However, these groups generally have higher rates for stomach, liver, and cervical cancers than do Whites.  Furthermore, minority populations are more likely to be diagnosed with advanced stage disease than are Whites.  Progress in reducing the burden from cancer can be accelerated by applying existing cancer control knowledge into practice among all segments of the population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTz-WXc55vIMtTiMd2aNQVUfW6udTcc2eZtn3BE_Je1vbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c%252FosFaluw%253D%253D&md5=e3b0ac1e230e37eeaaa5f385b3d439f9</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3322%2Fcanjclin.54.1.8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcanjclin.54.1.8%26sid%3Dliteratum%253Aachs%26aulast%3DJemal%26aufirst%3DA.%26aulast%3DTiwari%26aufirst%3DR.%2BC.%26aulast%3DMurray%26aufirst%3DT.%26aulast%3DGhafoor%26aufirst%3DA.%26aulast%3DSamuels%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DE.%26aulast%3DFeuer%26aufirst%3DE.%2BJ.%26aulast%3DThun%26aufirst%3DM.%2BJ.%26atitle%3DAmerican%2520Cancer%2520Society.%2520Cancer%2520Statistics%252C%25202004%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2004%26volume%3D54%26spage%3D8%26epage%3D29%26doi%3D10.3322%2Fcanjclin.54.1.8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Siegel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brawley, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jemal, A.</span><span> </span><span class="NLM_article-title">Cancer Statistics, 2011: The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths</span> <span class="citation_source-journal">Ca-Cancer J. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">â</span> <span class="NLM_lpage">236</span><span class="refDoi">Â DOI: 10.3322/caac.20121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.3322%2Fcaac.20121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=21685461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A280%3ADC%252BC3MnkslKhsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2011&pages=212-236&author=R.+Siegelauthor=E.+Wardauthor=O.+Brawleyauthor=A.+Jemal&title=Cancer+Statistics%2C+2011%3A+The+Impact+of+Eliminating+Socioeconomic+and+Racial+Disparities+on+Premature+Cancer+Deaths&doi=10.3322%2Fcaac.20121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths</span></div><div class="casAuthors">Siegel Rebecca; Ward Elizabeth; Brawley Otis; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">212-36</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics.  A total of 1,596,670 new cancer cases and 571,950 deaths from cancer are projected to occur in the United States in 2011.  Overall cancer incidence rates were stable in men in the most recent time period after decreasing by 1.9% per year from 2001 to 2005; in women, incidence rates have been declining by 0.6% annually since 1998.  Overall cancer death rates decreased in all racial/ethnic groups in both men and women from 1998 through 2007, with the exception of American Indian/Alaska Native women, in whom rates were stable.  African American and Hispanic men showed the largest annual decreases in cancer death rates during this time period (2.6% and 2.5%, respectively).  Lung cancer death rates showed a significant decline in women after continuously increasing since the 1930s.  The reduction in the overall cancer death rates since 1990 in men and 1991 in women translates to the avoidance of about 898,000 deaths from cancer.  However, this progress has not benefitted all segments of the population equally; cancer death rates for individuals with the least education are more than twice those of the most educated.  The elimination of educational and racial disparities could potentially have avoided about 37% (60,370) of the premature cancer deaths among individuals aged 25 to 64 years in 2007 alone.  Further progress can be accelerated by applying existing cancer control knowledge across all segments of the population with an emphasis on those groups in the lowest socioeconomic bracket.  CA Cancer J Clin 2011. Â© 2011 American Cancer Society.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSV6umkq5UbgGlSCSgBhwJFfW6udTcc2eZtn3BE_Je1vbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MnkslKhsg%253D%253D&md5=7fbc8af4359e652a7dd1048a031ffcc3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3322%2Fcaac.20121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.20121%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%26aulast%3DWard%26aufirst%3DE.%26aulast%3DBrawley%26aufirst%3DO.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520Statistics%252C%25202011%253A%2520The%2520Impact%2520of%2520Eliminating%2520Socioeconomic%2520and%2520Racial%2520Disparities%2520on%2520Premature%2520Cancer%2520Deaths%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2011%26volume%3D61%26spage%3D212%26epage%3D236%26doi%3D10.3322%2Fcaac.20121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Melosky, B.</span><span> </span><span class="NLM_article-title">Review of EGFR TKIs in Metastatic NSCLC, Including Ongoing Trials</span> <span class="citation_source-journal">Front. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">244</span><span class="refDoi">Â DOI: 10.3389/fonc.2014.00244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.3389%2Ffonc.2014.00244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=25309870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A280%3ADC%252BC2M7pvFCgsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=244&author=B.+Melosky&title=Review+of+EGFR+TKIs+in+Metastatic+NSCLC%2C+Including+Ongoing+Trials&doi=10.3389%2Ffonc.2014.00244"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Review of EGFR TKIs in Metastatic NSCLC, Including Ongoing Trials</span></div><div class="casAuthors">Melosky Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">244</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Recent clinical trials have demonstrated the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) in the treatment of patients with advanced metastatic non-small cell lung cancer.  Most of these recent trials were conducted in patients with EGFR mutation-positive tumors.  As our knowledge of the EGFR mutation and its resistant pathways develops, the complexity of the situation expands.  This article briefly reviews the pivotal trials leading to approval of EGFR TKIs in the first-line setting for patients with EGFR mutation-positive non-small cell lung carcinomas.  It discusses the historical use of EGFR TKIs after the first-line setting in unselected patients and briefly describes ongoing trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPQOldwlFiz6Nc3HjJRoFAfW6udTcc2eZtn3BE_Je1vbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7pvFCgsA%253D%253D&md5=fbb7ea5d5ec4d212909b317af2e48b16</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2014.00244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2014.00244%26sid%3Dliteratum%253Aachs%26aulast%3DMelosky%26aufirst%3DB.%26atitle%3DReview%2520of%2520EGFR%2520TKIs%2520in%2520Metastatic%2520NSCLC%252C%2520Including%2520Ongoing%2520Trials%26jtitle%3DFront.%2520Oncol.%26date%3D2014%26volume%3D4%26spage%3D244%26doi%3D10.3389%2Ffonc.2014.00244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Moran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quiroga, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil Mde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vila, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carcereny, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capdevila, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Marmol, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosell, R.</span><span> </span><span class="NLM_article-title">Targeting EML4-ALK Driven Non-Small Cell Lung Cancer (NSCLC)</span> <span class="citation_source-journal">Transl. Lung Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">â</span> <span class="NLM_lpage">141</span><span class="refDoi">Â DOI: 10.3978/j.issn.2218-6751.2013.03.04</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.3978%2Fj.issn.2218-6751.2013.03.04" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=25806224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCmt7rK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=128-141&author=T.+Moranauthor=V.+Quirogaauthor=L.+Gil+Mdeauthor=L.+Vilaauthor=N.+Pardoauthor=E.+Carcerenyauthor=L.+Capdevilaauthor=A.+M.+Munoz-Marmolauthor=R.+Rosell&title=Targeting+EML4-ALK+Driven+Non-Small+Cell+Lung+Cancer+%28NSCLC%29&doi=10.3978%2Fj.issn.2218-6751.2013.03.04"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting EML4-ALK driven non-small cell lung cancer (NSCLC)</span></div><div class="casAuthors">Moran, Teresa; Quiroga, Vanesa; de los Llanos Gil, Maria; Vila, Laia; Pardo, Nuria; Carcereny, Enric; Capdevila, Laia; Munoz-Marmol, Ana M.; Rosell, Rafael</div><div class="citationInfo"><span class="NLM_cas:title">Translational Lung Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">128-141</span>CODEN:
                <span class="NLM_cas:coden">TLCRA9</span>;
        ISSN:<span class="NLM_cas:issn">2226-4477</span>.
    
            (<span class="NLM_cas:orgname">Pioneer Bioscience Publishing Co.</span>)
        </div><div class="casAbstract">This article discusses about the targeting EML4-ALK driven non-small cell lung cancer (NSCLC).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHm_NJOSVQzrVg90H21EOLACvtfcHk0lhKPWHcVWCqxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCmt7rK&md5=09035b303089d09fc8ccc4d3e125b2e1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3978%2Fj.issn.2218-6751.2013.03.04&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3978%252Fj.issn.2218-6751.2013.03.04%26sid%3Dliteratum%253Aachs%26aulast%3DMoran%26aufirst%3DT.%26aulast%3DQuiroga%26aufirst%3DV.%26aulast%3DGil%2BMde%26aufirst%3DL.%26aulast%3DVila%26aufirst%3DL.%26aulast%3DPardo%26aufirst%3DN.%26aulast%3DCarcereny%26aufirst%3DE.%26aulast%3DCapdevila%26aufirst%3DL.%26aulast%3DMunoz-Marmol%26aufirst%3DA.%2BM.%26aulast%3DRosell%26aufirst%3DR.%26atitle%3DTargeting%2520EML4-ALK%2520Driven%2520Non-Small%2520Cell%2520Lung%2520Cancer%2520%2528NSCLC%2529%26jtitle%3DTransl.%2520Lung%2520Cancer%2520Res.%26date%3D2013%26volume%3D2%26spage%3D128%26epage%3D141%26doi%3D10.3978%2Fj.issn.2218-6751.2013.03.04" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Benedettini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sholl, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ware, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vena, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeap, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorentino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligon, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdar, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draetta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirieac, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutterbach, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loda, M.</span><span> </span><span class="NLM_article-title">Met Activation in Non-Small Cell Lung Cancer Is Associated with de Novo Resistance to EGFR Inhibitors and the Development of Brain Metastasis</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">177</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">â</span> <span class="NLM_lpage">423</span><span class="refDoi">Â DOI: 10.2353/ajpath.2010.090863</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.2353%2Fajpath.2010.090863" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=20489150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslCrsLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2010&pages=415-423&author=E.+Benedettiniauthor=L.+M.+Shollauthor=M.+Peytonauthor=J.+Reillyauthor=C.+Wareauthor=L.+Davisauthor=N.+Venaauthor=D.+Baileyauthor=B.+Y.+Yeapauthor=M.+Fiorentinoauthor=A.+H.+Ligonauthor=B.+S.+Panauthor=V.+Richonauthor=J.+D.+Minnaauthor=A.+F.+Gazdarauthor=G.+Draettaauthor=S.+Bosariauthor=L.+R.+Chirieacauthor=B.+Lutterbachauthor=M.+Loda&title=Met+Activation+in+Non-Small+Cell+Lung+Cancer+Is+Associated+with+de+Novo+Resistance+to+EGFR+Inhibitors+and+the+Development+of+Brain+Metastasis&doi=10.2353%2Fajpath.2010.090863"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis</span></div><div class="casAuthors">Benedettini, Elisa; Sholl, Lynette M.; Peyton, Michael; Reilly, John; Ware, Christopher; Davis, Lenora; Vena, Natalie; Bailey, Dyane; Yeap, Beow Y.; Fiorentino, Michelangelo; Ligon, Azra H.; Pan, Bo-Sheng; Richon, Victoria; Minna, John D.; Gazdar, Adi F.; Draetta, Giulio; Bosari, Silvano; Chirieac, Lucian R.; Lutterbach, Bart; Loda, Massimo</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">415-423</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Most non-small cell lung cancer (NSCLC) patients harboring activating epidermal growth factor receptor (EGFR) mutations respond to tyrosine kinase inhibitor (TKI) therapy.  However, about 30% exhibit primary resistance to EGFR TKI therapy.  Here we report that Met protein expression and phosphorylation were assocd. with primary resistance to EGFR TKI therapy in NSCLC patients harboring EGFR mutations, implicating Met as a de novo mechanism of resistance.  In a sep. patient cohort, Met expression and phosphorylation were also assocd. with development of NSCLC brain metastasis and were selectively enriched in brain metastases relative to paired primary lung tumors.  A similar metastasis-specific activation of Met occurred in vitro in the isogenous cell lines H2073 and H1993, which are derived from the primary lung tumor and a metastasis, resp., from the same patient.  We conclude that Met activation is found in NSCLC before EGFR-targeted therapy and is assocd. with both primary resistance to EGFR inhibitor therapy and with the development of metastases.  If confirmed in larger cohorts, our anal. suggests that patient tumors harboring both Met activation and EGFR mutation could potentially benefit from early intervention with a combination of EGFR and Met inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMvwl26ZS8a7Vg90H21EOLACvtfcHk0lhKPWHcVWCqxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslCrsLs%253D&md5=6419c3544bf5275738bdc05bcb6d0938</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2010.090863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2010.090863%26sid%3Dliteratum%253Aachs%26aulast%3DBenedettini%26aufirst%3DE.%26aulast%3DSholl%26aufirst%3DL.%2BM.%26aulast%3DPeyton%26aufirst%3DM.%26aulast%3DReilly%26aufirst%3DJ.%26aulast%3DWare%26aufirst%3DC.%26aulast%3DDavis%26aufirst%3DL.%26aulast%3DVena%26aufirst%3DN.%26aulast%3DBailey%26aufirst%3DD.%26aulast%3DYeap%26aufirst%3DB.%2BY.%26aulast%3DFiorentino%26aufirst%3DM.%26aulast%3DLigon%26aufirst%3DA.%2BH.%26aulast%3DPan%26aufirst%3DB.%2BS.%26aulast%3DRichon%26aufirst%3DV.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DGazdar%26aufirst%3DA.%2BF.%26aulast%3DDraetta%26aufirst%3DG.%26aulast%3DBosari%26aufirst%3DS.%26aulast%3DChirieac%26aufirst%3DL.%2BR.%26aulast%3DLutterbach%26aufirst%3DB.%26aulast%3DLoda%26aufirst%3DM.%26atitle%3DMet%2520Activation%2520in%2520Non-Small%2520Cell%2520Lung%2520Cancer%2520Is%2520Associated%2520with%2520de%2520Novo%2520Resistance%2520to%2520EGFR%2520Inhibitors%2520and%2520the%2520Development%2520of%2520Brain%2520Metastasis%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2010%26volume%3D177%26spage%3D415%26epage%3D423%26doi%3D10.2353%2Fajpath.2010.090863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Brose, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rishi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerrero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einhorn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albelda, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brignell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futreal, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wooster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratton, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, B. L.</span><span> </span><span class="NLM_article-title">BRAF and RAS Mutations in Human Lung Cancer and Melanoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">6997</span><span class="NLM_x">â</span> <span class="NLM_lpage">7000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=12460918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVahsbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=6997-7000&author=M.+S.+Broseauthor=P.+Volpeauthor=M.+Feldmanauthor=M.+Kumarauthor=I.+Rishiauthor=R.+Gerreroauthor=E.+Einhornauthor=M.+Herlynauthor=J.+Minnaauthor=A.+Nicholsonauthor=J.+A.+Rothauthor=S.+M.+Albeldaauthor=H.+Daviesauthor=C.+Coxauthor=G.+Brignellauthor=P.+Stephensauthor=P.+A.+Futrealauthor=R.+Woosterauthor=M.+R.+Strattonauthor=B.+L.+Weber&title=BRAF+and+RAS+Mutations+in+Human+Lung+Cancer+and+Melanoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">BRAF and RAS mutations in human lung cancer and melanoma</span></div><div class="casAuthors">Brose, Marcia S.; Volpe, Patricia; Feldman, Michael; Kumar, Madhu; Rishi, Irum; Gerrero, Renee; Einhorn, Eugene; Herlyn, Meenhard; Minna, John; Nicholson, Andrew; Roth, Jack A.; Albelda, Steven M.; Davies, Helen; Cox, Charles; Brignell, Graham; Stephens, Philip; Futreal, P. Andrew; Wooster, Richard; Stratton, Michael R.; Weber, Barbara L.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6997-7000</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">BRAF encodes a RAS-regulated kinase that mediates cell growth and malignant transformation kinase pathway activation.  Recently, we have identified activating BRAF mutations in 66% of melanomas and a smaller percentage of many other human cancers.  To det. whether BRAF mutations account for the MAP kinase pathway activation common in non-small cell lung carcinomas (NSCLCs) and to extend the initial findings in melanoma, we screened DNA from 179 NSCLCs and 35 melanomas for BRAF mutations (exons 11 and 15).  We identified BRAF mutations in 5 NSCLCs (3%; one V599 and four non-V599) and 22 melanomas (63%; 21 V599 and 1 non-V599).  Three BRAF mutations identified in this study are novel, altering residues important in AKT-mediated BRAF phosphorylation and suggesting that disruption of AKT -induced BRAF inhibition can play a role in malignant transformation.  To our knowledge, this is the first report of mutations documenting this interaction in human cancers.  Although >90% of BRAF mutations in melanoma involve codon 599 (57 of 60), 8 of 9 BRAF mutations reported to date in NSCLC are non-V599 (89%; P < 10-7), strongly suggesting that BRAF mutations in NSCLC are qual. different from those in melanoma; thus, there may be therapeutic differences between lung cancer and melanoma in response to RAF inhibitors.  Although uncommon, BRAF mutations in human lung cancers may identify a subset of tumors sensitive to targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTgYE0tREoTrVg90H21EOLACvtfcHk0lhKPWHcVWCqxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVahsbo%253D&md5=14d00ac58479d0a0f98830abe436dfde</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrose%26aufirst%3DM.%2BS.%26aulast%3DVolpe%26aufirst%3DP.%26aulast%3DFeldman%26aufirst%3DM.%26aulast%3DKumar%26aufirst%3DM.%26aulast%3DRishi%26aufirst%3DI.%26aulast%3DGerrero%26aufirst%3DR.%26aulast%3DEinhorn%26aufirst%3DE.%26aulast%3DHerlyn%26aufirst%3DM.%26aulast%3DMinna%26aufirst%3DJ.%26aulast%3DNicholson%26aufirst%3DA.%26aulast%3DRoth%26aufirst%3DJ.%2BA.%26aulast%3DAlbelda%26aufirst%3DS.%2BM.%26aulast%3DDavies%26aufirst%3DH.%26aulast%3DCox%26aufirst%3DC.%26aulast%3DBrignell%26aufirst%3DG.%26aulast%3DStephens%26aufirst%3DP.%26aulast%3DFutreal%26aufirst%3DP.%2BA.%26aulast%3DWooster%26aufirst%3DR.%26aulast%3DStratton%26aufirst%3DM.%2BR.%26aulast%3DWeber%26aufirst%3DB.%2BL.%26atitle%3DBRAF%2520and%2520RAS%2520Mutations%2520in%2520Human%2520Lung%2520Cancer%2520and%2520Melanoma%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D6997%26epage%3D7000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, L.</span><span> </span><span class="NLM_article-title">Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors</span> <span class="citation_source-journal">Acta Pharm. Sin. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">390</span><span class="NLM_x">â</span> <span class="NLM_lpage">401</span><span class="refDoi">Â DOI: 10.1016/j.apsb.2015.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.apsb.2015.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=26579470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A280%3ADC%252BC28rgtlOqsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=390-401&author=L.+Huangauthor=L.+Fu&title=Mechanisms+of+Resistance+to+EGFR+Tyrosine+Kinase+Inhibitors&doi=10.1016%2Fj.apsb.2015.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of resistance to EGFR tyrosine kinase inhibitors</span></div><div class="casAuthors">Huang Lihua; Fu Liwu</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">390-401</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">Since the discovery that non-small cell lung cancer (NSCLC) is driven by epidermal growth factor receptor (EGFR) mutations, the EGFR tyrosine kinase inhibitors (EGFR-TKIs, e.g., gefitinib and elrotinib) have been effectively used for clinical treatment.  However, patients eventually develop drug resistance.  Resistance to EGFR-TKIs is inevitable due to various mechanisms, such as the secondary mutation (T790M), activation of alternative pathways (c-Met, HGF, AXL), aberrance of the downstream pathways (K-RAS mutations, loss of PTEN), impairment of the EGFR-TKIs-mediated apoptosis pathway (BCL2-like 11/BIM deletion polymorphism), histologic transformation, ATP binding cassette (ABC) transporter effusion, etc.  Here we review and summarize the known resistant mechanisms to EGFR-TKIs and provide potential targets for development of new therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-qtzzXrDFl75XHngOXiV_fW6udTcc2ebh8U4CmA5YHbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rgtlOqsw%253D%253D&md5=8429fc78384f6e540b1fa8f6c57c363b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2015.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2015.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DFu%26aufirst%3DL.%26atitle%3DMechanisms%2520of%2520Resistance%2520to%2520EGFR%2520Tyrosine%2520Kinase%2520Inhibitors%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2015%26volume%3D5%26spage%3D390%26epage%3D401%26doi%3D10.1016%2Fj.apsb.2015.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Fukumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamauchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hippo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibahara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanari, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hironaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukayama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dosaka-Akita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aburatani, H.</span><span> </span><span class="NLM_article-title">Overexpression of the Aldo-Keto Reductase Family Protein AKR1B10 Is Highly Correlated with Smokersâ Non-Small Cell Lung Carcinomas</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1776</span><span class="NLM_x">â</span> <span class="NLM_lpage">1785</span><span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-04-1238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1158%2F1078-0432.CCR-04-1238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=15755999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVKrsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=1776-1785&author=S.+Fukumotoauthor=N.+Yamauchiauthor=H.+Moriguchiauthor=Y.+Hippoauthor=A.+Watanabeauthor=J.+Shibaharaauthor=H.+Taniguchiauthor=S.+Ishikawaauthor=H.+Itoauthor=S.+Yamamotoauthor=H.+Iwanariauthor=M.+Hironakaauthor=Y.+Ishikawaauthor=T.+Nikiauthor=Y.+Soharaauthor=T.+Kodamaauthor=M.+Nishimuraauthor=M.+Fukayamaauthor=H.+Dosaka-Akitaauthor=H.+Aburatani&title=Overexpression+of+the+Aldo-Keto+Reductase+Family+Protein+AKR1B10+Is+Highly+Correlated+with+Smokers%E2%80%99+Non-Small+Cell+Lung+Carcinomas&doi=10.1158%2F1078-0432.CCR-04-1238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of the Aldo-Keto Reductase Family Protein AKR1B10 Is Highly Correlated with Smokers' Non-Small Cell Lung Carcinomas</span></div><div class="casAuthors">Fukumoto, Shin-Ichi; Yamauchi, Naoko; Moriguchi, Hisashi; Hippo, Yoshitaka; Watanabe, Akira; Shibahara, Junji; Taniguchi, Hirokazu; Ishikawa, Shumpei; Ito, Hirotaka; Yamamoto, Shogo; Iwanari, Hiroko; Hironaka, Mitsugu; Ishikawa, Yuichi; Niki, Toshiro; Sohara, Yasunori; Kodama, Tatsuhiko; Nishimura, Masaharu; Fukayama, Masashi; Dosaka-Akita, Hirotoshi; Aburatani, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1776-1785</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Squamous cell carcinoma (SCC) and adenocarcinoma of the lung are currently subject to similar treatment regimens despite distinct differences in histol. and epidemiol.  The aim of this study is to identify a mol. target with diagnostic and therapeutic values for SCC.  Exptl. Design: Genes specifically up-regulated in SCC were explored through microarray anal. of 5 SCCs, 5 adenocarcinomas, 10 small cell lung carcinomas, 27 normal tissues, and 40 cancer cell lines.  Clin. usefulness of these genes was subsequently examd. mainly by immunohistochem. anal.  RESULTS: Seven genes, including aldo-keto reductase family 1, member B10 (AKR1B10), were identified as SCC-specific genes.  AKR1B10 was further examd. by immunohistochem. anal. of 101 non-small cell lung carcinomas (NSCLC) and its overexpression was obsd. in 27 of 32 (84.4%) SCCs and 19 of 65 (29.2%) adenocarcinomas.  Multiple regression anal. showed that smoking was an independent variable responsible for AKR1B10 overexpression in NSCLCs (P < 0.01) and adenocarcinomas (P < 0.01).  AKR1B10 staining was occasionally obsd. even in squamous metaplasia, a precancerous lesion of SCC.  CONCLUSION: AKR1B10 was overexpressed in most cases with SCC, which is closely assocd. with smoking, and many adenocarcinoma cases of smokers.  These results suggest that AKR1B10 is a potential diagnostic marker specific to smokers' NSCLCs and might be involved in tobacco-related carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmOUU7059FVrVg90H21EOLACvtfcHk0liKEa2gLHF6sA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVKrsrc%253D&md5=abe88dc2407e299102540c683b122f2f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-1238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-1238%26sid%3Dliteratum%253Aachs%26aulast%3DFukumoto%26aufirst%3DS.%26aulast%3DYamauchi%26aufirst%3DN.%26aulast%3DMoriguchi%26aufirst%3DH.%26aulast%3DHippo%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DA.%26aulast%3DShibahara%26aufirst%3DJ.%26aulast%3DTaniguchi%26aufirst%3DH.%26aulast%3DIshikawa%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DS.%26aulast%3DIwanari%26aufirst%3DH.%26aulast%3DHironaka%26aufirst%3DM.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DNiki%26aufirst%3DT.%26aulast%3DSohara%26aufirst%3DY.%26aulast%3DKodama%26aufirst%3DT.%26aulast%3DNishimura%26aufirst%3DM.%26aulast%3DFukayama%26aufirst%3DM.%26aulast%3DDosaka-Akita%26aufirst%3DH.%26aulast%3DAburatani%26aufirst%3DH.%26atitle%3DOverexpression%2520of%2520the%2520Aldo-Keto%2520Reductase%2520Family%2520Protein%2520AKR1B10%2520Is%2520Highly%2520Correlated%2520with%2520Smokers%25E2%2580%2599%2520Non-Small%2520Cell%2520Lung%2520Carcinomas%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D1776%26epage%3D1785%26doi%3D10.1158%2F1078-0432.CCR-04-1238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Son, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span> </span><span class="NLM_article-title">Clinical Validity of the Lung Cancer Biomarkers Identified by Bioinformatics Analysis of Public Expression Data</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">7431</span><span class="NLM_x">â</span> <span class="NLM_lpage">7438</span><span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-07-0003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1158%2F0008-5472.CAN-07-0003" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=7431-7438&author=B.+Kimauthor=H.+J.+Leeauthor=H.+Y.+Choiauthor=Y.+Shinauthor=S.+Namauthor=G.+Seoauthor=D.+S.+Sonauthor=J.+Joauthor=J.+Kimauthor=J.+Leeauthor=J.+Kimauthor=K.+Kimauthor=S.+Lee&title=Clinical+Validity+of+the+Lung+Cancer+Biomarkers+Identified+by+Bioinformatics+Analysis+of+Public+Expression+Data&doi=10.1158%2F0008-5472.CAN-07-0003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-0003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-0003%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DChoi%26aufirst%3DH.%2BY.%26aulast%3DShin%26aufirst%3DY.%26aulast%3DNam%26aufirst%3DS.%26aulast%3DSeo%26aufirst%3DG.%26aulast%3DSon%26aufirst%3DD.%2BS.%26aulast%3DJo%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DS.%26atitle%3DClinical%2520Validity%2520of%2520the%2520Lung%2520Cancer%2520Biomarkers%2520Identified%2520by%2520Bioinformatics%2520Analysis%2520of%2520Public%2520Expression%2520Data%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D7431%26epage%3D7438%26doi%3D10.1158%2F0008-5472.CAN-07-0003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Kang, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.</span><span> </span><span class="NLM_article-title">AKR1B10 Is Associated with Smoking and Smoking-Related Non-Small-Cell Lung Cancer</span> <span class="citation_source-journal">J. Int. Med. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">â</span> <span class="NLM_lpage">85</span><span class="refDoi">Â DOI: 10.1177/147323001103900110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1177%2F147323001103900110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=21672310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVeitL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=78-85&author=M.+W.+Kangauthor=E.+S.+Leeauthor=S.+Y.+Yoonauthor=J.+Joauthor=J.+Leeauthor=H.+K.+Kimauthor=Y.+S.+Choiauthor=K.+Kimauthor=Y.+M.+Shimauthor=J.+Kimauthor=H.+Kim&title=AKR1B10+Is+Associated+with+Smoking+and+Smoking-Related+Non-Small-Cell+Lung+Cancer&doi=10.1177%2F147323001103900110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">AKR1B10 is associated with smoking and smoking-related non-small-cell lung cancer</span></div><div class="casAuthors">Kang, M.-W.; Lee, E.-S.; Yoon, S. Y.; Jo, J.; Lee, J.; Kim, H. K.; Choi, Y. S.; Kim, K.; Shim, Y. M.; Kim, J.; Kim, H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of International Medical Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-85</span>CODEN:
                <span class="NLM_cas:coden">JIMRBV</span>;
        ISSN:<span class="NLM_cas:issn">0300-0605</span>.
    
            (<span class="NLM_cas:orgname">Field House Publishing LLP</span>)
        </div><div class="casAbstract">This prospective study explored the relationship between expression of AKR1B10 mRNA and various clin. parameters in non-small-cell lung cancer (NSCLC) in terms of its validation as a marker for NSCLC.  Tumor tissue samples were collected from 229 patients with NSCLC.  Tissue samples from adjacent non-malignant lung tissue (> 5 cm from the tumor) of 89 of these patients and samples from 20 patients with benign lung disease were used as controls.  Quant. reverse transcription-polymerase chain reaction showed significantly higher levels of AKR1B10 mRNA expression in NSCLC tumor tissue than in adjacent non-malignant lung tissue and benign lung tissue.  Statistically significant factors for AKR1B10 mRNA over-expression were found to be male gender, smoking, squamous cell carcinoma and moderate or poor cell differentiation.  It is concluded that AKR1B10 seems to have potential as a prognostic marker for NSCLC and warrants further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry72bL_A7eDLVg90H21EOLACvtfcHk0lhIh6lZty7taQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVeitL0%253D&md5=d066b70b99ce0b1c258ac9e7ae3fb41d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1177%2F147323001103900110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F147323001103900110%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DM.%2BW.%26aulast%3DLee%26aufirst%3DE.%2BS.%26aulast%3DYoon%26aufirst%3DS.%2BY.%26aulast%3DJo%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DH.%2BK.%26aulast%3DChoi%26aufirst%3DY.%2BS.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DShim%26aufirst%3DY.%2BM.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DH.%26atitle%3DAKR1B10%2520Is%2520Associated%2520with%2520Smoking%2520and%2520Smoking-Related%2520Non-Small-Cell%2520Lung%2520Cancer%26jtitle%3DJ.%2520Int.%2520Med.%2520Res.%26date%3D2011%26volume%3D39%26spage%3D78%26epage%3D85%26doi%3D10.1177%2F147323001103900110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Pastor, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nogal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina-Pinelo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melendez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salinas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez De la Pena, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Juan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corral, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Carbonero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carnero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paz-Ares, L.</span><span> </span><span class="NLM_article-title">Identification of Proteomic Signatures Associated with Lung Cancer and COPD</span> <span class="citation_source-journal">J. Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">â</span> <span class="NLM_lpage">237</span><span class="refDoi">Â DOI: 10.1016/j.jprot.2013.04.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.jprot.2013.04.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=23665002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1ekt77E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2013&pages=227-237&author=M.+D.+Pastorauthor=A.+Nogalauthor=S.+Molina-Pineloauthor=R.+Melendezauthor=A.+Salinasauthor=M.+Gonzalez+De+la+Penaauthor=J.+Martin-Juanauthor=J.+Corralauthor=R.+Garcia-Carboneroauthor=A.+Carneroauthor=L.+Paz-Ares&title=Identification+of+Proteomic+Signatures+Associated+with+Lung+Cancer+and+COPD&doi=10.1016%2Fj.jprot.2013.04.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of proteomic signatures associated with lung cancer and COPD</span></div><div class="casAuthors">Pastor, M. D.; Nogal, A.; Molina-Pinelo, S.; Melendez, R.; Salinas, A.; Gonzalez De la Pena, M.; Martin-Juan, J.; Corral, J.; Garcia-Carbonero, R.; Carnero, A.; Paz-Ares, L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteomics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">227-237</span>CODEN:
                <span class="NLM_cas:coden">JPORFQ</span>;
        ISSN:<span class="NLM_cas:issn">1874-3919</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lung cancer (LC) and chronic obstructive pulmonary disease (COPD) commonly coexist in smokers, and the presence of COPD increases the risk of developing LC.  The aim of this study was to identify distinct proteomic profiles able to discriminate these two pathol. entities.  Protein content was assessed in the bronchoalveolar lavage (BAL) of 60 patients classified in four groups: COPD, COPD and LC, LC without COPD, and control with neither COPD nor LC.  Proteins were sepd. into spots by bidimensional polyacrylamide gel electrophoresis (2D-PAGE) and examd. by matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF/TOF).  A total of 40 proteins were differentially expressed in the LC and/or COPD groups as compared with the control group.  Distinct protein profiles were identified and validated for each pathol. entity (LC and COPD).  The main networks involved were related to inflammatory signalling, free radical scavenging and oxidative stress response, and glycolysis and gluconeogenesis pathways.  The most relevant signalling link between LC and COPD was through the NF-ÎºB pathway.  In conclusion, the protein profiles identified contribute to elucidate the underlying pathogenic pathways of both diseases, and provide new tools of potential use as biomarkers for the early diagnosis of LC.  Sequence coverage: The protein sequence coverage (95%) was estd. for specific proteins by the percentage of matching amino acids from the identified peptides having confidence greater than or equal to 95% divided by the total no. of amino acids in the sequence.  Ingenuity Pathways Anal.: Mapping of our proteins onto biol. pathways and disease networks demonstrated that 22 proteins were linked to inflammatory signalling (p-value: 1.35 * 10-08-1.42 * 10-02), 15 proteins were assocd. with free radical scavenging and oxidative stress response (p-value: 4.93 * 10-11-1.27 * 10-02), and 9 proteins were related with glycolysis and gluconeogenesis pathways (p-value: 7.39 * 10-09-1.58 * 10-02).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6ciQrB9fukbVg90H21EOLACvtfcHk0lhIh6lZty7taQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1ekt77E&md5=f5931bf2652feb3cee5505fe65b6202c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.jprot.2013.04.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jprot.2013.04.037%26sid%3Dliteratum%253Aachs%26aulast%3DPastor%26aufirst%3DM.%2BD.%26aulast%3DNogal%26aufirst%3DA.%26aulast%3DMolina-Pinelo%26aufirst%3DS.%26aulast%3DMelendez%26aufirst%3DR.%26aulast%3DSalinas%26aufirst%3DA.%26aulast%3DGonzalez%2BDe%2Bla%2BPena%26aufirst%3DM.%26aulast%3DMartin-Juan%26aufirst%3DJ.%26aulast%3DCorral%26aufirst%3DJ.%26aulast%3DGarcia-Carbonero%26aufirst%3DR.%26aulast%3DCarnero%26aufirst%3DA.%26aulast%3DPaz-Ares%26aufirst%3DL.%26atitle%3DIdentification%2520of%2520Proteomic%2520Signatures%2520Associated%2520with%2520Lung%2520Cancer%2520and%2520COPD%26jtitle%3DJ.%2520Proteomics%26date%3D2013%26volume%3D89%26spage%3D227%26epage%3D237%26doi%3D10.1016%2Fj.jprot.2013.04.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Szymanowska-Narloch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jassem, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skrzypski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meister, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dienemann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rzepko, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarzab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marjanski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlowski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rzyman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jassem, J.</span><span> </span><span class="NLM_article-title">Molecular Profiles of Non-Small Cell Lung Cancers in Cigarette Smoking and Never-Smoking Patients</span> <span class="citation_source-journal">Adv. Med. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">â</span> <span class="NLM_lpage">206</span><span class="refDoi">Â DOI: 10.2478/ams-2013-0025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.2478%2Fams-2013-0025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=24451080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsFOlsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2013&pages=196-206&author=A.+Szymanowska-Narlochauthor=E.+Jassemauthor=M.+Skrzypskiauthor=T.+Muleyauthor=M.+Meisterauthor=H.+Dienemannauthor=M.+Taronauthor=R.+Rosellauthor=R.+Rzepkoauthor=M.+Jarzabauthor=T.+Marjanskiauthor=R.+Pawlowskiauthor=W.+Rzymanauthor=J.+Jassem&title=Molecular+Profiles+of+Non-Small+Cell+Lung+Cancers+in+Cigarette+Smoking+and+Never-Smoking+Patients&doi=10.2478%2Fams-2013-0025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular profiles of non-small cell lung cancers in cigarette smoking and never-smoking patients</span></div><div class="casAuthors">Szymanowska-Narloch, A.; Jassem, E.; Skrzypski, M.; Muley, T.; Meister, M.; Dienemann, H.; Taron, M.; Rosell, R.; Rzepko, R.; Jarzab, M.; Marjanski, T.; Pawlowski, R.; Rzyman, W.; Jassem, J.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Medical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">196-206</span>CODEN:
                <span class="NLM_cas:coden">AMSDCH</span>;
        ISSN:<span class="NLM_cas:issn">1896-1126</span>.
    
            (<span class="NLM_cas:orgname">Medical University of Bialystok</span>)
        </div><div class="casAbstract">Purpose: Mol. features of non-small cell lung cancer (NSCLC) in never-smokers are not well recognized.  We assessed the expression of genes potentially related to lung cancer etiol. in smoking vs. never-smoking NSCLC patients.  Methods: We assayed frozen tumor samples from surgically resected 31 never-smoking and 54 clin. pair-matched smoking NSCLC patients, and from corresponding normal lung tissue from 27 and 43 patients, resp.  Expression of 21 genes, including cell membrane kinases, sex hormone receptors, transcription factors, growth factors and others was assessed by reverse transcription - quant. PCR.  Results: Expression of 5 genes was significantly higher in tumors of non-smokers vs. smokers: CSF1R (p<0.0001), RRAD (p<0.0001), PR (p=0.0004), TGFBR2 (p=0.0027) and EPHB6 (p=0.0033).  Expression of AKR1B10 (p<0.0001), CDKN2A (p<0.0001), CHRNA6 (p<0.0001), SOX9 (p<0.0001), survivin (p<0.0001) and ER2 (p=0.002) was significantly higher in tumors compared to normal lung tissue.  Expression of AR (p<0.0001), EPHB6 (p<0.0001), PR (p<0.0001), TGFBR2 (p<0.0001), TGFBR3 (p<0.0001), ER1 (p=0.0006) and DLG1 (p=0.0016) was significantly lower in tumors than in normal lung tissue.  Expression of IGF2 was higher in tumors than in healthy lung tissue in never-smokers (p=0.003), and expression of AHR (p<0.0001), CSF1R (p<0.0001) and RRAD (p<0.0001) was lower in tumors than in healthy lung tissue in smokers.  Conclusion: Expression of several genes in NSCLC is strongly related to smoking history.  Lower expression of PR and higher expression of ER2 in tumors suggests a possibility of hormonal therapeutic intervention in selected NSCLC patients.  Distinct mol. features of NSCLC in never-smokers, e.g. CHRNA6 upregulation, may prompt new treatment strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovXLKkjaH2i7Vg90H21EOLACvtfcHk0lickXm87RgRCA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsFOlsLo%253D&md5=ad5bc8300fc0ac14bd3e36a6ab3a92fb</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2478%2Fams-2013-0025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2478%252Fams-2013-0025%26sid%3Dliteratum%253Aachs%26aulast%3DSzymanowska-Narloch%26aufirst%3DA.%26aulast%3DJassem%26aufirst%3DE.%26aulast%3DSkrzypski%26aufirst%3DM.%26aulast%3DMuley%26aufirst%3DT.%26aulast%3DMeister%26aufirst%3DM.%26aulast%3DDienemann%26aufirst%3DH.%26aulast%3DTaron%26aufirst%3DM.%26aulast%3DRosell%26aufirst%3DR.%26aulast%3DRzepko%26aufirst%3DR.%26aulast%3DJarzab%26aufirst%3DM.%26aulast%3DMarjanski%26aufirst%3DT.%26aulast%3DPawlowski%26aufirst%3DR.%26aulast%3DRzyman%26aufirst%3DW.%26aulast%3DJassem%26aufirst%3DJ.%26atitle%3DMolecular%2520Profiles%2520of%2520Non-Small%2520Cell%2520Lung%2520Cancers%2520in%2520Cigarette%2520Smoking%2520and%2520Never-Smoking%2520Patients%26jtitle%3DAdv.%2520Med.%2520Sci.%26date%3D2013%26volume%3D58%26spage%3D196%26epage%3D206%26doi%3D10.2478%2Fams-2013-0025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Ludovini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianconi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siggillino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piobbico, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vannucci, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellezza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puma, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Della Fazia, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Servillo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crino, L.</span><span> </span><span class="NLM_article-title">Gene Identification for Risk of Relapse in Stage I Lung Adenocarcinoma Patients: A Combined Methodology of Gene Expression Profiling and Computational Gene Network Analysis</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">30561</span><span class="NLM_x">â</span> <span class="NLM_lpage">30574</span><span class="refDoi">Â DOI: 10.18632/oncotarget.8723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.18632%2Foncotarget.8723" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=30561-30574&author=V.+Ludoviniauthor=F.+Bianconiauthor=A.+Siggillinoauthor=D.+Piobbicoauthor=J.+Vannucciauthor=G.+Metroauthor=R.+Chiariauthor=G.+Bellezzaauthor=F.+Pumaauthor=M.+A.+Della+Faziaauthor=G.+Servilloauthor=L.+Crino&title=Gene+Identification+for+Risk+of+Relapse+in+Stage+I+Lung+Adenocarcinoma+Patients%3A+A+Combined+Methodology+of+Gene+Expression+Profiling+and+Computational+Gene+Network+Analysis&doi=10.18632%2Foncotarget.8723"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.8723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.8723%26sid%3Dliteratum%253Aachs%26aulast%3DLudovini%26aufirst%3DV.%26aulast%3DBianconi%26aufirst%3DF.%26aulast%3DSiggillino%26aufirst%3DA.%26aulast%3DPiobbico%26aufirst%3DD.%26aulast%3DVannucci%26aufirst%3DJ.%26aulast%3DMetro%26aufirst%3DG.%26aulast%3DChiari%26aufirst%3DR.%26aulast%3DBellezza%26aufirst%3DG.%26aulast%3DPuma%26aufirst%3DF.%26aulast%3DDella%2BFazia%26aufirst%3DM.%2BA.%26aulast%3DServillo%26aufirst%3DG.%26aulast%3DCrino%26aufirst%3DL.%26atitle%3DGene%2520Identification%2520for%2520Risk%2520of%2520Relapse%2520in%2520Stage%2520I%2520Lung%2520Adenocarcinoma%2520Patients%253A%2520A%2520Combined%2520Methodology%2520of%2520Gene%2520Expression%2520Profiling%2520and%2520Computational%2520Gene%2520Network%2520Analysis%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D30561%26epage%3D30574%26doi%3D10.18632%2Foncotarget.8723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Cao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, S. S.</span><span> </span><span class="NLM_article-title">Identification and Characterization of a Novel Human Aldose Reductase-like Gene</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">11429</span><span class="NLM_x">â</span> <span class="NLM_lpage">11435</span><span class="refDoi">Â DOI: 10.1074/jbc.273.19.11429</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1074%2Fjbc.273.19.11429" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=11429-11435&author=D.+Caoauthor=S.+T.+Fanauthor=S.+S.+Chung&title=Identification+and+Characterization+of+a+Novel+Human+Aldose+Reductase-like+Gene&doi=10.1074%2Fjbc.273.19.11429"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.19.11429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.19.11429%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DD.%26aulast%3DFan%26aufirst%3DS.%2BT.%26aulast%3DChung%26aufirst%3DS.%2BS.%26atitle%3DIdentification%2520and%2520Characterization%2520of%2520a%2520Novel%2520Human%2520Aldose%2520Reductase-like%2520Gene%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D11429%26epage%3D11435%26doi%3D10.1074%2Fjbc.273.19.11429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Matkowskyj, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omary, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G. Y.</span><span> </span><span class="NLM_article-title">Aldoketoreductase Family 1B10 (AKR1B10) as a Biomarker to Distinguish Hepatocellular Carcinoma from Benign Liver Lesions</span> <span class="citation_source-journal">Hum. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">834</span><span class="NLM_x">â</span> <span class="NLM_lpage">843</span><span class="refDoi">Â DOI: 10.1016/j.humpath.2013.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.humpath.2013.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=24656094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksF2ntr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2014&pages=834-843&author=K.+A.+Matkowskyjauthor=H.+Baiauthor=J.+Liaoauthor=W.+Zhangauthor=H.+Liauthor=S.+Raoauthor=R.+Omaryauthor=G.+Y.+Yang&title=Aldoketoreductase+Family+1B10+%28AKR1B10%29+as+a+Biomarker+to+Distinguish+Hepatocellular+Carcinoma+from+Benign+Liver+Lesions&doi=10.1016%2Fj.humpath.2013.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions</span></div><div class="casAuthors">Matkowskyj, Kristina A.; Bai, Han; Liao, Jie; Zhang, Wanying; Li, Haonan; Rao, Sambasiva; Omary, Reed; Yang, Guang-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Human Pathology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">834-843</span>CODEN:
                <span class="NLM_cas:coden">HPCQA4</span>;
        ISSN:<span class="NLM_cas:issn">0046-8177</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma (HCC) is one of the most common highly aggressive malignant tumors worldwide.  Aldoketoreductase 1B10 (AKR1B10) was first isolated from HCC and further identified to be over-expressed in many cancers from various organs.  AKR1B10 contributes to detoxification of xenobiotics by lipid peroxidn. and metabolizes physiol. substrates such as farnesal, retinal, and carbonyls.  Metabolizing these lipid substrates plays a crucial role in promoting carcinogenesis.  In the present study, immunohistochem. anal. was performed to det. the prevalence/pattern of AKR1B10 expression in HCC and its usefulness to differentiate benign liver lesions from HCC.  Oncogenic function of AKR1B10 was examd. in hepatocellular carcinoma cells in vitro using Western blotting and shRNA knockdown approaches, with emphasis on cell apoptosis and response to chemotherapy.  Immunohistochem. anal. revealed AKR1B10 was overexpressed in 97% (86/89) of hepatocellular carcinomas, with minimal to no expression in adjacent hepatic tissue, while hepatic adenomas and focal nodular hyperplasia did not exhibit expression of AKR1B10. shRNA-mediated silencing of AKR1B10 expression in hepatocellular carcinoma cells resulted in (1) increased cell apoptosis, (2) decreased colony formation and size, and (3) enhanced cytoreductive response following exposure to doxorubicin chemotherapy.  Our findings provide first time evidence that AKR1B10 is a unique biomarker involved in hepatocellular carcinogenesis via modulation of proliferation, cell apoptosis and chemoresistance and is a potential promising biomarker to differentiate HCCs from benign hepatic lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovx1Rr7M89YbVg90H21EOLACvtfcHk0lickXm87RgRCA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksF2ntr0%253D&md5=0b996535b40ad8e18c9e740b945b7f21</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.humpath.2013.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.humpath.2013.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DMatkowskyj%26aufirst%3DK.%2BA.%26aulast%3DBai%26aufirst%3DH.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DOmary%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DG.%2BY.%26atitle%3DAldoketoreductase%2520Family%25201B10%2520%2528AKR1B10%2529%2520as%2520a%2520Biomarker%2520to%2520Distinguish%2520Hepatocellular%2520Carcinoma%2520from%2520Benign%2520Liver%2520Lesions%26jtitle%3DHum.%2520Pathol.%26date%3D2014%26volume%3D45%26spage%3D834%26epage%3D843%26doi%3D10.1016%2Fj.humpath.2013.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, D. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span> </span><span class="NLM_article-title">AKR1B10 Overexpression in Breast Cancer: Association with Tumor Size, Lymph Node Metastasis and Patient Survival and its Potential as a Novel Serum Marker</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">E862</span><span class="NLM_x">â</span> <span class="NLM_lpage">E871</span><span class="refDoi">Â DOI: 10.1002/ijc.27618</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1002%2Fijc.27618" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=22539036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1Crs7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2012&pages=E862-E871&author=J.+Maauthor=D.+X.+Luoauthor=C.+Huangauthor=Y.+Shenauthor=Y.+Buauthor=S.+Markwellauthor=J.+Gaoauthor=J.+Liuauthor=X.+Zuauthor=Z.+Caoauthor=Z.+Gaoauthor=F.+Luauthor=D.+F.+Liaoauthor=D.+Cao&title=AKR1B10+Overexpression+in+Breast+Cancer%3A+Association+with+Tumor+Size%2C+Lymph+Node+Metastasis+and+Patient+Survival+and+its+Potential+as+a+Novel+Serum+Marker&doi=10.1002%2Fijc.27618"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">AKR1B10 overexpression in breast cancer: Association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker</span></div><div class="casAuthors">Ma, Jun; Luo, Di-Xian; Huang, Chenfei; Shen, Yi; Bu, Yiwen; Markwell, Stephen; Gao, John; Liu, Jianghua; Zu, Xuyu; Cao, Zhe; Gao, Zachary; Lu, Fengmin; Liao, Duan-Fang; Cao, Deliang</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">E862-E871</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Aldo-keto reductase 1B10 (AKR1B10) is a secretory protein that is upregulated with tumorigenic transformation of human mammary epithelial cells.  This study demonstrated that AKR1B10 was overexpressed in 20 (71.4%) of 28 ductal carcinomas in situ, 184 (83.6%) of 220 infiltrating carcinomas and 28 (87.5%) of 32 recurrent tumors.  AKR1B10 expression in breast cancer was correlated pos. with tumor size (p = 0.0012) and lymph node metastasis (p = 0.0123) but inversely with disease-related survival (p = 0.0120).  Univariate (p = 0.0077) and multivariate (p = 0.0192) analyses both suggested that AKR1B10, alone or together with tumor size and node status, is a significant prognostic factor for breast cancer.  Silencing of AKR1B10 in BT-20 human breast cancer cells inhibited cell growth in culture and tumorigenesis in female nude mice.  Importantly, AKR1B10 in the serum of breast cancer patients was significantly increased to 15.18 Â± 9.08 ng/mL [n = 50; 95% confidence interval (CI), 12.60-17.76], with a high level up to 58.4 ng/mL, compared to 3.34 Â± 2.27 ng/mL in healthy donors (n = 60; 95% CI, 2.78-3.90).  In these patients, AKR1B10 levels in serum were correlated with its expression in tumors (r = 0.8066; p < 0.0001).  Together our data suggests that AKR1B10 is overexpressed in breast cancer and may be a novel prognostic factor and serum marker for this deadly disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR5IwWNSHIz7Vg90H21EOLACvtfcHk0ljDXxU76zjxzQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1Crs7w%253D&md5=64712b59c0c2daef9984db128478f045</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fijc.27618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.27618%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DD.%2BX.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DBu%26aufirst%3DY.%26aulast%3DMarkwell%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZu%26aufirst%3DX.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DGao%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DF.%26aulast%3DLiao%26aufirst%3DD.%2BF.%26aulast%3DCao%26aufirst%3DD.%26atitle%3DAKR1B10%2520Overexpression%2520in%2520Breast%2520Cancer%253A%2520Association%2520with%2520Tumor%2520Size%252C%2520Lymph%2520Node%2520Metastasis%2520and%2520Patient%2520Survival%2520and%2520its%2520Potential%2520as%2520a%2520Novel%2520Serum%2520Marker%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2012%26volume%3D131%26spage%3DE862%26epage%3DE871%26doi%3D10.1002%2Fijc.27618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Hayes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skouras, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haugk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charnley, R. M.</span><span> </span><span class="NLM_article-title">Keap1-Nrf2 Signalling in Pancreatic Cancer</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">288</span><span class="NLM_x">â</span> <span class="NLM_lpage">299</span><span class="refDoi">Â DOI: 10.1016/j.biocel.2015.06.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.biocel.2015.06.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=26117456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtV2iu7bK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2015&pages=288-299&author=A.+J.+Hayesauthor=C.+Skourasauthor=B.+Haugkauthor=R.+M.+Charnley&title=Keap1-Nrf2+Signalling+in+Pancreatic+Cancer&doi=10.1016%2Fj.biocel.2015.06.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1-Nrf2 signalling in pancreatic cancer</span></div><div class="casAuthors">Hayes, Alastair J.; Skouras, Christos; Haugk, Beate; Charnley, Richard M.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">288-299</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Transcription factor NF-E2 p45-related factor 2 (Nrf2, also called Nfe2l2), a master regulator of redox homeostasis, and its dominant neg. regulator, Kelch-like ECH-assocd. protein 1 (Keap1), together tightly control the expression of numerous detoxifying and antioxidant genes.  Nrf2 and the 'antioxidant response element' (ARE)-driven genes it controls are frequently upregulated in pancreatic cancer and correlate with poor survival.  Upregulation of Nrf2 is, at least in part, K-Ras oncogene-driven and contributes to pancreatic cancer proliferation and chemoresistance.  In this review, we aim to provide an overview of Keap1-Nrf2 signalling as it relates to pancreatic cancer, discussing the effects of inhibiting Nrf2 or Nrf2/ARE effector proteins to increase chemosensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9jxaff_vLBbVg90H21EOLACvtfcHk0ljDXxU76zjxzQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtV2iu7bK&md5=cba47c1f31618500e12a6b6839651ee2</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2015.06.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2015.06.017%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DA.%2BJ.%26aulast%3DSkouras%26aufirst%3DC.%26aulast%3DHaugk%26aufirst%3DB.%26aulast%3DCharnley%26aufirst%3DR.%2BM.%26atitle%3DKeap1-Nrf2%2520Signalling%2520in%2520Pancreatic%2520Cancer%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2015%26volume%3D65%26spage%3D288%26epage%3D299%26doi%3D10.1016%2Fj.biocel.2015.06.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Ko, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, S. J.</span><span> </span><span class="NLM_article-title">Expression of AKR1B10 as an Independent Marker for Poor Prognosis in Human Oral Squamous Cell Carcinoma</span> <span class="citation_source-journal">Head Neck</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1327</span><span class="NLM_x">â</span> <span class="NLM_lpage">1332</span><span class="refDoi">Â DOI: 10.1002/hed.24759</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1002%2Fhed.24759" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=28301069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A280%3ADC%252BC1czmvFGqsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2017&pages=1327-1332&author=H.+H.+Koauthor=S.+L.+Chengauthor=J.+J.+Leeauthor=H.+M.+Chenauthor=M.+Y.+Kuoauthor=S.+J.+Cheng&title=Expression+of+AKR1B10+as+an+Independent+Marker+for+Poor+Prognosis+in+Human+Oral+Squamous+Cell+Carcinoma&doi=10.1002%2Fhed.24759"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of AKR1B10 as an independent marker for poor prognosis in human oral squamous cell carcinoma</span></div><div class="casAuthors">Ko Hui-Hsin; Chen Hsin-Ming; Kuo Mark Yen-Ping; Cheng Shih-Jung; Ko Hui-Hsin; Lee Jang-Jaer; Chen Hsin-Ming; Kuo Mark Yen-Ping; Cheng Shih-Jung; Cheng Shih-Lung; Cheng Shih-Lung; Lee Jang-Jaer; Chen Hsin-Ming; Kuo Mark Yen-Ping; Cheng Shih-Jung; Chen Hsin-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Head & neck</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1327-1332</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Aldo-keto reductase family 1 member B10 (AKR1B10) is implicated in xenobiotic detoxification and has disparate functions in tumorigenesis that are dependent on the cell types.  The purpose of this study was to investigate the clinicopathological significance of AKR1B10 as a prognostic marker for oral squamous cell carcinomas (OSCCs).  METHODS:  AKR1B10 protein expression was analyzed by immunohistochemistry in 77 patients with OSCC.  RESULTS:  The AKR1B10 labeling score for OSCCs (1.16 Â± 1.14) was significantly higher than that for normal oral mucosa (0.10 Â± 0.23; p < .0001).  High expression of AKR1B10 significantly correlated with large tumor size (p = .041), advanced TNM classification (p = .037), and patient's areca quid chewing habit (p = .025).  Multivariate analysis revealed that high AKR1B10 labeling score >1.16 (hazard ratio, 3.647; p = .001) significantly correlated with mortality.  CONCLUSION:  AKR1B10 overexpression is an independent poor prognostic biomarker for OSCC.  AKR1B10 inhibitors may be promising in clinical trials against OSCC. Â© 2017 Wiley Periodicals, Inc.  Head Neck 39: 1327-1332, 2017.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXt68-4L-GNEHdcurJClFcfW6udTcc2ea4_BL118DKMbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czmvFGqsA%253D%253D&md5=9efbc0da1a2490a140c0de136877b718</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fhed.24759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhed.24759%26sid%3Dliteratum%253Aachs%26aulast%3DKo%26aufirst%3DH.%2BH.%26aulast%3DCheng%26aufirst%3DS.%2BL.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DChen%26aufirst%3DH.%2BM.%26aulast%3DKuo%26aufirst%3DM.%2BY.%26aulast%3DCheng%26aufirst%3DS.%2BJ.%26atitle%3DExpression%2520of%2520AKR1B10%2520as%2520an%2520Independent%2520Marker%2520for%2520Poor%2520Prognosis%2520in%2520Human%2520Oral%2520Squamous%2520Cell%2520Carcinoma%26jtitle%3DHead%2520Neck%26date%3D2017%26volume%3D39%26spage%3D1327%26epage%3D1332%26doi%3D10.1002%2Fhed.24759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitade, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Kinetic Studies of AKR1B10, Human Aldose Reductase-like Protein: Endogenous Substrates and Inhibition by Steroids</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">487</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">9</span><span class="refDoi">Â DOI: 10.1016/j.abb.2009.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.abb.2009.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=19464995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsFOgt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=487&publication_year=2009&pages=1-9&author=S.+Endoauthor=T.+Matsunagaauthor=H.+Mamiyaauthor=C.+Ohtaauthor=M.+Sodaauthor=Y.+Kitadeauthor=K.+Tajimaauthor=H.+T.+Zhaoauthor=O.+El-Kabbaniauthor=A.+Hara&title=Kinetic+Studies+of+AKR1B10%2C+Human+Aldose+Reductase-like+Protein%3A+Endogenous+Substrates+and+Inhibition+by+Steroids&doi=10.1016%2Fj.abb.2009.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic studies of AKR1B10, human aldose reductase-like protein: Endogenous substrates and inhibition by steroids</span></div><div class="casAuthors">Endo, Satoshi; Matsunaga, Toshiyuki; Mamiya, Hiroaki; Ohta, Chisato; Soda, Midori; Kitade, Yukio; Tajima, Kazuo; Zhao, Hai-Tao; El-Kabbani, Ossama; Hara, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">487</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A human member of the aldo-keto reductase (AKR) superfamily, AKR1B10, was identified as a biomarker of lung cancer, exhibiting high sequence identity with human aldose reductase (AKR1B1).  Using recombinant AKR1B10 and AKR1B1, we compared their substrate specificity for biogenic compds. and inhibition by endogenous compds. and found the following unique features of AKR1B10.  AKR1B10 efficiently reduced long-chain aliph. aldehydes including farnesal and geranylgeranial, which are generated from degrdn. of prenylated proteins and metab. of farnesol and geranylgeraniol derived from the mevalonate pathway.  The enzyme oxidized aliph. and arom. alcs. including 20Î±-hydroxysteroids.  In addn., AKR1B10 was inhibited by steroid hormones, bile acids and their metabolites, showing IC50 values of 0.03-25 Î¼M.  Kinetic analyses of the alc. oxidn. and inhibition by the steroids and tolrestat, together with the docked model of AKR1B10-inhibitor complex, suggest that the inhibitory steroids and tolrestat bind to overlapping sites within the active site of the enzyme-coenzyme complex.  Thus, we propose a novel role of AKR1B10 in controlling isoprenoid homeostasis that is important in cholesterol synthesis and cell proliferation through salvaging isoprenoid alcs., as well as its metabolic regulation by endogenous steroids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpeL1h3J-tgLVg90H21EOLACvtfcHk0ljDXxU76zjxzQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsFOgt7s%253D&md5=1788a9662b073c27fe8dd98849b4bfb1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2009.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2009.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DMamiya%26aufirst%3DH.%26aulast%3DOhta%26aufirst%3DC.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DKitade%26aufirst%3DY.%26aulast%3DTajima%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DH.%2BT.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DKinetic%2520Studies%2520of%2520AKR1B10%252C%2520Human%2520Aldose%2520Reductase-like%2520Protein%253A%2520Endogenous%2520Substrates%2520and%2520Inhibition%2520by%2520Steroids%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2009%26volume%3D487%26spage%3D1%26epage%3D9%26doi%3D10.1016%2Fj.abb.2009.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Martin, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maser, E.</span><span> </span><span class="NLM_article-title">Role of Human Aldo-Keto-Reductase AKR1B10 in the Protection against Toxic Aldehydes</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">178</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">â</span> <span class="NLM_lpage">150</span><span class="refDoi">Â DOI: 10.1016/j.cbi.2008.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.cbi.2008.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=19013440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFOjt7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2009&pages=145-150&author=H.+J.+Martinauthor=E.+Maser&title=Role+of+Human+Aldo-Keto-Reductase+AKR1B10+in+the+Protection+against+Toxic+Aldehydes&doi=10.1016%2Fj.cbi.2008.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Role of human aldo-keto-reductase AKR1B10 in the protection against toxic aldehydes</span></div><div class="casAuthors">Martin, Hans-Joerg; Maser, Edmund</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">145-150</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Damage of cell membranes by reactive oxygen species results in the formation of toxic lipid peroxides which may ultimately lead to cell death.  Among the best characterized intermediates of oxidative stress are the unsatd. aldehydes 4-hydroxynon-2-enal (4-HNE) and its oxidized counterpart 4-oxonon-2-enal (4-ONE).  4-HNE has been linked to various pathol. conditions including atherosclerosis, Parkinson's and Alzheimer's disease. 4-Methylpentanal (4-MP) is a side-chain cleavage product formed endogenously during steroidogenesis from cholesterol.  Like 4-HNE and 4-ONE, 4-MP is capable of binding covalently to and crosslinking of proteins.  These aldehydes are also damaging DNA by the formation of adducts.  We found that AKR1B10, a cytosolic member of the aldo-keto reductase superfamily, efficiently catalyzes the redn. of 4-HNE (Km = 0.3 mM, k cat = 43 min-1), 4-ONE (Km = 0.3 mM, k cat = 40 min-1) and 4-MP (Km = 0.05 mM, k cat = 25 min-1).  AKR1B10 catalyzed 4-MP redn. with a 30-fold increase in activity using NADPH as cofactor compared with NADH.  As was obsd. for aldose reductase (AKR1B1) 4-ONE rapidly inactivates AKR1B10, while this inactivation is not obsd. when the enzyme is preincubated with NADPH.  It was shown that cysteine 298 of aldose reductase was protected by NADPH from the Î±,Î²-unsatd. carbonyls of 4-ONE thus rendering resistance towards inactivation.  We generated a mutant AKR1B10, changing the resp. cysteine on position 299 of AKR1B10 into a serine.  This C299S mutant is still active towards 4-HNE and 4-ONE, albeit at a somewhat lower catalytic efficiency.  However, it is still inactivated by 4-ONE in the absence of NADPH.  While the best substrates for AKR1B10 are retinals, the high catalytic efficiency together with the protection from inactivation by NADPH suggests a role of AKR1B10 in the detoxification of biogenic aldehydes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsHuid09FnKLVg90H21EOLACvtfcHk0lg52UtOY8aegw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFOjt7c%253D&md5=cf098515950a42eba5b68e6e6d43a1cb</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2008.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2008.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DH.%2BJ.%26aulast%3DMaser%26aufirst%3DE.%26atitle%3DRole%2520of%2520Human%2520Aldo-Keto-Reductase%2520AKR1B10%2520in%2520the%2520Protection%2520against%2520Toxic%2520Aldehydes%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2009%26volume%3D178%26spage%3D145%26epage%3D150%26doi%3D10.1016%2Fj.cbi.2008.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span> </span><span class="NLM_article-title">Aldo-Keto Reductase Family 1 Member B10 Promotes Cell Survival by Regulating Lipid Synthesis and Eliminating Carbonyls</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">26742</span><span class="NLM_x">â</span> <span class="NLM_lpage">26748</span><span class="refDoi">Â DOI: 10.1074/jbc.M109.022897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1074%2Fjbc.M109.022897" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=26742-26748&author=C.+Wangauthor=R.+Yanauthor=D.+Luoauthor=K.+Watabeauthor=D.+F.+Liaoauthor=D.+Cao&title=Aldo-Keto+Reductase+Family+1+Member+B10+Promotes+Cell+Survival+by+Regulating+Lipid+Synthesis+and+Eliminating+Carbonyls&doi=10.1074%2Fjbc.M109.022897"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.022897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.022897%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DYan%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DD.%26aulast%3DWatabe%26aufirst%3DK.%26aulast%3DLiao%26aufirst%3DD.%2BF.%26aulast%3DCao%26aufirst%3DD.%26atitle%3DAldo-Keto%2520Reductase%2520Family%25201%2520Member%2520B10%2520Promotes%2520Cell%2520Survival%2520by%2520Regulating%2520Lipid%2520Synthesis%2520and%2520Eliminating%2520Carbonyls%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D26742%26epage%3D26748%26doi%3D10.1074%2Fjbc.M109.022897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adeyanju, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span> </span><span class="NLM_article-title">Aldo-Keto Reductase Family 1 B10 Gene Silencing Results in Growth Inhibition of Colorectal Cancer Cells: Implication for Cancer Intervention</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">2301</span><span class="NLM_x">â</span> <span class="NLM_lpage">2306</span><span class="refDoi">Â DOI: 10.1002/ijc.22933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1002%2Fijc.22933" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=17597105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1aisL%252FE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2007&pages=2301-2306&author=R.+Yanauthor=X.+Zuauthor=J.+Maauthor=Z.+Liuauthor=M.+Adeyanjuauthor=D.+Cao&title=Aldo-Keto+Reductase+Family+1+B10+Gene+Silencing+Results+in+Growth+Inhibition+of+Colorectal+Cancer+Cells%3A+Implication+for+Cancer+Intervention&doi=10.1002%2Fijc.22933"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: implication for cancer intervention</span></div><div class="casAuthors">Yan, Ruilan; Zu, Xuyu; Ma, Jun; Liu, Ziwen; Adeyanju, Moses; Cao, Deliang</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2301-2306</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Aldo-keto reductase family 1 B10 (AKR1B10), a member of aldo-keto reductase superfamily, is overexpressed in human hepatocellular carcinoma, lung squamous cell carcinoma and lung adenocarcinoma.  Our previous study had demonstrated that the ectopic expression of AKR1B10 in 293T cells promotes cell proliferation.  To evaluate its potential as a target for cancer intervention, in the current study we knocked down AKR1B10 expression in HCT-8 cells derived from a colorectal carcinoma, using chem. synthesized small interfering RNA (siRNA).  The siRNA 1, targeted to encoding region, downregulated AKR1B10 expression by more than 60%, and siRNA 2, targeted to 3' untranslational region, reduced AKR1B10 expression by more than 95%.  AKR1B10 silencing resulted in approx. a 50% decrease in cell growth rate and nearly 40% suppression of DNA synthesis.  More importantly, AKR1B10 downregulation significantly reduced focus formation rate and colony size in semisolid culture, indicating the crit. role of AKR1B10 in HCT-8 cell proliferation.  Recombinant AKR1B10 protein showed strong enzymic activity to acrolein and crotonaldehyde, with Km = 110.1 Â± 12.2 Î¼M and Vmax = 3,122.0 Â± 64.7 nmol/mg protein/min for acrolein and Km = 86.7 Â± 14.3 Î¼M and Vmax = 2,647.5 Â± 132.2 nmol/mg protein/min for crotonaldehyde.  AKR1B10 downregulation enhanced the susceptibility of HCT-8 cells to acrolein (25 Î¼M) and crotonaldehyde (50 Î¼M), resulting in rapid oncotic cell death characterized with lactate dehydrogenase efflux and annexin-V staining.  These results suggest that AKR1B10 may regulate cell proliferation and cellular response to addnl. carbonyl stress, thus being a potential target for cancer intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreRzjFH7dOLLVg90H21EOLACvtfcHk0lg52UtOY8aegw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1aisL%252FE&md5=4eefa9093766a7a953e361ca0508da0e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fijc.22933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.22933%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DZu%26aufirst%3DX.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DAdeyanju%26aufirst%3DM.%26aulast%3DCao%26aufirst%3DD.%26atitle%3DAldo-Keto%2520Reductase%2520Family%25201%2520B10%2520Gene%2520Silencing%2520Results%2520in%2520Growth%2520Inhibition%2520of%2520Colorectal%2520Cancer%2520Cells%253A%2520Implication%2520for%2520Cancer%2520Intervention%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2007%26volume%3D121%26spage%3D2301%26epage%3D2306%26doi%3D10.1002%2Fijc.22933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Zhong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span> </span><span class="NLM_article-title">Aldo-Keto Reductase Family 1 B10 Protein Detoxifies Dietary and Lipid-derived Î±,Î²-Unsaturated Carbonyls at Physiological Levels</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">â</span> <span class="NLM_lpage">250</span><span class="refDoi">Â DOI: 10.1016/j.bbrc.2009.06.123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.bbrc.2009.06.123" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2009&pages=245-250&author=L.+Zhongauthor=Z.+Liuauthor=R.+Yanauthor=S.+Johnsonauthor=Y.+Zhaoauthor=X.+Fangauthor=D.+Cao&title=Aldo-Keto+Reductase+Family+1+B10+Protein+Detoxifies+Dietary+and+Lipid-derived+%CE%B1%2C%CE%B2-Unsaturated+Carbonyls+at+Physiological+Levels&doi=10.1016%2Fj.bbrc.2009.06.123"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2009.06.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2009.06.123%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DYan%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DFang%26aufirst%3DX.%26aulast%3DCao%26aufirst%3DD.%26atitle%3DAldo-Keto%2520Reductase%2520Family%25201%2520B10%2520Protein%2520Detoxifies%2520Dietary%2520and%2520Lipid-derived%2520%25CE%25B1%252C%25CE%25B2-Unsaturated%2520Carbonyls%2520at%2520Physiological%2520Levels%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2009%26volume%3D387%26spage%3D245%26epage%3D250%26doi%3D10.1016%2Fj.bbrc.2009.06.123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Gallego, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardevol, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lera, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovira, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farres, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fita, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pares, X.</span><span> </span><span class="NLM_article-title">Structural Basis for the High <i>all</i>-<i>trans</i>-Retinaldehyde Reductase Activity of the Tumor Marker AKR1B10</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">20764</span><span class="NLM_x">â</span> <span class="NLM_lpage">20769</span><span class="refDoi">Â DOI: 10.1073/pnas.0705659105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1073%2Fpnas.0705659105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=18087047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1yjsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=20764-20769&author=O.+Gallegoauthor=F.+X.+Ruizauthor=A.+Ardevolauthor=M.+Dominguezauthor=R.+Alvarezauthor=A.+R.+de+Leraauthor=C.+Roviraauthor=J.+Farresauthor=I.+Fitaauthor=X.+Pares&title=Structural+Basis+for+the+High+all-trans-Retinaldehyde+Reductase+Activity+of+the+Tumor+Marker+AKR1B10&doi=10.1073%2Fpnas.0705659105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10</span></div><div class="casAuthors">Gallego, Oriol; Ruiz, F. Xavier; Ardevol, Albert; Dominguez, Marta; Alvarez, Rosana; de Lera, Angel R.; Rovira, Carme; Farres, Jaume; Fita, Ignacio; Pares, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">20764-20769</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">AKR1B10 is a human aldo-keto reductase (AKR) found to be elevated in several cancer types and in precancerous lesions.  In vitro, AKR1B10 exhibits a much higher retinaldehyde reductase activity than any other human AKR, including AKR1B1 (aldose reductase).  We here demonstrate that AKR1B10 also acts as a retinaldehyde reductase in vivo.  This activity may be relevant in controlling the first step of retinoic acid synthesis.  Up-regulation of AKR1B10, resulting in retinoic acid depletion, may lead to cellular proliferation.  Both in vitro and in vivo activities of AKR1B10 were inhibited by tolrestat, an AKR1B1 inhibitor developed for diabetes treatment.  The crystal structure of the ternary complex AKR1B10-NADP+-tolrestat was detd. at 1.25-Ã resoln.  Mol. dynamics models of AKR1B10 and AKR1B1 with retinaldehyde isomers and site-directed mutagenesis show that subtle differences at the entrance of the retinoid-binding site, esp. at position 125, are determinant for the all-trans-retinaldehyde specificity of AKR1B10.  Substitutions in the retinaldehyde cyclohexene ring also influence the specificity.  These structural features should facilitate the design of specific inhibitors, with potential use in cancer and diabetes treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_lNOfkwrAC7Vg90H21EOLACvtfcHk0lg1WoLeL38Pew"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1yjsw%253D%253D&md5=55504226956b2f2f692c87a9569a6616</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0705659105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0705659105%26sid%3Dliteratum%253Aachs%26aulast%3DGallego%26aufirst%3DO.%26aulast%3DRuiz%26aufirst%3DF.%2BX.%26aulast%3DArdevol%26aufirst%3DA.%26aulast%3DDominguez%26aufirst%3DM.%26aulast%3DAlvarez%26aufirst%3DR.%26aulast%3Dde%2BLera%26aufirst%3DA.%2BR.%26aulast%3DRovira%26aufirst%3DC.%26aulast%3DFarres%26aufirst%3DJ.%26aulast%3DFita%26aufirst%3DI.%26aulast%3DPares%26aufirst%3DX.%26atitle%3DStructural%2520Basis%2520for%2520the%2520High%2520all-trans-Retinaldehyde%2520Reductase%2520Activity%2520of%2520the%2520Tumor%2520Marker%2520AKR1B10%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D20764%26epage%3D20769%26doi%3D10.1073%2Fpnas.0705659105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Ruiz, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porte, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pares, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farres, J.</span><span> </span><span class="NLM_article-title">Biological Role of Aldo-Keto Reductases in Retinoic Acid Biosynthesis and Signaling</span> <span class="citation_source-journal">Front. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="refDoi">Â DOI: 10.3389/fphar.2012.00058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.3389%2Ffphar.2012.00058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=22529810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms12qtrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=58&author=F.+X.+Ruizauthor=S.+Porteauthor=X.+Paresauthor=J.+Farres&title=Biological+Role+of+Aldo-Keto+Reductases+in+Retinoic+Acid+Biosynthesis+and+Signaling&doi=10.3389%2Ffphar.2012.00058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Biological role of aldo-keto reductases in retinoic acid biosynthesis and signaling</span></div><div class="casAuthors">Ruiz, F. Xavier; Porte, Sergio; Pares, Xavier; Farres, Jaume</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Experimental Pharmacology and Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">April</span>),
    <span class="NLM_cas:pages">58</span>CODEN:
                <span class="NLM_cas:coden">FEPDAX</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Several aldo-keto reductase (AKR) enzymes from subfamilies 1B and 1C show retinaldehyde reductase activity, having low Km and kcat values.  Only AKR1B10 and 1B12, with all-trans-retinaldehyde and AKR1C3, with 9-cis-retinaldehyde, display high catalytic efficiency.  Major structural determinants for retinaldehyde isomer specificity are located in the external loops (A and C for AKR1B10 and B for AKR1C3), as assessed by site-directed mutagenesis and mol. dynamics.  Cellular models have shown that AKR1B and 1C enzymes are well suited to work in vivo as retinaldehyde reductases and to regulate retinoic acid (RA) biosynthesis at hormone pre-receptor level.  An addnl. physiol. role for the retinaldehyde reductase activity of these enzymes, consistent with their tissue localization, is their participation in Î²-carotene absorption.  Retinaldehyde metab. may be subjected to subcellular compartmentalization, based on enzyme localization.  While retinaldehyde oxidn. to RA takes place in the cytosol, redn. to retinol could take place in the cytosol by AKRs or in the membranes of endoplasmic reticulum by microsomal retinaldehyde reductases.  Upregulation of some AKR1 enzymes in different cancer types may be linked to their induction by oxidative stress and to their participation in different signaling pathways related to cell proliferation.  AKR1B10 and AKR1C3, through their retinaldehyde reductase activity, trigger a decrease in the RA biosynthesis flow, resulting in RA deprivation and consequently lower differentiation, with an increased cancer risk in target tissues.  Rational design of selective AKR inhibitors could lead to development of novel drugs for cancer treatment as well as redn. of chemotherapeutic drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv76t8qkWVjrVg90H21EOLACvtfcHk0lg1WoLeL38Pew"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms12qtrY%253D&md5=b0225d5106ce89054a82f1b0f33d63e6</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2012.00058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2012.00058%26sid%3Dliteratum%253Aachs%26aulast%3DRuiz%26aufirst%3DF.%2BX.%26aulast%3DPorte%26aufirst%3DS.%26aulast%3DPares%26aufirst%3DX.%26aulast%3DFarres%26aufirst%3DJ.%26atitle%3DBiological%2520Role%2520of%2520Aldo-Keto%2520Reductases%2520in%2520Retinoic%2520Acid%2520Biosynthesis%2520and%2520Signaling%26jtitle%3DFront.%2520Pharmacol.%26date%3D2012%26volume%3D3%26spage%3D58%26doi%3D10.3389%2Ffphar.2012.00058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanamori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitade, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Roles of Rat and Human Aldo-Keto Reductases in Metabolism of Farnesol and Geranylgeraniol</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">â</span> <span class="NLM_lpage">268</span><span class="refDoi">Â DOI: 10.1016/j.cbi.2010.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.cbi.2010.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=21187079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFaju7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2011&pages=261-268&author=S.+Endoauthor=T.+Matsunagaauthor=C.+Ohtaauthor=M.+Sodaauthor=A.+Kanamoriauthor=Y.+Kitadeauthor=S.+Ohnoauthor=K.+Tajimaauthor=O.+El-Kabbaniauthor=A.+Hara&title=Roles+of+Rat+and+Human+Aldo-Keto+Reductases+in+Metabolism+of+Farnesol+and+Geranylgeraniol&doi=10.1016%2Fj.cbi.2010.12.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of rat and human aldo-keto reductases in metabolism of farnesol and geranylgeraniol</span></div><div class="casAuthors">Endo, Satoshi; Matsunaga, Toshiyuki; Ohta, Chisato; Soda, Midori; Kanamori, Ayano; Kitade, Yukio; Ohno, Satoshi; Tajima, Kazuo; El-Kabbani, Ossama; Hara, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">261-268</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Farnesol (FOH) and geranylgeraniol (GGOH) with multiple biol. actions are produced from the mevalonate pathway, and catabolized into farnesoic acid and geranylgeranoic acid, resp., via the aldehyde intermediates (farnesal and geranylgeranial).  We investigated the intracellular distribution, sequences and properties of the oxidoreductases responsible for the metabolic steps in rat tissues.  The oxidn. of FOH and GGOH into their aldehyde intermediates were mainly mediated by alc. dehydrogenases 1 (in the liver and colon) and 7 (in the stomach and lung), and the subsequent step into the carboxylic acids was catalyzed by a microsomal aldehyde dehydrogenase.  In addn., high reductase activity catalyzing the aldehyde intermediates into FOH (or GGOH) was detected in the cytosols of the extra-hepatic tissues, where the major reductase was identified as aldo-keto reductase (AKR) 1C15.  Human reductases with similar specificity were identified as AKR1B10 and AKR1C3, which most efficiently reduced farnesal and geranylgeranial among seven enzymes in the AKR1A-1C subfamilies.  The overall metab. from FOH to farnesoic acid in cultured cells was significantly decreased by overexpression of AKR1C15, and increased by addn. of AKR1C3 inhibitors, tolfenamic acid and R-flurbiprofen.  Thus, AKRs (1C15 in rats, and 1B10 and 1C3 in humans) may play an important role in controlling the bioavailability of FOH and GGOH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriJe4bfgeadLVg90H21EOLACvtfcHk0lg1WoLeL38Pew"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFaju7g%253D&md5=894b62e1a3780d8349621c708f98ebcd</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2010.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2010.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DOhta%26aufirst%3DC.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DKanamori%26aufirst%3DA.%26aulast%3DKitade%26aufirst%3DY.%26aulast%3DOhno%26aufirst%3DS.%26aulast%3DTajima%26aufirst%3DK.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DRoles%2520of%2520Rat%2520and%2520Human%2520Aldo-Keto%2520Reductases%2520in%2520Metabolism%2520of%2520Farnesol%2520and%2520Geranylgeraniol%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2011%26volume%3D191%26spage%3D261%26epage%3D268%26doi%3D10.1016%2Fj.cbi.2010.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span> </span><span class="NLM_article-title">Aldo-Keto Reductase Family 1 B10 Affects Fatty Acid Synthesis by Regulating the Stability of Acetyl-CoA Carboxylase-Î± in Breast Cancer Cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">3418</span><span class="NLM_x">â</span> <span class="NLM_lpage">3423</span><span class="refDoi">Â DOI: 10.1074/jbc.M707650200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1074%2Fjbc.M707650200" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=3418-3423&author=J.+Maauthor=R.+Yanauthor=X.+Zuauthor=J.+M.+Chengauthor=K.+Raoauthor=D.+F.+Liaoauthor=D.+Cao&title=Aldo-Keto+Reductase+Family+1+B10+Affects+Fatty+Acid+Synthesis+by+Regulating+the+Stability+of+Acetyl-CoA+Carboxylase-%CE%B1+in+Breast+Cancer+Cells&doi=10.1074%2Fjbc.M707650200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M707650200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M707650200%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DR.%26aulast%3DZu%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DJ.%2BM.%26aulast%3DRao%26aufirst%3DK.%26aulast%3DLiao%26aufirst%3DD.%2BF.%26aulast%3DCao%26aufirst%3DD.%26atitle%3DAldo-Keto%2520Reductase%2520Family%25201%2520B10%2520Affects%2520Fatty%2520Acid%2520Synthesis%2520by%2520Regulating%2520the%2520Stability%2520of%2520Acetyl-CoA%2520Carboxylase-%25CE%25B1%2520in%2520Breast%2520Cancer%2520Cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D3418%26epage%3D3423%26doi%3D10.1074%2Fjbc.M707650200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, S.</span><span> </span><span class="NLM_article-title">Aldo-Keto Reductase Family 1 Member B 10 Mediates Liver Cancer Cell Proliferation through Sphingosine-1-Phosphate</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">22746</span><span class="refDoi">Â DOI: 10.1038/srep22746</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1038%2Fsrep22746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=26948042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC28XjslGgurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=22746&author=J.+Jinauthor=W.+Liaoauthor=W.+Yaoauthor=R.+Zhuauthor=Y.+Liauthor=S.+He&title=Aldo-Keto+Reductase+Family+1+Member+B+10+Mediates+Liver+Cancer+Cell+Proliferation+through+Sphingosine-1-Phosphate&doi=10.1038%2Fsrep22746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Aldo-keto Reductase Family 1 Member B 10 Mediates Liver Cancer Cell Proliferation through Sphingosine-1-Phosphate</span></div><div class="casAuthors">Jin, Junfei; Liao, Weijia; Yao, Wenmin; Zhu, Rongping; Li, Yulan; He, Songqing</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22746</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">AKR1B10 is involved in hepatocarcinogenesis via modulation of fatty acid and lipid synthesis.  AKR1B10 inhibition results in apoptosis of tumor cells whose lipids, esp. phospholipids, were decreased by over 50%, suggesting involvement of phospholipids like sphingosine-1-phosphate (S1P) in AKR1B10's oncogenic function.  Using a co-culture system, we found that co-culture of QSG-7701 (human hepatocyte) with HepG2 (hepatoma cell line) increases QSG-7701's proliferation, in which AKR1B10-S1P signaling plays a pivotal role.  Consistent with previous findings, AKR1B10 mRNA and protein levels were higher in primary hepatocellular carcinoma (PHC) tissues than in peri-tumor tissues.  Interestingly, the level of S1P was also higher in PHC tissues than in peri-tumor tissues.  After analyzing the correlation between AKR1B10 mRNA expression in PHC tissues and the clin. data, we found that AKR1B10 mRNA expression was assocd. with serum alpha-fetoprotein (AFP), tumor-node-metastasis (TNM) stage, and lymph node metastasis, but not with other clinicopathol. variables.  A higher AKR1B10 mRNA expression level is related to a shorter DFS (disease free survival) and OS (overall survival), serving as an independent predictor of DFS and OS in PHC patients with surgical resection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-kX9wmzGnHrVg90H21EOLACvtfcHk0li802ejzcVbKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjslGgurs%253D&md5=c5dcf43711ae5c35d8dbcc3376fd493d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fsrep22746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep22746%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DW.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DS.%26atitle%3DAldo-Keto%2520Reductase%2520Family%25201%2520Member%2520B%252010%2520Mediates%2520Liver%2520Cancer%2520Cell%2520Proliferation%2520through%2520Sphingosine-1-Phosphate%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D22746%26doi%3D10.1038%2Fsrep22746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhulst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span> </span><span class="NLM_article-title">AKR1B10 Promotes Breast Cancer Metastasis through Integrin Î±5/Î´-Catenin Mediated FAK/Src/Rac1 Signaling Pathway</span> <span class="citation_source-journal">Oncotarget.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">43779</span><span class="NLM_x">â</span> <span class="NLM_lpage">43791</span><span class="refDoi">Â DOI: 10.18632/oncotarget.9672</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.18632%2Foncotarget.9672" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=43779-43791&author=C.+Huangauthor=S.+Verhulstauthor=Y.+Shenauthor=Y.+Buauthor=Y.+Caoauthor=Y.+Heauthor=Y.+Wangauthor=D.+Huangauthor=C.+Caiauthor=K.+Raoauthor=D.+F.+Liaoauthor=J.+Jinauthor=D.+Cao&title=AKR1B10+Promotes+Breast+Cancer+Metastasis+through+Integrin+%CE%B15%2F%CE%B4-Catenin+Mediated+FAK%2FSrc%2FRac1+Signaling+Pathway&doi=10.18632%2Foncotarget.9672"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.9672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.9672%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DVerhulst%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DBu%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DCai%26aufirst%3DC.%26aulast%3DRao%26aufirst%3DK.%26aulast%3DLiao%26aufirst%3DD.%2BF.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DD.%26atitle%3DAKR1B10%2520Promotes%2520Breast%2520Cancer%2520Metastasis%2520through%2520Integrin%2520%25CE%25B15%252F%25CE%25B4-Catenin%2520Mediated%2520FAK%252FSrc%252FRac1%2520Signaling%2520Pathway%26jtitle%3DOncotarget.%26date%3D2016%26volume%3D7%26spage%3D43779%26epage%3D43791%26doi%3D10.18632%2Foncotarget.9672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Heibein, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprowl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclean, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parissenti, A. M.</span><span> </span><span class="NLM_article-title">Role of Aldo-Keto Reductases and Other Doxorubicin Pharmacokinetic Genes in Doxorubicin Resistance, DNA Binding, and Subcellular Localization</span> <span class="citation_source-journal">BMC Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="refDoi">Â DOI: 10.1186/1471-2407-12-381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1186%2F1471-2407-12-381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=22938713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVWnuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=381&author=A.+D.+Heibeinauthor=B.+Guoauthor=J.+A.+Sprowlauthor=D.+A.+Macleanauthor=A.+M.+Parissenti&title=Role+of+Aldo-Keto+Reductases+and+Other+Doxorubicin+Pharmacokinetic+Genes+in+Doxorubicin+Resistance%2C+DNA+Binding%2C+and+Subcellular+Localization&doi=10.1186%2F1471-2407-12-381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization</span></div><div class="casAuthors">Heibein, Allan D.; Guo, Baoqing; Sprowl, Jason A.; MacLean, David A.; Parissenti, Amadeo M.</div><div class="citationInfo"><span class="NLM_cas:title">BMC Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">381</span>CODEN:
                <span class="NLM_cas:coden">BCMACL</span>;
        ISSN:<span class="NLM_cas:issn">1471-2407</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Since proteins involved in chemotherapy drug pharmacokinetics and pharmacodynamics have a strong impact on the uptake, metab., and efflux of such drugs, they likely play crit. roles in resistance to chemotherapy drugs in cancer patients.  Methods: To investigate this hypothesis, we conducted a whole genome microarray study to identify difference in the expression of genes between isogenic doxorubicin-sensitive and doxorubicin-resistant MCF-7 breast tumor cells.  We then assessed the degree of over-representation of doxorubicin pharmacokinetic and pharmacodynamic genes in the dataset of doxorubicin resistance genes.  Results: Of 27,958 Entrez genes on the array, 7.4 per cent or 2,063 genes were differentially expressed by â¥ 2-fold between wildtype and doxorubicin-resistant cells.  The false discovery rate was set at 0.01 and the min. p value for significance for any gene within the "hit list" was 0.01.  Seventeen and 43 per cent of doxorubicin pharmacokinetic genes were over-represented in the hit list, depending upon whether the gene name was identical or within the same gene family, resp.  The most over-represented genes were within the 1C and 1B families of aldo-keto reductases (AKRs), which convert doxorubicin to doxorubicinol.  Other genes convert doxorubicin to other metabolites or affect the influx, efflux, or cytotoxicity of the drug.  In further support of the role of AKRs in doxorubicin resistance, we obsd. that, in comparison to doxorubicin, doxorubincol exhibited dramatically reduced cytotoxicity, reduced DNA-binding activity, and strong localization to extra nuclear lysosomes.  Pharmacol. inhibition of the above AKRs in doxorubicin-resistant cells increased cellular doxorubicin levels, restored doxorubicin cytotoxicity and re-established doxorubicin localization to the nucleus.  The properties of doxorubicinol were unaffected.  These findings demonstrate the utility of using curated pharmacokinetic and pharmacodynamic knowledge bases to identify highly relevant genes assocd. with doxorubicin resistance.  The induction of one or more of these genes was found to be correlated with changes in the drug's properties, while inhibiting one specific class of these genes (the AKRs) increased cellular doxorubicin content and restored drug DNA binding, cytotoxicity, and subcellular localization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9a9O8ky4XCrVg90H21EOLACvtfcHk0li802ejzcVbKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVWnuw%253D%253D&md5=30fbd88919205623ff0a5bbe82d32f3b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1186%2F1471-2407-12-381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2407-12-381%26sid%3Dliteratum%253Aachs%26aulast%3DHeibein%26aufirst%3DA.%2BD.%26aulast%3DGuo%26aufirst%3DB.%26aulast%3DSprowl%26aufirst%3DJ.%2BA.%26aulast%3DMaclean%26aufirst%3DD.%2BA.%26aulast%3DParissenti%26aufirst%3DA.%2BM.%26atitle%3DRole%2520of%2520Aldo-Keto%2520Reductases%2520and%2520Other%2520Doxorubicin%2520Pharmacokinetic%2520Genes%2520in%2520Doxorubicin%2520Resistance%252C%2520DNA%2520Binding%252C%2520and%2520Subcellular%2520Localization%26jtitle%3DBMC%2520Cancer%26date%3D2012%26volume%3D12%26spage%3D381%26doi%3D10.1186%2F1471-2407-12-381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaji, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomokuni, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonezawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Nitric Oxide Confers Cisplatin Resistance in Human Lung Cancer Cells through Upregulation of Aldo-Keto Reductase 1B10 and Proteasome</span> <span class="citation_source-journal">Free Radical Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1371</span><span class="NLM_x">â</span> <span class="NLM_lpage">1385</span><span class="refDoi">Â DOI: 10.3109/10715762.2014.957694</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.3109%2F10715762.2014.957694" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=25156503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Kgsr7O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2014&pages=1371-1385&author=T.+Matsunagaauthor=Y.+Yamajiauthor=T.+Tomokuniauthor=H.+Moritaauthor=Y.+Morikawaauthor=A.+Suzukiauthor=A.+Yonezawaauthor=S.+Endoauthor=A.+Ikariauthor=K.+Iguchiauthor=O.+El-Kabbaniauthor=K.+Tajimaauthor=A.+Hara&title=Nitric+Oxide+Confers+Cisplatin+Resistance+in+Human+Lung+Cancer+Cells+through+Upregulation+of+Aldo-Keto+Reductase+1B10+and+Proteasome&doi=10.3109%2F10715762.2014.957694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide confers cisplatin resistance in human lung cancer cells through upregulation of aldo-keto reductase 1B10 and proteasome</span></div><div class="casAuthors">Matsunaga, T.; Yamaji, Y.; Tomokuni, T.; Morita, H.; Morikawa, Y.; Suzuki, A.; Yonezawa, A.; Endo, S.; Ikari, A.; Iguchi, K.; El-Kabbani, O.; Tajima, K.; Hara, A.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1371-1385</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1029-2470</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">In this study, we show that exposure of human lung cancer A549 cells to cisplatin (cis-diamminedichloroplatinum, CDDP) promotes prodn. of nitric oxide (NO) through generation of reactive oxygen species (ROS) and resulting upregulation of inducible NO synthase (iNOS).  The incubation of the cells with a NO donor, diethylenetriamine NONOate, not only reduced the CDDP-induced cell death and apoptotic alterations (induction of CCAAT-enhancer-binding protein homologous protein and caspase-3 activation), but also elevated proteolytic activity of 26S proteasome, suggesting that the activation of proteasome function contributes to the redn. of CDDP sensitivity by NO.  Monitoring expression levels of six aldo-keto reductases (AKRs) (1A1, 1B1, 1B10, 1C1, 1C2, and 1C3) during the treatment with the NO donor and subsequent CDDP sensitivity test using the specific inhibitors also proposed that upregulation of AKR1B10 by NO is a key process for acquiring the CDDP resistance in A549 cells.  Treatment with CDDP and NO increased amts. of nitrotyrosine protein adducts, indicative of peroxynitrite formation, and promoted the induction of AKR1B10, inferring a relationship between peroxynitrite formation and the enzyme upregulation in the cells.  The treatment with CDDP or a ROS-related lipid aldehyde, 4-hydroxy-2-nonenal, facilitated the iNOS upregulation, which was restored by increasing the AKR1B10 expression.  In contrast, the facilitation of NO prodn. by CDDP treatment was hardly obsd. in AKR1B10-overexpressing A549 cells and established CDDP-resistant cancer cells (A549, LoVo, and PC3).  Collectively, these results suggest the NO functions as a key regulator controlling AKR1B10 expression and 26S proteasome function leading to gain of the CDDP resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKCNQD4NOHvbVg90H21EOLACvtfcHk0liRApt-xfMHMg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Kgsr7O&md5=6e1afc7b87649a0a5fec7d8f5b14e253</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.3109%2F10715762.2014.957694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10715762.2014.957694%26sid%3Dliteratum%253Aachs%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DYamaji%26aufirst%3DY.%26aulast%3DTomokuni%26aufirst%3DT.%26aulast%3DMorita%26aufirst%3DH.%26aulast%3DMorikawa%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DYonezawa%26aufirst%3DA.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DIkari%26aufirst%3DA.%26aulast%3DIguchi%26aufirst%3DK.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DTajima%26aufirst%3DK.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DNitric%2520Oxide%2520Confers%2520Cisplatin%2520Resistance%2520in%2520Human%2520Lung%2520Cancer%2520Cells%2520through%2520Upregulation%2520of%2520Aldo-Keto%2520Reductase%25201B10%2520and%2520Proteasome%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2014%26volume%3D48%26spage%3D1371%26epage%3D1385%26doi%3D10.3109%2F10715762.2014.957694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Morikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kezuka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyooka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span> </span><span class="NLM_article-title">Acquisition of Doxorubicin Resistance Facilitates Migrating and Invasive Potentials of Gastric Cancer MKN45 Cells through Up-regulating Aldo-Keto Reductase 1B10</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">230</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="NLM_x">â</span> <span class="NLM_lpage">39</span><span class="refDoi">Â DOI: 10.1016/j.cbi.2015.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.cbi.2015.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=25686905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivVSiurY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=230&publication_year=2015&pages=30-39&author=Y.+Morikawaauthor=C.+Kezukaauthor=S.+Endoauthor=A.+Ikariauthor=M.+Sodaauthor=K.+Yamamuraauthor=N.+Toyookaauthor=O.+El-Kabbaniauthor=A.+Haraauthor=T.+Matsunaga&title=Acquisition+of+Doxorubicin+Resistance+Facilitates+Migrating+and+Invasive+Potentials+of+Gastric+Cancer+MKN45+Cells+through+Up-regulating+Aldo-Keto+Reductase+1B10&doi=10.1016%2Fj.cbi.2015.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Acquisition of doxorubicin resistance facilitates migrating and invasive potentials of gastric cancer MKN45 cells through up-regulating aldo-keto reductase 1B10</span></div><div class="casAuthors">Morikawa, Yoshifumi; Kezuka, Chihiro; Endo, Satoshi; Ikari, Akira; Soda, Midori; Yamamura, Keiko; Toyooka, Naoki; El-Kabbani, Ossama; Hara, Akira; Matsunaga, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">230</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">30-39</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Continuous exposure to doxorubicin (DOX) accelerates hyposensitivity to the drug-elicited lethality of gastric cells, with increased risks of the recurrence and serious cardiovascular side effects.  However, the detailed mechanisms underlying the redn. of DOX sensitivity remain unclear.  In this study, we generated a DOX-resistant variant upon continuously treating human gastric cancer MKN45 cells with incremental concns. of the drug, and investigated whether the gain of DOX resistance influences gene expression of four aldo-keto reductases (AKRs: 1B10, 1C1, 1C2 and 1C3).  RT-PCR anal. revealed that among the enzymes AKR1B10 is most highly up-regulated during the chemoresistance induction.  The up-regulation of AKR1B10 was confirmed by analyses of Western blotting and enzyme activity.  The DOX sensitivity of MKN45 cells was reduced and elevated by overexpression and inhibition of AKR1B10, resp.  Compared to the parental MKN45 cells, the DOX-resistant cells had higher migrating and invasive abilities, which were significantly suppressed by addn. of AKR1B10 inhibitors.  Zymog. and real-time PCR analyses also revealed significant increases in secretion and expression of matrix metalloproteinase (MMP) 2 assocd. with DOX resistance.  Moreover, the overexpression of AKR1B10 in the parental cells remarkably facilitated malignant progression (elevation of migrating and invasive potentials) and MMP2 secretion, which were lowered by the AKR1B10 inhibitors.  These results suggest that AKR1B10 is a DOX-resistance gene in the gastric cancer cells, and is responsible for elevating the migrating and invasive potentials of the cells through induction of MMP2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocNGG2IId1sLVg90H21EOLACvtfcHk0liRApt-xfMHMg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivVSiurY%253D&md5=9bd6487118f6fec209de4474bea8aef1</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2015.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2015.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DMorikawa%26aufirst%3DY.%26aulast%3DKezuka%26aufirst%3DC.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DIkari%26aufirst%3DA.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DYamamura%26aufirst%3DK.%26aulast%3DToyooka%26aufirst%3DN.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DMatsunaga%26aufirst%3DT.%26atitle%3DAcquisition%2520of%2520Doxorubicin%2520Resistance%2520Facilitates%2520Migrating%2520and%2520Invasive%2520Potentials%2520of%2520Gastric%2520Cancer%2520MKN45%2520Cells%2520through%2520Up-regulating%2520Aldo-Keto%2520Reductase%25201B10%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2015%26volume%3D230%26spage%3D30%26epage%3D39%26doi%3D10.1016%2Fj.cbi.2015.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Matsunaga, T.; El-Kabbani, O.; Hara, A.</span><span> </span><span class="NLM_article-title">Aldo-Keto Reductases as New Therapeutic Targets for Colon Cancer Chemoresistance</span>. In  <span class="citation_source-book">Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy</span>; <span class="NLM_contrib-group">Bonavida, B.</span>, Ed.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">109</span><span class="NLM_x">â</span> <span class="NLM_lpage">133</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1007%2F978-1-4614-7070-0_6" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=109-133&author=T.+Matsunaga&author=O.+El-Kabbani&author=A.+Haraauthor=B.+Bonavida&title=Molecular+Mechanisms+of+Tumor+Cell+Resistance+to+Chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2F978-1-4614-7070-0_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4614-7070-0_6%26sid%3Dliteratum%253Aachs%26aulast%3DMatsunaga%26aufirst%3DT.%26atitle%3DAldo-Keto%2520Reductases%2520as%2520New%2520Therapeutic%2520Targets%2520for%2520Colon%2520Cancer%2520Chemoresistance%26btitle%3DMolecular%2520Mechanisms%2520of%2520Tumor%2520Cell%2520Resistance%2520to%2520Chemotherapy%26aulast%3DBonavida%26aufirst%3DB.%26pub%3DSpringer%26date%3D2013%26spage%3D109%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikari, A.</span><span> </span><span class="NLM_article-title">Roles of Aldo-Keto Reductases 1B10 and 1C3 and ATP-Binding Cassette Transporter in Docetaxel Tolerance</span> <span class="citation_source-journal">Free Radical Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1296</span><span class="NLM_x">â</span> <span class="NLM_lpage">1308</span><span class="refDoi">Â DOI: 10.1080/10715762.2016.1236373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1080%2F10715762.2016.1236373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=27629782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1yktrbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2016&pages=1296-1308&author=T.+Matsunagaauthor=H.+Saitoauthor=S.+Endoauthor=K.+Iguchiauthor=M.+Sodaauthor=O.+El-Kabbaniauthor=A.+Haraauthor=A.+Ikari&title=Roles+of+Aldo-Keto+Reductases+1B10+and+1C3+and+ATP-Binding+Cassette+Transporter+in+Docetaxel+Tolerance&doi=10.1080%2F10715762.2016.1236373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of aldo-keto reductases 1B10 and 1C3 and ATP-binding cassette transporter in docetaxel tolerance</span></div><div class="casAuthors">Matsunaga, Toshiyuki; Saito, Haruhi; Endo, Satoshi; Iguchi, Kazuhiro; Soda, Midori; El-Kabbani, Ossama; Hara, Akira; Ikari, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1296-1308</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1029-2470</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Docetaxel (DTX) is widely used for treatment of inveterate lung and prostate cancers, but its continuous administration elicits the hyposensitivity.  Here, we established the DTX-resistant variants of human lung cancer A549 and androgen-independent prostate cancer Du145 cells and found that the resistance development provoked aberrant up-regulations of aldo-keto reductase (AKR) 1B10 and AKR1C3 in A549 and Du145 cells, resp.  In addn., the sensitivity to the DTX toxicity was significantly decreased and increased by overexpression and knockdown of the two AKR isoforms, resp.  Furthermore, the resistant cells exhibited a decreased level of reactive 4-hydroxy-2-nonenal formed during DTX treatment, and the decrease was alleviated by adding the AKR inhibitors, inferring that the two AKRs confer the chemoresistance through elevating the antioxidant properties.  The development of DTX resistance was also assocd. with enhanced expression of an ATP-binding cassette (ABC) transporter ABCB1 among the ABC transporter isoforms.  The combined treatment with inhibitors of the two AKRs and ABCB1 additively sensitized the resistant cells to DTX.  Intriguingly, the AKR1B10 inhibitor also suppressed the lung cancer cross-resistance against cisplatin.  The results suggest that combined treatment with AKRs (1B10 and 1C3) and ABCB1 inhibitors exerts overcoming effect against the cancer resistance to DTX and cisplatin, and can be used as the adjuvant therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7Y07KrClAMLVg90H21EOLACvtfcHk0liRApt-xfMHMg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yktrbJ&md5=bf29bf9e253785dde3b04e370b948b55</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1080%2F10715762.2016.1236373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10715762.2016.1236373%26sid%3Dliteratum%253Aachs%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DSaito%26aufirst%3DH.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DIguchi%26aufirst%3DK.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DIkari%26aufirst%3DA.%26atitle%3DRoles%2520of%2520Aldo-Keto%2520Reductases%25201B10%2520and%25201C3%2520and%2520ATP-Binding%2520Cassette%2520Transporter%2520in%2520Docetaxel%2520Tolerance%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2016%26volume%3D50%26spage%3D1296%26epage%3D1308%26doi%3D10.1080%2F10715762.2016.1236373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Chewchuk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parissenti, A. M.</span><span> </span><span class="NLM_article-title">Alterations in Estrogen Signalling Pathways upon Acquisition of Anthracycline Resistance in Breast Tumor Cells</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0172244</span><span class="refDoi">Â DOI: 10.1371/journal.pone.0172244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1371%2Fjournal.pone.0172244" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0172244&author=S.+Chewchukauthor=B.+Guoauthor=A.+M.+Parissenti&title=Alterations+in+Estrogen+Signalling+Pathways+upon+Acquisition+of+Anthracycline+Resistance+in+Breast+Tumor+Cells&doi=10.1371%2Fjournal.pone.0172244"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0172244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0172244%26sid%3Dliteratum%253Aachs%26aulast%3DChewchuk%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DB.%26aulast%3DParissenti%26aufirst%3DA.%2BM.%26atitle%3DAlterations%2520in%2520Estrogen%2520Signalling%2520Pathways%2520upon%2520Acquisition%2520of%2520Anthracycline%2520Resistance%2520in%2520Breast%2520Tumor%2520Cells%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26spage%3De0172244%26doi%3D10.1371%2Fjournal.pone.0172244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, D.</span><span> </span><span class="NLM_article-title">Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment</span> <span class="citation_source-journal">Recent Pat. Anti-Cancer Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">â</span> <span class="NLM_lpage">196</span><span class="refDoi">Â DOI: 10.2174/1574892811888160304113346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.2174%2F1574892811888160304113346" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=184-196&author=L.+Huangauthor=R.+Heauthor=W.+Luoauthor=Y.+S.+Zhuauthor=J.+Liauthor=T.+Tanauthor=X.+Zhangauthor=Z.+Huauthor=D.+Luo&title=Aldo-Keto+Reductase+Family+1+Member+B10+Inhibitors%3A+Potential+Drugs+for+Cancer+Treatment&doi=10.2174%2F1574892811888160304113346"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2174%2F1574892811888160304113346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1574892811888160304113346%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DY.%2BS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DLuo%26aufirst%3DD.%26atitle%3DAldo-Keto%2520Reductase%2520Family%25201%2520Member%2520B10%2520Inhibitors%253A%2520Potential%2520Drugs%2520for%2520Cancer%2520Treatment%26jtitle%3DRecent%2520Pat.%2520Anti-Cancer%2520Drug%2520Discovery%26date%3D2016%26volume%3D11%26spage%3D184%26epage%3D196%26doi%3D10.2174%2F1574892811888160304113346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Polyhydroxy Steroids as Selective Inhibitors against AKR1B10 and Molecular Docking</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">8</span><span class="refDoi">Â DOI: 10.1016/j.steroids.2016.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.steroids.2016.03.004" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2016&pages=1-8&author=W.+Chenauthor=X.+Chenauthor=S.+Zhouauthor=H.+Zhangauthor=L.+Wangauthor=J.+Xuauthor=X.+Huauthor=W.+Yinauthor=G.+Yanauthor=J.+Zhang&title=Design+and+Synthesis+of+Polyhydroxy+Steroids+as+Selective+Inhibitors+against+AKR1B10+and+Molecular+Docking&doi=10.1016%2Fj.steroids.2016.03.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.steroids.2016.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.steroids.2016.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DYin%26aufirst%3DW.%26aulast%3DYan%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Polyhydroxy%2520Steroids%2520as%2520Selective%2520Inhibitors%2520against%2520AKR1B10%2520and%2520Molecular%2520Docking%26jtitle%3DSteroids%26date%3D2016%26volume%3D110%26spage%3D1%26epage%3D8%26doi%3D10.1016%2Fj.steroids.2016.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Cousido-Siah, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanfrlik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimenez-Dejoz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitschler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamlar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesely, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ajani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pares, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farres, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobza, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A. D.</span><span> </span><span class="NLM_article-title">IDD388 Polyhalogenated Derivatives as Probes for an Improved Structure-Based Selectivity of AKR1B10 Inhibitors</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2693</span><span class="NLM_x">â</span> <span class="NLM_lpage">2705</span><span class="refDoi">Â DOI: 10.1021/acschembio.6b00382</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00382" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVyitrvM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2693-2705&author=A.+Cousido-Siahauthor=F.+X.+Ruizauthor=J.+Fanfrlikauthor=J.+Gimenez-Dejozauthor=A.+Mitschlerauthor=M.+Kamlarauthor=J.+Veselyauthor=H.+Ajaniauthor=X.+Paresauthor=J.+Farresauthor=P.+Hobzaauthor=A.+D.+Podjarny&title=IDD388+Polyhalogenated+Derivatives+as+Probes+for+an+Improved+Structure-Based+Selectivity+of+AKR1B10+Inhibitors&doi=10.1021%2Facschembio.6b00382"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">IDD388 Polyhalogenated Derivatives as Probes for an Improved Structure-Based Selectivity of AKR1B10 Inhibitors</span></div><div class="casAuthors">Cousido-Siah, Alexandra; Ruiz, Francesc X.; Fanfrlik, Jindrich; Gimenez-Dejoz, Joan; Mitschler, Andre; Kamlar, Martin; Vesely, Jan; Ajani, Haresh; Pares, Xavier; Farres, Jaume; Hobza, Pavel; Podjarny, Alberto D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2693-2705</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human enzyme aldo-keto reductase family member 1B10 (AKR1B10) has evolved as a tumor marker and promising antineoplastic target.  It shares high structural similarity with the diabetes target enzyme aldose reductase (AR).  Starting from the potent AR inhibitor IDD388, we have synthesized a series of derivs. bearing the same halophenoxyacetic acid moiety with an increasing no. of bromine (Br) atoms on its aryl moiety.  Next, by means of IC50 measurements, X-ray crystallog., WaterMap anal., and advanced binding free energy calcns. with a quantum-mech. (QM) approach, we have studied their structure-activity relationship (SAR) against both enzymes.  The introduction of Br substituents decreases AR inhibition potency but improves it in the case of AKR1B10.  Indeed, the Br atoms in ortho position may impede these drugs to fit into the AR prototypical specificity pocket.  For AKR1B10, the smaller aryl moieties of MK181 and IDD388 can bind into the external loop A subpocket.  Instead, the bulkier MK184, MK319, and MK204 open an inner specificity pocket in AKR1B10 characterized by a Ï-Ï stacking interaction of their aryl moieties and Trp112 side chain in the native conformation (not possible in AR).  Among the three compds., only MK204 can make a strong halogen bond with the protein (-4.4 kcal/mol, using QM calcns.), while presenting the lowest desolvation cost among all the series, translated into the most selective and inhibitory potency AKR1B10 (IC50 = 80 nM).  Overall, SAR of these IDD388 polyhalogenated derivs. have unveiled several distinctive AKR1B10 features (shape, flexibility, hydration) that can be exploited to design novel types of AKR1B10 selective drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruTvJropgoFbVg90H21EOLACvtfcHk0lhhRyB5TnfYhg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVyitrvM&md5=6bf2b882453bc71f1fed80ece98a351e</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00382%26sid%3Dliteratum%253Aachs%26aulast%3DCousido-Siah%26aufirst%3DA.%26aulast%3DRuiz%26aufirst%3DF.%2BX.%26aulast%3DFanfrlik%26aufirst%3DJ.%26aulast%3DGimenez-Dejoz%26aufirst%3DJ.%26aulast%3DMitschler%26aufirst%3DA.%26aulast%3DKamlar%26aufirst%3DM.%26aulast%3DVesely%26aufirst%3DJ.%26aulast%3DAjani%26aufirst%3DH.%26aulast%3DPares%26aufirst%3DX.%26aulast%3DFarres%26aufirst%3DJ.%26aulast%3DHobza%26aufirst%3DP.%26aulast%3DPodjarny%26aufirst%3DA.%2BD.%26atitle%3DIDD388%2520Polyhalogenated%2520Derivatives%2520as%2520Probes%2520for%2520an%2520Improved%2520Structure-Based%2520Selectivity%2520of%2520AKR1B10%2520Inhibitors%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D2693%26epage%3D2705%26doi%3D10.1021%2Facschembio.6b00382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Kabututu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pointud, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LefranÃ§ois-Martinez, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urade, Y.</span><span> </span><span class="NLM_article-title">Prostaglandin F<sub>2Î±</sub> Synthase Activities of Aldo-Keto Reductase 1B1, 1B3 and 1B7</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">â</span> <span class="NLM_lpage">168</span><span class="refDoi">Â DOI: 10.1093/jb/mvn152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1093%2Fjb%2Fmvn152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=19010934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVegtL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2009&pages=161-168&author=Z.+Kabututuauthor=M.+Maninauthor=J.+C.+Pointudauthor=T.+Maruyamaauthor=N.+Nagataauthor=S.+Lambertauthor=A.+M.+Lefran%C3%A7ois-Martinezauthor=A.+Martinezauthor=Y.+Urade&title=Prostaglandin+F2%CE%B1+Synthase+Activities+of+Aldo-Keto+Reductase+1B1%2C+1B3+and+1B7&doi=10.1093%2Fjb%2Fmvn152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Prostaglandin F2Î± Synthase Activities of Aldo-Keto Reductase 1B1, 1B3 and 1B7</span></div><div class="casAuthors">Kabututu, Zakayi; Manin, Michele; Pointud, Jean-Christophe; Maruyama, Toshihiko; Nagata, Nanae; Lambert, Sarah; Lefrancois-Martinez, Anne-Marie; Martinez, Antoine; Urade, Yoshihiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-168</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">Here, we show that three enzymes belonging to the 1B group of the aldo-keto reductase (AKR) superfamily, i.e., human placental aldose reductase (AKR1B1), mouse kidney aldose reductase (AKR1B3) and mouse vas deferens protein (AKR1B7), catalyze the redn. of prostaglandin (PG) H2, a common intermediate of various prostanoids, to form PGF2Î± in the presence of NADPH.  AKR1B1, AKR1B3 and AKR1B7 displayed higher affinities for PGH2 (Km = 1.9, 9.3 and 3.8 Î¼M, resp.) and Vmax values (26, 53 and 44 nmol/min/mg protein, resp.) than did the human lung PGF2Î± synthase (AKR1C3; 18 Î¼M and 4 nmol/min/mg protein, resp.).  The PGF2Î± synthase activity of AKR1B1 and AKR1B3 was efficiently inhibited by two AKR inhibitors, tolrestat (Ki = 3.6 and 0.26 Î¼M, resp.) and sorbinil (Ki = 21.7 and 0.89 Î¼M, resp.), in a non-competitive or mixed-type manner, whereas that of AKR1B7 was not sensitive to these inhibitors (Ki = 9.2 and 18 mM, resp.).  These data provide a mol. basis for investigating novel functional roles for AKR1B members and PGF2Î± as mediators of physiol. and pathol. processes in mammalian organisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGS7kCR8AZsbVg90H21EOLACvtfcHk0lhdonmbr9MxgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVegtL8%253D&md5=ae150e6ba9dfb1613170751eec5c5068</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvn152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvn152%26sid%3Dliteratum%253Aachs%26aulast%3DKabututu%26aufirst%3DZ.%26aulast%3DManin%26aufirst%3DM.%26aulast%3DPointud%26aufirst%3DJ.%2BC.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DNagata%26aufirst%3DN.%26aulast%3DLambert%26aufirst%3DS.%26aulast%3DLefran%25C3%25A7ois-Martinez%26aufirst%3DA.%2BM.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DUrade%26aufirst%3DY.%26atitle%3DProstaglandin%2520F2%25CE%25B1%2520Synthase%2520Activities%2520of%2520Aldo-Keto%2520Reductase%25201B1%252C%25201B3%2520and%25201B7%26jtitle%3DJ.%2520Biochem.%26date%3D2009%26volume%3D145%26spage%3D161%26epage%3D168%26doi%3D10.1093%2Fjb%2Fmvn152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Tammali, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rychahou, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awasthi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Inhibition of Aldose Reductase Prevents Colon Cancer Metastasis</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1259</span><span class="NLM_x">â</span> <span class="NLM_lpage">1267</span><span class="refDoi">Â DOI: 10.1093/carcin/bgr102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1093%2Fcarcin%2Fbgr102" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=1259-1267&author=R.+Tammaliauthor=A.+B.+Reddyauthor=A.+Saxenaauthor=P.+G.+Rychahouauthor=B.+M.+Eversauthor=S.+Qiuauthor=S.+Awasthiauthor=K.+V.+Ramanaauthor=S.+K.+Srivastava&title=Inhibition+of+Aldose+Reductase+Prevents+Colon+Cancer+Metastasis&doi=10.1093%2Fcarcin%2Fbgr102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgr102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgr102%26sid%3Dliteratum%253Aachs%26aulast%3DTammali%26aufirst%3DR.%26aulast%3DReddy%26aufirst%3DA.%2BB.%26aulast%3DSaxena%26aufirst%3DA.%26aulast%3DRychahou%26aufirst%3DP.%2BG.%26aulast%3DEvers%26aufirst%3DB.%2BM.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DAwasthi%26aufirst%3DS.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DInhibition%2520of%2520Aldose%2520Reductase%2520Prevents%2520Colon%2520Cancer%2520Metastasis%26jtitle%3DCarcinogenesis%26date%3D2011%26volume%3D32%26spage%3D1259%26epage%3D1267%26doi%3D10.1093%2Fcarcin%2Fbgr102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Zu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span> </span><span class="NLM_article-title">Aldo-Keto Reductase 1B10 Protects Human Colon Cells from DNA Damage Induced by Electrophilic Carbonyl Compounds</span> <span class="citation_source-journal">Mol. Carcinog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">118</span><span class="NLM_x">â</span> <span class="NLM_lpage">129</span><span class="refDoi">Â DOI: 10.1002/mc.22477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1002%2Fmc.22477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=26969882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC28XktV2hsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=118-129&author=X.+Zuauthor=R.+Yanauthor=J.+Panauthor=L.+Zhongauthor=Y.+Caoauthor=J.+Maauthor=C.+Caiauthor=D.+Huangauthor=J.+Liuauthor=F.+L.+Chungauthor=D.+F.+Liaoauthor=D.+Cao&title=Aldo-Keto+Reductase+1B10+Protects+Human+Colon+Cells+from+DNA+Damage+Induced+by+Electrophilic+Carbonyl+Compounds&doi=10.1002%2Fmc.22477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Aldo-keto reductase 1B10 protects human colon cells from DNA damage induced by electrophilic carbonyl compounds</span></div><div class="casAuthors">Zu, Xuyu; Yan, Ruilan; Pan, Jishen; Zhong, Linlin; Cao, Yu; Ma, Jun; Cai, Chuan; Huang, Dan; Liu, Jianghua; Chung, Fung-Lung; Liao, Duan-Fang; Cao, Deliang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">118-129</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Electrophilic carbonyl compds. are highly cytotoxic and genotoxic.  Aldo-keto reductase 1B10 (AKR1B10) is an enzyme catalyzing redn. of carbonyl compds. to less toxic alc. forms.  This study presents novel evidence that AKR1B10 protects colon cells from DNA damage induced by electrophilic carbonyl compds.  AKR1B10 is specifically expressed in epithelial cells of the human colon, but this study found that AKR1B10 expression was lost or markedly diminished in colorectal cancer, precancerous tissues, and a notable portion of normal adjacent tissues (NAT).  SiRNA-mediated silencing of AKR1B10 in colon cancer cells HCT-8 enhanced cytotoxicity of acrolein and HNE, whereas ectopic expression of AKR1B10 in colon cancer cells RKO prevented the host cells against carbonyl cytotoxicity.  Furthermore, siRNA-mediated AKR1B10 silencing led to DNA breaks and activation of Î³-H2AX protein, a marker of DNA double strand breaks, particularly in the exposure of HNE (10 Î¼M).  In the AKR1B10 silenced HCT-8 cells, hypoxanthine-guanine phosphoribosyl transferase (HPRT) mutant frequency increased by 26.8 times at basal level and by 33.5 times in the presence of 10 Î¼M HNE when compared to vector control cells.  In these cells, the cyclic acrolein-deoxyguanosine adducts levels were increased by over 10 times.  These findings were confirmed by pharmacol. inhibition of AKR1B10 activity by Epalrestat.  Taken together, these data suggest that AKR1B10 is a crit. protein that protects host cells from DNA damage induced by electrophilic carbonyl compds.  AKR1B10 deficiency in the colon may be an important pathogenic factor in disease progression and carcinogenesis. Â© 2016 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreAi6ctzjZEbVg90H21EOLACvtfcHk0lhdonmbr9MxgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktV2hsr0%253D&md5=b20d0a5eac71ea8275da114c5f7c0ca4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fmc.22477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.22477%26sid%3Dliteratum%253Aachs%26aulast%3DZu%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DR.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DZhong%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DF.%2BL.%26aulast%3DLiao%26aufirst%3DD.%2BF.%26aulast%3DCao%26aufirst%3DD.%26atitle%3DAldo-Keto%2520Reductase%25201B10%2520Protects%2520Human%2520Colon%2520Cells%2520from%2520DNA%2520Damage%2520Induced%2520by%2520Electrophilic%2520Carbonyl%2520Compounds%26jtitle%3DMol.%2520Carcinog.%26date%3D2017%26volume%3D56%26spage%3D118%26epage%3D129%26doi%3D10.1002%2Fmc.22477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Takemura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iinuma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Selective Inhibition of the Tumor Marker Aldo-Keto Reductase Family Member 1B10 by Oleanolic Acid</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1201</span><span class="NLM_x">â</span> <span class="NLM_lpage">1206</span><span class="refDoi">Â DOI: 10.1021/np200118q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np200118q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtVWgu74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2011&pages=1201-1206&author=M.+Takemuraauthor=S.+Endoauthor=T.+Matsunagaauthor=M.+Sodaauthor=H.+T.+Zhaoauthor=O.+El-Kabbaniauthor=K.+Tajimaauthor=M.+Iinumaauthor=A.+Hara&title=Selective+Inhibition+of+the+Tumor+Marker+Aldo-Keto+Reductase+Family+Member+1B10+by+Oleanolic+Acid&doi=10.1021%2Fnp200118q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of the Tumor Marker Aldo-keto Reductase Family Member 1B10 by Oleanolic Acid</span></div><div class="casAuthors">Takemura, Mayuko; Endo, Satoshi; Matsunaga, Toshiyuki; Soda, Midori; Zhao, Hai-Tao; El-Kabbani, Ossama; Tajima, Kazuo; Iinuma, Munekazu; Hara, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1201-1206</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A human member of the aldo-keto reductase (AKR) superfamily, AKR1B10, was recently suggested as a therapeutic target in the treatment of several types of cancer.  Due to its high sequence identity with human aldose reductase (AKR1B1), selective inhibition of AKR1B10 compared with AKR1B1 is required for the development of anticancer agents.  In this study, we have examd. AKR1B10 inhibition by seven pentacyclic triterpenes (1-7) that show potential anticancer properties.  Among them, oleanolic acid (1) was found to be the most potent competitive inhibitor (inhibition const., 72 nM) with the highest AKR1B10/AKR1B1 selectivity ratio of 1370.  Mol. docking of 1 with AKR1B10 and AKR1B1 and site-directed mutagenesis studies suggested that the nonconserved residues Val301 and Gln303 in AKR1B10 are important for detg. its inhibitory potency and selectivity.  Oleanolic acid (1) also inhibited the cellular metab. by AKR1B10 (IC50, 4 Î¼M) and decreased mitomycin C tolerance of colon cancer HT29 cells.  Thus, the selective and potent inhibition of AKR1B10 by 1 may be related to a possible cancer inhibitory role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1SmlRtSPgBrVg90H21EOLACvtfcHk0liXyevqGYpM9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtVWgu74%253D&md5=5f4d4c3f214c268f6767edfa7f75c5a4</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fnp200118q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp200118q%26sid%3Dliteratum%253Aachs%26aulast%3DTakemura%26aufirst%3DM.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DH.%2BT.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DTajima%26aufirst%3DK.%26aulast%3DIinuma%26aufirst%3DM.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DSelective%2520Inhibition%2520of%2520the%2520Tumor%2520Marker%2520Aldo-Keto%2520Reductase%2520Family%2520Member%25201B10%2520by%2520Oleanolic%2520Acid%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2011%26volume%3D74%26spage%3D1201%26epage%3D1206%26doi%3D10.1021%2Fnp200118q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takemura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ifuku, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyooka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Evaluation of Caffeic Acid Phenethyl Ester-Based Inhibitors Targeting a Selectivity Pocket in the Active Site of Human Aldo-Keto Reductase 1B10</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">â</span> <span class="NLM_lpage">329</span><span class="refDoi">Â DOI: 10.1016/j.ejmech.2011.12.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.ejmech.2011.12.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=22236472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKmtLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2012&pages=321-329&author=M.+Sodaauthor=D.+Huauthor=S.+Endoauthor=M.+Takemuraauthor=J.+Liauthor=R.+Wadaauthor=S.+Ifukuauthor=H.+T.+Zhaoauthor=O.+El-Kabbaniauthor=S.+Ohtaauthor=K.+Yamamuraauthor=N.+Toyookaauthor=A.+Haraauthor=T.+Matsunaga&title=Design%2C+Synthesis+and+Evaluation+of+Caffeic+Acid+Phenethyl+Ester-Based+Inhibitors+Targeting+a+Selectivity+Pocket+in+the+Active+Site+of+Human+Aldo-Keto+Reductase+1B10&doi=10.1016%2Fj.ejmech.2011.12.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and evaluation of caffeic acid phenethyl ester-based inhibitors targeting a selectivity pocket in the active site of human aldo-keto reductase 1B10</span></div><div class="casAuthors">Soda, Midori; Hu, Dawei; Endo, Satoshi; Takemura, Mayuko; Li, Jie; Wada, Ryogo; Ifuku, Syohei; Zhao, Hai-Tao; El-Kabbani, Ossama; Ohta, Shozo; Yamamura, Keiko; Toyooka, Naoki; Hara, Akira; Matsunaga, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">321-329</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Inhibitors of a human aldo-keto reductase, AKR1B10, are regarded as promising therapeutics for the treatment of cancer, but those with both high potency and selectivity compared to the structurally similar aldose reductase (AKR1B1) have not been reported.  It was found that, among honeybee propolis products, caffeic acid phenethyl ester (CAPE) inhibited AKR1B10 (IC50 = 80 nM) with 7-fold selectivity over AKR1B1.  Based on a model of docked CAPE in AKR1B10, its derivs. were designed, synthesized and evaluated for inhibitory potency.  Among them, 3-(4-hydroxy-2-methoxyphenyl)acrylic acid 3-(3-hydroxyphenyl)propyl ester (I) was the most potent competitive inhibitor (Ki = 2.6 nM) with 790-fold selectivity for AKR1B10 over AKR1B1.  Mol. docking of I and site-directed mutagenesis of AKR1B10 residues suggested that the interactions between the 2-methoxy and 3-hydroxy groups of I and the enzyme's Val301 and Gln114, resp., are important for the inhibitor's selectivity.  Addnl., the sub-Î¼M concn. of I significantly suppressed the farnesal metab. and cellular proliferation in AKR1B10-overexpressing cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosUyXjN5NmeLVg90H21EOLACvtfcHk0liXyevqGYpM9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKmtLo%253D&md5=581f1fd9a8763e2e3c6520d8c0f8551b</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.12.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.12.034%26sid%3Dliteratum%253Aachs%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DTakemura%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWada%26aufirst%3DR.%26aulast%3DIfuku%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DH.%2BT.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DOhta%26aufirst%3DS.%26aulast%3DYamamura%26aufirst%3DK.%26aulast%3DToyooka%26aufirst%3DN.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DMatsunaga%26aufirst%3DT.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Evaluation%2520of%2520Caffeic%2520Acid%2520Phenethyl%2520Ester-Based%2520Inhibitors%2520Targeting%2520a%2520Selectivity%2520Pocket%2520in%2520the%2520Active%2520Site%2520of%2520Human%2520Aldo-Keto%2520Reductase%25201B10%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D48%26spage%3D321%26epage%3D329%26doi%3D10.1016%2Fj.ejmech.2011.12.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitade, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Chromene-3-carboxamide Derivatives Discovered from Virtual Screening as Potent Inhibitors of the Tumour Maker, AKR1B10</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2485</span><span class="NLM_x">â</span> <span class="NLM_lpage">2490</span><span class="refDoi">Â DOI: 10.1016/j.bmc.2010.02.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.bmc.2010.02.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=20304656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksVejsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=2485-2490&author=S.+Endoauthor=T.+Matsunagaauthor=K.+Kuwataauthor=H.+T.+Zhaoauthor=O.+El-Kabbaniauthor=Y.+Kitadeauthor=A.+Hara&title=Chromene-3-carboxamide+Derivatives+Discovered+from+Virtual+Screening+as+Potent+Inhibitors+of+the+Tumour+Maker%2C+AKR1B10&doi=10.1016%2Fj.bmc.2010.02.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Chromene-3-carboxamide derivatives discovered from virtual screening as potent inhibitors of the tumour marker, AKR1B10</span></div><div class="casAuthors">Endo, Satoshi; Matsunaga, Toshiyuki; Kuwata, Kazuo; Zhao, Hai-Tao; El-Kabbani, Ossama; Kitade, Yukio; Hara, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2485-2490</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A human aldose reductase-like protein, AKR1B10 in the aldo-keto reductase (AKR) superfamily, was recently identified as a therapeutic target in the treatment of several types of cancer.  In order to identify potential leads for new inhibitors of AKR1B10, we adopted the virtual screening approach using the automated program, which resulted in the discovery of several chromene-3-carboxamide derivs. as potent competitive inhibitors.  The most potent (Z)-2-(4-methoxyphenylimino)-7-hydroxy-N-(pyridin-2-yl)-2H-chromene-3-carboxamide inhibited the reductase activity of AKR1B10 with a K i value of 2.7 nM, and the metab. of farnesal and 4-hydroxynonenal in the AKR1B10-overexpressed cells from 0.1 Î¼M with an IC50 value equal to 0.8 Î¼M.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFQqgcsudULLVg90H21EOLACvtfcHk0liXyevqGYpM9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksVejsb4%253D&md5=0c7ee3d7aba8df660d657d87e9a33c01</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.02.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.02.050%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DKuwata%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DH.%2BT.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DKitade%26aufirst%3DY.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DChromene-3-carboxamide%2520Derivatives%2520Discovered%2520from%2520Virtual%2520Screening%2520as%2520Potent%2520Inhibitors%2520of%2520the%2520Tumour%2520Maker%252C%2520AKR1B10%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D2485%26epage%3D2490%26doi%3D10.1016%2Fj.bmc.2010.02.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z. Q.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Coumarin-3-acylamino Derivatives to Scavenge Radicals and to Protect DNA</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">7</span><span class="refDoi">Â DOI: 10.1016/j.ejmech.2014.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.ejmech.2014.07.009" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=1-7&author=Y.+Yangauthor=Q.+W.+Liuauthor=Y.+Shiauthor=Z.+G.+Songauthor=Y.+H.+Jinauthor=Z.+Q.+Liu&title=Design+and+Synthesis+of+Coumarin-3-acylamino+Derivatives+to+Scavenge+Radicals+and+to+Protect+DNA&doi=10.1016%2Fj.ejmech.2014.07.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DQ.%2BW.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DZ.%2BG.%26aulast%3DJin%26aufirst%3DY.%2BH.%26aulast%3DLiu%26aufirst%3DZ.%2BQ.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Coumarin-3-acylamino%2520Derivatives%2520to%2520Scavenge%2520Radicals%2520and%2520to%2520Protect%2520DNA%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D84%26spage%3D1%26epage%3D7%26doi%3D10.1016%2Fj.ejmech.2014.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Song, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, K. S.</span><span> </span><span class="NLM_article-title">A Convenient Synthesis of Coumarin-3-carboxylic Acids via Knoevenagel Condensation of Meldrumâs Acid with <i>ortho</i>-Hydroxyaryl Aldehydes or Ketones</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1755</span><span class="NLM_x">â</span> <span class="NLM_lpage">1758</span><span class="refDoi">Â DOI: 10.1016/S0040-4039(03)00108-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2FS0040-4039%2803%2900108-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtFCguro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=1755-1758&author=A.+Songauthor=X.+Wangauthor=K.+S.+Lam&title=A+Convenient+Synthesis+of+Coumarin-3-carboxylic+Acids+via+Knoevenagel+Condensation+of+Meldrum%E2%80%99s+Acid+with+ortho-Hydroxyaryl+Aldehydes+or+Ketones&doi=10.1016%2FS0040-4039%2803%2900108-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A convenient synthesis of coumarin-3-carboxylic acids via Knoevenagel condensation of Meldrum's acid with ortho-hydroxyaryl aldehydes or ketones</span></div><div class="casAuthors">Song, Aimin; Wang, Xiaobing; Lam, Kit S.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1755-1758</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Coumarin-3-carboxylic acids were obtained in high yields with excellent purity from o-hydroxybenzaldehydes and Meldrum's acid after a 2 h reflux in ethanol.  The less reactive ketones were first reacted with alc. ammonia to form ketimines, which were then condensed with Meldrum's acid to generate 4-alkylcoumarin-3-carboxylic acids in moderate yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHE1Ojsx-mDbVg90H21EOLACvtfcHk0lhDnqqQmJYxlQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtFCguro%253D&md5=b0e16858ce4bc05e66f8bb67ad6505b9</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2803%2900108-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252803%252900108-4%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLam%26aufirst%3DK.%2BS.%26atitle%3DA%2520Convenient%2520Synthesis%2520of%2520Coumarin-3-carboxylic%2520Acids%2520via%2520Knoevenagel%2520Condensation%2520of%2520Meldrum%25E2%2580%2599s%2520Acid%2520with%2520ortho-Hydroxyaryl%2520Aldehydes%2520or%2520Ketones%26jtitle%3DTetrahedron%2520Lett.%26date%3D2003%26volume%3D44%26spage%3D1755%26epage%3D1758%26doi%3D10.1016%2FS0040-4039%2803%2900108-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">True, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mais, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikel, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utterback, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyss, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakubowski, J. A.</span><span> </span><span class="NLM_article-title">Development of Dual-Acting Agents for Thromboxane Receptor Antagonism and Thromboxane Synthase Inhibition. 3. Synthesis and Biological Activities of Oxazolecarboxamide-Substituted Ï-Phenyl-Ï-(3-pyridyl)alkenoic Acid Derivatives and Related Compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">5362</span><span class="NLM_x">â</span> <span class="NLM_lpage">5374</span><span class="refDoi">Â DOI: 10.1021/jm980173n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm980173n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=5362-5374&author=K.+Takeuchiauthor=T.+J.+Kohnauthor=T.+A.+Trueauthor=D.+E.+Maisauthor=J.+H.+Wikelauthor=B.+G.+Utterbackauthor=V.+L.+Wyssauthor=J.+A.+Jakubowski&title=Development+of+Dual-Acting+Agents+for+Thromboxane+Receptor+Antagonism+and+Thromboxane+Synthase+Inhibition.+3.+Synthesis+and+Biological+Activities+of+Oxazolecarboxamide-Substituted+%CF%89-Phenyl-%CF%89-%283-pyridyl%29alkenoic+Acid+Derivatives+and+Related+Compounds&doi=10.1021%2Fjm980173n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm980173n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980173n%26sid%3Dliteratum%253Aachs%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DKohn%26aufirst%3DT.%2BJ.%26aulast%3DTrue%26aufirst%3DT.%2BA.%26aulast%3DMais%26aufirst%3DD.%2BE.%26aulast%3DWikel%26aufirst%3DJ.%2BH.%26aulast%3DUtterback%26aufirst%3DB.%2BG.%26aulast%3DWyss%26aufirst%3DV.%2BL.%26aulast%3DJakubowski%26aufirst%3DJ.%2BA.%26atitle%3DDevelopment%2520of%2520Dual-Acting%2520Agents%2520for%2520Thromboxane%2520Receptor%2520Antagonism%2520and%2520Thromboxane%2520Synthase%2520Inhibition.%25203.%2520Synthesis%2520and%2520Biological%2520Activities%2520of%2520Oxazolecarboxamide-Substituted%2520%25CF%2589-Phenyl-%25CF%2589-%25283-pyridyl%2529alkenoic%2520Acid%2520Derivatives%2520and%2520Related%2520Compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D5362%26epage%3D5374%26doi%3D10.1021%2Fjm980173n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shintani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Multiplicity of Mammalian Reductases for Xenobiotic Carbonyl Compounds</span> <span class="citation_source-journal">Drug Metab. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">18</span><span class="refDoi">Â DOI: 10.2133/dmpk.21.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.2133%2Fdmpk.21.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=16547389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjs1yrsL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=1-18&author=T.+Matsunagaauthor=S.+Shintaniauthor=A.+Hara&title=Multiplicity+of+Mammalian+Reductases+for+Xenobiotic+Carbonyl+Compounds&doi=10.2133%2Fdmpk.21.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Multiplicity of mammalian reductases for xenobiotic carbonyl compounds</span></div><div class="casAuthors">Matsunaga, Toshiyuki; Shintani, Shinichi; Hara, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-18</span>CODEN:
                <span class="NLM_cas:coden">DMPRB8</span>;
        ISSN:<span class="NLM_cas:issn">1347-4367</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society for the Study of Xenobiotics</span>)
        </div><div class="casAbstract">A review.  A variety of carbonyl compds. are present in foods, environmental pollutants, and drugs.  These xenobiotic carbonyl compds. are metabolized into the corresponding alcs. by many mammalian NAD(P)H-dependent reductases, which belong to the short-chain dehydrogenase/reductase (SDR) and aldo-keto reductase superfamilies.  Recent genomic anal., cDNA isolation and characterization of the recombinant enzymes suggested that, in humans, the six members of each of the two superfamilies, i.e., total of 12 enzymes, are involved in the reductive metab. of xenobiotic carbonyl compds.  They comprise three types of carbonyl reductase, dehydrogenase/reductase (SDR family) member 4, 11Î²-hydroxysteroid dehydrogenase type 1, L-xylulose reductase, two types of aflatoxin B1 aldehyde reductase, 20Î±-hydroxysteroid dehydrogenase, and three types of 3Î±-hydroxysteroid dehydrogenase.  Accumulating data on the human enzymes provide new insights into their roles in cellular and mol. reactions including xenobiotic metab.  On the other hand, mice and rats lack the gene for a protein corresponding to human 3Î±-hydroxysteroid dehydrogenase type 3, but instead possess addnl. five or six genes encoding proteins that are structurally related to human hydroxysteroid dehydrogenases.  Characterization of the addnl. enzymes suggested their involvement in species-specific biol. events and species differences in the metab. of xenobiotic carbonyl compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI7rMDVNUU5rVg90H21EOLACvtfcHk0lhDnqqQmJYxlQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjs1yrsL8%253D&md5=7ad14b51f39405673f435f409a8e3e4b</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.2133%2Fdmpk.21.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2133%252Fdmpk.21.1%26sid%3Dliteratum%253Aachs%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DShintani%26aufirst%3DS.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DMultiplicity%2520of%2520Mammalian%2520Reductases%2520for%2520Xenobiotic%2520Carbonyl%2520Compounds%26jtitle%3DDrug%2520Metab.%2520Pharmacokinet.%26date%3D2006%26volume%3D21%26spage%3D1%26epage%3D18%26doi%3D10.2133%2Fdmpk.21.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Hu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyagi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oguri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishinaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyooka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span> </span><span class="NLM_article-title">Synthesis of 8-Hydroxy-2-iminochromene Derivatives as Selective and Potent Inhibitors of Human Carbonyl Reductase 1</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">7487</span><span class="NLM_x">â</span> <span class="NLM_lpage">7499</span><span class="refDoi">Â DOI: 10.1039/C5OB00847F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1039%2FC5OB00847F" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=7487-7499&author=D.+Huauthor=N.+Miyagiauthor=Y.+Araiauthor=H.+Oguriauthor=T.+Miuraauthor=T.+Nishinakaauthor=T.+Teradaauthor=H.+Goudaauthor=O.+El-Kabbaniauthor=S.+Xiaauthor=N.+Toyookaauthor=A.+Haraauthor=T.+Matsunagaauthor=A.+Ikariauthor=S.+Endo&title=Synthesis+of+8-Hydroxy-2-iminochromene+Derivatives+as+Selective+and+Potent+Inhibitors+of+Human+Carbonyl+Reductase+1&doi=10.1039%2FC5OB00847F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1039%2FC5OB00847F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5OB00847F%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DD.%26aulast%3DMiyagi%26aufirst%3DN.%26aulast%3DArai%26aufirst%3DY.%26aulast%3DOguri%26aufirst%3DH.%26aulast%3DMiura%26aufirst%3DT.%26aulast%3DNishinaka%26aufirst%3DT.%26aulast%3DTerada%26aufirst%3DT.%26aulast%3DGouda%26aufirst%3DH.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DXia%26aufirst%3DS.%26aulast%3DToyooka%26aufirst%3DN.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DIkari%26aufirst%3DA.%26aulast%3DEndo%26aufirst%3DS.%26atitle%3DSynthesis%2520of%25208-Hydroxy-2-iminochromene%2520Derivatives%2520as%2520Selective%2520and%2520Potent%2520Inhibitors%2520of%2520Human%2520Carbonyl%2520Reductase%25201%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D7487%26epage%3D7499%26doi%3D10.1039%2FC5OB00847F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span> </span><span class="NLM_article-title">Structural Basis for the Inhibition of AKR1B10 by Caffeic Acid Phenethyl Ester (CAPE)</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">706</span><span class="NLM_x">â</span> <span class="NLM_lpage">709</span><span class="refDoi">Â DOI: 10.1002/cmdc.201300455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1002%2Fcmdc.201300455" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=706-709&author=L.+Zhangauthor=H.+Zhangauthor=X.+Zhengauthor=Y.+Zhaoauthor=S.+Chenauthor=Y.+Chenauthor=R.+Zhangauthor=Q.+Liauthor=X.+Hu&title=Structural+Basis+for+the+Inhibition+of+AKR1B10+by+Caffeic+Acid+Phenethyl+Ester+%28CAPE%29&doi=10.1002%2Fcmdc.201300455"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300455%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DHu%26aufirst%3DX.%26atitle%3DStructural%2520Basis%2520for%2520the%2520Inhibition%2520of%2520AKR1B10%2520by%2520Caffeic%2520Acid%2520Phenethyl%2520Ester%2520%2528CAPE%2529%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D706%26epage%3D709%26doi%3D10.1002%2Fcmdc.201300455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Case, D. A.; Babin, V.; Berryman, J. T.; Betz, R. M.; Cai, Q.; Cerutti, D. S.; Cheatham, T. E.,  III; Darden, T. A.; Duke, R. E.; Gohlke, H.; Goetz, A. W.; Gusarov, S.; Homeyer, N.; Janowski, P.; Kaus, J.; KolossvÃ¡ry, I.; Kovalenko, A.; Lee, T. S.; LeGrand, S.; Luchko, T.; Luo, R.; Madej, B.; Merz, K. M.; Paesani, F.; Roe, D. R.; Roitberg, A.; Sagui, C.; Salomon-Ferrer, R.; Seabra, G.; Simmerling, C. L.; Smith, W.; Swails, J.; Walker, R. C.; Wang, J.; Wolf, R. M.; Wu, X.; Kollman, P. A.</span> <span class="citation_source-book">AMBER 14</span>; <span class="NLM_publisher-name">University of California</span>: <span class="NLM_publisher-loc">San Francisco, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=D.+A.+Case&author=V.+Babin&author=J.+T.+Berryman&author=R.+M.+Betz&author=Q.+Cai&author=D.+S.+Cerutti&author=T.+E.+Cheatham&author=T.+A.+Darden&author=R.+E.+Duke&author=H.+Gohlke&author=A.+W.+Goetz&author=S.+Gusarov&author=N.+Homeyer&author=P.+Janowski&author=J.+Kaus&author=I.+Kolossv%C3%A1ry&author=A.+Kovalenko&author=T.+S.+Lee&author=S.+LeGrand&author=T.+Luchko&author=R.+Luo&author=B.+Madej&author=K.+M.+Merz&author=F.+Paesani&author=D.+R.+Roe&author=A.+Roitberg&author=C.+Sagui&author=R.+Salomon-Ferrer&author=G.+Seabra&author=C.+L.+Simmerling&author=W.+Smith&author=J.+Swails&author=R.+C.+Walker&author=J.+Wang&author=R.+M.+Wolf&author=X.+Wu&author=P.+A.+Kollman&title=AMBER+14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCase%26aufirst%3DD.%2BA.%26btitle%3DAMBER%252014%26pub%3DUniversity%2520of%2520California%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Aldo-Keto Reductase 1B10 and Its Role in Proliferation Capacity of Drug-Resistant Cancers</span> <span class="citation_source-journal">Front. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="refDoi">Â DOI: 10.3389/fphar.2012.00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.3389%2Ffphar.2012.00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=22319498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms12qtL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=5&author=T.+Matsunagaauthor=Y.+Wadaauthor=S.+Endoauthor=M.+Sodaauthor=O.+El-Kabbaniauthor=A.+Hara&title=Aldo-Keto+Reductase+1B10+and+Its+Role+in+Proliferation+Capacity+of+Drug-Resistant+Cancers&doi=10.3389%2Ffphar.2012.00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Aldo-keto reductase 1B10 and its role in proliferation capacity of drug-resistant cancers</span></div><div class="casAuthors">Matsunaga, Toshiyuki; Wada, Yasuhiro; Endo, Satoshi; Soda, Midori; El-Kabbani, Ossama; Hara, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Experimental Pharmacology and Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">Jan.</span>),
    <span class="NLM_cas:pages">5</span>CODEN:
                <span class="NLM_cas:coden">FEPDAX</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  The human aldo-keto reductase AKR1B10, originally identified as an aldose reductase-like protein and human small intestine aldose reductase, is a cytosolic NADPH-dependent reductase that metabolizes a variety of endogenous compds., such as arom. and aliph. aldehydes and dicarbonyl compds. and some drug ketones.  The enzyme is highly expressed in solid tumors of several tissues including lung and liver and as such has received considerable interest as a relevant biomarker for the development of those tumors.  In addn., AKR1B10 has been recently reported to be significantly up-regulated in some cancer cell lines (medulloblastoma D341 and colon cancer HT29) acquiring resistance toward chemotherapeutic agents (cyclophosphamide and mitomycin c), suggesting the validity of the enzyme as a chemoresistance marker.  Although the detailed information on the AKR1B10-mediated mechanisms leading to the drug resistance process is not well understood so far, the enzyme has been proposed to be involved in functional regulations of cell proliferation and metab. of drugs and endogenous lipids during the development of chemoresistance.  This article reviews the current literature focusing mainly on expression profile and roles of AKR1B10 in the drug resistance of cancer cells.  Recent developments of AKR1B10 inhibitors and their usefulness in restoring sensitivity to anticancer drugs are also reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR22RRliczILVg90H21EOLACvtfcHk0lhOfg0r7FqIEA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms12qtL4%253D&md5=4e8245dc0cd6debf2092c080e7b696b9</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2012.00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2012.00005%26sid%3Dliteratum%253Aachs%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DWada%26aufirst%3DY.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DAldo-Keto%2520Reductase%25201B10%2520and%2520Its%2520Role%2520in%2520Proliferation%2520Capacity%2520of%2520Drug-Resistant%2520Cancers%26jtitle%3DFront.%2520Pharmacol.%26date%3D2012%26volume%3D3%26spage%3D5%26doi%3D10.3389%2Ffphar.2012.00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Semmelhack, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helquist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendelson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryono, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorzynski Smith, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, R. D.</span><span> </span><span class="NLM_article-title">Reaction of Aryl and Vinyl Halides with Zerovalent Nickel - Preparative Aspects and the Synthesis of Alnusone</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">6460</span><span class="NLM_x">â</span> <span class="NLM_lpage">6471</span><span class="refDoi">Â DOI: 10.1021/ja00411a034</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00411a034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1981&pages=6460-6471&author=M.+F.+Semmelhackauthor=P.+Helquistauthor=L.+D.+Jonesauthor=L.+Kellerauthor=L.+Mendelsonauthor=L.+S.+Ryonoauthor=J.+Gorzynski+Smithauthor=R.+D.+Stauffer&title=Reaction+of+Aryl+and+Vinyl+Halides+with+Zerovalent+Nickel+-+Preparative+Aspects+and+the+Synthesis+of+Alnusone&doi=10.1021%2Fja00411a034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fja00411a034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00411a034%26sid%3Dliteratum%253Aachs%26aulast%3DSemmelhack%26aufirst%3DM.%2BF.%26aulast%3DHelquist%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DL.%2BD.%26aulast%3DKeller%26aufirst%3DL.%26aulast%3DMendelson%26aufirst%3DL.%26aulast%3DRyono%26aufirst%3DL.%2BS.%26aulast%3DGorzynski%2BSmith%26aufirst%3DJ.%26aulast%3DStauffer%26aufirst%3DR.%2BD.%26atitle%3DReaction%2520of%2520Aryl%2520and%2520Vinyl%2520Halides%2520with%2520Zerovalent%2520Nickel%2520-%2520Preparative%2520Aspects%2520and%2520the%2520Synthesis%2520of%2520Alnusone%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1981%26volume%3D103%26spage%3D6460%26epage%3D6471%26doi%3D10.1021%2Fja00411a034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Brimble, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flowers, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trzoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsang, K. Y.</span><span> </span><span class="NLM_article-title">A Facile Synthesis of Fused Aromatic Spiroacetals Based on the 3,4,3â²,4â²-Tetrahydro-2,2â²-spirobis(2H-1-benzopyran) Skeleton</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">5883</span><span class="NLM_x">â</span> <span class="NLM_lpage">5896</span><span class="refDoi">Â DOI: 10.1016/j.tet.2006.04.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.tet.2006.04.026" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=5883-5896&author=M.+A.+Brimbleauthor=C.+L.+Flowersauthor=M.+Trzossauthor=K.+Y.+Tsang&title=A+Facile+Synthesis+of+Fused+Aromatic+Spiroacetals+Based+on+the+3%2C4%2C3%E2%80%B2%2C4%E2%80%B2-Tetrahydro-2%2C2%E2%80%B2-spirobis%282H-1-benzopyran%29+Skeleton&doi=10.1016%2Fj.tet.2006.04.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2006.04.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2006.04.026%26sid%3Dliteratum%253Aachs%26aulast%3DBrimble%26aufirst%3DM.%2BA.%26aulast%3DFlowers%26aufirst%3DC.%2BL.%26aulast%3DTrzoss%26aufirst%3DM.%26aulast%3DTsang%26aufirst%3DK.%2BY.%26atitle%3DA%2520Facile%2520Synthesis%2520of%2520Fused%2520Aromatic%2520Spiroacetals%2520Based%2520on%2520the%25203%252C4%252C3%25E2%2580%25B2%252C4%25E2%2580%25B2-Tetrahydro-2%252C2%25E2%2580%25B2-spirobis%25282H-1-benzopyran%2529%2520Skeleton%26jtitle%3DTetrahedron%26date%3D2006%26volume%3D62%26spage%3D5883%26epage%3D5896%26doi%3D10.1016%2Fj.tet.2006.04.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Defauw, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagdmann, G. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollinshead, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heerding, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darges, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, S. E.</span><span> </span><span class="NLM_article-title">Synthesis and Protein Kinase C Inhibitory Activities of Acyclic Balanol Analogs that Are Highly Selective for Protein Kinase C over Protein Kinase A</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">5215</span><span class="NLM_x">â</span> <span class="NLM_lpage">5227</span><span class="refDoi">Â DOI: 10.1021/jm960581w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm960581w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADyaK28XntFaqtrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=5215-5227&author=J.+M.+Defauwauthor=M.+M.+Murphyauthor=G.+E.+Jagdmannauthor=H.+Huauthor=J.+W.+Lampeauthor=S.+P.+Hollinsheadauthor=T.+J.+Mitchellauthor=H.+M.+Craneauthor=J.+M.+Heerdingauthor=J.+S.+Mendozaauthor=J.+E.+Davisauthor=J.+W.+Dargesauthor=F.+R.+Hubbardauthor=S.+E.+Hall&title=Synthesis+and+Protein+Kinase+C+Inhibitory+Activities+of+Acyclic+Balanol+Analogs+that+Are+Highly+Selective+for+Protein+Kinase+C+over+Protein+Kinase+A&doi=10.1021%2Fjm960581w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Protein Kinase C Inhibitory Activities of Acyclic Balanol Analogs That Are Highly Selective for Protein Kinase C over Protein Kinase A</span></div><div class="casAuthors">Defauw, Jean M.; Murphy, Marcia M.; Jagdmann, G. Erik, Jr.; Hu, Hong; Lampe, John W.; Hollinshead, Sean P.; Mitchell, Thomas J.; Crane, Heidi M.; Heerding, Julia M.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">5215-5227</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of balanol analogs in which the perhydroazepine ring and the p-hydroxybenzamide moiety were combined into an acyclic linked unit have been prepd. and evaluated for their inhibitory properties against the serine/threonine kinase PKC.  Several low-micromolar to low-nanomolar inhibitors of the Î±, Î²I, Î²II, Î³, Î´, Îµ, and Î· PKC isoenzymes were prepd.  In general, these acyclic balanol analogs were found to be highly selective for PKC over the serine/threonine kinase PKA.  The type and no. of atoms linking the benzophenone ester to the p-hydroxyphenyl group necessary for optimal PKC inhibition were investigated.  The most potent compds. contained a three-carbon linker in which the carboxamide moiety of balanol had been replaced by a methylene group.  The effect of placing substituents on the three-carbon chain was also investigated.  The preferred compds. contained either a 2-benzenesulfonamido or a 1-Me substituent.  The preferred compds. were tested against a panel of serine/threonine kinases and found to be highly selective for PKC.  The effect of making the analogs more rigid by making the three-carbon chain part of a five-membered ring, but with retention of the methylene replacement for the carboxamide moiety, led to potent PKC inhibitors including an anti-substituted pyrrolidine analog and an anti-substituted cyclopentane analog.  The anti cyclopentane analog was a low-micromolar inhibitor of the PMA-induced superoxide burst in neutrophils, and its carboxylic ester was a high-nanomolar inhibitor of neutrophils.  Esterification of these potent PKC inhibitors turned them into low-micromolar inhibitors of neutrophils.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo359o5cM_CYLVg90H21EOLACvtfcHk0lhYURQ3byRgfQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntFaqtrk%253D&md5=391b08344ac29003d1d192821f049826</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm960581w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960581w%26sid%3Dliteratum%253Aachs%26aulast%3DDefauw%26aufirst%3DJ.%2BM.%26aulast%3DMurphy%26aufirst%3DM.%2BM.%26aulast%3DJagdmann%26aufirst%3DG.%2BE.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DLampe%26aufirst%3DJ.%2BW.%26aulast%3DHollinshead%26aufirst%3DS.%2BP.%26aulast%3DMitchell%26aufirst%3DT.%2BJ.%26aulast%3DCrane%26aufirst%3DH.%2BM.%26aulast%3DHeerding%26aufirst%3DJ.%2BM.%26aulast%3DMendoza%26aufirst%3DJ.%2BS.%26aulast%3DDavis%26aufirst%3DJ.%2BE.%26aulast%3DDarges%26aufirst%3DJ.%2BW.%26aulast%3DHubbard%26aufirst%3DF.%2BR.%26aulast%3DHall%26aufirst%3DS.%2BE.%26atitle%3DSynthesis%2520and%2520Protein%2520Kinase%2520C%2520Inhibitory%2520Activities%2520of%2520Acyclic%2520Balanol%2520Analogs%2520that%2520Are%2520Highly%2520Selective%2520for%2520Protein%2520Kinase%2520C%2520over%2520Protein%2520Kinase%2520A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D5215%26epage%3D5227%26doi%3D10.1021%2Fjm960581w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Kurata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokuda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shioya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komiya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habashita, H.</span><span> </span><span class="NLM_article-title">Structure-Activity Relationship Studies of S1P Agonists with a Dihydronaphthalene Scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">â</span> <span class="NLM_lpage">148</span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2011.11.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.bmcl.2011.11.048" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=144-148&author=H.+Kurataauthor=K.+Kusumiauthor=K.+Otsukiauthor=R.+Suzukiauthor=M.+Kuronoauthor=N.+Tokudaauthor=Y.+Takadaauthor=H.+Shioyaauthor=H.+Mizunoauthor=T.+Komiyaauthor=T.+Onoauthor=H.+Hagiyaauthor=M.+Minamiauthor=S.+Nakadeauthor=H.+Habashita&title=Structure-Activity+Relationship+Studies+of+S1P+Agonists+with+a+Dihydronaphthalene+Scaffold&doi=10.1016%2Fj.bmcl.2011.11.048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.11.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.11.048%26sid%3Dliteratum%253Aachs%26aulast%3DKurata%26aufirst%3DH.%26aulast%3DKusumi%26aufirst%3DK.%26aulast%3DOtsuki%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DR.%26aulast%3DKurono%26aufirst%3DM.%26aulast%3DTokuda%26aufirst%3DN.%26aulast%3DTakada%26aufirst%3DY.%26aulast%3DShioya%26aufirst%3DH.%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DKomiya%26aufirst%3DT.%26aulast%3DOno%26aufirst%3DT.%26aulast%3DHagiya%26aufirst%3DH.%26aulast%3DMinami%26aufirst%3DM.%26aulast%3DNakade%26aufirst%3DS.%26aulast%3DHabashita%26aufirst%3DH.%26atitle%3DStructure-Activity%2520Relationship%2520Studies%2520of%2520S1P%2520Agonists%2520with%2520a%2520Dihydronaphthalene%2520Scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D144%26epage%3D148%26doi%3D10.1016%2Fj.bmcl.2011.11.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Bertrand, I.; Capet, M.; Lecomte, J.-M.; Levoin, N.; Ligneau, X.; Poupardin-Olivier, O.; Robert, P.; Schwartz, J.-C.</span><span> </span><span class="NLM_article-title">Preparation of Pyrrolidinyl- and Piperidinylpropoxypropylarenes as Histamine H3 Receptor Ligands</span>. J.P. Patent WO2006117611A1, Nov 9,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=I.+Bertrand&author=M.+Capet&author=J.-M.+Lecomte&author=N.+Levoin&author=X.+Ligneau&author=O.+Poupardin-Olivier&author=P.+Robert&author=J.-C.+Schwartz&title=Preparation+of+Pyrrolidinyl-+and+Piperidinylpropoxypropylarenes+as+Histamine+H3+Receptor+Ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DI.%26atitle%3DPreparation%2520of%2520Pyrrolidinyl-%2520and%2520Piperidinylpropoxypropylarenes%2520as%2520Histamine%2520H3%2520Receptor%2520Ligands%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Sallares, J.; Petschen, I.; Camps, X.</span><span> </span><span class="NLM_article-title">Etherification Process for Preparing 1-[3-[3-(4-Chlorophenyl)propoxy]propyl]piperidine from 3-(Piperidino)propanol and 3-(4-Chlorophenyl)propyl Mesylate with Sodium hydride in an Aprotic Polar Solvent</span>. J.P. Patent WO2007006708A1, Jan 18,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=J.+Sallares&author=I.+Petschen&author=X.+Camps&title=Etherification+Process+for+Preparing+1-%5B3-%5B3-%284-Chlorophenyl%29propoxy%5Dpropyl%5Dpiperidine+from+3-%28Piperidino%29propanol+and+3-%284-Chlorophenyl%29propyl+Mesylate+with+Sodium+hydride+in+an+Aprotic+Polar+Solvent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSallares%26aufirst%3DJ.%26atitle%3DEtherification%2520Process%2520for%2520Preparing%25201-%255B3-%255B3-%25284-Chlorophenyl%2529propoxy%255Dpropyl%255Dpiperidine%2520from%25203-%2528Piperidino%2529propanol%2520and%25203-%25284-Chlorophenyl%2529propyl%2520Mesylate%2520with%2520Sodium%2520hydride%2520in%2520an%2520Aprotic%2520Polar%2520Solvent%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Ko, S. S.; Batt, D. G.; Delucca, G. V.; Duncia, J. V.; Gardner, D. S.; Santella, J. B.</span><span> </span><span class="NLM_article-title">A Preparation of (Thio)urea Derivatives, Useful as Modulators of Chemokine Receptor</span>. WO2005048932A2,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=S.+S.+Ko&author=D.+G.+Batt&author=G.+V.+Delucca&author=J.+V.+Duncia&author=D.+S.+Gardner&author=J.+B.+Santella&title=A+Preparation+of+%28Thio%29urea+Derivatives%2C+Useful+as+Modulators+of+Chemokine+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKo%26aufirst%3DS.%2BS.%26atitle%3DA%2520Preparation%2520of%2520%2528Thio%2529urea%2520Derivatives%252C%2520Useful%2520as%2520Modulators%2520of%2520Chemokine%2520Receptor%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Nikam, S. S.; Scott, I. L.; Sherer, B. A.; Wise, L. D.</span><span> </span><span class="NLM_article-title">Preparation of Aminocyclohexylbenzazolones as NMDA Receptor Antagonists</span>. J.P. Patent WO2001092239A1, Dec 6,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=S.+S.+Nikam&author=I.+L.+Scott&author=B.+A.+Sherer&author=L.+D.+Wise&title=Preparation+of+Aminocyclohexylbenzazolones+as+NMDA+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNikam%26aufirst%3DS.%2BS.%26atitle%3DPreparation%2520of%2520Aminocyclohexylbenzazolones%2520as%2520NMDA%2520Receptor%2520Antagonists%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Iino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shintaku, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Tetrahydrobiopterin is Synthesized from 6-Pyruvoyl-tetrahydropterin by the Human Aldo-Keto Reductase AKR1 Family Members</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">416</span><span class="NLM_x">, </span> <span class="NLM_fpage">180</span><span class="NLM_x">â</span> <span class="NLM_lpage">187</span><span class="refDoi">Â DOI: 10.1016/S0003-9861(03)00295-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2FS0003-9861%2803%2900295-9" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=416&publication_year=2003&pages=180-187&author=T.+Iinoauthor=M.+Tabataauthor=S.+Takikawaauthor=H.+Sawadaauthor=H.+Shintakuauthor=S.+Ishikuraauthor=A.+Hara&title=Tetrahydrobiopterin+is+Synthesized+from+6-Pyruvoyl-tetrahydropterin+by+the+Human+Aldo-Keto+Reductase+AKR1+Family+Members&doi=10.1016%2FS0003-9861%2803%2900295-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2FS0003-9861%2803%2900295-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0003-9861%252803%252900295-9%26sid%3Dliteratum%253Aachs%26aulast%3DIino%26aufirst%3DT.%26aulast%3DTabata%26aufirst%3DM.%26aulast%3DTakikawa%26aufirst%3DS.%26aulast%3DSawada%26aufirst%3DH.%26aulast%3DShintaku%26aufirst%3DH.%26aulast%3DIshikura%26aufirst%3DS.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DTetrahydrobiopterin%2520is%2520Synthesized%2520from%25206-Pyruvoyl-tetrahydropterin%2520by%2520the%2520Human%2520Aldo-Keto%2520Reductase%2520AKR1%2520Family%2520Members%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2003%26volume%3D416%26spage%3D180%26epage%3D187%26doi%3D10.1016%2FS0003-9861%2803%2900295-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Matsuura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deyashiki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kume, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katagiri, Y.</span><span> </span><span class="NLM_article-title">Roles of the C-terminal Domains of Human Dihydrodiol Dehydrogenase Isoforms in the Binding of Substrates and Modulators: Probing with Chimaeric Enzymes</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">â</span> <span class="NLM_lpage">436</span><span class="refDoi">Â DOI: 10.1042/bj3360429</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1042%2Fbj3360429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=9820821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADyaK1MXhtFWitA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=1998&pages=429-436&author=K.+Matsuuraauthor=A.+Haraauthor=Y.+Deyashikiauthor=H.+Iwasaauthor=T.+Kumeauthor=S.+Ishikuraauthor=H.+Shiraishiauthor=Y.+Katagiri&title=Roles+of+the+C-terminal+Domains+of+Human+Dihydrodiol+Dehydrogenase+Isoforms+in+the+Binding+of+Substrates+and+Modulators%3A+Probing+with+Chimaeric+Enzymes&doi=10.1042%2Fbj3360429"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of the C-terminal domains of human dihydrodiol dehydrogenase isoforms in the binding of substrates and modulators: probing with chimeric enzymes</span></div><div class="casAuthors">Matsuura, Kazuya; Hara, Akira; Deyashiki, Yoshihiro; Iwasa, Harunori; Kume, Toshiyuki; Ishikura, Syuhei; Shiraishi, Hiroaki; Katagiri, Yoshihiro</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">429-436</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Human liver dihydrodiol dehydrogenase (DD; E.C. 1.3.1.20) exists in isoforms (DD1, DD2 and DD4) composed of 323 amino acids.  DD1 and DD2 share 98% amino acid sequence identity, but show lower identities (approx. 83%) with DD4, in which a marked difference is seen in the C-terminal ten amino acids.  DD4 exhibits unique catalytic properties, such as the ability to oxidize both (R)- and (S)-alicyclic alcs. equally, high dehydrogenase activity for bile acids, potent inhibition by steroidal anti-inflammatory drugs and activation by sulfobromophthalein and clofibric acid derivs.  In this study, the authors have prepd. chimeric enzymes, in which the authors exchanged the C-terminal 39 residues between the two enzymes.  Compared with DD1, CDD1-4 (DD1 with the C-terminal sequence of DD4) had increased kcat/Km values for 3Î±-hydroxy-5Î²-androstanes and bile acids of 3-9-fold and decreased values for the other substrates by 5-100-fold.  It also became highly sensitive to DD4 inhibitors such as phenolphthalein and hexoestrol.  Another chimeric enzyme, CDD4-1 (DD4 with the C-terminal sequence of DD1), showed the same (S)-stereospecificity for the alicyclic alcs. as DD1, had decreased kcat/Km values for bile acids with 7Î²- or 12Î±-hydroxy groups by more than 120-fold and was resistant to inhibition by betamethasone.  In addn., the activation effects of sulfobromophthalein and bezafibrate decreased or disappeared for CDD4-1.  The recombinant DD4 with the His314 â Pro (the corresponding residue of DD1) mutation showed intermediate changes in the properties between those of wild-type DD4 and CDD4-1.  The results indicate that the binding of substrates, inhibitors and activators to the enzymes is controlled by residues in their C-terminal domains; multiple residues coordinately act as determinants for substrate specificity and inhibitor sensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob6FlqCEcrKbVg90H21EOLACvtfcHk0liiZWFHtpDnww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtFWitA%253D%253D&md5=5ca353704b56ed92fe72f34303fc7203</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1042%2Fbj3360429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3360429%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuura%26aufirst%3DK.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DDeyashiki%26aufirst%3DY.%26aulast%3DIwasa%26aufirst%3DH.%26aulast%3DKume%26aufirst%3DT.%26aulast%3DIshikura%26aufirst%3DS.%26aulast%3DShiraishi%26aufirst%3DH.%26aulast%3DKatagiri%26aufirst%3DY.%26atitle%3DRoles%2520of%2520the%2520C-terminal%2520Domains%2520of%2520Human%2520Dihydrodiol%2520Dehydrogenase%2520Isoforms%2520in%2520the%2520Binding%2520of%2520Substrates%2520and%2520Modulators%253A%2520Probing%2520with%2520Chimaeric%2520Enzymes%26jtitle%3DBiochem.%2520J.%26date%3D1998%26volume%3D336%26spage%3D429%26epage%3D436%26doi%3D10.1042%2Fbj3360429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Shiraishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deyashiki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninomiya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Sequence of the cDNA of a Human Dihydrodiol Dehydrogenase Isoform (AKR1C2) and Tissue Distribution of Its mRNA</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">334</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">â</span> <span class="NLM_lpage">405</span><span class="refDoi">Â DOI: 10.1042/bj3340399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1042%2Fbj3340399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=9716498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADyaK1cXmtFOlsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=1998&pages=399-405&author=H.+Shiraishiauthor=S.+Ishikuraauthor=K.+Matsuuraauthor=Y.+Deyashikiauthor=M.+Ninomiyaauthor=S.+Sakaiauthor=A.+Hara&title=Sequence+of+the+cDNA+of+a+Human+Dihydrodiol+Dehydrogenase+Isoform+%28AKR1C2%29+and+Tissue+Distribution+of+Its+mRNA&doi=10.1042%2Fbj3340399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Sequence of the cDNA of a human dihydrodiol dehydrogenase isoform (AKR1C2) and tissue distribution of its mRNA</span></div><div class="casAuthors">Shiraishi, Hiroaki; Ishikura, Syuhei; Matsuura, Kazuya; Deyashiki, Yoshihiro; Ninomiya, Mitsuo; Sakai, Syunsuke; Hara, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">399-405</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Human liver contains three isoforms (DD1, DD2 and DD4) of dihydrodiol dehydrogenase with 20Î±- or 3Î±-hydroxysteroid dehydrogenase activity; the dehydrogenases belong to the aldo-oxo reductase (AKR) superfamily.  CDNA species encoding DD1 and DD4 have been identified.  However, four cDNA species with more than 99% sequence identity have been cloned and are compatible with a partial amino acid sequence of DD2.  In this study we have isolated a cDNA clone encoding DD2, which was confirmed by comparison of the properties of the recombinant and hepatic enzymes.  This cDNA showed differences of one, two, four and five nucleotides from the previously reported four cDNA species for a dehydrogenase of human colon carcinoma HT29 cells, human prostatic 3Î±-hydroxysteroid dehydrogenase, a human liver 3Î±-hydroxysteroid dehydrogenase-like protein and chlordecone reductase-like protein resp.  Expression of mRNA species for the five similar cDNA species in 20 liver samples and 10 other different tissue samples was examd. by reverse transcriptase-mediated PCR with specific primers followed by diagnostic restriction with endonucleases.  All the tissues expressed only one mRNA species corresponding to the newly identified cDNA for DD2: mRNA transcripts corresponding to the other cDNA species were not detected.  We suggest that the new cDNA is derived from the principal gene for DD2, which has been named AKR1C2 by a new nomenclature for the AKR superfamily.  It is possible that some of the other cDNA species previously reported are rare allelic variants of this gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwKJqD5RzmnLVg90H21EOLACvtfcHk0liiZWFHtpDnww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtFOlsb4%253D&md5=41a45423ebcd7db47886cc5fd6878869</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1042%2Fbj3340399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3340399%26sid%3Dliteratum%253Aachs%26aulast%3DShiraishi%26aufirst%3DH.%26aulast%3DIshikura%26aufirst%3DS.%26aulast%3DMatsuura%26aufirst%3DK.%26aulast%3DDeyashiki%26aufirst%3DY.%26aulast%3DNinomiya%26aufirst%3DM.%26aulast%3DSakai%26aufirst%3DS.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DSequence%2520of%2520the%2520cDNA%2520of%2520a%2520Human%2520Dihydrodiol%2520Dehydrogenase%2520Isoform%2520%2528AKR1C2%2529%2520and%2520Tissue%2520Distribution%2520of%2520Its%2520mRNA%26jtitle%3DBiochem.%2520J.%26date%3D1998%26volume%3D334%26spage%3D399%26epage%3D405%26doi%3D10.1042%2Fbj3340399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Arai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyagi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishinaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikari, A.</span><span> </span><span class="NLM_article-title">Structure-Activity Relationship of Flavonoids as Potent Inhibitors of Carbonyl Reductase 1 (CBR1)</span> <span class="citation_source-journal">Fitoterapia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">â</span> <span class="NLM_lpage">56</span><span class="refDoi">Â DOI: 10.1016/j.fitote.2014.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.fitote.2014.12.010" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2015&pages=51-56&author=Y.+Araiauthor=S.+Endoauthor=N.+Miyagiauthor=N.+Abeauthor=T.+Miuraauthor=T.+Nishinakaauthor=T.+Teradaauthor=M.+Oyamaauthor=H.+Godaauthor=O.+El-Kabbaniauthor=A.+Haraauthor=T.+Matsunagaauthor=A.+Ikari&title=Structure-Activity+Relationship+of+Flavonoids+as+Potent+Inhibitors+of+Carbonyl+Reductase+1+%28CBR1%29&doi=10.1016%2Fj.fitote.2014.12.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.fitote.2014.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fitote.2014.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DY.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DMiyagi%26aufirst%3DN.%26aulast%3DAbe%26aufirst%3DN.%26aulast%3DMiura%26aufirst%3DT.%26aulast%3DNishinaka%26aufirst%3DT.%26aulast%3DTerada%26aufirst%3DT.%26aulast%3DOyama%26aufirst%3DM.%26aulast%3DGoda%26aufirst%3DH.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DIkari%26aufirst%3DA.%26atitle%3DStructure-Activity%2520Relationship%2520of%2520Flavonoids%2520as%2520Potent%2520Inhibitors%2520of%2520Carbonyl%2520Reductase%25201%2520%2528CBR1%2529%26jtitle%3DFitoterapia%26date%3D2015%26volume%3D101%26spage%3D51%26epage%3D56%26doi%3D10.1016%2Fj.fitote.2014.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Selective Inhibition of the Tumor Marker AKR1B10 by Antiinflammatory N-Phenylanthranilic Acids and Glycyrrhetic Acid</span> <span class="citation_source-journal">Biol. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">886</span><span class="NLM_x">â</span> <span class="NLM_lpage">890</span><span class="refDoi">Â DOI: 10.1248/bpb.33.886</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1248%2Fbpb.33.886" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=20460771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1Oht7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=886-890&author=S.+Endoauthor=T.+Matsunagaauthor=M.+Sodaauthor=K.+Tajimaauthor=H.+T.+Zhaoauthor=O.+El-Kabbaniauthor=A.+Hara&title=Selective+Inhibition+of+the+Tumor+Marker+AKR1B10+by+Antiinflammatory+N-Phenylanthranilic+Acids+and+Glycyrrhetic+Acid&doi=10.1248%2Fbpb.33.886"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of the tumor marker AKR1B10 by antiinflammatory N-phenylanthranilic acids and glycyrrhetic acid</span></div><div class="casAuthors">Endo, Satoshi; Matsunaga, Toshiyuki; Soda, Midori; Tajima, Kazuo; Zhao, Hi-Tai; El-Kabbani, Ossama; Hara, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">886-890</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A human aldose reductase-like protein, AKR1B10 in the aldo-keto reductase (AKR) superfamily, was recently identified as a tumor marker of several types of cancer.  Tolrestat, an aldose reductase inhibitor (ARI), is known to be the most potent inhibitor of the enzyme.  In this study, we compared the inhibitory effects of other ARIs including flavonoids on AKR1B10 and aldose reductase to evaluate their specificity.  However, ARIs showed lower inhibitory potency for AKR1B10 than for aldose reductase.  In the search for potent and selective inhibitors of AKR1B10 from other drugs used clin., we found that non-steroidal antiinflammatory N-phenylanthranilic acids, diclofenac and glycyrrhetic acid competitively inhibited AKR1B10, showing Ki values of 0.35-2.9 Î¼M and high selectivity to this enzyme (43-57 fold vs. aldose reductase).  Mol. docking studies of mefenamic acid and glycyrrhetic acid in the AKR1B10-NADP (NADP+) complex and site-directed mutagenesis of the putative binding residues suggest that the side chain of Val301 and a hydrogen-bonding network among residues Val301, Gln114 and Ser304 are important for detg. the inhibitory potency and selectivity of the non-steroidal antiinflammatory drugs.  Thus, the potent and selective inhibition may be related to the cancer chemopreventive roles of the drugs, and their structural features may facilitate the design of new anti-cancer agents targeting AKR1B10.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDHEPGYUtiEbVg90H21EOLACvtfcHk0liiZWFHtpDnww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1Oht7Y%253D&md5=89b4e78d049e6bccaab07c410f541a0c</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1248%2Fbpb.33.886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.33.886%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DTajima%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DH.%2BT.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DSelective%2520Inhibition%2520of%2520the%2520Tumor%2520Marker%2520AKR1B10%2520by%2520Antiinflammatory%2520N-Phenylanthranilic%2520Acids%2520and%2520Glycyrrhetic%2520Acid%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2010%26volume%3D33%26spage%3D886%26epage%3D890%26doi%3D10.1248%2Fbpb.33.886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Higaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usami, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shintani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Selective and Potent Inhibitors of Human 20Î±-Hydroxysteroid Dehydrogenase (AKR1C1) that Metabolizes Neurosteroids Derived from Progesterone</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">143â144</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span><span class="NLM_x">â</span> <span class="NLM_lpage">513</span><span class="refDoi">Â DOI: 10.1016/S0009-2797(02)00206-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2FS0009-2797%2802%2900206-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=12604236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsVagsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143%E2%80%93144&publication_year=2003&pages=503-513&author=Y.+Higakiauthor=N.+Usamiauthor=S.+Shintaniauthor=S.+Ishikuraauthor=O.+El-Kabbaniauthor=A.+Hara&title=Selective+and+Potent+Inhibitors+of+Human+20%CE%B1-Hydroxysteroid+Dehydrogenase+%28AKR1C1%29+that+Metabolizes+Neurosteroids+Derived+from+Progesterone&doi=10.1016%2FS0009-2797%2802%2900206-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Selective and potent inhibitors of human 20Î±-hydroxysteroid dehydrogenase (AKR1C1) that metabolizes neurosteroids derived from progesterone</span></div><div class="casAuthors">Higaki, Yu; Usami, Noriyuki; Shintani, Syunichi; Ishikura, Shuhei; El-Kabbani, Ossama; Hara, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">143-144</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">503-513</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Neuroactive steroids, such as 3Î±,5Î±-tetrahydroprogesterone (3Î±,5Î±-THP) and 3Î±,5Î±-tetrahydrodeoxycorticosterone have been shown to be synthesized from progesterone in animal brains.  Comparison of kinetic consts. for the neuroactive steroids and their precursors among four human 3(20)Î±-hydroxysteroid dehydrogenases (AKR1C1-AKR1C4) suggests that AKR1C1 and AKR1C2 are involved in the catabolism and synthesis, resp., of the neuroactive steroids in the human brain.  In our efforts to identify agents that would specifically inhibit the two enzymes, benzbromarone and 3',3'',5',5''-tetrabromophenolphthalein were found to be relatively selective and potent inhibitors of AKR1C1.  Kinetic analyses in the oxidoredn. catalyzed by AKR1C1 in the presence of the inhibitors suggest that the inhibitors bind to the enzyme-NADP(H) complex (Ki = 0.7 nM) in the ordered bi-bi pathway, including an isomerization step.  The inhibitors effectively also decreased the redn. of 3Î±,5Î±-THP to its 20Î±-hydroxy metabolite in HepG2 cells treated with ethacrynic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdJuac4OAQ0bVg90H21EOLACvtfcHk0lg_5is61u1C8Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsVagsrc%253D&md5=58f99324f1cb35aba4937a6551a4974d</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2FS0009-2797%2802%2900206-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-2797%252802%252900206-5%26sid%3Dliteratum%253Aachs%26aulast%3DHigaki%26aufirst%3DY.%26aulast%3DUsami%26aufirst%3DN.%26aulast%3DShintani%26aufirst%3DS.%26aulast%3DIshikura%26aufirst%3DS.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DSelective%2520and%2520Potent%2520Inhibitors%2520of%2520Human%252020%25CE%25B1-Hydroxysteroid%2520Dehydrogenase%2520%2528AKR1C1%2529%2520that%2520Metabolizes%2520Neurosteroids%2520Derived%2520from%2520Progesterone%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2003%26volume%3D143%25E2%2580%2593144%26spage%3D503%26epage%3D513%26doi%3D10.1016%2FS0009-2797%2802%2900206-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitade, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyooka, N.</span><span> </span><span class="NLM_article-title">Synthesis and Structure-Activity Relationship of 2-Phenyliminochromene Derivatives as Inhibitors for Aldo-Keto Reductase (AKR) 1B10</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6378</span><span class="NLM_x">â</span> <span class="NLM_lpage">6384</span><span class="refDoi">Â DOI: 10.1016/j.bmc.2013.08.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.bmc.2013.08.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=24071447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsV2nu73M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=6378-6384&author=S.+Endoauthor=D.+Huauthor=M.+Suyamaauthor=T.+Matsunagaauthor=K.+Sugimotoauthor=Y.+Matsuyaauthor=O.+El-Kabbaniauthor=K.+Kuwataauthor=A.+Haraauthor=Y.+Kitadeauthor=N.+Toyooka&title=Synthesis+and+Structure-Activity+Relationship+of+2-Phenyliminochromene+Derivatives+as+Inhibitors+for+Aldo-Keto+Reductase+%28AKR%29+1B10&doi=10.1016%2Fj.bmc.2013.08.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structure-activity relationship of 2-phenyliminochromene derivatives as inhibitors for aldo-keto reductase (AKR) 1B10</span></div><div class="casAuthors">Endo, Satoshi; Hu, Dawei; Suyama, Miho; Matsunaga, Toshiyuki; Sugimoto, Kenji; Matsuya, Yuji; El-Kabbani, Ossama; Kuwata, Kazuo; Hara, Akira; Kitade, Yukio; Toyooka, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6378-6384</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inhibitors of a human member (AKR1B10) of the aldo-keto reductase superfamily are regarded as promising therapeutics for the treatment of cancer.  Recently, we have discovered (Z)-2-(4-methoxyphenylimino)-7-hydroxy-N-(pyridin-2-yl)-2H-chromene-3-carboxamide (1) as the potent competitive inhibitor using the virtual screening approach, and proposed its 4-methoxy group on the 2-phenylimino moiety as an essential structural prerequisite for the inhibition.  In this study, 18 derivs. of 1 were synthesized and their inhibitory potency against AKR1B10 evaluated.  Among them, 7-hydroxy-2-(4-methoxyphenylimino)-2H-chromene-3-carboxylic acid benzylamide (5n) was the most potent inhibitor showing a Ki value of 1.3 nM.  The structure-activity relationship of the derivs. indicated that the 7-hydroxyl group on the chromene ring, but not the 4-methoxy group, was absolutely required for inhibitory activity, The mol. docking of 5n in AKR1B10 and site-directed mutagenesis of the enzyme residues suggested that the hydrogen-bond interactions between the 7-hydroxyl group of 5n and the catalytic residues (Tyr49 and His111) of the enzyme, together with a Ï-stacking interaction of the benzylamide moiety of 5n with Trp220, are important for the potent inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj7CHzZirCtbVg90H21EOLACvtfcHk0lg_5is61u1C8Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsV2nu73M&md5=8b2ba23e95c0ef3b2beab844c457dadc</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.08.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.08.059%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DSuyama%26aufirst%3DM.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DSugimoto%26aufirst%3DK.%26aulast%3DMatsuya%26aufirst%3DY.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DKuwata%26aufirst%3DK.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DKitade%26aufirst%3DY.%26aulast%3DToyooka%26aufirst%3DN.%26atitle%3DSynthesis%2520and%2520Structure-Activity%2520Relationship%2520of%25202-Phenyliminochromene%2520Derivatives%2520as%2520Inhibitors%2520for%2520Aldo-Keto%2520Reductase%2520%2528AKR%2529%25201B10%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D6378%26epage%3D6384%26doi%3D10.1016%2Fj.bmc.2013.08.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiyama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takemura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikari, A.</span><span> </span><span class="NLM_article-title">Protective Roles of Aldo-Keto Reductase 1B10 and Autophagy against Toxicity Induced by <i>p</i>-Quinone Metabolites of <i>tert</i>-Butylhydroquinone in Lung Cancer A549 Cells</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">234</span><span class="NLM_x">, </span> <span class="NLM_fpage">282</span><span class="NLM_x">â</span> <span class="NLM_lpage">289</span><span class="refDoi">Â DOI: 10.1016/j.cbi.2014.09.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.cbi.2014.09.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=25289770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslehsbbO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=234&publication_year=2015&pages=282-289&author=S.+Endoauthor=A.+Nishiyamaauthor=M.+Suyamaauthor=M.+Takemuraauthor=M.+Sodaauthor=H.+Chenauthor=K.+Tajimaauthor=O.+El-Kabbaniauthor=Y.+Bunaiauthor=A.+Haraauthor=T.+Matsunagaauthor=A.+Ikari&title=Protective+Roles+of+Aldo-Keto+Reductase+1B10+and+Autophagy+against+Toxicity+Induced+by+p-Quinone+Metabolites+of+tert-Butylhydroquinone+in+Lung+Cancer+A549+Cells&doi=10.1016%2Fj.cbi.2014.09.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Protective roles of aldo-keto reductase 1B10 and autophagy against toxicity induced by p-quinone metabolites of tert-butylhydroquinone in lung cancer A549 cells</span></div><div class="casAuthors">Endo, Satoshi; Nishiyama, Ayako; Suyama, Miho; Takemura, Mayuko; Soda, Midori; Chen, Huayue; Tajima, Kazuo; El-Kabbani, Ossama; Bunai, Yasuo; Hara, Akira; Matsunaga, Toshiyuki; Ikari, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">234</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">282-289</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Tert-Butylhydroquinone (BHQ), an antioxidant used as a food additive, exhibits an anticancer effect at low doses, but is carcinogenic in rodents at high doses.  BHQ is metabolized into cytotoxic tert-butylquinone (TBQ), which is further converted to 6-tert-butyl-2,3-epoxy-4-hydroxy-5-cyclohexen-1-one (TBEH) through 6-tert-butyl-2,3-epoxy-4-benzoquinone (TBE).  Both TBQ and TBE are cytotoxic, but their toxic mechanisms have not been fully characterized.  In this study, we have investigated the toxic mechanisms of TBQ and TBE, and the defense system against the two p-quinones using lung cancer A549 cells.  TBQ and TBE, but not BHQ and TBEH, showed cytotoxicity to A549 cells.  Neither caspase-3 activation nor an increase in the expression of endoplasmic reticulum stress-assocg. target genes was obsd.  TBQ and TBE reacted with reduced glutathione, and significantly decreased the glutathione level in A549 cells, suggesting that the cytotoxicity of the p-quinones is caused by their high electrophilicity reacting with biomols.  The A549 cells treated with the p-quinones also showed increased levels of autophagic vacuoles and LC3-II protein, which are specific autophagy markers.  An autophagy inhibitor, 3-methyladenine (3MA), decreased the LC3-II prodn. by the p-quinones, but enhanced the cytotoxicity induced by TBQ and TBE, suggesting that autophagy contributes to alleviating the p-quinone-triggered cytotoxicity.  In addn., the TBE-induced cytotoxicity and autophagy activation in the cells were significantly suppressed by overexpression of aldo-keto reductase (AKR)1B10 that efficiently reduces TBE into TBEH, and were augmented by pretreatment with a potent AKR1B10 inhibitor, C1.  The effects of 3MA and C1 on the TBE-induced cytotoxicity were additive.  The data provides evidence for the first time that autophagy and AKR1B10 contribute to the defense system against the cytotoxicity caused by the electrophilic p-quinone metabolites of BHQ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpA-bYunP__9bVg90H21EOLACvtfcHk0lg_5is61u1C8Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslehsbbO&md5=a2a8d101138ff66c0382eba1e172f571</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2014.09.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2014.09.023%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DNishiyama%26aufirst%3DA.%26aulast%3DSuyama%26aufirst%3DM.%26aulast%3DTakemura%26aufirst%3DM.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DTajima%26aufirst%3DK.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DBunai%26aufirst%3DY.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DIkari%26aufirst%3DA.%26atitle%3DProtective%2520Roles%2520of%2520Aldo-Keto%2520Reductase%25201B10%2520and%2520Autophagy%2520against%2520Toxicity%2520Induced%2520by%2520p-Quinone%2520Metabolites%2520of%2520tert-Butylhydroquinone%2520in%2520Lung%2520Cancer%2520A549%2520Cells%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2015%26volume%3D234%26spage%3D282%26epage%3D289%26doi%3D10.1016%2Fj.cbi.2014.09.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Exposure to 9,10-Phenanthrenequinone Accelerates Malignant Progression of Lung Cancer Cells through Up-Regulation of Aldo-Keto Reductase 1B10</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">180</span><span class="NLM_x">â</span> <span class="NLM_lpage">189</span><span class="refDoi">Â DOI: 10.1016/j.taap.2014.04.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.taap.2014.04.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=24813866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC2cXoslCmsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2014&pages=180-189&author=T.+Matsunagaauthor=Y.+Morikawaauthor=M.+Hagaauthor=S.+Endoauthor=M.+Sodaauthor=K.+Yamamuraauthor=O.+El-Kabbaniauthor=K.+Tajimaauthor=A.+Ikariauthor=A.+Hara&title=Exposure+to+9%2C10-Phenanthrenequinone+Accelerates+Malignant+Progression+of+Lung+Cancer+Cells+through+Up-Regulation+of+Aldo-Keto+Reductase+1B10&doi=10.1016%2Fj.taap.2014.04.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Exposure to 9,10-phenanthrenequinone accelerates malignant progression of lung cancer cells through up-regulation of aldo-keto reductase 1B10</span></div><div class="casAuthors">Matsunaga, Toshiyuki; Morikawa, Yoshifumi; Haga, Mariko; Endo, Satoshi; Soda, Midori; Yamamura, Keiko; El-Kabbani, Ossama; Tajima, Kazuo; Ikari, Akira; Hara, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">180-189</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Inhalation of 9,10-phenanthrenequinone (9,10-PQ), a major quinone in diesel exhaust, exerts fatal damage against a variety of cells involved in respiratory function.  Here, we show that treatment with high concns. of 9,10-PQ evokes apoptosis of lung cancer A549 cells through prodn. of reactive oxygen species (ROS).  In contrast, 9,10-PQ at its concns. of 2 and 5 Î¼M elevated the potentials for proliferation, invasion, metastasis and tumorigenesis, all of which were almost completely inhibited by addn. of an antioxidant N-acetyl-L-cysteine, inferring a crucial role of ROS in the overgrowth and malignant progression of lung cancer cells.  Comparison of mRNA expression levels of six aldo-keto reductases (AKRs) in the 9,10-PQ-treated cells advocated up-regulation of AKR1B10 as a major cause contributing to the lung cancer malignancy.  In support of this, the elevation of invasive, metastatic and tumorigenic activities in the 9,10-PQ-treated cells was significantly abolished by the addn. of a selective AKR1B10 inhibitor oleanolic acid.  Intriguingly, zymog. and real-time PCR analyses revealed remarkable increases in secretion and expression, resp., of matrix metalloproteinase 2 during the 9,10-PQ treatment, and suggested that the AKR1B10 up-regulation and resultant activation of mitogen-activated protein kinase cascade are predominant mechanisms underlying the metalloproteinase induction.  In addn., HPLC anal. and cytochrome c redn. assay in in vitro 9,10-PQ redn. by AKR1B10 demonstrated that the enzyme catalyzes redox-cycling of this quinone, by which ROS are produced.  Collectively, these results suggest that AKR1B10 is a key regulator involved in overgrowth and malignant progression of the lung cancer cells through ROS prodn. due to 9,10-PQ redox-cycling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYfQ6ZwQdsjrVg90H21EOLACvtfcHk0lhxDeD4Ny4rhQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXoslCmsbY%253D&md5=8a75135338ed053f854c530d20035d69</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2014.04.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2014.04.024%26sid%3Dliteratum%253Aachs%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DMorikawa%26aufirst%3DY.%26aulast%3DHaga%26aufirst%3DM.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DYamamura%26aufirst%3DK.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DTajima%26aufirst%3DK.%26aulast%3DIkari%26aufirst%3DA.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DExposure%2520to%25209%252C10-Phenanthrenequinone%2520Accelerates%2520Malignant%2520Progression%2520of%2520Lung%2520Cancer%2520Cells%2520through%2520Up-Regulation%2520of%2520Aldo-Keto%2520Reductase%25201B10%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2014%26volume%3D278%26spage%3D180%26epage%3D189%26doi%3D10.1016%2Fj.taap.2014.04.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Usui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ukai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiho, T.</span><span> </span><span class="NLM_article-title">Growth Suppressing Activity for Endothelial Cells Induced from Macrophages by Carboxymethylated Curdlan</span> <span class="citation_source-journal">Biosci., Biotechnol., Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1924</span><span class="NLM_x">â</span> <span class="NLM_lpage">1925</span><span class="refDoi">Â DOI: 10.1271/bbb.61.1924</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1271%2Fbbb.61.1924" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1997&pages=1924-1925&author=S.+Usuiauthor=T.+Matsunagaauthor=S.+Ukaiauthor=T.+Kiho&title=Growth+Suppressing+Activity+for+Endothelial+Cells+Induced+from+Macrophages+by+Carboxymethylated+Curdlan&doi=10.1271%2Fbbb.61.1924"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1271%2Fbbb.61.1924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1271%252Fbbb.61.1924%26sid%3Dliteratum%253Aachs%26aulast%3DUsui%26aufirst%3DS.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DUkai%26aufirst%3DS.%26aulast%3DKiho%26aufirst%3DT.%26atitle%3DGrowth%2520Suppressing%2520Activity%2520for%2520Endothelial%2520Cells%2520Induced%2520from%2520Macrophages%2520by%2520Carboxymethylated%2520Curdlan%26jtitle%3DBiosci.%252C%2520Biotechnol.%252C%2520Biochem.%26date%3D1997%26volume%3D61%26spage%3D1924%26epage%3D1925%26doi%3D10.1271%2Fbbb.61.1924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Kato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwakami, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiki, I.</span><span> </span><span class="NLM_article-title">p38 Pathway as a Key Downstream Signal of Connective Tissue Growth Factor to Regulate Metastatic Potential in Non-Small-Cell Lung Cancer</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">1416</span><span class="NLM_x">â</span> <span class="NLM_lpage">1421</span><span class="refDoi">Â DOI: 10.1111/cas.13009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1111%2Fcas.13009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=27403934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVegtrbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2016&pages=1416-1421&author=S.+Katoauthor=S.+Yokoyamaauthor=Y.+Hayakawaauthor=L.+Liauthor=Y.+Iwakamiauthor=H.+Sakuraiauthor=I.+Saiki&title=p38+Pathway+as+a+Key+Downstream+Signal+of+Connective+Tissue+Growth+Factor+to+Regulate+Metastatic+Potential+in+Non-Small-Cell+Lung+Cancer&doi=10.1111%2Fcas.13009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">P38 pathway as a key downstream signal of connective tissue growth factor to regulate metastatic potential in non-small-cell lung cancer</span></div><div class="casAuthors">Kato, Shinichiro; Yokoyama, Satoru; Hayakawa, Yoshihiro; Li, Luhui; Iwakami, Yusuke; Sakurai, Hiroaki; Saiki, Ikuo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1416-1421</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Although the secretory matricellular protein connective tissue growth factor (CTGF) has been reported to be related to lung cancer metastasis, the precise mechanism by which CTGF regulates lung cancer metastasis has not been elucidated.  In the present study, we show the mol. link between CTGF secretion and the p38 pathway in the invasive and metastatic potential of non-small-cell lung cancer (NSCLC).  Among three different human NSCLC cell lines (PC-14, A549, and PC-9), their in vitro invasiveness was inversely correlated with the level of CTGF secretion.  By supplementing or reducing CTGF secretion in NSCLC culture, dysregulation of the invasive and metastatic potential of NSCLC cell lines was largely compensated.  By focusing on the protein kinases that are known to be regulated by CTGF, we found that the p38 pathway is a key downstream signal of CTGF to regulate the metastatic potential of NSCLC.  Importantly, a neg. correlation between CTGF and phosphorylation status of p38 was identified in The Cancer Genome Atlas lung adenocarcinoma dataset.  In the context of the clin. importance of our findings, we showed that p38 inhibitor, SB203580, reduced the metastatic potential of NSCLC secreting low levels of CTGF.  Collectively, our present findings indicate that the CTGF/p38 axis is a novel therapeutic target of NSCLC metastasis, particularly NSCLC secreting low levels of CTGF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJk9GNwDz9xLVg90H21EOLACvtfcHk0lhxDeD4Ny4rhQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVegtrbJ&md5=ec1dc41761223c00e74ea991df1c66aa</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1111%2Fcas.13009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.13009%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DS.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DHayakawa%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DIwakami%26aufirst%3DY.%26aulast%3DSakurai%26aufirst%3DH.%26aulast%3DSaiki%26aufirst%3DI.%26atitle%3Dp38%2520Pathway%2520as%2520a%2520Key%2520Downstream%2520Signal%2520of%2520Connective%2520Tissue%2520Growth%2520Factor%2520to%2520Regulate%2520Metastatic%2520Potential%2520in%2520Non-Small-Cell%2520Lung%2520Cancer%26jtitle%3DCancer%2520Sci.%26date%3D2016%26volume%3D107%26spage%3D1416%26epage%3D1421%26doi%3D10.1111%2Fcas.13009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nairong  Yu</span>, <span class="hlFld-ContribAuthor ">Na  Li</span>, <span class="hlFld-ContribAuthor ">Kun  Wang</span>, <span class="hlFld-ContribAuthor ">Qi  Deng</span>, <span class="hlFld-ContribAuthor ">Zhichao  Lei</span>, <span class="hlFld-ContribAuthor ">Jianbo  Sun</span>, <span class="hlFld-ContribAuthor ">Li  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological activity evaluation of novel scopoletin-NO donor derivatives against MCF-7 human breast cancer inÂ vitro and inÂ vivo. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>224 </em>, 113701. <a href="https://doi.org/10.1016/j.ejmech.2021.113701" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113701</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113701%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bactivity%252Bevaluation%252Bof%252Bnovel%252Bscopoletin-NO%252Bdonor%252Bderivatives%252Bagainst%252BMCF-7%252Bhuman%252Bbreast%252Bcancer%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%26aulast%3DYu%26aufirst%3DNairong%26date%3D2021%26volume%3D224%26spage%3D113701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Megumi  Kikuya</span>, <span class="hlFld-ContribAuthor ">Kenta  Furuichi</span>, <span class="hlFld-ContribAuthor ">Takuya  Hirao</span>, <span class="hlFld-ContribAuthor ">Satoshi  Endo</span>, <span class="hlFld-ContribAuthor ">Naoki  Toyooka</span>, <span class="hlFld-ContribAuthor ">Kousei  Ito</span>, <span class="hlFld-ContribAuthor ">Shigeki  Aoki</span>. </span><span class="cited-content_cbyCitation_article-title">Aldo-keto reductase inhibitors increase the anticancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacological Sciences</span><span> <strong>2021,</strong> <em>147 </em>
                                    (1)
                                     , 1-8. <a href="https://doi.org/10.1016/j.jphs.2021.05.001" title="DOI URL">https://doi.org/10.1016/j.jphs.2021.05.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jphs.2021.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jphs.2021.05.001%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacological%2520Sciences%26atitle%3DAldo-keto%252Breductase%252Binhibitors%252Bincrease%252Bthe%252Banticancer%252Beffects%252Bof%252Btyrosine%252Bkinase%252Binhibitors%252Bin%252Bchronic%252Bmyelogenous%252Bleukemia%26aulast%3DKikuya%26aufirst%3DMegumi%26date%3D2021%26volume%3D147%26issue%3D1%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satoshi  Endo</span>, <span class="hlFld-ContribAuthor ">Toshiyuki  Matsunaga</span>, <span class="hlFld-ContribAuthor ">Toru  Nishinaka</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of AKR1B10 in Physiology and Pathophysiology. </span><span class="cited-content_cbyCitation_journal-name">Metabolites</span><span> <strong>2021,</strong> <em>11 </em>
                                    (6)
                                     , 332. <a href="https://doi.org/10.3390/metabo11060332" title="DOI URL">https://doi.org/10.3390/metabo11060332</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/metabo11060332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmetabo11060332%26sid%3Dliteratum%253Aachs%26jtitle%3DMetabolites%26atitle%3DThe%252BRole%252Bof%252BAKR1B10%252Bin%252BPhysiology%252Band%252BPathophysiology%26aulast%3DEndo%26aufirst%3DSatoshi%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D6%26spage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fedor V.  Ryzhkov</span>, <span class="hlFld-ContribAuthor ">Michail N.  Elinson</span>, <span class="hlFld-ContribAuthor ">Yuliya E.  Ryzhkova</span>, <span class="hlFld-ContribAuthor ">Anatoly N.  Vereshchagin</span>, <span class="hlFld-ContribAuthor ">Victor A.  Korolev</span>, <span class="hlFld-ContribAuthor ">Mikhail P.  Egorov</span>. </span><span class="cited-content_cbyCitation_article-title">Pseudoâfourâcomponent synthesis and in silico studies of 5â(
              
                5âhydroxyâ3âmethylâ1
                H
              
              âpyrazolâ4âyl)âsubstituted
              
                5
                H
              
              âchromeno[2,3â
              b
              ]pyridines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2021,</strong> <em>58 </em>
                                    (3)
                                     , 793-804. <a href="https://doi.org/10.1002/jhet.4215" title="DOI URL">https://doi.org/10.1002/jhet.4215</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.4215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.4215%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DPseudo%2525E2%252580%252590four%2525E2%252580%252590component%252Bsynthesis%252Band%252Bin%252Bsilico%252Bstudies%252Bof%252B5%2525E2%252580%252590%252528%252B5%2525E2%252580%252590hydroxy%2525E2%252580%2525903%2525E2%252580%252590methyl%2525E2%252580%2525901%252BH%252B%2525E2%252580%252590pyrazol%2525E2%252580%2525904%2525E2%252580%252590yl%252529%2525E2%252580%252590substituted%252B5%252BH%252B%2525E2%252580%252590chromeno%25255B2%25252C3%2525E2%252580%252590%252Bb%252B%25255Dpyridines%26aulast%3DRyzhkov%26aufirst%3DFedor%2BV.%26date%3D2021%26date%3D2021%26volume%3D58%26issue%3D3%26spage%3D793%26epage%3D804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi  Wu</span>, <span class="hlFld-ContribAuthor ">Jing  Xu</span>, <span class="hlFld-ContribAuthor ">Yiting  Liu</span>, <span class="hlFld-ContribAuthor ">Yiyu  Zeng</span>, <span class="hlFld-ContribAuthor ">Guojun  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">A Review on Anti-Tumor Mechanisms of Coumarins. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.3389/fonc.2020.592853" title="DOI URL">https://doi.org/10.3389/fonc.2020.592853</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2020.592853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2020.592853%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DA%252BReview%252Bon%252BAnti-Tumor%252BMechanisms%252Bof%252BCoumarins%26aulast%3DWu%26aufirst%3DYi%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yizhou  Yao</span>, <span class="hlFld-ContribAuthor ">Xuchao  Wang</span>, <span class="hlFld-ContribAuthor ">Diyuan  Zhou</span>, <span class="hlFld-ContribAuthor ">Hao  Li</span>, <span class="hlFld-ContribAuthor ">Huan  Qian</span>, <span class="hlFld-ContribAuthor ">Jiawen  Zhang</span>, <span class="hlFld-ContribAuthor ">Linhua  Jiang</span>, <span class="hlFld-ContribAuthor ">Bin  Wang</span>, <span class="hlFld-ContribAuthor ">Qi  Lin</span>, <span class="hlFld-ContribAuthor ">Xinguo  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Loss of AKR1B10 promotes colorectal cancer cells proliferation and migration via regulating FGF1-dependent pathway. </span><span class="cited-content_cbyCitation_journal-name">Aging</span><span> <strong>2020,</strong> <em>12 </em>
                                    (13)
                                     , 13059-13075. <a href="https://doi.org/10.18632/aging.103393" title="DOI URL">https://doi.org/10.18632/aging.103393</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/aging.103393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Faging.103393%26sid%3Dliteratum%253Aachs%26jtitle%3DAging%26atitle%3DLoss%252Bof%252BAKR1B10%252Bpromotes%252Bcolorectal%252Bcancer%252Bcells%252Bproliferation%252Band%252Bmigration%252Bvia%252Bregulating%252BFGF1-dependent%252Bpathway%26aulast%3DYao%26aufirst%3DYizhou%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D13%26spage%3D13059%26epage%3D13075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sofia  Oliveira-Pinto</span>, <span class="hlFld-ContribAuthor ">OlÃ­via  Pontes</span>, <span class="hlFld-ContribAuthor ">Diogo  Lopes</span>, <span class="hlFld-ContribAuthor ">BelÃ©m  Sampaio-Marques</span>, <span class="hlFld-ContribAuthor ">Marta D.  Costa</span>, <span class="hlFld-ContribAuthor ">LuÃ­sa  Carvalho</span>, <span class="hlFld-ContribAuthor ">CÃ©line S.  GonÃ§alves</span>, <span class="hlFld-ContribAuthor ">Bruno M.  Costa</span>, <span class="hlFld-ContribAuthor ">PatrÃ­cia  Maciel</span>, <span class="hlFld-ContribAuthor ">Paula  Ludovico</span>, <span class="hlFld-ContribAuthor ">FÃ¡tima  Baltazar</span>, <span class="hlFld-ContribAuthor ">Fernanda  ProenÃ§a</span>, <span class="hlFld-ContribAuthor ">Marta  Costa</span>. </span><span class="cited-content_cbyCitation_article-title">Unravelling the anticancer potential of functionalized chromeno[2,3-b]pyridines for breast cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>100 </em>, 103942. <a href="https://doi.org/10.1016/j.bioorg.2020.103942" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103942</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103942%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DUnravelling%252Bthe%252Banticancer%252Bpotential%252Bof%252Bfunctionalized%252Bchromeno%25255B2%25252C3-b%25255Dpyridines%252Bfor%252Bbreast%252Bcancer%252Btreatment%26aulast%3DOliveira-Pinto%26aufirst%3DSofia%26date%3D2020%26volume%3D100%26spage%3D103942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satoshi  Endo</span>, <span class="hlFld-ContribAuthor ">Mai  Uchibori</span>, <span class="hlFld-ContribAuthor ">Miho  Suyama</span>, <span class="hlFld-ContribAuthor ">Mei  Fujita</span>, <span class="hlFld-ContribAuthor ">Yuki  Arai</span>, <span class="hlFld-ContribAuthor ">Dawei  Hu</span>, <span class="hlFld-ContribAuthor ">Shuang  Xia</span>, <span class="hlFld-ContribAuthor ">Biao  Ma</span>, <span class="hlFld-ContribAuthor ">Aurangazeb  Kabir</span>, <span class="hlFld-ContribAuthor ">Yuji O.  Kamatari</span>, <span class="hlFld-ContribAuthor ">Kazuo  Kuwata</span>, <span class="hlFld-ContribAuthor ">Naoki  Toyooka</span>, <span class="hlFld-ContribAuthor ">Toshiyuki  Matsunaga</span>, <span class="hlFld-ContribAuthor ">Akira  Ikari</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Atg4B inhibitors potentiate cisplatin therapy in lung cancer cells through blockade of autophagy. </span><span class="cited-content_cbyCitation_journal-name">Computational Toxicology</span><span> <strong>2019,</strong> <em>12 </em>, 100095. <a href="https://doi.org/10.1016/j.comtox.2019.100095" title="DOI URL">https://doi.org/10.1016/j.comtox.2019.100095</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.comtox.2019.100095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.comtox.2019.100095%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Toxicology%26atitle%3DNovel%252BAtg4B%252Binhibitors%252Bpotentiate%252Bcisplatin%252Btherapy%252Bin%252Blung%252Bcancer%252Bcells%252Bthrough%252Bblockade%252Bof%252Bautophagy%26aulast%3DEndo%26aufirst%3DSatoshi%26date%3D2019%26volume%3D12%26spage%3D100095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Suresh  Awale</span>, <span class="hlFld-ContribAuthor ">Takahiro  Okada</span>, <span class="hlFld-ContribAuthor ">Dya Fita  Dibwe</span>, <span class="hlFld-ContribAuthor ">Takahiro  Maruyama</span>, <span class="hlFld-ContribAuthor ">Satoyuki  Takahara</span>, <span class="hlFld-ContribAuthor ">Takuya  Okada</span>, <span class="hlFld-ContribAuthor ">Satoshi  Endo</span>, <span class="hlFld-ContribAuthor ">Naoki  Toyooka</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of functionalized coumarins as potential anti-austerity agents that eliminates cancer cells' tolerance to nutrition starvation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (14)
                                     , 1779-1784. <a href="https://doi.org/10.1016/j.bmcl.2019.05.010" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.05.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.05.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bfunctionalized%252Bcoumarins%252Bas%252Bpotential%252Banti-austerity%252Bagents%252Bthat%252Beliminates%252Bcancer%252Bcells%252527%252Btolerance%252Bto%252Bnutrition%252Bstarvation%26aulast%3DAwale%26aufirst%3DSuresh%26date%3D2019%26volume%3D29%26issue%3D14%26spage%3D1779%26epage%3D1784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenwen  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  Song</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Du</span>, <span class="hlFld-ContribAuthor ">Yang  Zhou</span>, <span class="hlFld-ContribAuthor ">Yang  Li</span>, <span class="hlFld-ContribAuthor ">Rui  Li</span>, <span class="hlFld-ContribAuthor ">Li  Lyu</span>, <span class="hlFld-ContribAuthor ">Yeting  He</span>, <span class="hlFld-ContribAuthor ">Junxia  Hao</span>, <span class="hlFld-ContribAuthor ">Jing  Ben</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Haibin  Shi</span>, <span class="hlFld-ContribAuthor ">Qi  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">AKR1B10 (Aldo-keto reductase family 1 B10) promotes brain metastasis of lung cancer cells in a multi-organ microfluidic chip model. </span><span class="cited-content_cbyCitation_journal-name">Acta Biomaterialia</span><span> <strong>2019,</strong> <em>91 </em>, 195-208. <a href="https://doi.org/10.1016/j.actbio.2019.04.053" title="DOI URL">https://doi.org/10.1016/j.actbio.2019.04.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.actbio.2019.04.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.actbio.2019.04.053%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Biomaterialia%26atitle%3DAKR1B10%252B%252528Aldo-keto%252Breductase%252Bfamily%252B1%252BB10%252529%252Bpromotes%252Bbrain%252Bmetastasis%252Bof%252Blung%252Bcancer%252Bcells%252Bin%252Ba%252Bmulti-organ%252Bmicrofluidic%252Bchip%252Bmodel%26aulast%3DLiu%26aufirst%3DWenwen%26date%3D2019%26volume%3D91%26spage%3D195%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/medium/jm-2017-00830q_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00830&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/medium/jm-2017-00830q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of representative AKR1B10 inhibitors and their inhibitory potency toward AKR1B10 (1B10) and its structurally similar enzyme AKR1B1 (1B1). Abbreviations: MHPC, (<i>Z</i>)-2-(4-methoxyphenylimino)-7-hydroxy-<i>N</i>-(pyridin-2-yl)-2<i>H</i>-chromene-3-carboxamide; and BDMC, bisdemethoxycurcumin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00830&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/medium/jm-2017-00830q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>C1</b>â<b>C9</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00830&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/medium/jm-2017-00830q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Coumarin Derivatives <b>4a</b>â<b>4l</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00830&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/medium/jm-2017-00830q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design process of selective AKR1B10 inhibitor <b>4a</b> from the lead compound HMCB.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00830&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/medium/jm-2017-00830q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Improved Synthesis of <b>4e</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00830&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/medium/jm-2017-00830q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Docked models of <b>4c</b> (A) and HMCB (B) in AKR1B10âNADP<sup>+</sup> complex. The portion of NADP<sup>+</sup> (yellow) and AKR1B10 residues (light gray) within 4.0 Ã from the inhibitors are depicted with possible hydrogen bond interactions, which are shown in dotted lines with distances (Ã).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00830&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/medium/jm-2017-00830q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of invasive and proliferative potential of A549 cells by <b>4c</b> and <b>4e</b>. (A) Wound-healing assay. The cells were scratched and then treated for 24 h with vehicle dimethyl sulfoxide (DMSO), 20 Î¼M <b>4c</b>, or 20 Î¼M <b>4e</b>. As representative photographs at 0 h and 24 h culture are shown, the cells migrated into the scratch wounds (two dotted lines). The migration distance of the inhibitor-treated cells is expressed as the percentage to that of the DMSO-treated control cells in the bar graph. Significant difference from the control cells, *<i>p</i> < 0.05 (<i>n</i> = 3). (B) Proliferative assay. A549 cells (left) and A549/1B10 cells (right) were cultured in the absence or presence of the indicated concentrations of <b>4c</b> and <b>4e</b>, and the viable cell numbers were estimated at 96 h. Significant differences (<i>p</i> < 0.05) from the inhibitor-free A549 cells and A549/1B10 cells are shown with * and <sup>#</sup>, respectively (<i>n</i> = 4).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00830&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/medium/jm-2017-00830q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibition of A549 cells metastasis into mouse lung by <b>4c</b> and <b>4e</b>. Cultured A549âLuc2 cells were treated with 20 Î¼M <b>4c</b> or <b>4e</b> or vehicle DMSO (as a control) for 48 h and then injected into the tail vein of BALB/c nude mice (<i>n</i> = 5). After 4 days, luciferase luminescence in the lungs was evaluated. Significant difference from the control, *<i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00830&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/medium/jm-2017-00830q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Overcoming CDDP resistance of A549 cells by treatments with <b>4c</b> and <b>4e</b>. (A) Effects of <b>4c</b> and <b>4e</b> on CDDP sensitivity of CDDP-R-A549 cells. The CDDP-R-A549 cells and parental A549 cells were pretreated for 2 h without or with the indicated concentrations of <b>4c</b> or <b>4e</b>, and then treated for 24 h with 40 Î¼M CDDP. The viability values are expressed as percentages to that of the parental cells treated without inhibitor. (B) Growth curves of A549 and CDDP-R-A549 cells in medium containing 0.5 Î¼M CDDP (<i>n</i> = 3). (C) Effects of <b>4c</b> and <b>4e</b> on the growth of CDDP-R-A549 cells in the presence of 0.5 Î¼M CDDP. The cells were cultured for 96 h in the absence or presence of <b>4c</b> or <b>4e</b>. The viable cell numbers are expressed as percentages to that of the parental A549 cells treated without inhibitor. Significant difference from CDDP-R-A549 cells treated without inhibitor, *<i>p</i> < 0.05 (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00830&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/medium/jm-2017-00830q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of <b>4c</b> and <b>4e</b> on metastatic and invasive potentials of CDDP-R-A549 cells. The cells were seeded on a polycarbonate membrane and Type I collagen-coated polycarbonate membrane in Boyden chambers for analyzing the metastatic (white bar) and invasive potentials (black bar), respectively, and then treated for 48 h without or with the indicated concentrations of <b>4c</b> or <b>4e</b>. The cells passed through pores of the membrane were counted microscopically, and their numbers are expressed as the percentages to those of the control cells treated without inhibitor. Significant difference from the control cells, *<i>p</i> < 0.05 (<i>n</i> â¥ 4).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00830/20171020/images/large/jm-2017-00830q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00830&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i80">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86312" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86312" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 71 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Jemal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiwari, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghafoor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuels, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feuer, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thun, M. J.</span><span> </span><span class="NLM_article-title">American Cancer Society. Cancer Statistics, 2004</span> <span class="citation_source-journal">Ca-Cancer J. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">â</span> <span class="NLM_lpage">29</span><span class="refDoi">Â DOI: 10.3322/canjclin.54.1.8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.3322%2Fcanjclin.54.1.8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=14974761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A280%3ADC%252BD2c%252FosFaluw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2004&pages=8-29&author=A.+Jemalauthor=R.+C.+Tiwariauthor=T.+Murrayauthor=A.+Ghafoorauthor=A.+Samuelsauthor=E.+Wardauthor=E.+J.+Feuerauthor=M.+J.+Thun&title=American+Cancer+Society.+Cancer+Statistics%2C+2004&doi=10.3322%2Fcanjclin.54.1.8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2004</span></div><div class="casAuthors">Jemal Ahmedin; Tiwari Ram C; Murray Taylor; Ghafoor Asma; Samuels Alicia; Ward Elizabeth; Feuer Eric J; Thun Michael J</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-29</span>
        ISSN:<span class="NLM_cas:issn">0007-9235</span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival rates based on incidence data from the National Cancer Institute and mortality data from the National Center for Health Statistics.  Incidence and mortality rates are age standardized to the 2000 US standard million population.  A total of 1,368,030 new cancer cases and 563,700 deaths are expected in the United States in 2004.  Incidence rates stabilized among men from 1995 through 2000 but continued to increase among females by 0.4% per year from 1987 through 2000.  Mortality rates have decreased by 1.5% per year since 1992 among men, but have stabilized from 1998 through 2000 among women.  Cancer death rates continued to decrease from the three major cancer sites in men (lung and bronchus, colon and rectum, and prostate) and from female breast and colorectal cancers in women.  In analyses by race and ethnicity, African-American men and women have 40% and 20% higher death rates from all cancers combined compared with White men and women, respectively.  Cancer incidence and mortality rates are lower in other racial and ethnic groups than in Whites and African Americans for all sites combined and for the four major cancer sites.  However, these groups generally have higher rates for stomach, liver, and cervical cancers than do Whites.  Furthermore, minority populations are more likely to be diagnosed with advanced stage disease than are Whites.  Progress in reducing the burden from cancer can be accelerated by applying existing cancer control knowledge into practice among all segments of the population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTz-WXc55vIMtTiMd2aNQVUfW6udTcc2eYs5MsL8Xdfurntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c%252FosFaluw%253D%253D&md5=e3b0ac1e230e37eeaaa5f385b3d439f9</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3322%2Fcanjclin.54.1.8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcanjclin.54.1.8%26sid%3Dliteratum%253Aachs%26aulast%3DJemal%26aufirst%3DA.%26aulast%3DTiwari%26aufirst%3DR.%2BC.%26aulast%3DMurray%26aufirst%3DT.%26aulast%3DGhafoor%26aufirst%3DA.%26aulast%3DSamuels%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DE.%26aulast%3DFeuer%26aufirst%3DE.%2BJ.%26aulast%3DThun%26aufirst%3DM.%2BJ.%26atitle%3DAmerican%2520Cancer%2520Society.%2520Cancer%2520Statistics%252C%25202004%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2004%26volume%3D54%26spage%3D8%26epage%3D29%26doi%3D10.3322%2Fcanjclin.54.1.8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Siegel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brawley, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jemal, A.</span><span> </span><span class="NLM_article-title">Cancer Statistics, 2011: The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths</span> <span class="citation_source-journal">Ca-Cancer J. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">â</span> <span class="NLM_lpage">236</span><span class="refDoi">Â DOI: 10.3322/caac.20121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.3322%2Fcaac.20121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=21685461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A280%3ADC%252BC3MnkslKhsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2011&pages=212-236&author=R.+Siegelauthor=E.+Wardauthor=O.+Brawleyauthor=A.+Jemal&title=Cancer+Statistics%2C+2011%3A+The+Impact+of+Eliminating+Socioeconomic+and+Racial+Disparities+on+Premature+Cancer+Deaths&doi=10.3322%2Fcaac.20121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths</span></div><div class="casAuthors">Siegel Rebecca; Ward Elizabeth; Brawley Otis; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">212-36</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics.  A total of 1,596,670 new cancer cases and 571,950 deaths from cancer are projected to occur in the United States in 2011.  Overall cancer incidence rates were stable in men in the most recent time period after decreasing by 1.9% per year from 2001 to 2005; in women, incidence rates have been declining by 0.6% annually since 1998.  Overall cancer death rates decreased in all racial/ethnic groups in both men and women from 1998 through 2007, with the exception of American Indian/Alaska Native women, in whom rates were stable.  African American and Hispanic men showed the largest annual decreases in cancer death rates during this time period (2.6% and 2.5%, respectively).  Lung cancer death rates showed a significant decline in women after continuously increasing since the 1930s.  The reduction in the overall cancer death rates since 1990 in men and 1991 in women translates to the avoidance of about 898,000 deaths from cancer.  However, this progress has not benefitted all segments of the population equally; cancer death rates for individuals with the least education are more than twice those of the most educated.  The elimination of educational and racial disparities could potentially have avoided about 37% (60,370) of the premature cancer deaths among individuals aged 25 to 64 years in 2007 alone.  Further progress can be accelerated by applying existing cancer control knowledge across all segments of the population with an emphasis on those groups in the lowest socioeconomic bracket.  CA Cancer J Clin 2011. Â© 2011 American Cancer Society.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSV6umkq5UbgGlSCSgBhwJFfW6udTcc2eZvrwLycvMi97ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MnkslKhsg%253D%253D&md5=7fbc8af4359e652a7dd1048a031ffcc3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3322%2Fcaac.20121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.20121%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%26aulast%3DWard%26aufirst%3DE.%26aulast%3DBrawley%26aufirst%3DO.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520Statistics%252C%25202011%253A%2520The%2520Impact%2520of%2520Eliminating%2520Socioeconomic%2520and%2520Racial%2520Disparities%2520on%2520Premature%2520Cancer%2520Deaths%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2011%26volume%3D61%26spage%3D212%26epage%3D236%26doi%3D10.3322%2Fcaac.20121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Melosky, B.</span><span> </span><span class="NLM_article-title">Review of EGFR TKIs in Metastatic NSCLC, Including Ongoing Trials</span> <span class="citation_source-journal">Front. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">244</span><span class="refDoi">Â DOI: 10.3389/fonc.2014.00244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.3389%2Ffonc.2014.00244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=25309870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A280%3ADC%252BC2M7pvFCgsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=244&author=B.+Melosky&title=Review+of+EGFR+TKIs+in+Metastatic+NSCLC%2C+Including+Ongoing+Trials&doi=10.3389%2Ffonc.2014.00244"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Review of EGFR TKIs in Metastatic NSCLC, Including Ongoing Trials</span></div><div class="casAuthors">Melosky Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">244</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Recent clinical trials have demonstrated the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) in the treatment of patients with advanced metastatic non-small cell lung cancer.  Most of these recent trials were conducted in patients with EGFR mutation-positive tumors.  As our knowledge of the EGFR mutation and its resistant pathways develops, the complexity of the situation expands.  This article briefly reviews the pivotal trials leading to approval of EGFR TKIs in the first-line setting for patients with EGFR mutation-positive non-small cell lung carcinomas.  It discusses the historical use of EGFR TKIs after the first-line setting in unselected patients and briefly describes ongoing trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPQOldwlFiz6Nc3HjJRoFAfW6udTcc2eZvrwLycvMi97ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7pvFCgsA%253D%253D&md5=fbb7ea5d5ec4d212909b317af2e48b16</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2014.00244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2014.00244%26sid%3Dliteratum%253Aachs%26aulast%3DMelosky%26aufirst%3DB.%26atitle%3DReview%2520of%2520EGFR%2520TKIs%2520in%2520Metastatic%2520NSCLC%252C%2520Including%2520Ongoing%2520Trials%26jtitle%3DFront.%2520Oncol.%26date%3D2014%26volume%3D4%26spage%3D244%26doi%3D10.3389%2Ffonc.2014.00244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Moran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quiroga, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil Mde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vila, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carcereny, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capdevila, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Marmol, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosell, R.</span><span> </span><span class="NLM_article-title">Targeting EML4-ALK Driven Non-Small Cell Lung Cancer (NSCLC)</span> <span class="citation_source-journal">Transl. Lung Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">â</span> <span class="NLM_lpage">141</span><span class="refDoi">Â DOI: 10.3978/j.issn.2218-6751.2013.03.04</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.3978%2Fj.issn.2218-6751.2013.03.04" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=25806224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCmt7rK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=128-141&author=T.+Moranauthor=V.+Quirogaauthor=L.+Gil+Mdeauthor=L.+Vilaauthor=N.+Pardoauthor=E.+Carcerenyauthor=L.+Capdevilaauthor=A.+M.+Munoz-Marmolauthor=R.+Rosell&title=Targeting+EML4-ALK+Driven+Non-Small+Cell+Lung+Cancer+%28NSCLC%29&doi=10.3978%2Fj.issn.2218-6751.2013.03.04"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting EML4-ALK driven non-small cell lung cancer (NSCLC)</span></div><div class="casAuthors">Moran, Teresa; Quiroga, Vanesa; de los Llanos Gil, Maria; Vila, Laia; Pardo, Nuria; Carcereny, Enric; Capdevila, Laia; Munoz-Marmol, Ana M.; Rosell, Rafael</div><div class="citationInfo"><span class="NLM_cas:title">Translational Lung Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">128-141</span>CODEN:
                <span class="NLM_cas:coden">TLCRA9</span>;
        ISSN:<span class="NLM_cas:issn">2226-4477</span>.
    
            (<span class="NLM_cas:orgname">Pioneer Bioscience Publishing Co.</span>)
        </div><div class="casAbstract">This article discusses about the targeting EML4-ALK driven non-small cell lung cancer (NSCLC).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHm_NJOSVQzrVg90H21EOLACvtfcHk0lguoQcZ6yyFog"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCmt7rK&md5=09035b303089d09fc8ccc4d3e125b2e1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3978%2Fj.issn.2218-6751.2013.03.04&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3978%252Fj.issn.2218-6751.2013.03.04%26sid%3Dliteratum%253Aachs%26aulast%3DMoran%26aufirst%3DT.%26aulast%3DQuiroga%26aufirst%3DV.%26aulast%3DGil%2BMde%26aufirst%3DL.%26aulast%3DVila%26aufirst%3DL.%26aulast%3DPardo%26aufirst%3DN.%26aulast%3DCarcereny%26aufirst%3DE.%26aulast%3DCapdevila%26aufirst%3DL.%26aulast%3DMunoz-Marmol%26aufirst%3DA.%2BM.%26aulast%3DRosell%26aufirst%3DR.%26atitle%3DTargeting%2520EML4-ALK%2520Driven%2520Non-Small%2520Cell%2520Lung%2520Cancer%2520%2528NSCLC%2529%26jtitle%3DTransl.%2520Lung%2520Cancer%2520Res.%26date%3D2013%26volume%3D2%26spage%3D128%26epage%3D141%26doi%3D10.3978%2Fj.issn.2218-6751.2013.03.04" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Benedettini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sholl, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ware, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vena, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeap, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorentino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligon, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdar, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draetta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirieac, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutterbach, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loda, M.</span><span> </span><span class="NLM_article-title">Met Activation in Non-Small Cell Lung Cancer Is Associated with de Novo Resistance to EGFR Inhibitors and the Development of Brain Metastasis</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">177</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">â</span> <span class="NLM_lpage">423</span><span class="refDoi">Â DOI: 10.2353/ajpath.2010.090863</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.2353%2Fajpath.2010.090863" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=20489150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslCrsLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2010&pages=415-423&author=E.+Benedettiniauthor=L.+M.+Shollauthor=M.+Peytonauthor=J.+Reillyauthor=C.+Wareauthor=L.+Davisauthor=N.+Venaauthor=D.+Baileyauthor=B.+Y.+Yeapauthor=M.+Fiorentinoauthor=A.+H.+Ligonauthor=B.+S.+Panauthor=V.+Richonauthor=J.+D.+Minnaauthor=A.+F.+Gazdarauthor=G.+Draettaauthor=S.+Bosariauthor=L.+R.+Chirieacauthor=B.+Lutterbachauthor=M.+Loda&title=Met+Activation+in+Non-Small+Cell+Lung+Cancer+Is+Associated+with+de+Novo+Resistance+to+EGFR+Inhibitors+and+the+Development+of+Brain+Metastasis&doi=10.2353%2Fajpath.2010.090863"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis</span></div><div class="casAuthors">Benedettini, Elisa; Sholl, Lynette M.; Peyton, Michael; Reilly, John; Ware, Christopher; Davis, Lenora; Vena, Natalie; Bailey, Dyane; Yeap, Beow Y.; Fiorentino, Michelangelo; Ligon, Azra H.; Pan, Bo-Sheng; Richon, Victoria; Minna, John D.; Gazdar, Adi F.; Draetta, Giulio; Bosari, Silvano; Chirieac, Lucian R.; Lutterbach, Bart; Loda, Massimo</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">415-423</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Most non-small cell lung cancer (NSCLC) patients harboring activating epidermal growth factor receptor (EGFR) mutations respond to tyrosine kinase inhibitor (TKI) therapy.  However, about 30% exhibit primary resistance to EGFR TKI therapy.  Here we report that Met protein expression and phosphorylation were assocd. with primary resistance to EGFR TKI therapy in NSCLC patients harboring EGFR mutations, implicating Met as a de novo mechanism of resistance.  In a sep. patient cohort, Met expression and phosphorylation were also assocd. with development of NSCLC brain metastasis and were selectively enriched in brain metastases relative to paired primary lung tumors.  A similar metastasis-specific activation of Met occurred in vitro in the isogenous cell lines H2073 and H1993, which are derived from the primary lung tumor and a metastasis, resp., from the same patient.  We conclude that Met activation is found in NSCLC before EGFR-targeted therapy and is assocd. with both primary resistance to EGFR inhibitor therapy and with the development of metastases.  If confirmed in larger cohorts, our anal. suggests that patient tumors harboring both Met activation and EGFR mutation could potentially benefit from early intervention with a combination of EGFR and Met inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMvwl26ZS8a7Vg90H21EOLACvtfcHk0lguoQcZ6yyFog"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslCrsLs%253D&md5=6419c3544bf5275738bdc05bcb6d0938</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2010.090863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2010.090863%26sid%3Dliteratum%253Aachs%26aulast%3DBenedettini%26aufirst%3DE.%26aulast%3DSholl%26aufirst%3DL.%2BM.%26aulast%3DPeyton%26aufirst%3DM.%26aulast%3DReilly%26aufirst%3DJ.%26aulast%3DWare%26aufirst%3DC.%26aulast%3DDavis%26aufirst%3DL.%26aulast%3DVena%26aufirst%3DN.%26aulast%3DBailey%26aufirst%3DD.%26aulast%3DYeap%26aufirst%3DB.%2BY.%26aulast%3DFiorentino%26aufirst%3DM.%26aulast%3DLigon%26aufirst%3DA.%2BH.%26aulast%3DPan%26aufirst%3DB.%2BS.%26aulast%3DRichon%26aufirst%3DV.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DGazdar%26aufirst%3DA.%2BF.%26aulast%3DDraetta%26aufirst%3DG.%26aulast%3DBosari%26aufirst%3DS.%26aulast%3DChirieac%26aufirst%3DL.%2BR.%26aulast%3DLutterbach%26aufirst%3DB.%26aulast%3DLoda%26aufirst%3DM.%26atitle%3DMet%2520Activation%2520in%2520Non-Small%2520Cell%2520Lung%2520Cancer%2520Is%2520Associated%2520with%2520de%2520Novo%2520Resistance%2520to%2520EGFR%2520Inhibitors%2520and%2520the%2520Development%2520of%2520Brain%2520Metastasis%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2010%26volume%3D177%26spage%3D415%26epage%3D423%26doi%3D10.2353%2Fajpath.2010.090863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Brose, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rishi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerrero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einhorn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albelda, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brignell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futreal, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wooster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratton, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, B. L.</span><span> </span><span class="NLM_article-title">BRAF and RAS Mutations in Human Lung Cancer and Melanoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">6997</span><span class="NLM_x">â</span> <span class="NLM_lpage">7000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=12460918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVahsbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=6997-7000&author=M.+S.+Broseauthor=P.+Volpeauthor=M.+Feldmanauthor=M.+Kumarauthor=I.+Rishiauthor=R.+Gerreroauthor=E.+Einhornauthor=M.+Herlynauthor=J.+Minnaauthor=A.+Nicholsonauthor=J.+A.+Rothauthor=S.+M.+Albeldaauthor=H.+Daviesauthor=C.+Coxauthor=G.+Brignellauthor=P.+Stephensauthor=P.+A.+Futrealauthor=R.+Woosterauthor=M.+R.+Strattonauthor=B.+L.+Weber&title=BRAF+and+RAS+Mutations+in+Human+Lung+Cancer+and+Melanoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">BRAF and RAS mutations in human lung cancer and melanoma</span></div><div class="casAuthors">Brose, Marcia S.; Volpe, Patricia; Feldman, Michael; Kumar, Madhu; Rishi, Irum; Gerrero, Renee; Einhorn, Eugene; Herlyn, Meenhard; Minna, John; Nicholson, Andrew; Roth, Jack A.; Albelda, Steven M.; Davies, Helen; Cox, Charles; Brignell, Graham; Stephens, Philip; Futreal, P. Andrew; Wooster, Richard; Stratton, Michael R.; Weber, Barbara L.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6997-7000</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">BRAF encodes a RAS-regulated kinase that mediates cell growth and malignant transformation kinase pathway activation.  Recently, we have identified activating BRAF mutations in 66% of melanomas and a smaller percentage of many other human cancers.  To det. whether BRAF mutations account for the MAP kinase pathway activation common in non-small cell lung carcinomas (NSCLCs) and to extend the initial findings in melanoma, we screened DNA from 179 NSCLCs and 35 melanomas for BRAF mutations (exons 11 and 15).  We identified BRAF mutations in 5 NSCLCs (3%; one V599 and four non-V599) and 22 melanomas (63%; 21 V599 and 1 non-V599).  Three BRAF mutations identified in this study are novel, altering residues important in AKT-mediated BRAF phosphorylation and suggesting that disruption of AKT -induced BRAF inhibition can play a role in malignant transformation.  To our knowledge, this is the first report of mutations documenting this interaction in human cancers.  Although >90% of BRAF mutations in melanoma involve codon 599 (57 of 60), 8 of 9 BRAF mutations reported to date in NSCLC are non-V599 (89%; P < 10-7), strongly suggesting that BRAF mutations in NSCLC are qual. different from those in melanoma; thus, there may be therapeutic differences between lung cancer and melanoma in response to RAF inhibitors.  Although uncommon, BRAF mutations in human lung cancers may identify a subset of tumors sensitive to targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTgYE0tREoTrVg90H21EOLACvtfcHk0lguoQcZ6yyFog"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVahsbo%253D&md5=14d00ac58479d0a0f98830abe436dfde</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrose%26aufirst%3DM.%2BS.%26aulast%3DVolpe%26aufirst%3DP.%26aulast%3DFeldman%26aufirst%3DM.%26aulast%3DKumar%26aufirst%3DM.%26aulast%3DRishi%26aufirst%3DI.%26aulast%3DGerrero%26aufirst%3DR.%26aulast%3DEinhorn%26aufirst%3DE.%26aulast%3DHerlyn%26aufirst%3DM.%26aulast%3DMinna%26aufirst%3DJ.%26aulast%3DNicholson%26aufirst%3DA.%26aulast%3DRoth%26aufirst%3DJ.%2BA.%26aulast%3DAlbelda%26aufirst%3DS.%2BM.%26aulast%3DDavies%26aufirst%3DH.%26aulast%3DCox%26aufirst%3DC.%26aulast%3DBrignell%26aufirst%3DG.%26aulast%3DStephens%26aufirst%3DP.%26aulast%3DFutreal%26aufirst%3DP.%2BA.%26aulast%3DWooster%26aufirst%3DR.%26aulast%3DStratton%26aufirst%3DM.%2BR.%26aulast%3DWeber%26aufirst%3DB.%2BL.%26atitle%3DBRAF%2520and%2520RAS%2520Mutations%2520in%2520Human%2520Lung%2520Cancer%2520and%2520Melanoma%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D6997%26epage%3D7000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, L.</span><span> </span><span class="NLM_article-title">Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors</span> <span class="citation_source-journal">Acta Pharm. Sin. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">390</span><span class="NLM_x">â</span> <span class="NLM_lpage">401</span><span class="refDoi">Â DOI: 10.1016/j.apsb.2015.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.apsb.2015.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=26579470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A280%3ADC%252BC28rgtlOqsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=390-401&author=L.+Huangauthor=L.+Fu&title=Mechanisms+of+Resistance+to+EGFR+Tyrosine+Kinase+Inhibitors&doi=10.1016%2Fj.apsb.2015.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of resistance to EGFR tyrosine kinase inhibitors</span></div><div class="casAuthors">Huang Lihua; Fu Liwu</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">390-401</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">Since the discovery that non-small cell lung cancer (NSCLC) is driven by epidermal growth factor receptor (EGFR) mutations, the EGFR tyrosine kinase inhibitors (EGFR-TKIs, e.g., gefitinib and elrotinib) have been effectively used for clinical treatment.  However, patients eventually develop drug resistance.  Resistance to EGFR-TKIs is inevitable due to various mechanisms, such as the secondary mutation (T790M), activation of alternative pathways (c-Met, HGF, AXL), aberrance of the downstream pathways (K-RAS mutations, loss of PTEN), impairment of the EGFR-TKIs-mediated apoptosis pathway (BCL2-like 11/BIM deletion polymorphism), histologic transformation, ATP binding cassette (ABC) transporter effusion, etc.  Here we review and summarize the known resistant mechanisms to EGFR-TKIs and provide potential targets for development of new therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-qtzzXrDFl75XHngOXiV_fW6udTcc2eb1ZmB3mDqm1Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rgtlOqsw%253D%253D&md5=8429fc78384f6e540b1fa8f6c57c363b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2015.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2015.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DFu%26aufirst%3DL.%26atitle%3DMechanisms%2520of%2520Resistance%2520to%2520EGFR%2520Tyrosine%2520Kinase%2520Inhibitors%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2015%26volume%3D5%26spage%3D390%26epage%3D401%26doi%3D10.1016%2Fj.apsb.2015.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Fukumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamauchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hippo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibahara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanari, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hironaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukayama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dosaka-Akita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aburatani, H.</span><span> </span><span class="NLM_article-title">Overexpression of the Aldo-Keto Reductase Family Protein AKR1B10 Is Highly Correlated with Smokersâ Non-Small Cell Lung Carcinomas</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1776</span><span class="NLM_x">â</span> <span class="NLM_lpage">1785</span><span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-04-1238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1158%2F1078-0432.CCR-04-1238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=15755999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVKrsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=1776-1785&author=S.+Fukumotoauthor=N.+Yamauchiauthor=H.+Moriguchiauthor=Y.+Hippoauthor=A.+Watanabeauthor=J.+Shibaharaauthor=H.+Taniguchiauthor=S.+Ishikawaauthor=H.+Itoauthor=S.+Yamamotoauthor=H.+Iwanariauthor=M.+Hironakaauthor=Y.+Ishikawaauthor=T.+Nikiauthor=Y.+Soharaauthor=T.+Kodamaauthor=M.+Nishimuraauthor=M.+Fukayamaauthor=H.+Dosaka-Akitaauthor=H.+Aburatani&title=Overexpression+of+the+Aldo-Keto+Reductase+Family+Protein+AKR1B10+Is+Highly+Correlated+with+Smokers%E2%80%99+Non-Small+Cell+Lung+Carcinomas&doi=10.1158%2F1078-0432.CCR-04-1238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of the Aldo-Keto Reductase Family Protein AKR1B10 Is Highly Correlated with Smokers' Non-Small Cell Lung Carcinomas</span></div><div class="casAuthors">Fukumoto, Shin-Ichi; Yamauchi, Naoko; Moriguchi, Hisashi; Hippo, Yoshitaka; Watanabe, Akira; Shibahara, Junji; Taniguchi, Hirokazu; Ishikawa, Shumpei; Ito, Hirotaka; Yamamoto, Shogo; Iwanari, Hiroko; Hironaka, Mitsugu; Ishikawa, Yuichi; Niki, Toshiro; Sohara, Yasunori; Kodama, Tatsuhiko; Nishimura, Masaharu; Fukayama, Masashi; Dosaka-Akita, Hirotoshi; Aburatani, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1776-1785</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Squamous cell carcinoma (SCC) and adenocarcinoma of the lung are currently subject to similar treatment regimens despite distinct differences in histol. and epidemiol.  The aim of this study is to identify a mol. target with diagnostic and therapeutic values for SCC.  Exptl. Design: Genes specifically up-regulated in SCC were explored through microarray anal. of 5 SCCs, 5 adenocarcinomas, 10 small cell lung carcinomas, 27 normal tissues, and 40 cancer cell lines.  Clin. usefulness of these genes was subsequently examd. mainly by immunohistochem. anal.  RESULTS: Seven genes, including aldo-keto reductase family 1, member B10 (AKR1B10), were identified as SCC-specific genes.  AKR1B10 was further examd. by immunohistochem. anal. of 101 non-small cell lung carcinomas (NSCLC) and its overexpression was obsd. in 27 of 32 (84.4%) SCCs and 19 of 65 (29.2%) adenocarcinomas.  Multiple regression anal. showed that smoking was an independent variable responsible for AKR1B10 overexpression in NSCLCs (P < 0.01) and adenocarcinomas (P < 0.01).  AKR1B10 staining was occasionally obsd. even in squamous metaplasia, a precancerous lesion of SCC.  CONCLUSION: AKR1B10 was overexpressed in most cases with SCC, which is closely assocd. with smoking, and many adenocarcinoma cases of smokers.  These results suggest that AKR1B10 is a potential diagnostic marker specific to smokers' NSCLCs and might be involved in tobacco-related carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmOUU7059FVrVg90H21EOLACvtfcHk0lj0LNnFW2az_g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVKrsrc%253D&md5=abe88dc2407e299102540c683b122f2f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-1238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-1238%26sid%3Dliteratum%253Aachs%26aulast%3DFukumoto%26aufirst%3DS.%26aulast%3DYamauchi%26aufirst%3DN.%26aulast%3DMoriguchi%26aufirst%3DH.%26aulast%3DHippo%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DA.%26aulast%3DShibahara%26aufirst%3DJ.%26aulast%3DTaniguchi%26aufirst%3DH.%26aulast%3DIshikawa%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DS.%26aulast%3DIwanari%26aufirst%3DH.%26aulast%3DHironaka%26aufirst%3DM.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DNiki%26aufirst%3DT.%26aulast%3DSohara%26aufirst%3DY.%26aulast%3DKodama%26aufirst%3DT.%26aulast%3DNishimura%26aufirst%3DM.%26aulast%3DFukayama%26aufirst%3DM.%26aulast%3DDosaka-Akita%26aufirst%3DH.%26aulast%3DAburatani%26aufirst%3DH.%26atitle%3DOverexpression%2520of%2520the%2520Aldo-Keto%2520Reductase%2520Family%2520Protein%2520AKR1B10%2520Is%2520Highly%2520Correlated%2520with%2520Smokers%25E2%2580%2599%2520Non-Small%2520Cell%2520Lung%2520Carcinomas%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D1776%26epage%3D1785%26doi%3D10.1158%2F1078-0432.CCR-04-1238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Son, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span> </span><span class="NLM_article-title">Clinical Validity of the Lung Cancer Biomarkers Identified by Bioinformatics Analysis of Public Expression Data</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">7431</span><span class="NLM_x">â</span> <span class="NLM_lpage">7438</span><span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-07-0003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1158%2F0008-5472.CAN-07-0003" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=7431-7438&author=B.+Kimauthor=H.+J.+Leeauthor=H.+Y.+Choiauthor=Y.+Shinauthor=S.+Namauthor=G.+Seoauthor=D.+S.+Sonauthor=J.+Joauthor=J.+Kimauthor=J.+Leeauthor=J.+Kimauthor=K.+Kimauthor=S.+Lee&title=Clinical+Validity+of+the+Lung+Cancer+Biomarkers+Identified+by+Bioinformatics+Analysis+of+Public+Expression+Data&doi=10.1158%2F0008-5472.CAN-07-0003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-0003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-0003%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DChoi%26aufirst%3DH.%2BY.%26aulast%3DShin%26aufirst%3DY.%26aulast%3DNam%26aufirst%3DS.%26aulast%3DSeo%26aufirst%3DG.%26aulast%3DSon%26aufirst%3DD.%2BS.%26aulast%3DJo%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DS.%26atitle%3DClinical%2520Validity%2520of%2520the%2520Lung%2520Cancer%2520Biomarkers%2520Identified%2520by%2520Bioinformatics%2520Analysis%2520of%2520Public%2520Expression%2520Data%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D7431%26epage%3D7438%26doi%3D10.1158%2F0008-5472.CAN-07-0003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Kang, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.</span><span> </span><span class="NLM_article-title">AKR1B10 Is Associated with Smoking and Smoking-Related Non-Small-Cell Lung Cancer</span> <span class="citation_source-journal">J. Int. Med. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">â</span> <span class="NLM_lpage">85</span><span class="refDoi">Â DOI: 10.1177/147323001103900110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1177%2F147323001103900110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=21672310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVeitL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=78-85&author=M.+W.+Kangauthor=E.+S.+Leeauthor=S.+Y.+Yoonauthor=J.+Joauthor=J.+Leeauthor=H.+K.+Kimauthor=Y.+S.+Choiauthor=K.+Kimauthor=Y.+M.+Shimauthor=J.+Kimauthor=H.+Kim&title=AKR1B10+Is+Associated+with+Smoking+and+Smoking-Related+Non-Small-Cell+Lung+Cancer&doi=10.1177%2F147323001103900110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">AKR1B10 is associated with smoking and smoking-related non-small-cell lung cancer</span></div><div class="casAuthors">Kang, M.-W.; Lee, E.-S.; Yoon, S. Y.; Jo, J.; Lee, J.; Kim, H. K.; Choi, Y. S.; Kim, K.; Shim, Y. M.; Kim, J.; Kim, H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of International Medical Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-85</span>CODEN:
                <span class="NLM_cas:coden">JIMRBV</span>;
        ISSN:<span class="NLM_cas:issn">0300-0605</span>.
    
            (<span class="NLM_cas:orgname">Field House Publishing LLP</span>)
        </div><div class="casAbstract">This prospective study explored the relationship between expression of AKR1B10 mRNA and various clin. parameters in non-small-cell lung cancer (NSCLC) in terms of its validation as a marker for NSCLC.  Tumor tissue samples were collected from 229 patients with NSCLC.  Tissue samples from adjacent non-malignant lung tissue (> 5 cm from the tumor) of 89 of these patients and samples from 20 patients with benign lung disease were used as controls.  Quant. reverse transcription-polymerase chain reaction showed significantly higher levels of AKR1B10 mRNA expression in NSCLC tumor tissue than in adjacent non-malignant lung tissue and benign lung tissue.  Statistically significant factors for AKR1B10 mRNA over-expression were found to be male gender, smoking, squamous cell carcinoma and moderate or poor cell differentiation.  It is concluded that AKR1B10 seems to have potential as a prognostic marker for NSCLC and warrants further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry72bL_A7eDLVg90H21EOLACvtfcHk0lgdiZa8o_Lx_w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVeitL0%253D&md5=d066b70b99ce0b1c258ac9e7ae3fb41d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1177%2F147323001103900110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F147323001103900110%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DM.%2BW.%26aulast%3DLee%26aufirst%3DE.%2BS.%26aulast%3DYoon%26aufirst%3DS.%2BY.%26aulast%3DJo%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DH.%2BK.%26aulast%3DChoi%26aufirst%3DY.%2BS.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DShim%26aufirst%3DY.%2BM.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DH.%26atitle%3DAKR1B10%2520Is%2520Associated%2520with%2520Smoking%2520and%2520Smoking-Related%2520Non-Small-Cell%2520Lung%2520Cancer%26jtitle%3DJ.%2520Int.%2520Med.%2520Res.%26date%3D2011%26volume%3D39%26spage%3D78%26epage%3D85%26doi%3D10.1177%2F147323001103900110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Pastor, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nogal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina-Pinelo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melendez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salinas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez De la Pena, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Juan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corral, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Carbonero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carnero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paz-Ares, L.</span><span> </span><span class="NLM_article-title">Identification of Proteomic Signatures Associated with Lung Cancer and COPD</span> <span class="citation_source-journal">J. Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">â</span> <span class="NLM_lpage">237</span><span class="refDoi">Â DOI: 10.1016/j.jprot.2013.04.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.jprot.2013.04.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=23665002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1ekt77E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2013&pages=227-237&author=M.+D.+Pastorauthor=A.+Nogalauthor=S.+Molina-Pineloauthor=R.+Melendezauthor=A.+Salinasauthor=M.+Gonzalez+De+la+Penaauthor=J.+Martin-Juanauthor=J.+Corralauthor=R.+Garcia-Carboneroauthor=A.+Carneroauthor=L.+Paz-Ares&title=Identification+of+Proteomic+Signatures+Associated+with+Lung+Cancer+and+COPD&doi=10.1016%2Fj.jprot.2013.04.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of proteomic signatures associated with lung cancer and COPD</span></div><div class="casAuthors">Pastor, M. D.; Nogal, A.; Molina-Pinelo, S.; Melendez, R.; Salinas, A.; Gonzalez De la Pena, M.; Martin-Juan, J.; Corral, J.; Garcia-Carbonero, R.; Carnero, A.; Paz-Ares, L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteomics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">227-237</span>CODEN:
                <span class="NLM_cas:coden">JPORFQ</span>;
        ISSN:<span class="NLM_cas:issn">1874-3919</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lung cancer (LC) and chronic obstructive pulmonary disease (COPD) commonly coexist in smokers, and the presence of COPD increases the risk of developing LC.  The aim of this study was to identify distinct proteomic profiles able to discriminate these two pathol. entities.  Protein content was assessed in the bronchoalveolar lavage (BAL) of 60 patients classified in four groups: COPD, COPD and LC, LC without COPD, and control with neither COPD nor LC.  Proteins were sepd. into spots by bidimensional polyacrylamide gel electrophoresis (2D-PAGE) and examd. by matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF/TOF).  A total of 40 proteins were differentially expressed in the LC and/or COPD groups as compared with the control group.  Distinct protein profiles were identified and validated for each pathol. entity (LC and COPD).  The main networks involved were related to inflammatory signalling, free radical scavenging and oxidative stress response, and glycolysis and gluconeogenesis pathways.  The most relevant signalling link between LC and COPD was through the NF-ÎºB pathway.  In conclusion, the protein profiles identified contribute to elucidate the underlying pathogenic pathways of both diseases, and provide new tools of potential use as biomarkers for the early diagnosis of LC.  Sequence coverage: The protein sequence coverage (95%) was estd. for specific proteins by the percentage of matching amino acids from the identified peptides having confidence greater than or equal to 95% divided by the total no. of amino acids in the sequence.  Ingenuity Pathways Anal.: Mapping of our proteins onto biol. pathways and disease networks demonstrated that 22 proteins were linked to inflammatory signalling (p-value: 1.35 * 10-08-1.42 * 10-02), 15 proteins were assocd. with free radical scavenging and oxidative stress response (p-value: 4.93 * 10-11-1.27 * 10-02), and 9 proteins were related with glycolysis and gluconeogenesis pathways (p-value: 7.39 * 10-09-1.58 * 10-02).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6ciQrB9fukbVg90H21EOLACvtfcHk0lgdiZa8o_Lx_w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1ekt77E&md5=f5931bf2652feb3cee5505fe65b6202c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.jprot.2013.04.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jprot.2013.04.037%26sid%3Dliteratum%253Aachs%26aulast%3DPastor%26aufirst%3DM.%2BD.%26aulast%3DNogal%26aufirst%3DA.%26aulast%3DMolina-Pinelo%26aufirst%3DS.%26aulast%3DMelendez%26aufirst%3DR.%26aulast%3DSalinas%26aufirst%3DA.%26aulast%3DGonzalez%2BDe%2Bla%2BPena%26aufirst%3DM.%26aulast%3DMartin-Juan%26aufirst%3DJ.%26aulast%3DCorral%26aufirst%3DJ.%26aulast%3DGarcia-Carbonero%26aufirst%3DR.%26aulast%3DCarnero%26aufirst%3DA.%26aulast%3DPaz-Ares%26aufirst%3DL.%26atitle%3DIdentification%2520of%2520Proteomic%2520Signatures%2520Associated%2520with%2520Lung%2520Cancer%2520and%2520COPD%26jtitle%3DJ.%2520Proteomics%26date%3D2013%26volume%3D89%26spage%3D227%26epage%3D237%26doi%3D10.1016%2Fj.jprot.2013.04.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Szymanowska-Narloch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jassem, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skrzypski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meister, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dienemann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rzepko, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarzab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marjanski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlowski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rzyman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jassem, J.</span><span> </span><span class="NLM_article-title">Molecular Profiles of Non-Small Cell Lung Cancers in Cigarette Smoking and Never-Smoking Patients</span> <span class="citation_source-journal">Adv. Med. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">â</span> <span class="NLM_lpage">206</span><span class="refDoi">Â DOI: 10.2478/ams-2013-0025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.2478%2Fams-2013-0025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=24451080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsFOlsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2013&pages=196-206&author=A.+Szymanowska-Narlochauthor=E.+Jassemauthor=M.+Skrzypskiauthor=T.+Muleyauthor=M.+Meisterauthor=H.+Dienemannauthor=M.+Taronauthor=R.+Rosellauthor=R.+Rzepkoauthor=M.+Jarzabauthor=T.+Marjanskiauthor=R.+Pawlowskiauthor=W.+Rzymanauthor=J.+Jassem&title=Molecular+Profiles+of+Non-Small+Cell+Lung+Cancers+in+Cigarette+Smoking+and+Never-Smoking+Patients&doi=10.2478%2Fams-2013-0025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular profiles of non-small cell lung cancers in cigarette smoking and never-smoking patients</span></div><div class="casAuthors">Szymanowska-Narloch, A.; Jassem, E.; Skrzypski, M.; Muley, T.; Meister, M.; Dienemann, H.; Taron, M.; Rosell, R.; Rzepko, R.; Jarzab, M.; Marjanski, T.; Pawlowski, R.; Rzyman, W.; Jassem, J.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Medical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">196-206</span>CODEN:
                <span class="NLM_cas:coden">AMSDCH</span>;
        ISSN:<span class="NLM_cas:issn">1896-1126</span>.
    
            (<span class="NLM_cas:orgname">Medical University of Bialystok</span>)
        </div><div class="casAbstract">Purpose: Mol. features of non-small cell lung cancer (NSCLC) in never-smokers are not well recognized.  We assessed the expression of genes potentially related to lung cancer etiol. in smoking vs. never-smoking NSCLC patients.  Methods: We assayed frozen tumor samples from surgically resected 31 never-smoking and 54 clin. pair-matched smoking NSCLC patients, and from corresponding normal lung tissue from 27 and 43 patients, resp.  Expression of 21 genes, including cell membrane kinases, sex hormone receptors, transcription factors, growth factors and others was assessed by reverse transcription - quant. PCR.  Results: Expression of 5 genes was significantly higher in tumors of non-smokers vs. smokers: CSF1R (p<0.0001), RRAD (p<0.0001), PR (p=0.0004), TGFBR2 (p=0.0027) and EPHB6 (p=0.0033).  Expression of AKR1B10 (p<0.0001), CDKN2A (p<0.0001), CHRNA6 (p<0.0001), SOX9 (p<0.0001), survivin (p<0.0001) and ER2 (p=0.002) was significantly higher in tumors compared to normal lung tissue.  Expression of AR (p<0.0001), EPHB6 (p<0.0001), PR (p<0.0001), TGFBR2 (p<0.0001), TGFBR3 (p<0.0001), ER1 (p=0.0006) and DLG1 (p=0.0016) was significantly lower in tumors than in normal lung tissue.  Expression of IGF2 was higher in tumors than in healthy lung tissue in never-smokers (p=0.003), and expression of AHR (p<0.0001), CSF1R (p<0.0001) and RRAD (p<0.0001) was lower in tumors than in healthy lung tissue in smokers.  Conclusion: Expression of several genes in NSCLC is strongly related to smoking history.  Lower expression of PR and higher expression of ER2 in tumors suggests a possibility of hormonal therapeutic intervention in selected NSCLC patients.  Distinct mol. features of NSCLC in never-smokers, e.g. CHRNA6 upregulation, may prompt new treatment strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovXLKkjaH2i7Vg90H21EOLACvtfcHk0lgdiZa8o_Lx_w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsFOlsLo%253D&md5=ad5bc8300fc0ac14bd3e36a6ab3a92fb</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2478%2Fams-2013-0025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2478%252Fams-2013-0025%26sid%3Dliteratum%253Aachs%26aulast%3DSzymanowska-Narloch%26aufirst%3DA.%26aulast%3DJassem%26aufirst%3DE.%26aulast%3DSkrzypski%26aufirst%3DM.%26aulast%3DMuley%26aufirst%3DT.%26aulast%3DMeister%26aufirst%3DM.%26aulast%3DDienemann%26aufirst%3DH.%26aulast%3DTaron%26aufirst%3DM.%26aulast%3DRosell%26aufirst%3DR.%26aulast%3DRzepko%26aufirst%3DR.%26aulast%3DJarzab%26aufirst%3DM.%26aulast%3DMarjanski%26aufirst%3DT.%26aulast%3DPawlowski%26aufirst%3DR.%26aulast%3DRzyman%26aufirst%3DW.%26aulast%3DJassem%26aufirst%3DJ.%26atitle%3DMolecular%2520Profiles%2520of%2520Non-Small%2520Cell%2520Lung%2520Cancers%2520in%2520Cigarette%2520Smoking%2520and%2520Never-Smoking%2520Patients%26jtitle%3DAdv.%2520Med.%2520Sci.%26date%3D2013%26volume%3D58%26spage%3D196%26epage%3D206%26doi%3D10.2478%2Fams-2013-0025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Ludovini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianconi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siggillino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piobbico, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vannucci, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellezza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puma, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Della Fazia, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Servillo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crino, L.</span><span> </span><span class="NLM_article-title">Gene Identification for Risk of Relapse in Stage I Lung Adenocarcinoma Patients: A Combined Methodology of Gene Expression Profiling and Computational Gene Network Analysis</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">30561</span><span class="NLM_x">â</span> <span class="NLM_lpage">30574</span><span class="refDoi">Â DOI: 10.18632/oncotarget.8723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.18632%2Foncotarget.8723" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=30561-30574&author=V.+Ludoviniauthor=F.+Bianconiauthor=A.+Siggillinoauthor=D.+Piobbicoauthor=J.+Vannucciauthor=G.+Metroauthor=R.+Chiariauthor=G.+Bellezzaauthor=F.+Pumaauthor=M.+A.+Della+Faziaauthor=G.+Servilloauthor=L.+Crino&title=Gene+Identification+for+Risk+of+Relapse+in+Stage+I+Lung+Adenocarcinoma+Patients%3A+A+Combined+Methodology+of+Gene+Expression+Profiling+and+Computational+Gene+Network+Analysis&doi=10.18632%2Foncotarget.8723"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.8723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.8723%26sid%3Dliteratum%253Aachs%26aulast%3DLudovini%26aufirst%3DV.%26aulast%3DBianconi%26aufirst%3DF.%26aulast%3DSiggillino%26aufirst%3DA.%26aulast%3DPiobbico%26aufirst%3DD.%26aulast%3DVannucci%26aufirst%3DJ.%26aulast%3DMetro%26aufirst%3DG.%26aulast%3DChiari%26aufirst%3DR.%26aulast%3DBellezza%26aufirst%3DG.%26aulast%3DPuma%26aufirst%3DF.%26aulast%3DDella%2BFazia%26aufirst%3DM.%2BA.%26aulast%3DServillo%26aufirst%3DG.%26aulast%3DCrino%26aufirst%3DL.%26atitle%3DGene%2520Identification%2520for%2520Risk%2520of%2520Relapse%2520in%2520Stage%2520I%2520Lung%2520Adenocarcinoma%2520Patients%253A%2520A%2520Combined%2520Methodology%2520of%2520Gene%2520Expression%2520Profiling%2520and%2520Computational%2520Gene%2520Network%2520Analysis%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D30561%26epage%3D30574%26doi%3D10.18632%2Foncotarget.8723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Cao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, S. S.</span><span> </span><span class="NLM_article-title">Identification and Characterization of a Novel Human Aldose Reductase-like Gene</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">11429</span><span class="NLM_x">â</span> <span class="NLM_lpage">11435</span><span class="refDoi">Â DOI: 10.1074/jbc.273.19.11429</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1074%2Fjbc.273.19.11429" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=11429-11435&author=D.+Caoauthor=S.+T.+Fanauthor=S.+S.+Chung&title=Identification+and+Characterization+of+a+Novel+Human+Aldose+Reductase-like+Gene&doi=10.1074%2Fjbc.273.19.11429"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.19.11429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.19.11429%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DD.%26aulast%3DFan%26aufirst%3DS.%2BT.%26aulast%3DChung%26aufirst%3DS.%2BS.%26atitle%3DIdentification%2520and%2520Characterization%2520of%2520a%2520Novel%2520Human%2520Aldose%2520Reductase-like%2520Gene%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D11429%26epage%3D11435%26doi%3D10.1074%2Fjbc.273.19.11429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Matkowskyj, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omary, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G. Y.</span><span> </span><span class="NLM_article-title">Aldoketoreductase Family 1B10 (AKR1B10) as a Biomarker to Distinguish Hepatocellular Carcinoma from Benign Liver Lesions</span> <span class="citation_source-journal">Hum. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">834</span><span class="NLM_x">â</span> <span class="NLM_lpage">843</span><span class="refDoi">Â DOI: 10.1016/j.humpath.2013.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.humpath.2013.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=24656094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksF2ntr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2014&pages=834-843&author=K.+A.+Matkowskyjauthor=H.+Baiauthor=J.+Liaoauthor=W.+Zhangauthor=H.+Liauthor=S.+Raoauthor=R.+Omaryauthor=G.+Y.+Yang&title=Aldoketoreductase+Family+1B10+%28AKR1B10%29+as+a+Biomarker+to+Distinguish+Hepatocellular+Carcinoma+from+Benign+Liver+Lesions&doi=10.1016%2Fj.humpath.2013.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions</span></div><div class="casAuthors">Matkowskyj, Kristina A.; Bai, Han; Liao, Jie; Zhang, Wanying; Li, Haonan; Rao, Sambasiva; Omary, Reed; Yang, Guang-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Human Pathology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">834-843</span>CODEN:
                <span class="NLM_cas:coden">HPCQA4</span>;
        ISSN:<span class="NLM_cas:issn">0046-8177</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma (HCC) is one of the most common highly aggressive malignant tumors worldwide.  Aldoketoreductase 1B10 (AKR1B10) was first isolated from HCC and further identified to be over-expressed in many cancers from various organs.  AKR1B10 contributes to detoxification of xenobiotics by lipid peroxidn. and metabolizes physiol. substrates such as farnesal, retinal, and carbonyls.  Metabolizing these lipid substrates plays a crucial role in promoting carcinogenesis.  In the present study, immunohistochem. anal. was performed to det. the prevalence/pattern of AKR1B10 expression in HCC and its usefulness to differentiate benign liver lesions from HCC.  Oncogenic function of AKR1B10 was examd. in hepatocellular carcinoma cells in vitro using Western blotting and shRNA knockdown approaches, with emphasis on cell apoptosis and response to chemotherapy.  Immunohistochem. anal. revealed AKR1B10 was overexpressed in 97% (86/89) of hepatocellular carcinomas, with minimal to no expression in adjacent hepatic tissue, while hepatic adenomas and focal nodular hyperplasia did not exhibit expression of AKR1B10. shRNA-mediated silencing of AKR1B10 expression in hepatocellular carcinoma cells resulted in (1) increased cell apoptosis, (2) decreased colony formation and size, and (3) enhanced cytoreductive response following exposure to doxorubicin chemotherapy.  Our findings provide first time evidence that AKR1B10 is a unique biomarker involved in hepatocellular carcinogenesis via modulation of proliferation, cell apoptosis and chemoresistance and is a potential promising biomarker to differentiate HCCs from benign hepatic lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovx1Rr7M89YbVg90H21EOLACvtfcHk0lhsGeCe1zytxg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksF2ntr0%253D&md5=0b996535b40ad8e18c9e740b945b7f21</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.humpath.2013.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.humpath.2013.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DMatkowskyj%26aufirst%3DK.%2BA.%26aulast%3DBai%26aufirst%3DH.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DOmary%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DG.%2BY.%26atitle%3DAldoketoreductase%2520Family%25201B10%2520%2528AKR1B10%2529%2520as%2520a%2520Biomarker%2520to%2520Distinguish%2520Hepatocellular%2520Carcinoma%2520from%2520Benign%2520Liver%2520Lesions%26jtitle%3DHum.%2520Pathol.%26date%3D2014%26volume%3D45%26spage%3D834%26epage%3D843%26doi%3D10.1016%2Fj.humpath.2013.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, D. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span> </span><span class="NLM_article-title">AKR1B10 Overexpression in Breast Cancer: Association with Tumor Size, Lymph Node Metastasis and Patient Survival and its Potential as a Novel Serum Marker</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">E862</span><span class="NLM_x">â</span> <span class="NLM_lpage">E871</span><span class="refDoi">Â DOI: 10.1002/ijc.27618</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1002%2Fijc.27618" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=22539036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1Crs7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2012&pages=E862-E871&author=J.+Maauthor=D.+X.+Luoauthor=C.+Huangauthor=Y.+Shenauthor=Y.+Buauthor=S.+Markwellauthor=J.+Gaoauthor=J.+Liuauthor=X.+Zuauthor=Z.+Caoauthor=Z.+Gaoauthor=F.+Luauthor=D.+F.+Liaoauthor=D.+Cao&title=AKR1B10+Overexpression+in+Breast+Cancer%3A+Association+with+Tumor+Size%2C+Lymph+Node+Metastasis+and+Patient+Survival+and+its+Potential+as+a+Novel+Serum+Marker&doi=10.1002%2Fijc.27618"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">AKR1B10 overexpression in breast cancer: Association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker</span></div><div class="casAuthors">Ma, Jun; Luo, Di-Xian; Huang, Chenfei; Shen, Yi; Bu, Yiwen; Markwell, Stephen; Gao, John; Liu, Jianghua; Zu, Xuyu; Cao, Zhe; Gao, Zachary; Lu, Fengmin; Liao, Duan-Fang; Cao, Deliang</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">E862-E871</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Aldo-keto reductase 1B10 (AKR1B10) is a secretory protein that is upregulated with tumorigenic transformation of human mammary epithelial cells.  This study demonstrated that AKR1B10 was overexpressed in 20 (71.4%) of 28 ductal carcinomas in situ, 184 (83.6%) of 220 infiltrating carcinomas and 28 (87.5%) of 32 recurrent tumors.  AKR1B10 expression in breast cancer was correlated pos. with tumor size (p = 0.0012) and lymph node metastasis (p = 0.0123) but inversely with disease-related survival (p = 0.0120).  Univariate (p = 0.0077) and multivariate (p = 0.0192) analyses both suggested that AKR1B10, alone or together with tumor size and node status, is a significant prognostic factor for breast cancer.  Silencing of AKR1B10 in BT-20 human breast cancer cells inhibited cell growth in culture and tumorigenesis in female nude mice.  Importantly, AKR1B10 in the serum of breast cancer patients was significantly increased to 15.18 Â± 9.08 ng/mL [n = 50; 95% confidence interval (CI), 12.60-17.76], with a high level up to 58.4 ng/mL, compared to 3.34 Â± 2.27 ng/mL in healthy donors (n = 60; 95% CI, 2.78-3.90).  In these patients, AKR1B10 levels in serum were correlated with its expression in tumors (r = 0.8066; p < 0.0001).  Together our data suggests that AKR1B10 is overexpressed in breast cancer and may be a novel prognostic factor and serum marker for this deadly disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR5IwWNSHIz7Vg90H21EOLACvtfcHk0lhsGeCe1zytxg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1Crs7w%253D&md5=64712b59c0c2daef9984db128478f045</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fijc.27618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.27618%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DD.%2BX.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DBu%26aufirst%3DY.%26aulast%3DMarkwell%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZu%26aufirst%3DX.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DGao%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DF.%26aulast%3DLiao%26aufirst%3DD.%2BF.%26aulast%3DCao%26aufirst%3DD.%26atitle%3DAKR1B10%2520Overexpression%2520in%2520Breast%2520Cancer%253A%2520Association%2520with%2520Tumor%2520Size%252C%2520Lymph%2520Node%2520Metastasis%2520and%2520Patient%2520Survival%2520and%2520its%2520Potential%2520as%2520a%2520Novel%2520Serum%2520Marker%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2012%26volume%3D131%26spage%3DE862%26epage%3DE871%26doi%3D10.1002%2Fijc.27618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Hayes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skouras, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haugk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charnley, R. M.</span><span> </span><span class="NLM_article-title">Keap1-Nrf2 Signalling in Pancreatic Cancer</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">288</span><span class="NLM_x">â</span> <span class="NLM_lpage">299</span><span class="refDoi">Â DOI: 10.1016/j.biocel.2015.06.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.biocel.2015.06.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=26117456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtV2iu7bK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2015&pages=288-299&author=A.+J.+Hayesauthor=C.+Skourasauthor=B.+Haugkauthor=R.+M.+Charnley&title=Keap1-Nrf2+Signalling+in+Pancreatic+Cancer&doi=10.1016%2Fj.biocel.2015.06.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Keap1-Nrf2 signalling in pancreatic cancer</span></div><div class="casAuthors">Hayes, Alastair J.; Skouras, Christos; Haugk, Beate; Charnley, Richard M.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">288-299</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Transcription factor NF-E2 p45-related factor 2 (Nrf2, also called Nfe2l2), a master regulator of redox homeostasis, and its dominant neg. regulator, Kelch-like ECH-assocd. protein 1 (Keap1), together tightly control the expression of numerous detoxifying and antioxidant genes.  Nrf2 and the 'antioxidant response element' (ARE)-driven genes it controls are frequently upregulated in pancreatic cancer and correlate with poor survival.  Upregulation of Nrf2 is, at least in part, K-Ras oncogene-driven and contributes to pancreatic cancer proliferation and chemoresistance.  In this review, we aim to provide an overview of Keap1-Nrf2 signalling as it relates to pancreatic cancer, discussing the effects of inhibiting Nrf2 or Nrf2/ARE effector proteins to increase chemosensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9jxaff_vLBbVg90H21EOLACvtfcHk0ljI5ZqiD5BFmw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtV2iu7bK&md5=cba47c1f31618500e12a6b6839651ee2</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2015.06.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2015.06.017%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DA.%2BJ.%26aulast%3DSkouras%26aufirst%3DC.%26aulast%3DHaugk%26aufirst%3DB.%26aulast%3DCharnley%26aufirst%3DR.%2BM.%26atitle%3DKeap1-Nrf2%2520Signalling%2520in%2520Pancreatic%2520Cancer%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2015%26volume%3D65%26spage%3D288%26epage%3D299%26doi%3D10.1016%2Fj.biocel.2015.06.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Ko, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, S. J.</span><span> </span><span class="NLM_article-title">Expression of AKR1B10 as an Independent Marker for Poor Prognosis in Human Oral Squamous Cell Carcinoma</span> <span class="citation_source-journal">Head Neck</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1327</span><span class="NLM_x">â</span> <span class="NLM_lpage">1332</span><span class="refDoi">Â DOI: 10.1002/hed.24759</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1002%2Fhed.24759" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=28301069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A280%3ADC%252BC1czmvFGqsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2017&pages=1327-1332&author=H.+H.+Koauthor=S.+L.+Chengauthor=J.+J.+Leeauthor=H.+M.+Chenauthor=M.+Y.+Kuoauthor=S.+J.+Cheng&title=Expression+of+AKR1B10+as+an+Independent+Marker+for+Poor+Prognosis+in+Human+Oral+Squamous+Cell+Carcinoma&doi=10.1002%2Fhed.24759"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of AKR1B10 as an independent marker for poor prognosis in human oral squamous cell carcinoma</span></div><div class="casAuthors">Ko Hui-Hsin; Chen Hsin-Ming; Kuo Mark Yen-Ping; Cheng Shih-Jung; Ko Hui-Hsin; Lee Jang-Jaer; Chen Hsin-Ming; Kuo Mark Yen-Ping; Cheng Shih-Jung; Cheng Shih-Lung; Cheng Shih-Lung; Lee Jang-Jaer; Chen Hsin-Ming; Kuo Mark Yen-Ping; Cheng Shih-Jung; Chen Hsin-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Head & neck</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1327-1332</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Aldo-keto reductase family 1 member B10 (AKR1B10) is implicated in xenobiotic detoxification and has disparate functions in tumorigenesis that are dependent on the cell types.  The purpose of this study was to investigate the clinicopathological significance of AKR1B10 as a prognostic marker for oral squamous cell carcinomas (OSCCs).  METHODS:  AKR1B10 protein expression was analyzed by immunohistochemistry in 77 patients with OSCC.  RESULTS:  The AKR1B10 labeling score for OSCCs (1.16 Â± 1.14) was significantly higher than that for normal oral mucosa (0.10 Â± 0.23; p < .0001).  High expression of AKR1B10 significantly correlated with large tumor size (p = .041), advanced TNM classification (p = .037), and patient's areca quid chewing habit (p = .025).  Multivariate analysis revealed that high AKR1B10 labeling score >1.16 (hazard ratio, 3.647; p = .001) significantly correlated with mortality.  CONCLUSION:  AKR1B10 overexpression is an independent poor prognostic biomarker for OSCC.  AKR1B10 inhibitors may be promising in clinical trials against OSCC. Â© 2017 Wiley Periodicals, Inc.  Head Neck 39: 1327-1332, 2017.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXt68-4L-GNEHdcurJClFcfW6udTcc2eZsCCxMp5bSv7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czmvFGqsA%253D%253D&md5=9efbc0da1a2490a140c0de136877b718</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fhed.24759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhed.24759%26sid%3Dliteratum%253Aachs%26aulast%3DKo%26aufirst%3DH.%2BH.%26aulast%3DCheng%26aufirst%3DS.%2BL.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DChen%26aufirst%3DH.%2BM.%26aulast%3DKuo%26aufirst%3DM.%2BY.%26aulast%3DCheng%26aufirst%3DS.%2BJ.%26atitle%3DExpression%2520of%2520AKR1B10%2520as%2520an%2520Independent%2520Marker%2520for%2520Poor%2520Prognosis%2520in%2520Human%2520Oral%2520Squamous%2520Cell%2520Carcinoma%26jtitle%3DHead%2520Neck%26date%3D2017%26volume%3D39%26spage%3D1327%26epage%3D1332%26doi%3D10.1002%2Fhed.24759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitade, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Kinetic Studies of AKR1B10, Human Aldose Reductase-like Protein: Endogenous Substrates and Inhibition by Steroids</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">487</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">9</span><span class="refDoi">Â DOI: 10.1016/j.abb.2009.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.abb.2009.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=19464995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsFOgt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=487&publication_year=2009&pages=1-9&author=S.+Endoauthor=T.+Matsunagaauthor=H.+Mamiyaauthor=C.+Ohtaauthor=M.+Sodaauthor=Y.+Kitadeauthor=K.+Tajimaauthor=H.+T.+Zhaoauthor=O.+El-Kabbaniauthor=A.+Hara&title=Kinetic+Studies+of+AKR1B10%2C+Human+Aldose+Reductase-like+Protein%3A+Endogenous+Substrates+and+Inhibition+by+Steroids&doi=10.1016%2Fj.abb.2009.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic studies of AKR1B10, human aldose reductase-like protein: Endogenous substrates and inhibition by steroids</span></div><div class="casAuthors">Endo, Satoshi; Matsunaga, Toshiyuki; Mamiya, Hiroaki; Ohta, Chisato; Soda, Midori; Kitade, Yukio; Tajima, Kazuo; Zhao, Hai-Tao; El-Kabbani, Ossama; Hara, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">487</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A human member of the aldo-keto reductase (AKR) superfamily, AKR1B10, was identified as a biomarker of lung cancer, exhibiting high sequence identity with human aldose reductase (AKR1B1).  Using recombinant AKR1B10 and AKR1B1, we compared their substrate specificity for biogenic compds. and inhibition by endogenous compds. and found the following unique features of AKR1B10.  AKR1B10 efficiently reduced long-chain aliph. aldehydes including farnesal and geranylgeranial, which are generated from degrdn. of prenylated proteins and metab. of farnesol and geranylgeraniol derived from the mevalonate pathway.  The enzyme oxidized aliph. and arom. alcs. including 20Î±-hydroxysteroids.  In addn., AKR1B10 was inhibited by steroid hormones, bile acids and their metabolites, showing IC50 values of 0.03-25 Î¼M.  Kinetic analyses of the alc. oxidn. and inhibition by the steroids and tolrestat, together with the docked model of AKR1B10-inhibitor complex, suggest that the inhibitory steroids and tolrestat bind to overlapping sites within the active site of the enzyme-coenzyme complex.  Thus, we propose a novel role of AKR1B10 in controlling isoprenoid homeostasis that is important in cholesterol synthesis and cell proliferation through salvaging isoprenoid alcs., as well as its metabolic regulation by endogenous steroids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpeL1h3J-tgLVg90H21EOLACvtfcHk0ljI5ZqiD5BFmw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsFOgt7s%253D&md5=1788a9662b073c27fe8dd98849b4bfb1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2009.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2009.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DMamiya%26aufirst%3DH.%26aulast%3DOhta%26aufirst%3DC.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DKitade%26aufirst%3DY.%26aulast%3DTajima%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DH.%2BT.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DKinetic%2520Studies%2520of%2520AKR1B10%252C%2520Human%2520Aldose%2520Reductase-like%2520Protein%253A%2520Endogenous%2520Substrates%2520and%2520Inhibition%2520by%2520Steroids%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2009%26volume%3D487%26spage%3D1%26epage%3D9%26doi%3D10.1016%2Fj.abb.2009.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Martin, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maser, E.</span><span> </span><span class="NLM_article-title">Role of Human Aldo-Keto-Reductase AKR1B10 in the Protection against Toxic Aldehydes</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">178</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">â</span> <span class="NLM_lpage">150</span><span class="refDoi">Â DOI: 10.1016/j.cbi.2008.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.cbi.2008.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=19013440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFOjt7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2009&pages=145-150&author=H.+J.+Martinauthor=E.+Maser&title=Role+of+Human+Aldo-Keto-Reductase+AKR1B10+in+the+Protection+against+Toxic+Aldehydes&doi=10.1016%2Fj.cbi.2008.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Role of human aldo-keto-reductase AKR1B10 in the protection against toxic aldehydes</span></div><div class="casAuthors">Martin, Hans-Joerg; Maser, Edmund</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">145-150</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Damage of cell membranes by reactive oxygen species results in the formation of toxic lipid peroxides which may ultimately lead to cell death.  Among the best characterized intermediates of oxidative stress are the unsatd. aldehydes 4-hydroxynon-2-enal (4-HNE) and its oxidized counterpart 4-oxonon-2-enal (4-ONE).  4-HNE has been linked to various pathol. conditions including atherosclerosis, Parkinson's and Alzheimer's disease. 4-Methylpentanal (4-MP) is a side-chain cleavage product formed endogenously during steroidogenesis from cholesterol.  Like 4-HNE and 4-ONE, 4-MP is capable of binding covalently to and crosslinking of proteins.  These aldehydes are also damaging DNA by the formation of adducts.  We found that AKR1B10, a cytosolic member of the aldo-keto reductase superfamily, efficiently catalyzes the redn. of 4-HNE (Km = 0.3 mM, k cat = 43 min-1), 4-ONE (Km = 0.3 mM, k cat = 40 min-1) and 4-MP (Km = 0.05 mM, k cat = 25 min-1).  AKR1B10 catalyzed 4-MP redn. with a 30-fold increase in activity using NADPH as cofactor compared with NADH.  As was obsd. for aldose reductase (AKR1B1) 4-ONE rapidly inactivates AKR1B10, while this inactivation is not obsd. when the enzyme is preincubated with NADPH.  It was shown that cysteine 298 of aldose reductase was protected by NADPH from the Î±,Î²-unsatd. carbonyls of 4-ONE thus rendering resistance towards inactivation.  We generated a mutant AKR1B10, changing the resp. cysteine on position 299 of AKR1B10 into a serine.  This C299S mutant is still active towards 4-HNE and 4-ONE, albeit at a somewhat lower catalytic efficiency.  However, it is still inactivated by 4-ONE in the absence of NADPH.  While the best substrates for AKR1B10 are retinals, the high catalytic efficiency together with the protection from inactivation by NADPH suggests a role of AKR1B10 in the detoxification of biogenic aldehydes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsHuid09FnKLVg90H21EOLACvtfcHk0li39uNvEHY5Bw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFOjt7c%253D&md5=cf098515950a42eba5b68e6e6d43a1cb</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2008.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2008.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DH.%2BJ.%26aulast%3DMaser%26aufirst%3DE.%26atitle%3DRole%2520of%2520Human%2520Aldo-Keto-Reductase%2520AKR1B10%2520in%2520the%2520Protection%2520against%2520Toxic%2520Aldehydes%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2009%26volume%3D178%26spage%3D145%26epage%3D150%26doi%3D10.1016%2Fj.cbi.2008.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span> </span><span class="NLM_article-title">Aldo-Keto Reductase Family 1 Member B10 Promotes Cell Survival by Regulating Lipid Synthesis and Eliminating Carbonyls</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">26742</span><span class="NLM_x">â</span> <span class="NLM_lpage">26748</span><span class="refDoi">Â DOI: 10.1074/jbc.M109.022897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1074%2Fjbc.M109.022897" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=26742-26748&author=C.+Wangauthor=R.+Yanauthor=D.+Luoauthor=K.+Watabeauthor=D.+F.+Liaoauthor=D.+Cao&title=Aldo-Keto+Reductase+Family+1+Member+B10+Promotes+Cell+Survival+by+Regulating+Lipid+Synthesis+and+Eliminating+Carbonyls&doi=10.1074%2Fjbc.M109.022897"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.022897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.022897%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DYan%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DD.%26aulast%3DWatabe%26aufirst%3DK.%26aulast%3DLiao%26aufirst%3DD.%2BF.%26aulast%3DCao%26aufirst%3DD.%26atitle%3DAldo-Keto%2520Reductase%2520Family%25201%2520Member%2520B10%2520Promotes%2520Cell%2520Survival%2520by%2520Regulating%2520Lipid%2520Synthesis%2520and%2520Eliminating%2520Carbonyls%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D26742%26epage%3D26748%26doi%3D10.1074%2Fjbc.M109.022897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adeyanju, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span> </span><span class="NLM_article-title">Aldo-Keto Reductase Family 1 B10 Gene Silencing Results in Growth Inhibition of Colorectal Cancer Cells: Implication for Cancer Intervention</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">2301</span><span class="NLM_x">â</span> <span class="NLM_lpage">2306</span><span class="refDoi">Â DOI: 10.1002/ijc.22933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1002%2Fijc.22933" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=17597105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1aisL%252FE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2007&pages=2301-2306&author=R.+Yanauthor=X.+Zuauthor=J.+Maauthor=Z.+Liuauthor=M.+Adeyanjuauthor=D.+Cao&title=Aldo-Keto+Reductase+Family+1+B10+Gene+Silencing+Results+in+Growth+Inhibition+of+Colorectal+Cancer+Cells%3A+Implication+for+Cancer+Intervention&doi=10.1002%2Fijc.22933"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: implication for cancer intervention</span></div><div class="casAuthors">Yan, Ruilan; Zu, Xuyu; Ma, Jun; Liu, Ziwen; Adeyanju, Moses; Cao, Deliang</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2301-2306</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Aldo-keto reductase family 1 B10 (AKR1B10), a member of aldo-keto reductase superfamily, is overexpressed in human hepatocellular carcinoma, lung squamous cell carcinoma and lung adenocarcinoma.  Our previous study had demonstrated that the ectopic expression of AKR1B10 in 293T cells promotes cell proliferation.  To evaluate its potential as a target for cancer intervention, in the current study we knocked down AKR1B10 expression in HCT-8 cells derived from a colorectal carcinoma, using chem. synthesized small interfering RNA (siRNA).  The siRNA 1, targeted to encoding region, downregulated AKR1B10 expression by more than 60%, and siRNA 2, targeted to 3' untranslational region, reduced AKR1B10 expression by more than 95%.  AKR1B10 silencing resulted in approx. a 50% decrease in cell growth rate and nearly 40% suppression of DNA synthesis.  More importantly, AKR1B10 downregulation significantly reduced focus formation rate and colony size in semisolid culture, indicating the crit. role of AKR1B10 in HCT-8 cell proliferation.  Recombinant AKR1B10 protein showed strong enzymic activity to acrolein and crotonaldehyde, with Km = 110.1 Â± 12.2 Î¼M and Vmax = 3,122.0 Â± 64.7 nmol/mg protein/min for acrolein and Km = 86.7 Â± 14.3 Î¼M and Vmax = 2,647.5 Â± 132.2 nmol/mg protein/min for crotonaldehyde.  AKR1B10 downregulation enhanced the susceptibility of HCT-8 cells to acrolein (25 Î¼M) and crotonaldehyde (50 Î¼M), resulting in rapid oncotic cell death characterized with lactate dehydrogenase efflux and annexin-V staining.  These results suggest that AKR1B10 may regulate cell proliferation and cellular response to addnl. carbonyl stress, thus being a potential target for cancer intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreRzjFH7dOLLVg90H21EOLACvtfcHk0li39uNvEHY5Bw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1aisL%252FE&md5=4eefa9093766a7a953e361ca0508da0e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fijc.22933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.22933%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DZu%26aufirst%3DX.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DAdeyanju%26aufirst%3DM.%26aulast%3DCao%26aufirst%3DD.%26atitle%3DAldo-Keto%2520Reductase%2520Family%25201%2520B10%2520Gene%2520Silencing%2520Results%2520in%2520Growth%2520Inhibition%2520of%2520Colorectal%2520Cancer%2520Cells%253A%2520Implication%2520for%2520Cancer%2520Intervention%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2007%26volume%3D121%26spage%3D2301%26epage%3D2306%26doi%3D10.1002%2Fijc.22933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Zhong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span> </span><span class="NLM_article-title">Aldo-Keto Reductase Family 1 B10 Protein Detoxifies Dietary and Lipid-derived Î±,Î²-Unsaturated Carbonyls at Physiological Levels</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">â</span> <span class="NLM_lpage">250</span><span class="refDoi">Â DOI: 10.1016/j.bbrc.2009.06.123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.bbrc.2009.06.123" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2009&pages=245-250&author=L.+Zhongauthor=Z.+Liuauthor=R.+Yanauthor=S.+Johnsonauthor=Y.+Zhaoauthor=X.+Fangauthor=D.+Cao&title=Aldo-Keto+Reductase+Family+1+B10+Protein+Detoxifies+Dietary+and+Lipid-derived+%CE%B1%2C%CE%B2-Unsaturated+Carbonyls+at+Physiological+Levels&doi=10.1016%2Fj.bbrc.2009.06.123"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2009.06.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2009.06.123%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DYan%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DFang%26aufirst%3DX.%26aulast%3DCao%26aufirst%3DD.%26atitle%3DAldo-Keto%2520Reductase%2520Family%25201%2520B10%2520Protein%2520Detoxifies%2520Dietary%2520and%2520Lipid-derived%2520%25CE%25B1%252C%25CE%25B2-Unsaturated%2520Carbonyls%2520at%2520Physiological%2520Levels%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2009%26volume%3D387%26spage%3D245%26epage%3D250%26doi%3D10.1016%2Fj.bbrc.2009.06.123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Gallego, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardevol, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lera, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovira, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farres, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fita, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pares, X.</span><span> </span><span class="NLM_article-title">Structural Basis for the High <i>all</i>-<i>trans</i>-Retinaldehyde Reductase Activity of the Tumor Marker AKR1B10</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">20764</span><span class="NLM_x">â</span> <span class="NLM_lpage">20769</span><span class="refDoi">Â DOI: 10.1073/pnas.0705659105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1073%2Fpnas.0705659105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=18087047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1yjsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=20764-20769&author=O.+Gallegoauthor=F.+X.+Ruizauthor=A.+Ardevolauthor=M.+Dominguezauthor=R.+Alvarezauthor=A.+R.+de+Leraauthor=C.+Roviraauthor=J.+Farresauthor=I.+Fitaauthor=X.+Pares&title=Structural+Basis+for+the+High+all-trans-Retinaldehyde+Reductase+Activity+of+the+Tumor+Marker+AKR1B10&doi=10.1073%2Fpnas.0705659105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10</span></div><div class="casAuthors">Gallego, Oriol; Ruiz, F. Xavier; Ardevol, Albert; Dominguez, Marta; Alvarez, Rosana; de Lera, Angel R.; Rovira, Carme; Farres, Jaume; Fita, Ignacio; Pares, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">20764-20769</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">AKR1B10 is a human aldo-keto reductase (AKR) found to be elevated in several cancer types and in precancerous lesions.  In vitro, AKR1B10 exhibits a much higher retinaldehyde reductase activity than any other human AKR, including AKR1B1 (aldose reductase).  We here demonstrate that AKR1B10 also acts as a retinaldehyde reductase in vivo.  This activity may be relevant in controlling the first step of retinoic acid synthesis.  Up-regulation of AKR1B10, resulting in retinoic acid depletion, may lead to cellular proliferation.  Both in vitro and in vivo activities of AKR1B10 were inhibited by tolrestat, an AKR1B1 inhibitor developed for diabetes treatment.  The crystal structure of the ternary complex AKR1B10-NADP+-tolrestat was detd. at 1.25-Ã resoln.  Mol. dynamics models of AKR1B10 and AKR1B1 with retinaldehyde isomers and site-directed mutagenesis show that subtle differences at the entrance of the retinoid-binding site, esp. at position 125, are determinant for the all-trans-retinaldehyde specificity of AKR1B10.  Substitutions in the retinaldehyde cyclohexene ring also influence the specificity.  These structural features should facilitate the design of specific inhibitors, with potential use in cancer and diabetes treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_lNOfkwrAC7Vg90H21EOLACvtfcHk0li39uNvEHY5Bw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1yjsw%253D%253D&md5=55504226956b2f2f692c87a9569a6616</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0705659105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0705659105%26sid%3Dliteratum%253Aachs%26aulast%3DGallego%26aufirst%3DO.%26aulast%3DRuiz%26aufirst%3DF.%2BX.%26aulast%3DArdevol%26aufirst%3DA.%26aulast%3DDominguez%26aufirst%3DM.%26aulast%3DAlvarez%26aufirst%3DR.%26aulast%3Dde%2BLera%26aufirst%3DA.%2BR.%26aulast%3DRovira%26aufirst%3DC.%26aulast%3DFarres%26aufirst%3DJ.%26aulast%3DFita%26aufirst%3DI.%26aulast%3DPares%26aufirst%3DX.%26atitle%3DStructural%2520Basis%2520for%2520the%2520High%2520all-trans-Retinaldehyde%2520Reductase%2520Activity%2520of%2520the%2520Tumor%2520Marker%2520AKR1B10%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D20764%26epage%3D20769%26doi%3D10.1073%2Fpnas.0705659105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Ruiz, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porte, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pares, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farres, J.</span><span> </span><span class="NLM_article-title">Biological Role of Aldo-Keto Reductases in Retinoic Acid Biosynthesis and Signaling</span> <span class="citation_source-journal">Front. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="refDoi">Â DOI: 10.3389/fphar.2012.00058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.3389%2Ffphar.2012.00058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=22529810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms12qtrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=58&author=F.+X.+Ruizauthor=S.+Porteauthor=X.+Paresauthor=J.+Farres&title=Biological+Role+of+Aldo-Keto+Reductases+in+Retinoic+Acid+Biosynthesis+and+Signaling&doi=10.3389%2Ffphar.2012.00058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Biological role of aldo-keto reductases in retinoic acid biosynthesis and signaling</span></div><div class="casAuthors">Ruiz, F. Xavier; Porte, Sergio; Pares, Xavier; Farres, Jaume</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Experimental Pharmacology and Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">April</span>),
    <span class="NLM_cas:pages">58</span>CODEN:
                <span class="NLM_cas:coden">FEPDAX</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Several aldo-keto reductase (AKR) enzymes from subfamilies 1B and 1C show retinaldehyde reductase activity, having low Km and kcat values.  Only AKR1B10 and 1B12, with all-trans-retinaldehyde and AKR1C3, with 9-cis-retinaldehyde, display high catalytic efficiency.  Major structural determinants for retinaldehyde isomer specificity are located in the external loops (A and C for AKR1B10 and B for AKR1C3), as assessed by site-directed mutagenesis and mol. dynamics.  Cellular models have shown that AKR1B and 1C enzymes are well suited to work in vivo as retinaldehyde reductases and to regulate retinoic acid (RA) biosynthesis at hormone pre-receptor level.  An addnl. physiol. role for the retinaldehyde reductase activity of these enzymes, consistent with their tissue localization, is their participation in Î²-carotene absorption.  Retinaldehyde metab. may be subjected to subcellular compartmentalization, based on enzyme localization.  While retinaldehyde oxidn. to RA takes place in the cytosol, redn. to retinol could take place in the cytosol by AKRs or in the membranes of endoplasmic reticulum by microsomal retinaldehyde reductases.  Upregulation of some AKR1 enzymes in different cancer types may be linked to their induction by oxidative stress and to their participation in different signaling pathways related to cell proliferation.  AKR1B10 and AKR1C3, through their retinaldehyde reductase activity, trigger a decrease in the RA biosynthesis flow, resulting in RA deprivation and consequently lower differentiation, with an increased cancer risk in target tissues.  Rational design of selective AKR inhibitors could lead to development of novel drugs for cancer treatment as well as redn. of chemotherapeutic drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv76t8qkWVjrVg90H21EOLACvtfcHk0liDX1JZzixZmg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms12qtrY%253D&md5=b0225d5106ce89054a82f1b0f33d63e6</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2012.00058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2012.00058%26sid%3Dliteratum%253Aachs%26aulast%3DRuiz%26aufirst%3DF.%2BX.%26aulast%3DPorte%26aufirst%3DS.%26aulast%3DPares%26aufirst%3DX.%26aulast%3DFarres%26aufirst%3DJ.%26atitle%3DBiological%2520Role%2520of%2520Aldo-Keto%2520Reductases%2520in%2520Retinoic%2520Acid%2520Biosynthesis%2520and%2520Signaling%26jtitle%3DFront.%2520Pharmacol.%26date%3D2012%26volume%3D3%26spage%3D58%26doi%3D10.3389%2Ffphar.2012.00058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanamori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitade, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Roles of Rat and Human Aldo-Keto Reductases in Metabolism of Farnesol and Geranylgeraniol</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">â</span> <span class="NLM_lpage">268</span><span class="refDoi">Â DOI: 10.1016/j.cbi.2010.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.cbi.2010.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=21187079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFaju7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2011&pages=261-268&author=S.+Endoauthor=T.+Matsunagaauthor=C.+Ohtaauthor=M.+Sodaauthor=A.+Kanamoriauthor=Y.+Kitadeauthor=S.+Ohnoauthor=K.+Tajimaauthor=O.+El-Kabbaniauthor=A.+Hara&title=Roles+of+Rat+and+Human+Aldo-Keto+Reductases+in+Metabolism+of+Farnesol+and+Geranylgeraniol&doi=10.1016%2Fj.cbi.2010.12.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of rat and human aldo-keto reductases in metabolism of farnesol and geranylgeraniol</span></div><div class="casAuthors">Endo, Satoshi; Matsunaga, Toshiyuki; Ohta, Chisato; Soda, Midori; Kanamori, Ayano; Kitade, Yukio; Ohno, Satoshi; Tajima, Kazuo; El-Kabbani, Ossama; Hara, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">261-268</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Farnesol (FOH) and geranylgeraniol (GGOH) with multiple biol. actions are produced from the mevalonate pathway, and catabolized into farnesoic acid and geranylgeranoic acid, resp., via the aldehyde intermediates (farnesal and geranylgeranial).  We investigated the intracellular distribution, sequences and properties of the oxidoreductases responsible for the metabolic steps in rat tissues.  The oxidn. of FOH and GGOH into their aldehyde intermediates were mainly mediated by alc. dehydrogenases 1 (in the liver and colon) and 7 (in the stomach and lung), and the subsequent step into the carboxylic acids was catalyzed by a microsomal aldehyde dehydrogenase.  In addn., high reductase activity catalyzing the aldehyde intermediates into FOH (or GGOH) was detected in the cytosols of the extra-hepatic tissues, where the major reductase was identified as aldo-keto reductase (AKR) 1C15.  Human reductases with similar specificity were identified as AKR1B10 and AKR1C3, which most efficiently reduced farnesal and geranylgeranial among seven enzymes in the AKR1A-1C subfamilies.  The overall metab. from FOH to farnesoic acid in cultured cells was significantly decreased by overexpression of AKR1C15, and increased by addn. of AKR1C3 inhibitors, tolfenamic acid and R-flurbiprofen.  Thus, AKRs (1C15 in rats, and 1B10 and 1C3 in humans) may play an important role in controlling the bioavailability of FOH and GGOH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriJe4bfgeadLVg90H21EOLACvtfcHk0liDX1JZzixZmg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFaju7g%253D&md5=894b62e1a3780d8349621c708f98ebcd</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2010.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2010.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DOhta%26aufirst%3DC.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DKanamori%26aufirst%3DA.%26aulast%3DKitade%26aufirst%3DY.%26aulast%3DOhno%26aufirst%3DS.%26aulast%3DTajima%26aufirst%3DK.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DRoles%2520of%2520Rat%2520and%2520Human%2520Aldo-Keto%2520Reductases%2520in%2520Metabolism%2520of%2520Farnesol%2520and%2520Geranylgeraniol%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2011%26volume%3D191%26spage%3D261%26epage%3D268%26doi%3D10.1016%2Fj.cbi.2010.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span> </span><span class="NLM_article-title">Aldo-Keto Reductase Family 1 B10 Affects Fatty Acid Synthesis by Regulating the Stability of Acetyl-CoA Carboxylase-Î± in Breast Cancer Cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">3418</span><span class="NLM_x">â</span> <span class="NLM_lpage">3423</span><span class="refDoi">Â DOI: 10.1074/jbc.M707650200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1074%2Fjbc.M707650200" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=3418-3423&author=J.+Maauthor=R.+Yanauthor=X.+Zuauthor=J.+M.+Chengauthor=K.+Raoauthor=D.+F.+Liaoauthor=D.+Cao&title=Aldo-Keto+Reductase+Family+1+B10+Affects+Fatty+Acid+Synthesis+by+Regulating+the+Stability+of+Acetyl-CoA+Carboxylase-%CE%B1+in+Breast+Cancer+Cells&doi=10.1074%2Fjbc.M707650200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M707650200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M707650200%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DR.%26aulast%3DZu%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DJ.%2BM.%26aulast%3DRao%26aufirst%3DK.%26aulast%3DLiao%26aufirst%3DD.%2BF.%26aulast%3DCao%26aufirst%3DD.%26atitle%3DAldo-Keto%2520Reductase%2520Family%25201%2520B10%2520Affects%2520Fatty%2520Acid%2520Synthesis%2520by%2520Regulating%2520the%2520Stability%2520of%2520Acetyl-CoA%2520Carboxylase-%25CE%25B1%2520in%2520Breast%2520Cancer%2520Cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D3418%26epage%3D3423%26doi%3D10.1074%2Fjbc.M707650200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, S.</span><span> </span><span class="NLM_article-title">Aldo-Keto Reductase Family 1 Member B 10 Mediates Liver Cancer Cell Proliferation through Sphingosine-1-Phosphate</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">22746</span><span class="refDoi">Â DOI: 10.1038/srep22746</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1038%2Fsrep22746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=26948042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC28XjslGgurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=22746&author=J.+Jinauthor=W.+Liaoauthor=W.+Yaoauthor=R.+Zhuauthor=Y.+Liauthor=S.+He&title=Aldo-Keto+Reductase+Family+1+Member+B+10+Mediates+Liver+Cancer+Cell+Proliferation+through+Sphingosine-1-Phosphate&doi=10.1038%2Fsrep22746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Aldo-keto Reductase Family 1 Member B 10 Mediates Liver Cancer Cell Proliferation through Sphingosine-1-Phosphate</span></div><div class="casAuthors">Jin, Junfei; Liao, Weijia; Yao, Wenmin; Zhu, Rongping; Li, Yulan; He, Songqing</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22746</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">AKR1B10 is involved in hepatocarcinogenesis via modulation of fatty acid and lipid synthesis.  AKR1B10 inhibition results in apoptosis of tumor cells whose lipids, esp. phospholipids, were decreased by over 50%, suggesting involvement of phospholipids like sphingosine-1-phosphate (S1P) in AKR1B10's oncogenic function.  Using a co-culture system, we found that co-culture of QSG-7701 (human hepatocyte) with HepG2 (hepatoma cell line) increases QSG-7701's proliferation, in which AKR1B10-S1P signaling plays a pivotal role.  Consistent with previous findings, AKR1B10 mRNA and protein levels were higher in primary hepatocellular carcinoma (PHC) tissues than in peri-tumor tissues.  Interestingly, the level of S1P was also higher in PHC tissues than in peri-tumor tissues.  After analyzing the correlation between AKR1B10 mRNA expression in PHC tissues and the clin. data, we found that AKR1B10 mRNA expression was assocd. with serum alpha-fetoprotein (AFP), tumor-node-metastasis (TNM) stage, and lymph node metastasis, but not with other clinicopathol. variables.  A higher AKR1B10 mRNA expression level is related to a shorter DFS (disease free survival) and OS (overall survival), serving as an independent predictor of DFS and OS in PHC patients with surgical resection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-kX9wmzGnHrVg90H21EOLACvtfcHk0ljdzvb_VIh0Pg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjslGgurs%253D&md5=c5dcf43711ae5c35d8dbcc3376fd493d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fsrep22746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep22746%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DW.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DS.%26atitle%3DAldo-Keto%2520Reductase%2520Family%25201%2520Member%2520B%252010%2520Mediates%2520Liver%2520Cancer%2520Cell%2520Proliferation%2520through%2520Sphingosine-1-Phosphate%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D22746%26doi%3D10.1038%2Fsrep22746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhulst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span> </span><span class="NLM_article-title">AKR1B10 Promotes Breast Cancer Metastasis through Integrin Î±5/Î´-Catenin Mediated FAK/Src/Rac1 Signaling Pathway</span> <span class="citation_source-journal">Oncotarget.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">43779</span><span class="NLM_x">â</span> <span class="NLM_lpage">43791</span><span class="refDoi">Â DOI: 10.18632/oncotarget.9672</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.18632%2Foncotarget.9672" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=43779-43791&author=C.+Huangauthor=S.+Verhulstauthor=Y.+Shenauthor=Y.+Buauthor=Y.+Caoauthor=Y.+Heauthor=Y.+Wangauthor=D.+Huangauthor=C.+Caiauthor=K.+Raoauthor=D.+F.+Liaoauthor=J.+Jinauthor=D.+Cao&title=AKR1B10+Promotes+Breast+Cancer+Metastasis+through+Integrin+%CE%B15%2F%CE%B4-Catenin+Mediated+FAK%2FSrc%2FRac1+Signaling+Pathway&doi=10.18632%2Foncotarget.9672"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.9672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.9672%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DVerhulst%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DBu%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DCai%26aufirst%3DC.%26aulast%3DRao%26aufirst%3DK.%26aulast%3DLiao%26aufirst%3DD.%2BF.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DD.%26atitle%3DAKR1B10%2520Promotes%2520Breast%2520Cancer%2520Metastasis%2520through%2520Integrin%2520%25CE%25B15%252F%25CE%25B4-Catenin%2520Mediated%2520FAK%252FSrc%252FRac1%2520Signaling%2520Pathway%26jtitle%3DOncotarget.%26date%3D2016%26volume%3D7%26spage%3D43779%26epage%3D43791%26doi%3D10.18632%2Foncotarget.9672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Heibein, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprowl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclean, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parissenti, A. M.</span><span> </span><span class="NLM_article-title">Role of Aldo-Keto Reductases and Other Doxorubicin Pharmacokinetic Genes in Doxorubicin Resistance, DNA Binding, and Subcellular Localization</span> <span class="citation_source-journal">BMC Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="refDoi">Â DOI: 10.1186/1471-2407-12-381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1186%2F1471-2407-12-381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=22938713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVWnuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=381&author=A.+D.+Heibeinauthor=B.+Guoauthor=J.+A.+Sprowlauthor=D.+A.+Macleanauthor=A.+M.+Parissenti&title=Role+of+Aldo-Keto+Reductases+and+Other+Doxorubicin+Pharmacokinetic+Genes+in+Doxorubicin+Resistance%2C+DNA+Binding%2C+and+Subcellular+Localization&doi=10.1186%2F1471-2407-12-381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization</span></div><div class="casAuthors">Heibein, Allan D.; Guo, Baoqing; Sprowl, Jason A.; MacLean, David A.; Parissenti, Amadeo M.</div><div class="citationInfo"><span class="NLM_cas:title">BMC Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">381</span>CODEN:
                <span class="NLM_cas:coden">BCMACL</span>;
        ISSN:<span class="NLM_cas:issn">1471-2407</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Since proteins involved in chemotherapy drug pharmacokinetics and pharmacodynamics have a strong impact on the uptake, metab., and efflux of such drugs, they likely play crit. roles in resistance to chemotherapy drugs in cancer patients.  Methods: To investigate this hypothesis, we conducted a whole genome microarray study to identify difference in the expression of genes between isogenic doxorubicin-sensitive and doxorubicin-resistant MCF-7 breast tumor cells.  We then assessed the degree of over-representation of doxorubicin pharmacokinetic and pharmacodynamic genes in the dataset of doxorubicin resistance genes.  Results: Of 27,958 Entrez genes on the array, 7.4 per cent or 2,063 genes were differentially expressed by â¥ 2-fold between wildtype and doxorubicin-resistant cells.  The false discovery rate was set at 0.01 and the min. p value for significance for any gene within the "hit list" was 0.01.  Seventeen and 43 per cent of doxorubicin pharmacokinetic genes were over-represented in the hit list, depending upon whether the gene name was identical or within the same gene family, resp.  The most over-represented genes were within the 1C and 1B families of aldo-keto reductases (AKRs), which convert doxorubicin to doxorubicinol.  Other genes convert doxorubicin to other metabolites or affect the influx, efflux, or cytotoxicity of the drug.  In further support of the role of AKRs in doxorubicin resistance, we obsd. that, in comparison to doxorubicin, doxorubincol exhibited dramatically reduced cytotoxicity, reduced DNA-binding activity, and strong localization to extra nuclear lysosomes.  Pharmacol. inhibition of the above AKRs in doxorubicin-resistant cells increased cellular doxorubicin levels, restored doxorubicin cytotoxicity and re-established doxorubicin localization to the nucleus.  The properties of doxorubicinol were unaffected.  These findings demonstrate the utility of using curated pharmacokinetic and pharmacodynamic knowledge bases to identify highly relevant genes assocd. with doxorubicin resistance.  The induction of one or more of these genes was found to be correlated with changes in the drug's properties, while inhibiting one specific class of these genes (the AKRs) increased cellular doxorubicin content and restored drug DNA binding, cytotoxicity, and subcellular localization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9a9O8ky4XCrVg90H21EOLACvtfcHk0lisu87ORDcRVQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVWnuw%253D%253D&md5=30fbd88919205623ff0a5bbe82d32f3b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1186%2F1471-2407-12-381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2407-12-381%26sid%3Dliteratum%253Aachs%26aulast%3DHeibein%26aufirst%3DA.%2BD.%26aulast%3DGuo%26aufirst%3DB.%26aulast%3DSprowl%26aufirst%3DJ.%2BA.%26aulast%3DMaclean%26aufirst%3DD.%2BA.%26aulast%3DParissenti%26aufirst%3DA.%2BM.%26atitle%3DRole%2520of%2520Aldo-Keto%2520Reductases%2520and%2520Other%2520Doxorubicin%2520Pharmacokinetic%2520Genes%2520in%2520Doxorubicin%2520Resistance%252C%2520DNA%2520Binding%252C%2520and%2520Subcellular%2520Localization%26jtitle%3DBMC%2520Cancer%26date%3D2012%26volume%3D12%26spage%3D381%26doi%3D10.1186%2F1471-2407-12-381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaji, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomokuni, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonezawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Nitric Oxide Confers Cisplatin Resistance in Human Lung Cancer Cells through Upregulation of Aldo-Keto Reductase 1B10 and Proteasome</span> <span class="citation_source-journal">Free Radical Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1371</span><span class="NLM_x">â</span> <span class="NLM_lpage">1385</span><span class="refDoi">Â DOI: 10.3109/10715762.2014.957694</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.3109%2F10715762.2014.957694" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=25156503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Kgsr7O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2014&pages=1371-1385&author=T.+Matsunagaauthor=Y.+Yamajiauthor=T.+Tomokuniauthor=H.+Moritaauthor=Y.+Morikawaauthor=A.+Suzukiauthor=A.+Yonezawaauthor=S.+Endoauthor=A.+Ikariauthor=K.+Iguchiauthor=O.+El-Kabbaniauthor=K.+Tajimaauthor=A.+Hara&title=Nitric+Oxide+Confers+Cisplatin+Resistance+in+Human+Lung+Cancer+Cells+through+Upregulation+of+Aldo-Keto+Reductase+1B10+and+Proteasome&doi=10.3109%2F10715762.2014.957694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide confers cisplatin resistance in human lung cancer cells through upregulation of aldo-keto reductase 1B10 and proteasome</span></div><div class="casAuthors">Matsunaga, T.; Yamaji, Y.; Tomokuni, T.; Morita, H.; Morikawa, Y.; Suzuki, A.; Yonezawa, A.; Endo, S.; Ikari, A.; Iguchi, K.; El-Kabbani, O.; Tajima, K.; Hara, A.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1371-1385</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1029-2470</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">In this study, we show that exposure of human lung cancer A549 cells to cisplatin (cis-diamminedichloroplatinum, CDDP) promotes prodn. of nitric oxide (NO) through generation of reactive oxygen species (ROS) and resulting upregulation of inducible NO synthase (iNOS).  The incubation of the cells with a NO donor, diethylenetriamine NONOate, not only reduced the CDDP-induced cell death and apoptotic alterations (induction of CCAAT-enhancer-binding protein homologous protein and caspase-3 activation), but also elevated proteolytic activity of 26S proteasome, suggesting that the activation of proteasome function contributes to the redn. of CDDP sensitivity by NO.  Monitoring expression levels of six aldo-keto reductases (AKRs) (1A1, 1B1, 1B10, 1C1, 1C2, and 1C3) during the treatment with the NO donor and subsequent CDDP sensitivity test using the specific inhibitors also proposed that upregulation of AKR1B10 by NO is a key process for acquiring the CDDP resistance in A549 cells.  Treatment with CDDP and NO increased amts. of nitrotyrosine protein adducts, indicative of peroxynitrite formation, and promoted the induction of AKR1B10, inferring a relationship between peroxynitrite formation and the enzyme upregulation in the cells.  The treatment with CDDP or a ROS-related lipid aldehyde, 4-hydroxy-2-nonenal, facilitated the iNOS upregulation, which was restored by increasing the AKR1B10 expression.  In contrast, the facilitation of NO prodn. by CDDP treatment was hardly obsd. in AKR1B10-overexpressing A549 cells and established CDDP-resistant cancer cells (A549, LoVo, and PC3).  Collectively, these results suggest the NO functions as a key regulator controlling AKR1B10 expression and 26S proteasome function leading to gain of the CDDP resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKCNQD4NOHvbVg90H21EOLACvtfcHk0lisu87ORDcRVQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Kgsr7O&md5=6e1afc7b87649a0a5fec7d8f5b14e253</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.3109%2F10715762.2014.957694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10715762.2014.957694%26sid%3Dliteratum%253Aachs%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DYamaji%26aufirst%3DY.%26aulast%3DTomokuni%26aufirst%3DT.%26aulast%3DMorita%26aufirst%3DH.%26aulast%3DMorikawa%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DYonezawa%26aufirst%3DA.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DIkari%26aufirst%3DA.%26aulast%3DIguchi%26aufirst%3DK.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DTajima%26aufirst%3DK.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DNitric%2520Oxide%2520Confers%2520Cisplatin%2520Resistance%2520in%2520Human%2520Lung%2520Cancer%2520Cells%2520through%2520Upregulation%2520of%2520Aldo-Keto%2520Reductase%25201B10%2520and%2520Proteasome%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2014%26volume%3D48%26spage%3D1371%26epage%3D1385%26doi%3D10.3109%2F10715762.2014.957694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Morikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kezuka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyooka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span> </span><span class="NLM_article-title">Acquisition of Doxorubicin Resistance Facilitates Migrating and Invasive Potentials of Gastric Cancer MKN45 Cells through Up-regulating Aldo-Keto Reductase 1B10</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">230</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="NLM_x">â</span> <span class="NLM_lpage">39</span><span class="refDoi">Â DOI: 10.1016/j.cbi.2015.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.cbi.2015.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=25686905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivVSiurY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=230&publication_year=2015&pages=30-39&author=Y.+Morikawaauthor=C.+Kezukaauthor=S.+Endoauthor=A.+Ikariauthor=M.+Sodaauthor=K.+Yamamuraauthor=N.+Toyookaauthor=O.+El-Kabbaniauthor=A.+Haraauthor=T.+Matsunaga&title=Acquisition+of+Doxorubicin+Resistance+Facilitates+Migrating+and+Invasive+Potentials+of+Gastric+Cancer+MKN45+Cells+through+Up-regulating+Aldo-Keto+Reductase+1B10&doi=10.1016%2Fj.cbi.2015.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Acquisition of doxorubicin resistance facilitates migrating and invasive potentials of gastric cancer MKN45 cells through up-regulating aldo-keto reductase 1B10</span></div><div class="casAuthors">Morikawa, Yoshifumi; Kezuka, Chihiro; Endo, Satoshi; Ikari, Akira; Soda, Midori; Yamamura, Keiko; Toyooka, Naoki; El-Kabbani, Ossama; Hara, Akira; Matsunaga, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">230</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">30-39</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Continuous exposure to doxorubicin (DOX) accelerates hyposensitivity to the drug-elicited lethality of gastric cells, with increased risks of the recurrence and serious cardiovascular side effects.  However, the detailed mechanisms underlying the redn. of DOX sensitivity remain unclear.  In this study, we generated a DOX-resistant variant upon continuously treating human gastric cancer MKN45 cells with incremental concns. of the drug, and investigated whether the gain of DOX resistance influences gene expression of four aldo-keto reductases (AKRs: 1B10, 1C1, 1C2 and 1C3).  RT-PCR anal. revealed that among the enzymes AKR1B10 is most highly up-regulated during the chemoresistance induction.  The up-regulation of AKR1B10 was confirmed by analyses of Western blotting and enzyme activity.  The DOX sensitivity of MKN45 cells was reduced and elevated by overexpression and inhibition of AKR1B10, resp.  Compared to the parental MKN45 cells, the DOX-resistant cells had higher migrating and invasive abilities, which were significantly suppressed by addn. of AKR1B10 inhibitors.  Zymog. and real-time PCR analyses also revealed significant increases in secretion and expression of matrix metalloproteinase (MMP) 2 assocd. with DOX resistance.  Moreover, the overexpression of AKR1B10 in the parental cells remarkably facilitated malignant progression (elevation of migrating and invasive potentials) and MMP2 secretion, which were lowered by the AKR1B10 inhibitors.  These results suggest that AKR1B10 is a DOX-resistance gene in the gastric cancer cells, and is responsible for elevating the migrating and invasive potentials of the cells through induction of MMP2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocNGG2IId1sLVg90H21EOLACvtfcHk0lisu87ORDcRVQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivVSiurY%253D&md5=9bd6487118f6fec209de4474bea8aef1</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2015.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2015.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DMorikawa%26aufirst%3DY.%26aulast%3DKezuka%26aufirst%3DC.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DIkari%26aufirst%3DA.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DYamamura%26aufirst%3DK.%26aulast%3DToyooka%26aufirst%3DN.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DMatsunaga%26aufirst%3DT.%26atitle%3DAcquisition%2520of%2520Doxorubicin%2520Resistance%2520Facilitates%2520Migrating%2520and%2520Invasive%2520Potentials%2520of%2520Gastric%2520Cancer%2520MKN45%2520Cells%2520through%2520Up-regulating%2520Aldo-Keto%2520Reductase%25201B10%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2015%26volume%3D230%26spage%3D30%26epage%3D39%26doi%3D10.1016%2Fj.cbi.2015.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Matsunaga, T.; El-Kabbani, O.; Hara, A.</span><span> </span><span class="NLM_article-title">Aldo-Keto Reductases as New Therapeutic Targets for Colon Cancer Chemoresistance</span>. In  <span class="citation_source-book">Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy</span>; <span class="NLM_contrib-group">Bonavida, B.</span>, Ed.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">109</span><span class="NLM_x">â</span> <span class="NLM_lpage">133</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1007%2F978-1-4614-7070-0_6" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=109-133&author=T.+Matsunaga&author=O.+El-Kabbani&author=A.+Haraauthor=B.+Bonavida&title=Molecular+Mechanisms+of+Tumor+Cell+Resistance+to+Chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2F978-1-4614-7070-0_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4614-7070-0_6%26sid%3Dliteratum%253Aachs%26aulast%3DMatsunaga%26aufirst%3DT.%26atitle%3DAldo-Keto%2520Reductases%2520as%2520New%2520Therapeutic%2520Targets%2520for%2520Colon%2520Cancer%2520Chemoresistance%26btitle%3DMolecular%2520Mechanisms%2520of%2520Tumor%2520Cell%2520Resistance%2520to%2520Chemotherapy%26aulast%3DBonavida%26aufirst%3DB.%26pub%3DSpringer%26date%3D2013%26spage%3D109%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikari, A.</span><span> </span><span class="NLM_article-title">Roles of Aldo-Keto Reductases 1B10 and 1C3 and ATP-Binding Cassette Transporter in Docetaxel Tolerance</span> <span class="citation_source-journal">Free Radical Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1296</span><span class="NLM_x">â</span> <span class="NLM_lpage">1308</span><span class="refDoi">Â DOI: 10.1080/10715762.2016.1236373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1080%2F10715762.2016.1236373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=27629782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1yktrbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2016&pages=1296-1308&author=T.+Matsunagaauthor=H.+Saitoauthor=S.+Endoauthor=K.+Iguchiauthor=M.+Sodaauthor=O.+El-Kabbaniauthor=A.+Haraauthor=A.+Ikari&title=Roles+of+Aldo-Keto+Reductases+1B10+and+1C3+and+ATP-Binding+Cassette+Transporter+in+Docetaxel+Tolerance&doi=10.1080%2F10715762.2016.1236373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of aldo-keto reductases 1B10 and 1C3 and ATP-binding cassette transporter in docetaxel tolerance</span></div><div class="casAuthors">Matsunaga, Toshiyuki; Saito, Haruhi; Endo, Satoshi; Iguchi, Kazuhiro; Soda, Midori; El-Kabbani, Ossama; Hara, Akira; Ikari, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1296-1308</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1029-2470</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Docetaxel (DTX) is widely used for treatment of inveterate lung and prostate cancers, but its continuous administration elicits the hyposensitivity.  Here, we established the DTX-resistant variants of human lung cancer A549 and androgen-independent prostate cancer Du145 cells and found that the resistance development provoked aberrant up-regulations of aldo-keto reductase (AKR) 1B10 and AKR1C3 in A549 and Du145 cells, resp.  In addn., the sensitivity to the DTX toxicity was significantly decreased and increased by overexpression and knockdown of the two AKR isoforms, resp.  Furthermore, the resistant cells exhibited a decreased level of reactive 4-hydroxy-2-nonenal formed during DTX treatment, and the decrease was alleviated by adding the AKR inhibitors, inferring that the two AKRs confer the chemoresistance through elevating the antioxidant properties.  The development of DTX resistance was also assocd. with enhanced expression of an ATP-binding cassette (ABC) transporter ABCB1 among the ABC transporter isoforms.  The combined treatment with inhibitors of the two AKRs and ABCB1 additively sensitized the resistant cells to DTX.  Intriguingly, the AKR1B10 inhibitor also suppressed the lung cancer cross-resistance against cisplatin.  The results suggest that combined treatment with AKRs (1B10 and 1C3) and ABCB1 inhibitors exerts overcoming effect against the cancer resistance to DTX and cisplatin, and can be used as the adjuvant therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7Y07KrClAMLVg90H21EOLACvtfcHk0lhe7UAUInn80g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yktrbJ&md5=bf29bf9e253785dde3b04e370b948b55</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1080%2F10715762.2016.1236373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10715762.2016.1236373%26sid%3Dliteratum%253Aachs%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DSaito%26aufirst%3DH.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DIguchi%26aufirst%3DK.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DIkari%26aufirst%3DA.%26atitle%3DRoles%2520of%2520Aldo-Keto%2520Reductases%25201B10%2520and%25201C3%2520and%2520ATP-Binding%2520Cassette%2520Transporter%2520in%2520Docetaxel%2520Tolerance%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2016%26volume%3D50%26spage%3D1296%26epage%3D1308%26doi%3D10.1080%2F10715762.2016.1236373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Chewchuk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parissenti, A. M.</span><span> </span><span class="NLM_article-title">Alterations in Estrogen Signalling Pathways upon Acquisition of Anthracycline Resistance in Breast Tumor Cells</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0172244</span><span class="refDoi">Â DOI: 10.1371/journal.pone.0172244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1371%2Fjournal.pone.0172244" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0172244&author=S.+Chewchukauthor=B.+Guoauthor=A.+M.+Parissenti&title=Alterations+in+Estrogen+Signalling+Pathways+upon+Acquisition+of+Anthracycline+Resistance+in+Breast+Tumor+Cells&doi=10.1371%2Fjournal.pone.0172244"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0172244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0172244%26sid%3Dliteratum%253Aachs%26aulast%3DChewchuk%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DB.%26aulast%3DParissenti%26aufirst%3DA.%2BM.%26atitle%3DAlterations%2520in%2520Estrogen%2520Signalling%2520Pathways%2520upon%2520Acquisition%2520of%2520Anthracycline%2520Resistance%2520in%2520Breast%2520Tumor%2520Cells%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26spage%3De0172244%26doi%3D10.1371%2Fjournal.pone.0172244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, D.</span><span> </span><span class="NLM_article-title">Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment</span> <span class="citation_source-journal">Recent Pat. Anti-Cancer Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">â</span> <span class="NLM_lpage">196</span><span class="refDoi">Â DOI: 10.2174/1574892811888160304113346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.2174%2F1574892811888160304113346" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=184-196&author=L.+Huangauthor=R.+Heauthor=W.+Luoauthor=Y.+S.+Zhuauthor=J.+Liauthor=T.+Tanauthor=X.+Zhangauthor=Z.+Huauthor=D.+Luo&title=Aldo-Keto+Reductase+Family+1+Member+B10+Inhibitors%3A+Potential+Drugs+for+Cancer+Treatment&doi=10.2174%2F1574892811888160304113346"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2174%2F1574892811888160304113346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1574892811888160304113346%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DY.%2BS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DLuo%26aufirst%3DD.%26atitle%3DAldo-Keto%2520Reductase%2520Family%25201%2520Member%2520B10%2520Inhibitors%253A%2520Potential%2520Drugs%2520for%2520Cancer%2520Treatment%26jtitle%3DRecent%2520Pat.%2520Anti-Cancer%2520Drug%2520Discovery%26date%3D2016%26volume%3D11%26spage%3D184%26epage%3D196%26doi%3D10.2174%2F1574892811888160304113346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Polyhydroxy Steroids as Selective Inhibitors against AKR1B10 and Molecular Docking</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">8</span><span class="refDoi">Â DOI: 10.1016/j.steroids.2016.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.steroids.2016.03.004" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2016&pages=1-8&author=W.+Chenauthor=X.+Chenauthor=S.+Zhouauthor=H.+Zhangauthor=L.+Wangauthor=J.+Xuauthor=X.+Huauthor=W.+Yinauthor=G.+Yanauthor=J.+Zhang&title=Design+and+Synthesis+of+Polyhydroxy+Steroids+as+Selective+Inhibitors+against+AKR1B10+and+Molecular+Docking&doi=10.1016%2Fj.steroids.2016.03.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.steroids.2016.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.steroids.2016.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DYin%26aufirst%3DW.%26aulast%3DYan%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Polyhydroxy%2520Steroids%2520as%2520Selective%2520Inhibitors%2520against%2520AKR1B10%2520and%2520Molecular%2520Docking%26jtitle%3DSteroids%26date%3D2016%26volume%3D110%26spage%3D1%26epage%3D8%26doi%3D10.1016%2Fj.steroids.2016.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Cousido-Siah, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanfrlik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimenez-Dejoz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitschler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamlar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesely, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ajani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pares, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farres, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobza, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A. D.</span><span> </span><span class="NLM_article-title">IDD388 Polyhalogenated Derivatives as Probes for an Improved Structure-Based Selectivity of AKR1B10 Inhibitors</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2693</span><span class="NLM_x">â</span> <span class="NLM_lpage">2705</span><span class="refDoi">Â DOI: 10.1021/acschembio.6b00382</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00382" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVyitrvM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2693-2705&author=A.+Cousido-Siahauthor=F.+X.+Ruizauthor=J.+Fanfrlikauthor=J.+Gimenez-Dejozauthor=A.+Mitschlerauthor=M.+Kamlarauthor=J.+Veselyauthor=H.+Ajaniauthor=X.+Paresauthor=J.+Farresauthor=P.+Hobzaauthor=A.+D.+Podjarny&title=IDD388+Polyhalogenated+Derivatives+as+Probes+for+an+Improved+Structure-Based+Selectivity+of+AKR1B10+Inhibitors&doi=10.1021%2Facschembio.6b00382"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">IDD388 Polyhalogenated Derivatives as Probes for an Improved Structure-Based Selectivity of AKR1B10 Inhibitors</span></div><div class="casAuthors">Cousido-Siah, Alexandra; Ruiz, Francesc X.; Fanfrlik, Jindrich; Gimenez-Dejoz, Joan; Mitschler, Andre; Kamlar, Martin; Vesely, Jan; Ajani, Haresh; Pares, Xavier; Farres, Jaume; Hobza, Pavel; Podjarny, Alberto D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2693-2705</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human enzyme aldo-keto reductase family member 1B10 (AKR1B10) has evolved as a tumor marker and promising antineoplastic target.  It shares high structural similarity with the diabetes target enzyme aldose reductase (AR).  Starting from the potent AR inhibitor IDD388, we have synthesized a series of derivs. bearing the same halophenoxyacetic acid moiety with an increasing no. of bromine (Br) atoms on its aryl moiety.  Next, by means of IC50 measurements, X-ray crystallog., WaterMap anal., and advanced binding free energy calcns. with a quantum-mech. (QM) approach, we have studied their structure-activity relationship (SAR) against both enzymes.  The introduction of Br substituents decreases AR inhibition potency but improves it in the case of AKR1B10.  Indeed, the Br atoms in ortho position may impede these drugs to fit into the AR prototypical specificity pocket.  For AKR1B10, the smaller aryl moieties of MK181 and IDD388 can bind into the external loop A subpocket.  Instead, the bulkier MK184, MK319, and MK204 open an inner specificity pocket in AKR1B10 characterized by a Ï-Ï stacking interaction of their aryl moieties and Trp112 side chain in the native conformation (not possible in AR).  Among the three compds., only MK204 can make a strong halogen bond with the protein (-4.4 kcal/mol, using QM calcns.), while presenting the lowest desolvation cost among all the series, translated into the most selective and inhibitory potency AKR1B10 (IC50 = 80 nM).  Overall, SAR of these IDD388 polyhalogenated derivs. have unveiled several distinctive AKR1B10 features (shape, flexibility, hydration) that can be exploited to design novel types of AKR1B10 selective drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruTvJropgoFbVg90H21EOLACvtfcHk0lhe7UAUInn80g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVyitrvM&md5=6bf2b882453bc71f1fed80ece98a351e</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00382%26sid%3Dliteratum%253Aachs%26aulast%3DCousido-Siah%26aufirst%3DA.%26aulast%3DRuiz%26aufirst%3DF.%2BX.%26aulast%3DFanfrlik%26aufirst%3DJ.%26aulast%3DGimenez-Dejoz%26aufirst%3DJ.%26aulast%3DMitschler%26aufirst%3DA.%26aulast%3DKamlar%26aufirst%3DM.%26aulast%3DVesely%26aufirst%3DJ.%26aulast%3DAjani%26aufirst%3DH.%26aulast%3DPares%26aufirst%3DX.%26aulast%3DFarres%26aufirst%3DJ.%26aulast%3DHobza%26aufirst%3DP.%26aulast%3DPodjarny%26aufirst%3DA.%2BD.%26atitle%3DIDD388%2520Polyhalogenated%2520Derivatives%2520as%2520Probes%2520for%2520an%2520Improved%2520Structure-Based%2520Selectivity%2520of%2520AKR1B10%2520Inhibitors%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D2693%26epage%3D2705%26doi%3D10.1021%2Facschembio.6b00382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Kabututu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pointud, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LefranÃ§ois-Martinez, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urade, Y.</span><span> </span><span class="NLM_article-title">Prostaglandin F<sub>2Î±</sub> Synthase Activities of Aldo-Keto Reductase 1B1, 1B3 and 1B7</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">â</span> <span class="NLM_lpage">168</span><span class="refDoi">Â DOI: 10.1093/jb/mvn152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1093%2Fjb%2Fmvn152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=19010934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVegtL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2009&pages=161-168&author=Z.+Kabututuauthor=M.+Maninauthor=J.+C.+Pointudauthor=T.+Maruyamaauthor=N.+Nagataauthor=S.+Lambertauthor=A.+M.+Lefran%C3%A7ois-Martinezauthor=A.+Martinezauthor=Y.+Urade&title=Prostaglandin+F2%CE%B1+Synthase+Activities+of+Aldo-Keto+Reductase+1B1%2C+1B3+and+1B7&doi=10.1093%2Fjb%2Fmvn152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Prostaglandin F2Î± Synthase Activities of Aldo-Keto Reductase 1B1, 1B3 and 1B7</span></div><div class="casAuthors">Kabututu, Zakayi; Manin, Michele; Pointud, Jean-Christophe; Maruyama, Toshihiko; Nagata, Nanae; Lambert, Sarah; Lefrancois-Martinez, Anne-Marie; Martinez, Antoine; Urade, Yoshihiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-168</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">Here, we show that three enzymes belonging to the 1B group of the aldo-keto reductase (AKR) superfamily, i.e., human placental aldose reductase (AKR1B1), mouse kidney aldose reductase (AKR1B3) and mouse vas deferens protein (AKR1B7), catalyze the redn. of prostaglandin (PG) H2, a common intermediate of various prostanoids, to form PGF2Î± in the presence of NADPH.  AKR1B1, AKR1B3 and AKR1B7 displayed higher affinities for PGH2 (Km = 1.9, 9.3 and 3.8 Î¼M, resp.) and Vmax values (26, 53 and 44 nmol/min/mg protein, resp.) than did the human lung PGF2Î± synthase (AKR1C3; 18 Î¼M and 4 nmol/min/mg protein, resp.).  The PGF2Î± synthase activity of AKR1B1 and AKR1B3 was efficiently inhibited by two AKR inhibitors, tolrestat (Ki = 3.6 and 0.26 Î¼M, resp.) and sorbinil (Ki = 21.7 and 0.89 Î¼M, resp.), in a non-competitive or mixed-type manner, whereas that of AKR1B7 was not sensitive to these inhibitors (Ki = 9.2 and 18 mM, resp.).  These data provide a mol. basis for investigating novel functional roles for AKR1B members and PGF2Î± as mediators of physiol. and pathol. processes in mammalian organisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGS7kCR8AZsbVg90H21EOLACvtfcHk0ljK7e8NFRY3ZQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVegtL8%253D&md5=ae150e6ba9dfb1613170751eec5c5068</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvn152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvn152%26sid%3Dliteratum%253Aachs%26aulast%3DKabututu%26aufirst%3DZ.%26aulast%3DManin%26aufirst%3DM.%26aulast%3DPointud%26aufirst%3DJ.%2BC.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DNagata%26aufirst%3DN.%26aulast%3DLambert%26aufirst%3DS.%26aulast%3DLefran%25C3%25A7ois-Martinez%26aufirst%3DA.%2BM.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DUrade%26aufirst%3DY.%26atitle%3DProstaglandin%2520F2%25CE%25B1%2520Synthase%2520Activities%2520of%2520Aldo-Keto%2520Reductase%25201B1%252C%25201B3%2520and%25201B7%26jtitle%3DJ.%2520Biochem.%26date%3D2009%26volume%3D145%26spage%3D161%26epage%3D168%26doi%3D10.1093%2Fjb%2Fmvn152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Tammali, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rychahou, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awasthi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Inhibition of Aldose Reductase Prevents Colon Cancer Metastasis</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1259</span><span class="NLM_x">â</span> <span class="NLM_lpage">1267</span><span class="refDoi">Â DOI: 10.1093/carcin/bgr102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1093%2Fcarcin%2Fbgr102" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=1259-1267&author=R.+Tammaliauthor=A.+B.+Reddyauthor=A.+Saxenaauthor=P.+G.+Rychahouauthor=B.+M.+Eversauthor=S.+Qiuauthor=S.+Awasthiauthor=K.+V.+Ramanaauthor=S.+K.+Srivastava&title=Inhibition+of+Aldose+Reductase+Prevents+Colon+Cancer+Metastasis&doi=10.1093%2Fcarcin%2Fbgr102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgr102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgr102%26sid%3Dliteratum%253Aachs%26aulast%3DTammali%26aufirst%3DR.%26aulast%3DReddy%26aufirst%3DA.%2BB.%26aulast%3DSaxena%26aufirst%3DA.%26aulast%3DRychahou%26aufirst%3DP.%2BG.%26aulast%3DEvers%26aufirst%3DB.%2BM.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DAwasthi%26aufirst%3DS.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DInhibition%2520of%2520Aldose%2520Reductase%2520Prevents%2520Colon%2520Cancer%2520Metastasis%26jtitle%3DCarcinogenesis%26date%3D2011%26volume%3D32%26spage%3D1259%26epage%3D1267%26doi%3D10.1093%2Fcarcin%2Fbgr102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Zu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span> </span><span class="NLM_article-title">Aldo-Keto Reductase 1B10 Protects Human Colon Cells from DNA Damage Induced by Electrophilic Carbonyl Compounds</span> <span class="citation_source-journal">Mol. Carcinog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">118</span><span class="NLM_x">â</span> <span class="NLM_lpage">129</span><span class="refDoi">Â DOI: 10.1002/mc.22477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1002%2Fmc.22477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=26969882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC28XktV2hsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=118-129&author=X.+Zuauthor=R.+Yanauthor=J.+Panauthor=L.+Zhongauthor=Y.+Caoauthor=J.+Maauthor=C.+Caiauthor=D.+Huangauthor=J.+Liuauthor=F.+L.+Chungauthor=D.+F.+Liaoauthor=D.+Cao&title=Aldo-Keto+Reductase+1B10+Protects+Human+Colon+Cells+from+DNA+Damage+Induced+by+Electrophilic+Carbonyl+Compounds&doi=10.1002%2Fmc.22477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Aldo-keto reductase 1B10 protects human colon cells from DNA damage induced by electrophilic carbonyl compounds</span></div><div class="casAuthors">Zu, Xuyu; Yan, Ruilan; Pan, Jishen; Zhong, Linlin; Cao, Yu; Ma, Jun; Cai, Chuan; Huang, Dan; Liu, Jianghua; Chung, Fung-Lung; Liao, Duan-Fang; Cao, Deliang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">118-129</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Electrophilic carbonyl compds. are highly cytotoxic and genotoxic.  Aldo-keto reductase 1B10 (AKR1B10) is an enzyme catalyzing redn. of carbonyl compds. to less toxic alc. forms.  This study presents novel evidence that AKR1B10 protects colon cells from DNA damage induced by electrophilic carbonyl compds.  AKR1B10 is specifically expressed in epithelial cells of the human colon, but this study found that AKR1B10 expression was lost or markedly diminished in colorectal cancer, precancerous tissues, and a notable portion of normal adjacent tissues (NAT).  SiRNA-mediated silencing of AKR1B10 in colon cancer cells HCT-8 enhanced cytotoxicity of acrolein and HNE, whereas ectopic expression of AKR1B10 in colon cancer cells RKO prevented the host cells against carbonyl cytotoxicity.  Furthermore, siRNA-mediated AKR1B10 silencing led to DNA breaks and activation of Î³-H2AX protein, a marker of DNA double strand breaks, particularly in the exposure of HNE (10 Î¼M).  In the AKR1B10 silenced HCT-8 cells, hypoxanthine-guanine phosphoribosyl transferase (HPRT) mutant frequency increased by 26.8 times at basal level and by 33.5 times in the presence of 10 Î¼M HNE when compared to vector control cells.  In these cells, the cyclic acrolein-deoxyguanosine adducts levels were increased by over 10 times.  These findings were confirmed by pharmacol. inhibition of AKR1B10 activity by Epalrestat.  Taken together, these data suggest that AKR1B10 is a crit. protein that protects host cells from DNA damage induced by electrophilic carbonyl compds.  AKR1B10 deficiency in the colon may be an important pathogenic factor in disease progression and carcinogenesis. Â© 2016 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreAi6ctzjZEbVg90H21EOLACvtfcHk0ljK7e8NFRY3ZQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktV2hsr0%253D&md5=b20d0a5eac71ea8275da114c5f7c0ca4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fmc.22477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.22477%26sid%3Dliteratum%253Aachs%26aulast%3DZu%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DR.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DZhong%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DF.%2BL.%26aulast%3DLiao%26aufirst%3DD.%2BF.%26aulast%3DCao%26aufirst%3DD.%26atitle%3DAldo-Keto%2520Reductase%25201B10%2520Protects%2520Human%2520Colon%2520Cells%2520from%2520DNA%2520Damage%2520Induced%2520by%2520Electrophilic%2520Carbonyl%2520Compounds%26jtitle%3DMol.%2520Carcinog.%26date%3D2017%26volume%3D56%26spage%3D118%26epage%3D129%26doi%3D10.1002%2Fmc.22477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Takemura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iinuma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Selective Inhibition of the Tumor Marker Aldo-Keto Reductase Family Member 1B10 by Oleanolic Acid</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1201</span><span class="NLM_x">â</span> <span class="NLM_lpage">1206</span><span class="refDoi">Â DOI: 10.1021/np200118q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np200118q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtVWgu74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2011&pages=1201-1206&author=M.+Takemuraauthor=S.+Endoauthor=T.+Matsunagaauthor=M.+Sodaauthor=H.+T.+Zhaoauthor=O.+El-Kabbaniauthor=K.+Tajimaauthor=M.+Iinumaauthor=A.+Hara&title=Selective+Inhibition+of+the+Tumor+Marker+Aldo-Keto+Reductase+Family+Member+1B10+by+Oleanolic+Acid&doi=10.1021%2Fnp200118q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of the Tumor Marker Aldo-keto Reductase Family Member 1B10 by Oleanolic Acid</span></div><div class="casAuthors">Takemura, Mayuko; Endo, Satoshi; Matsunaga, Toshiyuki; Soda, Midori; Zhao, Hai-Tao; El-Kabbani, Ossama; Tajima, Kazuo; Iinuma, Munekazu; Hara, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1201-1206</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A human member of the aldo-keto reductase (AKR) superfamily, AKR1B10, was recently suggested as a therapeutic target in the treatment of several types of cancer.  Due to its high sequence identity with human aldose reductase (AKR1B1), selective inhibition of AKR1B10 compared with AKR1B1 is required for the development of anticancer agents.  In this study, we have examd. AKR1B10 inhibition by seven pentacyclic triterpenes (1-7) that show potential anticancer properties.  Among them, oleanolic acid (1) was found to be the most potent competitive inhibitor (inhibition const., 72 nM) with the highest AKR1B10/AKR1B1 selectivity ratio of 1370.  Mol. docking of 1 with AKR1B10 and AKR1B1 and site-directed mutagenesis studies suggested that the nonconserved residues Val301 and Gln303 in AKR1B10 are important for detg. its inhibitory potency and selectivity.  Oleanolic acid (1) also inhibited the cellular metab. by AKR1B10 (IC50, 4 Î¼M) and decreased mitomycin C tolerance of colon cancer HT29 cells.  Thus, the selective and potent inhibition of AKR1B10 by 1 may be related to a possible cancer inhibitory role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1SmlRtSPgBrVg90H21EOLACvtfcHk0ljK7e8NFRY3ZQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtVWgu74%253D&md5=5f4d4c3f214c268f6767edfa7f75c5a4</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fnp200118q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp200118q%26sid%3Dliteratum%253Aachs%26aulast%3DTakemura%26aufirst%3DM.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DH.%2BT.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DTajima%26aufirst%3DK.%26aulast%3DIinuma%26aufirst%3DM.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DSelective%2520Inhibition%2520of%2520the%2520Tumor%2520Marker%2520Aldo-Keto%2520Reductase%2520Family%2520Member%25201B10%2520by%2520Oleanolic%2520Acid%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2011%26volume%3D74%26spage%3D1201%26epage%3D1206%26doi%3D10.1021%2Fnp200118q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takemura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ifuku, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyooka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Evaluation of Caffeic Acid Phenethyl Ester-Based Inhibitors Targeting a Selectivity Pocket in the Active Site of Human Aldo-Keto Reductase 1B10</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">â</span> <span class="NLM_lpage">329</span><span class="refDoi">Â DOI: 10.1016/j.ejmech.2011.12.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.ejmech.2011.12.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=22236472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKmtLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2012&pages=321-329&author=M.+Sodaauthor=D.+Huauthor=S.+Endoauthor=M.+Takemuraauthor=J.+Liauthor=R.+Wadaauthor=S.+Ifukuauthor=H.+T.+Zhaoauthor=O.+El-Kabbaniauthor=S.+Ohtaauthor=K.+Yamamuraauthor=N.+Toyookaauthor=A.+Haraauthor=T.+Matsunaga&title=Design%2C+Synthesis+and+Evaluation+of+Caffeic+Acid+Phenethyl+Ester-Based+Inhibitors+Targeting+a+Selectivity+Pocket+in+the+Active+Site+of+Human+Aldo-Keto+Reductase+1B10&doi=10.1016%2Fj.ejmech.2011.12.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and evaluation of caffeic acid phenethyl ester-based inhibitors targeting a selectivity pocket in the active site of human aldo-keto reductase 1B10</span></div><div class="casAuthors">Soda, Midori; Hu, Dawei; Endo, Satoshi; Takemura, Mayuko; Li, Jie; Wada, Ryogo; Ifuku, Syohei; Zhao, Hai-Tao; El-Kabbani, Ossama; Ohta, Shozo; Yamamura, Keiko; Toyooka, Naoki; Hara, Akira; Matsunaga, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">321-329</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Inhibitors of a human aldo-keto reductase, AKR1B10, are regarded as promising therapeutics for the treatment of cancer, but those with both high potency and selectivity compared to the structurally similar aldose reductase (AKR1B1) have not been reported.  It was found that, among honeybee propolis products, caffeic acid phenethyl ester (CAPE) inhibited AKR1B10 (IC50 = 80 nM) with 7-fold selectivity over AKR1B1.  Based on a model of docked CAPE in AKR1B10, its derivs. were designed, synthesized and evaluated for inhibitory potency.  Among them, 3-(4-hydroxy-2-methoxyphenyl)acrylic acid 3-(3-hydroxyphenyl)propyl ester (I) was the most potent competitive inhibitor (Ki = 2.6 nM) with 790-fold selectivity for AKR1B10 over AKR1B1.  Mol. docking of I and site-directed mutagenesis of AKR1B10 residues suggested that the interactions between the 2-methoxy and 3-hydroxy groups of I and the enzyme's Val301 and Gln114, resp., are important for the inhibitor's selectivity.  Addnl., the sub-Î¼M concn. of I significantly suppressed the farnesal metab. and cellular proliferation in AKR1B10-overexpressing cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosUyXjN5NmeLVg90H21EOLACvtfcHk0lhOoprIxEr8XQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKmtLo%253D&md5=581f1fd9a8763e2e3c6520d8c0f8551b</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.12.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.12.034%26sid%3Dliteratum%253Aachs%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DTakemura%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWada%26aufirst%3DR.%26aulast%3DIfuku%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DH.%2BT.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DOhta%26aufirst%3DS.%26aulast%3DYamamura%26aufirst%3DK.%26aulast%3DToyooka%26aufirst%3DN.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DMatsunaga%26aufirst%3DT.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Evaluation%2520of%2520Caffeic%2520Acid%2520Phenethyl%2520Ester-Based%2520Inhibitors%2520Targeting%2520a%2520Selectivity%2520Pocket%2520in%2520the%2520Active%2520Site%2520of%2520Human%2520Aldo-Keto%2520Reductase%25201B10%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D48%26spage%3D321%26epage%3D329%26doi%3D10.1016%2Fj.ejmech.2011.12.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitade, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Chromene-3-carboxamide Derivatives Discovered from Virtual Screening as Potent Inhibitors of the Tumour Maker, AKR1B10</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2485</span><span class="NLM_x">â</span> <span class="NLM_lpage">2490</span><span class="refDoi">Â DOI: 10.1016/j.bmc.2010.02.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.bmc.2010.02.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=20304656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksVejsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=2485-2490&author=S.+Endoauthor=T.+Matsunagaauthor=K.+Kuwataauthor=H.+T.+Zhaoauthor=O.+El-Kabbaniauthor=Y.+Kitadeauthor=A.+Hara&title=Chromene-3-carboxamide+Derivatives+Discovered+from+Virtual+Screening+as+Potent+Inhibitors+of+the+Tumour+Maker%2C+AKR1B10&doi=10.1016%2Fj.bmc.2010.02.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Chromene-3-carboxamide derivatives discovered from virtual screening as potent inhibitors of the tumour marker, AKR1B10</span></div><div class="casAuthors">Endo, Satoshi; Matsunaga, Toshiyuki; Kuwata, Kazuo; Zhao, Hai-Tao; El-Kabbani, Ossama; Kitade, Yukio; Hara, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2485-2490</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A human aldose reductase-like protein, AKR1B10 in the aldo-keto reductase (AKR) superfamily, was recently identified as a therapeutic target in the treatment of several types of cancer.  In order to identify potential leads for new inhibitors of AKR1B10, we adopted the virtual screening approach using the automated program, which resulted in the discovery of several chromene-3-carboxamide derivs. as potent competitive inhibitors.  The most potent (Z)-2-(4-methoxyphenylimino)-7-hydroxy-N-(pyridin-2-yl)-2H-chromene-3-carboxamide inhibited the reductase activity of AKR1B10 with a K i value of 2.7 nM, and the metab. of farnesal and 4-hydroxynonenal in the AKR1B10-overexpressed cells from 0.1 Î¼M with an IC50 value equal to 0.8 Î¼M.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFQqgcsudULLVg90H21EOLACvtfcHk0ljMS-VsJo59Zg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksVejsb4%253D&md5=0c7ee3d7aba8df660d657d87e9a33c01</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.02.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.02.050%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DKuwata%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DH.%2BT.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DKitade%26aufirst%3DY.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DChromene-3-carboxamide%2520Derivatives%2520Discovered%2520from%2520Virtual%2520Screening%2520as%2520Potent%2520Inhibitors%2520of%2520the%2520Tumour%2520Maker%252C%2520AKR1B10%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D2485%26epage%3D2490%26doi%3D10.1016%2Fj.bmc.2010.02.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z. Q.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Coumarin-3-acylamino Derivatives to Scavenge Radicals and to Protect DNA</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">7</span><span class="refDoi">Â DOI: 10.1016/j.ejmech.2014.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.ejmech.2014.07.009" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=1-7&author=Y.+Yangauthor=Q.+W.+Liuauthor=Y.+Shiauthor=Z.+G.+Songauthor=Y.+H.+Jinauthor=Z.+Q.+Liu&title=Design+and+Synthesis+of+Coumarin-3-acylamino+Derivatives+to+Scavenge+Radicals+and+to+Protect+DNA&doi=10.1016%2Fj.ejmech.2014.07.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DQ.%2BW.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DZ.%2BG.%26aulast%3DJin%26aufirst%3DY.%2BH.%26aulast%3DLiu%26aufirst%3DZ.%2BQ.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Coumarin-3-acylamino%2520Derivatives%2520to%2520Scavenge%2520Radicals%2520and%2520to%2520Protect%2520DNA%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D84%26spage%3D1%26epage%3D7%26doi%3D10.1016%2Fj.ejmech.2014.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Song, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, K. S.</span><span> </span><span class="NLM_article-title">A Convenient Synthesis of Coumarin-3-carboxylic Acids via Knoevenagel Condensation of Meldrumâs Acid with <i>ortho</i>-Hydroxyaryl Aldehydes or Ketones</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1755</span><span class="NLM_x">â</span> <span class="NLM_lpage">1758</span><span class="refDoi">Â DOI: 10.1016/S0040-4039(03)00108-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2FS0040-4039%2803%2900108-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtFCguro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=1755-1758&author=A.+Songauthor=X.+Wangauthor=K.+S.+Lam&title=A+Convenient+Synthesis+of+Coumarin-3-carboxylic+Acids+via+Knoevenagel+Condensation+of+Meldrum%E2%80%99s+Acid+with+ortho-Hydroxyaryl+Aldehydes+or+Ketones&doi=10.1016%2FS0040-4039%2803%2900108-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A convenient synthesis of coumarin-3-carboxylic acids via Knoevenagel condensation of Meldrum's acid with ortho-hydroxyaryl aldehydes or ketones</span></div><div class="casAuthors">Song, Aimin; Wang, Xiaobing; Lam, Kit S.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1755-1758</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Coumarin-3-carboxylic acids were obtained in high yields with excellent purity from o-hydroxybenzaldehydes and Meldrum's acid after a 2 h reflux in ethanol.  The less reactive ketones were first reacted with alc. ammonia to form ketimines, which were then condensed with Meldrum's acid to generate 4-alkylcoumarin-3-carboxylic acids in moderate yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHE1Ojsx-mDbVg90H21EOLACvtfcHk0ljMS-VsJo59Zg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtFCguro%253D&md5=b0e16858ce4bc05e66f8bb67ad6505b9</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2803%2900108-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252803%252900108-4%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLam%26aufirst%3DK.%2BS.%26atitle%3DA%2520Convenient%2520Synthesis%2520of%2520Coumarin-3-carboxylic%2520Acids%2520via%2520Knoevenagel%2520Condensation%2520of%2520Meldrum%25E2%2580%2599s%2520Acid%2520with%2520ortho-Hydroxyaryl%2520Aldehydes%2520or%2520Ketones%26jtitle%3DTetrahedron%2520Lett.%26date%3D2003%26volume%3D44%26spage%3D1755%26epage%3D1758%26doi%3D10.1016%2FS0040-4039%2803%2900108-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">True, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mais, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikel, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utterback, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyss, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakubowski, J. A.</span><span> </span><span class="NLM_article-title">Development of Dual-Acting Agents for Thromboxane Receptor Antagonism and Thromboxane Synthase Inhibition. 3. Synthesis and Biological Activities of Oxazolecarboxamide-Substituted Ï-Phenyl-Ï-(3-pyridyl)alkenoic Acid Derivatives and Related Compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">5362</span><span class="NLM_x">â</span> <span class="NLM_lpage">5374</span><span class="refDoi">Â DOI: 10.1021/jm980173n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm980173n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=5362-5374&author=K.+Takeuchiauthor=T.+J.+Kohnauthor=T.+A.+Trueauthor=D.+E.+Maisauthor=J.+H.+Wikelauthor=B.+G.+Utterbackauthor=V.+L.+Wyssauthor=J.+A.+Jakubowski&title=Development+of+Dual-Acting+Agents+for+Thromboxane+Receptor+Antagonism+and+Thromboxane+Synthase+Inhibition.+3.+Synthesis+and+Biological+Activities+of+Oxazolecarboxamide-Substituted+%CF%89-Phenyl-%CF%89-%283-pyridyl%29alkenoic+Acid+Derivatives+and+Related+Compounds&doi=10.1021%2Fjm980173n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm980173n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980173n%26sid%3Dliteratum%253Aachs%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DKohn%26aufirst%3DT.%2BJ.%26aulast%3DTrue%26aufirst%3DT.%2BA.%26aulast%3DMais%26aufirst%3DD.%2BE.%26aulast%3DWikel%26aufirst%3DJ.%2BH.%26aulast%3DUtterback%26aufirst%3DB.%2BG.%26aulast%3DWyss%26aufirst%3DV.%2BL.%26aulast%3DJakubowski%26aufirst%3DJ.%2BA.%26atitle%3DDevelopment%2520of%2520Dual-Acting%2520Agents%2520for%2520Thromboxane%2520Receptor%2520Antagonism%2520and%2520Thromboxane%2520Synthase%2520Inhibition.%25203.%2520Synthesis%2520and%2520Biological%2520Activities%2520of%2520Oxazolecarboxamide-Substituted%2520%25CF%2589-Phenyl-%25CF%2589-%25283-pyridyl%2529alkenoic%2520Acid%2520Derivatives%2520and%2520Related%2520Compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D5362%26epage%3D5374%26doi%3D10.1021%2Fjm980173n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shintani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Multiplicity of Mammalian Reductases for Xenobiotic Carbonyl Compounds</span> <span class="citation_source-journal">Drug Metab. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">18</span><span class="refDoi">Â DOI: 10.2133/dmpk.21.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.2133%2Fdmpk.21.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=16547389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjs1yrsL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=1-18&author=T.+Matsunagaauthor=S.+Shintaniauthor=A.+Hara&title=Multiplicity+of+Mammalian+Reductases+for+Xenobiotic+Carbonyl+Compounds&doi=10.2133%2Fdmpk.21.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Multiplicity of mammalian reductases for xenobiotic carbonyl compounds</span></div><div class="casAuthors">Matsunaga, Toshiyuki; Shintani, Shinichi; Hara, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-18</span>CODEN:
                <span class="NLM_cas:coden">DMPRB8</span>;
        ISSN:<span class="NLM_cas:issn">1347-4367</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society for the Study of Xenobiotics</span>)
        </div><div class="casAbstract">A review.  A variety of carbonyl compds. are present in foods, environmental pollutants, and drugs.  These xenobiotic carbonyl compds. are metabolized into the corresponding alcs. by many mammalian NAD(P)H-dependent reductases, which belong to the short-chain dehydrogenase/reductase (SDR) and aldo-keto reductase superfamilies.  Recent genomic anal., cDNA isolation and characterization of the recombinant enzymes suggested that, in humans, the six members of each of the two superfamilies, i.e., total of 12 enzymes, are involved in the reductive metab. of xenobiotic carbonyl compds.  They comprise three types of carbonyl reductase, dehydrogenase/reductase (SDR family) member 4, 11Î²-hydroxysteroid dehydrogenase type 1, L-xylulose reductase, two types of aflatoxin B1 aldehyde reductase, 20Î±-hydroxysteroid dehydrogenase, and three types of 3Î±-hydroxysteroid dehydrogenase.  Accumulating data on the human enzymes provide new insights into their roles in cellular and mol. reactions including xenobiotic metab.  On the other hand, mice and rats lack the gene for a protein corresponding to human 3Î±-hydroxysteroid dehydrogenase type 3, but instead possess addnl. five or six genes encoding proteins that are structurally related to human hydroxysteroid dehydrogenases.  Characterization of the addnl. enzymes suggested their involvement in species-specific biol. events and species differences in the metab. of xenobiotic carbonyl compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI7rMDVNUU5rVg90H21EOLACvtfcHk0ljh8LtqzYRnYA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjs1yrsL8%253D&md5=7ad14b51f39405673f435f409a8e3e4b</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.2133%2Fdmpk.21.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2133%252Fdmpk.21.1%26sid%3Dliteratum%253Aachs%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DShintani%26aufirst%3DS.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DMultiplicity%2520of%2520Mammalian%2520Reductases%2520for%2520Xenobiotic%2520Carbonyl%2520Compounds%26jtitle%3DDrug%2520Metab.%2520Pharmacokinet.%26date%3D2006%26volume%3D21%26spage%3D1%26epage%3D18%26doi%3D10.2133%2Fdmpk.21.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Hu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyagi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oguri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishinaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyooka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span> </span><span class="NLM_article-title">Synthesis of 8-Hydroxy-2-iminochromene Derivatives as Selective and Potent Inhibitors of Human Carbonyl Reductase 1</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">7487</span><span class="NLM_x">â</span> <span class="NLM_lpage">7499</span><span class="refDoi">Â DOI: 10.1039/C5OB00847F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1039%2FC5OB00847F" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=7487-7499&author=D.+Huauthor=N.+Miyagiauthor=Y.+Araiauthor=H.+Oguriauthor=T.+Miuraauthor=T.+Nishinakaauthor=T.+Teradaauthor=H.+Goudaauthor=O.+El-Kabbaniauthor=S.+Xiaauthor=N.+Toyookaauthor=A.+Haraauthor=T.+Matsunagaauthor=A.+Ikariauthor=S.+Endo&title=Synthesis+of+8-Hydroxy-2-iminochromene+Derivatives+as+Selective+and+Potent+Inhibitors+of+Human+Carbonyl+Reductase+1&doi=10.1039%2FC5OB00847F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1039%2FC5OB00847F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5OB00847F%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DD.%26aulast%3DMiyagi%26aufirst%3DN.%26aulast%3DArai%26aufirst%3DY.%26aulast%3DOguri%26aufirst%3DH.%26aulast%3DMiura%26aufirst%3DT.%26aulast%3DNishinaka%26aufirst%3DT.%26aulast%3DTerada%26aufirst%3DT.%26aulast%3DGouda%26aufirst%3DH.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DXia%26aufirst%3DS.%26aulast%3DToyooka%26aufirst%3DN.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DIkari%26aufirst%3DA.%26aulast%3DEndo%26aufirst%3DS.%26atitle%3DSynthesis%2520of%25208-Hydroxy-2-iminochromene%2520Derivatives%2520as%2520Selective%2520and%2520Potent%2520Inhibitors%2520of%2520Human%2520Carbonyl%2520Reductase%25201%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D7487%26epage%3D7499%26doi%3D10.1039%2FC5OB00847F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span> </span><span class="NLM_article-title">Structural Basis for the Inhibition of AKR1B10 by Caffeic Acid Phenethyl Ester (CAPE)</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">706</span><span class="NLM_x">â</span> <span class="NLM_lpage">709</span><span class="refDoi">Â DOI: 10.1002/cmdc.201300455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1002%2Fcmdc.201300455" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=706-709&author=L.+Zhangauthor=H.+Zhangauthor=X.+Zhengauthor=Y.+Zhaoauthor=S.+Chenauthor=Y.+Chenauthor=R.+Zhangauthor=Q.+Liauthor=X.+Hu&title=Structural+Basis+for+the+Inhibition+of+AKR1B10+by+Caffeic+Acid+Phenethyl+Ester+%28CAPE%29&doi=10.1002%2Fcmdc.201300455"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300455%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DHu%26aufirst%3DX.%26atitle%3DStructural%2520Basis%2520for%2520the%2520Inhibition%2520of%2520AKR1B10%2520by%2520Caffeic%2520Acid%2520Phenethyl%2520Ester%2520%2528CAPE%2529%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D706%26epage%3D709%26doi%3D10.1002%2Fcmdc.201300455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Case, D. A.; Babin, V.; Berryman, J. T.; Betz, R. M.; Cai, Q.; Cerutti, D. S.; Cheatham, T. E.,  III; Darden, T. A.; Duke, R. E.; Gohlke, H.; Goetz, A. W.; Gusarov, S.; Homeyer, N.; Janowski, P.; Kaus, J.; KolossvÃ¡ry, I.; Kovalenko, A.; Lee, T. S.; LeGrand, S.; Luchko, T.; Luo, R.; Madej, B.; Merz, K. M.; Paesani, F.; Roe, D. R.; Roitberg, A.; Sagui, C.; Salomon-Ferrer, R.; Seabra, G.; Simmerling, C. L.; Smith, W.; Swails, J.; Walker, R. C.; Wang, J.; Wolf, R. M.; Wu, X.; Kollman, P. A.</span> <span class="citation_source-book">AMBER 14</span>; <span class="NLM_publisher-name">University of California</span>: <span class="NLM_publisher-loc">San Francisco, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=D.+A.+Case&author=V.+Babin&author=J.+T.+Berryman&author=R.+M.+Betz&author=Q.+Cai&author=D.+S.+Cerutti&author=T.+E.+Cheatham&author=T.+A.+Darden&author=R.+E.+Duke&author=H.+Gohlke&author=A.+W.+Goetz&author=S.+Gusarov&author=N.+Homeyer&author=P.+Janowski&author=J.+Kaus&author=I.+Kolossv%C3%A1ry&author=A.+Kovalenko&author=T.+S.+Lee&author=S.+LeGrand&author=T.+Luchko&author=R.+Luo&author=B.+Madej&author=K.+M.+Merz&author=F.+Paesani&author=D.+R.+Roe&author=A.+Roitberg&author=C.+Sagui&author=R.+Salomon-Ferrer&author=G.+Seabra&author=C.+L.+Simmerling&author=W.+Smith&author=J.+Swails&author=R.+C.+Walker&author=J.+Wang&author=R.+M.+Wolf&author=X.+Wu&author=P.+A.+Kollman&title=AMBER+14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCase%26aufirst%3DD.%2BA.%26btitle%3DAMBER%252014%26pub%3DUniversity%2520of%2520California%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Aldo-Keto Reductase 1B10 and Its Role in Proliferation Capacity of Drug-Resistant Cancers</span> <span class="citation_source-journal">Front. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="refDoi">Â DOI: 10.3389/fphar.2012.00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.3389%2Ffphar.2012.00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=22319498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms12qtL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=5&author=T.+Matsunagaauthor=Y.+Wadaauthor=S.+Endoauthor=M.+Sodaauthor=O.+El-Kabbaniauthor=A.+Hara&title=Aldo-Keto+Reductase+1B10+and+Its+Role+in+Proliferation+Capacity+of+Drug-Resistant+Cancers&doi=10.3389%2Ffphar.2012.00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Aldo-keto reductase 1B10 and its role in proliferation capacity of drug-resistant cancers</span></div><div class="casAuthors">Matsunaga, Toshiyuki; Wada, Yasuhiro; Endo, Satoshi; Soda, Midori; El-Kabbani, Ossama; Hara, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Experimental Pharmacology and Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">Jan.</span>),
    <span class="NLM_cas:pages">5</span>CODEN:
                <span class="NLM_cas:coden">FEPDAX</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  The human aldo-keto reductase AKR1B10, originally identified as an aldose reductase-like protein and human small intestine aldose reductase, is a cytosolic NADPH-dependent reductase that metabolizes a variety of endogenous compds., such as arom. and aliph. aldehydes and dicarbonyl compds. and some drug ketones.  The enzyme is highly expressed in solid tumors of several tissues including lung and liver and as such has received considerable interest as a relevant biomarker for the development of those tumors.  In addn., AKR1B10 has been recently reported to be significantly up-regulated in some cancer cell lines (medulloblastoma D341 and colon cancer HT29) acquiring resistance toward chemotherapeutic agents (cyclophosphamide and mitomycin c), suggesting the validity of the enzyme as a chemoresistance marker.  Although the detailed information on the AKR1B10-mediated mechanisms leading to the drug resistance process is not well understood so far, the enzyme has been proposed to be involved in functional regulations of cell proliferation and metab. of drugs and endogenous lipids during the development of chemoresistance.  This article reviews the current literature focusing mainly on expression profile and roles of AKR1B10 in the drug resistance of cancer cells.  Recent developments of AKR1B10 inhibitors and their usefulness in restoring sensitivity to anticancer drugs are also reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR22RRliczILVg90H21EOLACvtfcHk0lhtxRqdp8yBGQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms12qtL4%253D&md5=4e8245dc0cd6debf2092c080e7b696b9</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2012.00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2012.00005%26sid%3Dliteratum%253Aachs%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DWada%26aufirst%3DY.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DAldo-Keto%2520Reductase%25201B10%2520and%2520Its%2520Role%2520in%2520Proliferation%2520Capacity%2520of%2520Drug-Resistant%2520Cancers%26jtitle%3DFront.%2520Pharmacol.%26date%3D2012%26volume%3D3%26spage%3D5%26doi%3D10.3389%2Ffphar.2012.00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Semmelhack, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helquist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendelson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryono, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorzynski Smith, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, R. D.</span><span> </span><span class="NLM_article-title">Reaction of Aryl and Vinyl Halides with Zerovalent Nickel - Preparative Aspects and the Synthesis of Alnusone</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">6460</span><span class="NLM_x">â</span> <span class="NLM_lpage">6471</span><span class="refDoi">Â DOI: 10.1021/ja00411a034</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00411a034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1981&pages=6460-6471&author=M.+F.+Semmelhackauthor=P.+Helquistauthor=L.+D.+Jonesauthor=L.+Kellerauthor=L.+Mendelsonauthor=L.+S.+Ryonoauthor=J.+Gorzynski+Smithauthor=R.+D.+Stauffer&title=Reaction+of+Aryl+and+Vinyl+Halides+with+Zerovalent+Nickel+-+Preparative+Aspects+and+the+Synthesis+of+Alnusone&doi=10.1021%2Fja00411a034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fja00411a034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00411a034%26sid%3Dliteratum%253Aachs%26aulast%3DSemmelhack%26aufirst%3DM.%2BF.%26aulast%3DHelquist%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DL.%2BD.%26aulast%3DKeller%26aufirst%3DL.%26aulast%3DMendelson%26aufirst%3DL.%26aulast%3DRyono%26aufirst%3DL.%2BS.%26aulast%3DGorzynski%2BSmith%26aufirst%3DJ.%26aulast%3DStauffer%26aufirst%3DR.%2BD.%26atitle%3DReaction%2520of%2520Aryl%2520and%2520Vinyl%2520Halides%2520with%2520Zerovalent%2520Nickel%2520-%2520Preparative%2520Aspects%2520and%2520the%2520Synthesis%2520of%2520Alnusone%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1981%26volume%3D103%26spage%3D6460%26epage%3D6471%26doi%3D10.1021%2Fja00411a034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Brimble, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flowers, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trzoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsang, K. Y.</span><span> </span><span class="NLM_article-title">A Facile Synthesis of Fused Aromatic Spiroacetals Based on the 3,4,3â²,4â²-Tetrahydro-2,2â²-spirobis(2H-1-benzopyran) Skeleton</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">5883</span><span class="NLM_x">â</span> <span class="NLM_lpage">5896</span><span class="refDoi">Â DOI: 10.1016/j.tet.2006.04.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.tet.2006.04.026" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=5883-5896&author=M.+A.+Brimbleauthor=C.+L.+Flowersauthor=M.+Trzossauthor=K.+Y.+Tsang&title=A+Facile+Synthesis+of+Fused+Aromatic+Spiroacetals+Based+on+the+3%2C4%2C3%E2%80%B2%2C4%E2%80%B2-Tetrahydro-2%2C2%E2%80%B2-spirobis%282H-1-benzopyran%29+Skeleton&doi=10.1016%2Fj.tet.2006.04.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2006.04.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2006.04.026%26sid%3Dliteratum%253Aachs%26aulast%3DBrimble%26aufirst%3DM.%2BA.%26aulast%3DFlowers%26aufirst%3DC.%2BL.%26aulast%3DTrzoss%26aufirst%3DM.%26aulast%3DTsang%26aufirst%3DK.%2BY.%26atitle%3DA%2520Facile%2520Synthesis%2520of%2520Fused%2520Aromatic%2520Spiroacetals%2520Based%2520on%2520the%25203%252C4%252C3%25E2%2580%25B2%252C4%25E2%2580%25B2-Tetrahydro-2%252C2%25E2%2580%25B2-spirobis%25282H-1-benzopyran%2529%2520Skeleton%26jtitle%3DTetrahedron%26date%3D2006%26volume%3D62%26spage%3D5883%26epage%3D5896%26doi%3D10.1016%2Fj.tet.2006.04.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Defauw, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagdmann, G. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollinshead, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heerding, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darges, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, S. E.</span><span> </span><span class="NLM_article-title">Synthesis and Protein Kinase C Inhibitory Activities of Acyclic Balanol Analogs that Are Highly Selective for Protein Kinase C over Protein Kinase A</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">5215</span><span class="NLM_x">â</span> <span class="NLM_lpage">5227</span><span class="refDoi">Â DOI: 10.1021/jm960581w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm960581w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADyaK28XntFaqtrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=5215-5227&author=J.+M.+Defauwauthor=M.+M.+Murphyauthor=G.+E.+Jagdmannauthor=H.+Huauthor=J.+W.+Lampeauthor=S.+P.+Hollinsheadauthor=T.+J.+Mitchellauthor=H.+M.+Craneauthor=J.+M.+Heerdingauthor=J.+S.+Mendozaauthor=J.+E.+Davisauthor=J.+W.+Dargesauthor=F.+R.+Hubbardauthor=S.+E.+Hall&title=Synthesis+and+Protein+Kinase+C+Inhibitory+Activities+of+Acyclic+Balanol+Analogs+that+Are+Highly+Selective+for+Protein+Kinase+C+over+Protein+Kinase+A&doi=10.1021%2Fjm960581w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Protein Kinase C Inhibitory Activities of Acyclic Balanol Analogs That Are Highly Selective for Protein Kinase C over Protein Kinase A</span></div><div class="casAuthors">Defauw, Jean M.; Murphy, Marcia M.; Jagdmann, G. Erik, Jr.; Hu, Hong; Lampe, John W.; Hollinshead, Sean P.; Mitchell, Thomas J.; Crane, Heidi M.; Heerding, Julia M.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">5215-5227</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of balanol analogs in which the perhydroazepine ring and the p-hydroxybenzamide moiety were combined into an acyclic linked unit have been prepd. and evaluated for their inhibitory properties against the serine/threonine kinase PKC.  Several low-micromolar to low-nanomolar inhibitors of the Î±, Î²I, Î²II, Î³, Î´, Îµ, and Î· PKC isoenzymes were prepd.  In general, these acyclic balanol analogs were found to be highly selective for PKC over the serine/threonine kinase PKA.  The type and no. of atoms linking the benzophenone ester to the p-hydroxyphenyl group necessary for optimal PKC inhibition were investigated.  The most potent compds. contained a three-carbon linker in which the carboxamide moiety of balanol had been replaced by a methylene group.  The effect of placing substituents on the three-carbon chain was also investigated.  The preferred compds. contained either a 2-benzenesulfonamido or a 1-Me substituent.  The preferred compds. were tested against a panel of serine/threonine kinases and found to be highly selective for PKC.  The effect of making the analogs more rigid by making the three-carbon chain part of a five-membered ring, but with retention of the methylene replacement for the carboxamide moiety, led to potent PKC inhibitors including an anti-substituted pyrrolidine analog and an anti-substituted cyclopentane analog.  The anti cyclopentane analog was a low-micromolar inhibitor of the PMA-induced superoxide burst in neutrophils, and its carboxylic ester was a high-nanomolar inhibitor of neutrophils.  Esterification of these potent PKC inhibitors turned them into low-micromolar inhibitors of neutrophils.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo359o5cM_CYLVg90H21EOLACvtfcHk0lhtxRqdp8yBGQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntFaqtrk%253D&md5=391b08344ac29003d1d192821f049826</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm960581w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960581w%26sid%3Dliteratum%253Aachs%26aulast%3DDefauw%26aufirst%3DJ.%2BM.%26aulast%3DMurphy%26aufirst%3DM.%2BM.%26aulast%3DJagdmann%26aufirst%3DG.%2BE.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DLampe%26aufirst%3DJ.%2BW.%26aulast%3DHollinshead%26aufirst%3DS.%2BP.%26aulast%3DMitchell%26aufirst%3DT.%2BJ.%26aulast%3DCrane%26aufirst%3DH.%2BM.%26aulast%3DHeerding%26aufirst%3DJ.%2BM.%26aulast%3DMendoza%26aufirst%3DJ.%2BS.%26aulast%3DDavis%26aufirst%3DJ.%2BE.%26aulast%3DDarges%26aufirst%3DJ.%2BW.%26aulast%3DHubbard%26aufirst%3DF.%2BR.%26aulast%3DHall%26aufirst%3DS.%2BE.%26atitle%3DSynthesis%2520and%2520Protein%2520Kinase%2520C%2520Inhibitory%2520Activities%2520of%2520Acyclic%2520Balanol%2520Analogs%2520that%2520Are%2520Highly%2520Selective%2520for%2520Protein%2520Kinase%2520C%2520over%2520Protein%2520Kinase%2520A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D5215%26epage%3D5227%26doi%3D10.1021%2Fjm960581w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Kurata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokuda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shioya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komiya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habashita, H.</span><span> </span><span class="NLM_article-title">Structure-Activity Relationship Studies of S1P Agonists with a Dihydronaphthalene Scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">â</span> <span class="NLM_lpage">148</span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2011.11.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.bmcl.2011.11.048" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=144-148&author=H.+Kurataauthor=K.+Kusumiauthor=K.+Otsukiauthor=R.+Suzukiauthor=M.+Kuronoauthor=N.+Tokudaauthor=Y.+Takadaauthor=H.+Shioyaauthor=H.+Mizunoauthor=T.+Komiyaauthor=T.+Onoauthor=H.+Hagiyaauthor=M.+Minamiauthor=S.+Nakadeauthor=H.+Habashita&title=Structure-Activity+Relationship+Studies+of+S1P+Agonists+with+a+Dihydronaphthalene+Scaffold&doi=10.1016%2Fj.bmcl.2011.11.048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.11.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.11.048%26sid%3Dliteratum%253Aachs%26aulast%3DKurata%26aufirst%3DH.%26aulast%3DKusumi%26aufirst%3DK.%26aulast%3DOtsuki%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DR.%26aulast%3DKurono%26aufirst%3DM.%26aulast%3DTokuda%26aufirst%3DN.%26aulast%3DTakada%26aufirst%3DY.%26aulast%3DShioya%26aufirst%3DH.%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DKomiya%26aufirst%3DT.%26aulast%3DOno%26aufirst%3DT.%26aulast%3DHagiya%26aufirst%3DH.%26aulast%3DMinami%26aufirst%3DM.%26aulast%3DNakade%26aufirst%3DS.%26aulast%3DHabashita%26aufirst%3DH.%26atitle%3DStructure-Activity%2520Relationship%2520Studies%2520of%2520S1P%2520Agonists%2520with%2520a%2520Dihydronaphthalene%2520Scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D144%26epage%3D148%26doi%3D10.1016%2Fj.bmcl.2011.11.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Bertrand, I.; Capet, M.; Lecomte, J.-M.; Levoin, N.; Ligneau, X.; Poupardin-Olivier, O.; Robert, P.; Schwartz, J.-C.</span><span> </span><span class="NLM_article-title">Preparation of Pyrrolidinyl- and Piperidinylpropoxypropylarenes as Histamine H3 Receptor Ligands</span>. J.P. Patent WO2006117611A1, Nov 9,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=I.+Bertrand&author=M.+Capet&author=J.-M.+Lecomte&author=N.+Levoin&author=X.+Ligneau&author=O.+Poupardin-Olivier&author=P.+Robert&author=J.-C.+Schwartz&title=Preparation+of+Pyrrolidinyl-+and+Piperidinylpropoxypropylarenes+as+Histamine+H3+Receptor+Ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DI.%26atitle%3DPreparation%2520of%2520Pyrrolidinyl-%2520and%2520Piperidinylpropoxypropylarenes%2520as%2520Histamine%2520H3%2520Receptor%2520Ligands%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Sallares, J.; Petschen, I.; Camps, X.</span><span> </span><span class="NLM_article-title">Etherification Process for Preparing 1-[3-[3-(4-Chlorophenyl)propoxy]propyl]piperidine from 3-(Piperidino)propanol and 3-(4-Chlorophenyl)propyl Mesylate with Sodium hydride in an Aprotic Polar Solvent</span>. J.P. Patent WO2007006708A1, Jan 18,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=J.+Sallares&author=I.+Petschen&author=X.+Camps&title=Etherification+Process+for+Preparing+1-%5B3-%5B3-%284-Chlorophenyl%29propoxy%5Dpropyl%5Dpiperidine+from+3-%28Piperidino%29propanol+and+3-%284-Chlorophenyl%29propyl+Mesylate+with+Sodium+hydride+in+an+Aprotic+Polar+Solvent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSallares%26aufirst%3DJ.%26atitle%3DEtherification%2520Process%2520for%2520Preparing%25201-%255B3-%255B3-%25284-Chlorophenyl%2529propoxy%255Dpropyl%255Dpiperidine%2520from%25203-%2528Piperidino%2529propanol%2520and%25203-%25284-Chlorophenyl%2529propyl%2520Mesylate%2520with%2520Sodium%2520hydride%2520in%2520an%2520Aprotic%2520Polar%2520Solvent%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Ko, S. S.; Batt, D. G.; Delucca, G. V.; Duncia, J. V.; Gardner, D. S.; Santella, J. B.</span><span> </span><span class="NLM_article-title">A Preparation of (Thio)urea Derivatives, Useful as Modulators of Chemokine Receptor</span>. WO2005048932A2,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=S.+S.+Ko&author=D.+G.+Batt&author=G.+V.+Delucca&author=J.+V.+Duncia&author=D.+S.+Gardner&author=J.+B.+Santella&title=A+Preparation+of+%28Thio%29urea+Derivatives%2C+Useful+as+Modulators+of+Chemokine+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKo%26aufirst%3DS.%2BS.%26atitle%3DA%2520Preparation%2520of%2520%2528Thio%2529urea%2520Derivatives%252C%2520Useful%2520as%2520Modulators%2520of%2520Chemokine%2520Receptor%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Nikam, S. S.; Scott, I. L.; Sherer, B. A.; Wise, L. D.</span><span> </span><span class="NLM_article-title">Preparation of Aminocyclohexylbenzazolones as NMDA Receptor Antagonists</span>. J.P. Patent WO2001092239A1, Dec 6,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=S.+S.+Nikam&author=I.+L.+Scott&author=B.+A.+Sherer&author=L.+D.+Wise&title=Preparation+of+Aminocyclohexylbenzazolones+as+NMDA+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNikam%26aufirst%3DS.%2BS.%26atitle%3DPreparation%2520of%2520Aminocyclohexylbenzazolones%2520as%2520NMDA%2520Receptor%2520Antagonists%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Iino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shintaku, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Tetrahydrobiopterin is Synthesized from 6-Pyruvoyl-tetrahydropterin by the Human Aldo-Keto Reductase AKR1 Family Members</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">416</span><span class="NLM_x">, </span> <span class="NLM_fpage">180</span><span class="NLM_x">â</span> <span class="NLM_lpage">187</span><span class="refDoi">Â DOI: 10.1016/S0003-9861(03)00295-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2FS0003-9861%2803%2900295-9" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=416&publication_year=2003&pages=180-187&author=T.+Iinoauthor=M.+Tabataauthor=S.+Takikawaauthor=H.+Sawadaauthor=H.+Shintakuauthor=S.+Ishikuraauthor=A.+Hara&title=Tetrahydrobiopterin+is+Synthesized+from+6-Pyruvoyl-tetrahydropterin+by+the+Human+Aldo-Keto+Reductase+AKR1+Family+Members&doi=10.1016%2FS0003-9861%2803%2900295-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2FS0003-9861%2803%2900295-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0003-9861%252803%252900295-9%26sid%3Dliteratum%253Aachs%26aulast%3DIino%26aufirst%3DT.%26aulast%3DTabata%26aufirst%3DM.%26aulast%3DTakikawa%26aufirst%3DS.%26aulast%3DSawada%26aufirst%3DH.%26aulast%3DShintaku%26aufirst%3DH.%26aulast%3DIshikura%26aufirst%3DS.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DTetrahydrobiopterin%2520is%2520Synthesized%2520from%25206-Pyruvoyl-tetrahydropterin%2520by%2520the%2520Human%2520Aldo-Keto%2520Reductase%2520AKR1%2520Family%2520Members%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2003%26volume%3D416%26spage%3D180%26epage%3D187%26doi%3D10.1016%2FS0003-9861%2803%2900295-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Matsuura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deyashiki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kume, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katagiri, Y.</span><span> </span><span class="NLM_article-title">Roles of the C-terminal Domains of Human Dihydrodiol Dehydrogenase Isoforms in the Binding of Substrates and Modulators: Probing with Chimaeric Enzymes</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">â</span> <span class="NLM_lpage">436</span><span class="refDoi">Â DOI: 10.1042/bj3360429</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1042%2Fbj3360429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=9820821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADyaK1MXhtFWitA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=1998&pages=429-436&author=K.+Matsuuraauthor=A.+Haraauthor=Y.+Deyashikiauthor=H.+Iwasaauthor=T.+Kumeauthor=S.+Ishikuraauthor=H.+Shiraishiauthor=Y.+Katagiri&title=Roles+of+the+C-terminal+Domains+of+Human+Dihydrodiol+Dehydrogenase+Isoforms+in+the+Binding+of+Substrates+and+Modulators%3A+Probing+with+Chimaeric+Enzymes&doi=10.1042%2Fbj3360429"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of the C-terminal domains of human dihydrodiol dehydrogenase isoforms in the binding of substrates and modulators: probing with chimeric enzymes</span></div><div class="casAuthors">Matsuura, Kazuya; Hara, Akira; Deyashiki, Yoshihiro; Iwasa, Harunori; Kume, Toshiyuki; Ishikura, Syuhei; Shiraishi, Hiroaki; Katagiri, Yoshihiro</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">429-436</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Human liver dihydrodiol dehydrogenase (DD; E.C. 1.3.1.20) exists in isoforms (DD1, DD2 and DD4) composed of 323 amino acids.  DD1 and DD2 share 98% amino acid sequence identity, but show lower identities (approx. 83%) with DD4, in which a marked difference is seen in the C-terminal ten amino acids.  DD4 exhibits unique catalytic properties, such as the ability to oxidize both (R)- and (S)-alicyclic alcs. equally, high dehydrogenase activity for bile acids, potent inhibition by steroidal anti-inflammatory drugs and activation by sulfobromophthalein and clofibric acid derivs.  In this study, the authors have prepd. chimeric enzymes, in which the authors exchanged the C-terminal 39 residues between the two enzymes.  Compared with DD1, CDD1-4 (DD1 with the C-terminal sequence of DD4) had increased kcat/Km values for 3Î±-hydroxy-5Î²-androstanes and bile acids of 3-9-fold and decreased values for the other substrates by 5-100-fold.  It also became highly sensitive to DD4 inhibitors such as phenolphthalein and hexoestrol.  Another chimeric enzyme, CDD4-1 (DD4 with the C-terminal sequence of DD1), showed the same (S)-stereospecificity for the alicyclic alcs. as DD1, had decreased kcat/Km values for bile acids with 7Î²- or 12Î±-hydroxy groups by more than 120-fold and was resistant to inhibition by betamethasone.  In addn., the activation effects of sulfobromophthalein and bezafibrate decreased or disappeared for CDD4-1.  The recombinant DD4 with the His314 â Pro (the corresponding residue of DD1) mutation showed intermediate changes in the properties between those of wild-type DD4 and CDD4-1.  The results indicate that the binding of substrates, inhibitors and activators to the enzymes is controlled by residues in their C-terminal domains; multiple residues coordinately act as determinants for substrate specificity and inhibitor sensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob6FlqCEcrKbVg90H21EOLACvtfcHk0ljxWEqVOHYBNA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtFWitA%253D%253D&md5=5ca353704b56ed92fe72f34303fc7203</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1042%2Fbj3360429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3360429%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuura%26aufirst%3DK.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DDeyashiki%26aufirst%3DY.%26aulast%3DIwasa%26aufirst%3DH.%26aulast%3DKume%26aufirst%3DT.%26aulast%3DIshikura%26aufirst%3DS.%26aulast%3DShiraishi%26aufirst%3DH.%26aulast%3DKatagiri%26aufirst%3DY.%26atitle%3DRoles%2520of%2520the%2520C-terminal%2520Domains%2520of%2520Human%2520Dihydrodiol%2520Dehydrogenase%2520Isoforms%2520in%2520the%2520Binding%2520of%2520Substrates%2520and%2520Modulators%253A%2520Probing%2520with%2520Chimaeric%2520Enzymes%26jtitle%3DBiochem.%2520J.%26date%3D1998%26volume%3D336%26spage%3D429%26epage%3D436%26doi%3D10.1042%2Fbj3360429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Shiraishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deyashiki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninomiya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Sequence of the cDNA of a Human Dihydrodiol Dehydrogenase Isoform (AKR1C2) and Tissue Distribution of Its mRNA</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">334</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">â</span> <span class="NLM_lpage">405</span><span class="refDoi">Â DOI: 10.1042/bj3340399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1042%2Fbj3340399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=9716498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADyaK1cXmtFOlsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=1998&pages=399-405&author=H.+Shiraishiauthor=S.+Ishikuraauthor=K.+Matsuuraauthor=Y.+Deyashikiauthor=M.+Ninomiyaauthor=S.+Sakaiauthor=A.+Hara&title=Sequence+of+the+cDNA+of+a+Human+Dihydrodiol+Dehydrogenase+Isoform+%28AKR1C2%29+and+Tissue+Distribution+of+Its+mRNA&doi=10.1042%2Fbj3340399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Sequence of the cDNA of a human dihydrodiol dehydrogenase isoform (AKR1C2) and tissue distribution of its mRNA</span></div><div class="casAuthors">Shiraishi, Hiroaki; Ishikura, Syuhei; Matsuura, Kazuya; Deyashiki, Yoshihiro; Ninomiya, Mitsuo; Sakai, Syunsuke; Hara, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">399-405</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Human liver contains three isoforms (DD1, DD2 and DD4) of dihydrodiol dehydrogenase with 20Î±- or 3Î±-hydroxysteroid dehydrogenase activity; the dehydrogenases belong to the aldo-oxo reductase (AKR) superfamily.  CDNA species encoding DD1 and DD4 have been identified.  However, four cDNA species with more than 99% sequence identity have been cloned and are compatible with a partial amino acid sequence of DD2.  In this study we have isolated a cDNA clone encoding DD2, which was confirmed by comparison of the properties of the recombinant and hepatic enzymes.  This cDNA showed differences of one, two, four and five nucleotides from the previously reported four cDNA species for a dehydrogenase of human colon carcinoma HT29 cells, human prostatic 3Î±-hydroxysteroid dehydrogenase, a human liver 3Î±-hydroxysteroid dehydrogenase-like protein and chlordecone reductase-like protein resp.  Expression of mRNA species for the five similar cDNA species in 20 liver samples and 10 other different tissue samples was examd. by reverse transcriptase-mediated PCR with specific primers followed by diagnostic restriction with endonucleases.  All the tissues expressed only one mRNA species corresponding to the newly identified cDNA for DD2: mRNA transcripts corresponding to the other cDNA species were not detected.  We suggest that the new cDNA is derived from the principal gene for DD2, which has been named AKR1C2 by a new nomenclature for the AKR superfamily.  It is possible that some of the other cDNA species previously reported are rare allelic variants of this gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwKJqD5RzmnLVg90H21EOLACvtfcHk0lhBn-0mPMv54g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtFOlsb4%253D&md5=41a45423ebcd7db47886cc5fd6878869</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1042%2Fbj3340399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3340399%26sid%3Dliteratum%253Aachs%26aulast%3DShiraishi%26aufirst%3DH.%26aulast%3DIshikura%26aufirst%3DS.%26aulast%3DMatsuura%26aufirst%3DK.%26aulast%3DDeyashiki%26aufirst%3DY.%26aulast%3DNinomiya%26aufirst%3DM.%26aulast%3DSakai%26aufirst%3DS.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DSequence%2520of%2520the%2520cDNA%2520of%2520a%2520Human%2520Dihydrodiol%2520Dehydrogenase%2520Isoform%2520%2528AKR1C2%2529%2520and%2520Tissue%2520Distribution%2520of%2520Its%2520mRNA%26jtitle%3DBiochem.%2520J.%26date%3D1998%26volume%3D334%26spage%3D399%26epage%3D405%26doi%3D10.1042%2Fbj3340399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Arai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyagi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishinaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikari, A.</span><span> </span><span class="NLM_article-title">Structure-Activity Relationship of Flavonoids as Potent Inhibitors of Carbonyl Reductase 1 (CBR1)</span> <span class="citation_source-journal">Fitoterapia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">â</span> <span class="NLM_lpage">56</span><span class="refDoi">Â DOI: 10.1016/j.fitote.2014.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.fitote.2014.12.010" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2015&pages=51-56&author=Y.+Araiauthor=S.+Endoauthor=N.+Miyagiauthor=N.+Abeauthor=T.+Miuraauthor=T.+Nishinakaauthor=T.+Teradaauthor=M.+Oyamaauthor=H.+Godaauthor=O.+El-Kabbaniauthor=A.+Haraauthor=T.+Matsunagaauthor=A.+Ikari&title=Structure-Activity+Relationship+of+Flavonoids+as+Potent+Inhibitors+of+Carbonyl+Reductase+1+%28CBR1%29&doi=10.1016%2Fj.fitote.2014.12.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.fitote.2014.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fitote.2014.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DY.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DMiyagi%26aufirst%3DN.%26aulast%3DAbe%26aufirst%3DN.%26aulast%3DMiura%26aufirst%3DT.%26aulast%3DNishinaka%26aufirst%3DT.%26aulast%3DTerada%26aufirst%3DT.%26aulast%3DOyama%26aufirst%3DM.%26aulast%3DGoda%26aufirst%3DH.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DIkari%26aufirst%3DA.%26atitle%3DStructure-Activity%2520Relationship%2520of%2520Flavonoids%2520as%2520Potent%2520Inhibitors%2520of%2520Carbonyl%2520Reductase%25201%2520%2528CBR1%2529%26jtitle%3DFitoterapia%26date%3D2015%26volume%3D101%26spage%3D51%26epage%3D56%26doi%3D10.1016%2Fj.fitote.2014.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Selective Inhibition of the Tumor Marker AKR1B10 by Antiinflammatory N-Phenylanthranilic Acids and Glycyrrhetic Acid</span> <span class="citation_source-journal">Biol. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">886</span><span class="NLM_x">â</span> <span class="NLM_lpage">890</span><span class="refDoi">Â DOI: 10.1248/bpb.33.886</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1248%2Fbpb.33.886" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=20460771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1Oht7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=886-890&author=S.+Endoauthor=T.+Matsunagaauthor=M.+Sodaauthor=K.+Tajimaauthor=H.+T.+Zhaoauthor=O.+El-Kabbaniauthor=A.+Hara&title=Selective+Inhibition+of+the+Tumor+Marker+AKR1B10+by+Antiinflammatory+N-Phenylanthranilic+Acids+and+Glycyrrhetic+Acid&doi=10.1248%2Fbpb.33.886"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of the tumor marker AKR1B10 by antiinflammatory N-phenylanthranilic acids and glycyrrhetic acid</span></div><div class="casAuthors">Endo, Satoshi; Matsunaga, Toshiyuki; Soda, Midori; Tajima, Kazuo; Zhao, Hi-Tai; El-Kabbani, Ossama; Hara, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">886-890</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A human aldose reductase-like protein, AKR1B10 in the aldo-keto reductase (AKR) superfamily, was recently identified as a tumor marker of several types of cancer.  Tolrestat, an aldose reductase inhibitor (ARI), is known to be the most potent inhibitor of the enzyme.  In this study, we compared the inhibitory effects of other ARIs including flavonoids on AKR1B10 and aldose reductase to evaluate their specificity.  However, ARIs showed lower inhibitory potency for AKR1B10 than for aldose reductase.  In the search for potent and selective inhibitors of AKR1B10 from other drugs used clin., we found that non-steroidal antiinflammatory N-phenylanthranilic acids, diclofenac and glycyrrhetic acid competitively inhibited AKR1B10, showing Ki values of 0.35-2.9 Î¼M and high selectivity to this enzyme (43-57 fold vs. aldose reductase).  Mol. docking studies of mefenamic acid and glycyrrhetic acid in the AKR1B10-NADP (NADP+) complex and site-directed mutagenesis of the putative binding residues suggest that the side chain of Val301 and a hydrogen-bonding network among residues Val301, Gln114 and Ser304 are important for detg. the inhibitory potency and selectivity of the non-steroidal antiinflammatory drugs.  Thus, the potent and selective inhibition may be related to the cancer chemopreventive roles of the drugs, and their structural features may facilitate the design of new anti-cancer agents targeting AKR1B10.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDHEPGYUtiEbVg90H21EOLACvtfcHk0lhBn-0mPMv54g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1Oht7Y%253D&md5=89b4e78d049e6bccaab07c410f541a0c</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1248%2Fbpb.33.886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.33.886%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DTajima%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DH.%2BT.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DSelective%2520Inhibition%2520of%2520the%2520Tumor%2520Marker%2520AKR1B10%2520by%2520Antiinflammatory%2520N-Phenylanthranilic%2520Acids%2520and%2520Glycyrrhetic%2520Acid%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2010%26volume%3D33%26spage%3D886%26epage%3D890%26doi%3D10.1248%2Fbpb.33.886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Higaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usami, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shintani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Selective and Potent Inhibitors of Human 20Î±-Hydroxysteroid Dehydrogenase (AKR1C1) that Metabolizes Neurosteroids Derived from Progesterone</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">143â144</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span><span class="NLM_x">â</span> <span class="NLM_lpage">513</span><span class="refDoi">Â DOI: 10.1016/S0009-2797(02)00206-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2FS0009-2797%2802%2900206-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=12604236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsVagsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143%E2%80%93144&publication_year=2003&pages=503-513&author=Y.+Higakiauthor=N.+Usamiauthor=S.+Shintaniauthor=S.+Ishikuraauthor=O.+El-Kabbaniauthor=A.+Hara&title=Selective+and+Potent+Inhibitors+of+Human+20%CE%B1-Hydroxysteroid+Dehydrogenase+%28AKR1C1%29+that+Metabolizes+Neurosteroids+Derived+from+Progesterone&doi=10.1016%2FS0009-2797%2802%2900206-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Selective and potent inhibitors of human 20Î±-hydroxysteroid dehydrogenase (AKR1C1) that metabolizes neurosteroids derived from progesterone</span></div><div class="casAuthors">Higaki, Yu; Usami, Noriyuki; Shintani, Syunichi; Ishikura, Shuhei; El-Kabbani, Ossama; Hara, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">143-144</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">503-513</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Neuroactive steroids, such as 3Î±,5Î±-tetrahydroprogesterone (3Î±,5Î±-THP) and 3Î±,5Î±-tetrahydrodeoxycorticosterone have been shown to be synthesized from progesterone in animal brains.  Comparison of kinetic consts. for the neuroactive steroids and their precursors among four human 3(20)Î±-hydroxysteroid dehydrogenases (AKR1C1-AKR1C4) suggests that AKR1C1 and AKR1C2 are involved in the catabolism and synthesis, resp., of the neuroactive steroids in the human brain.  In our efforts to identify agents that would specifically inhibit the two enzymes, benzbromarone and 3',3'',5',5''-tetrabromophenolphthalein were found to be relatively selective and potent inhibitors of AKR1C1.  Kinetic analyses in the oxidoredn. catalyzed by AKR1C1 in the presence of the inhibitors suggest that the inhibitors bind to the enzyme-NADP(H) complex (Ki = 0.7 nM) in the ordered bi-bi pathway, including an isomerization step.  The inhibitors effectively also decreased the redn. of 3Î±,5Î±-THP to its 20Î±-hydroxy metabolite in HepG2 cells treated with ethacrynic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdJuac4OAQ0bVg90H21EOLACvtfcHk0lhBn-0mPMv54g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsVagsrc%253D&md5=58f99324f1cb35aba4937a6551a4974d</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2FS0009-2797%2802%2900206-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-2797%252802%252900206-5%26sid%3Dliteratum%253Aachs%26aulast%3DHigaki%26aufirst%3DY.%26aulast%3DUsami%26aufirst%3DN.%26aulast%3DShintani%26aufirst%3DS.%26aulast%3DIshikura%26aufirst%3DS.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DSelective%2520and%2520Potent%2520Inhibitors%2520of%2520Human%252020%25CE%25B1-Hydroxysteroid%2520Dehydrogenase%2520%2528AKR1C1%2529%2520that%2520Metabolizes%2520Neurosteroids%2520Derived%2520from%2520Progesterone%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2003%26volume%3D143%25E2%2580%2593144%26spage%3D503%26epage%3D513%26doi%3D10.1016%2FS0009-2797%2802%2900206-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitade, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyooka, N.</span><span> </span><span class="NLM_article-title">Synthesis and Structure-Activity Relationship of 2-Phenyliminochromene Derivatives as Inhibitors for Aldo-Keto Reductase (AKR) 1B10</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6378</span><span class="NLM_x">â</span> <span class="NLM_lpage">6384</span><span class="refDoi">Â DOI: 10.1016/j.bmc.2013.08.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.bmc.2013.08.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=24071447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsV2nu73M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=6378-6384&author=S.+Endoauthor=D.+Huauthor=M.+Suyamaauthor=T.+Matsunagaauthor=K.+Sugimotoauthor=Y.+Matsuyaauthor=O.+El-Kabbaniauthor=K.+Kuwataauthor=A.+Haraauthor=Y.+Kitadeauthor=N.+Toyooka&title=Synthesis+and+Structure-Activity+Relationship+of+2-Phenyliminochromene+Derivatives+as+Inhibitors+for+Aldo-Keto+Reductase+%28AKR%29+1B10&doi=10.1016%2Fj.bmc.2013.08.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structure-activity relationship of 2-phenyliminochromene derivatives as inhibitors for aldo-keto reductase (AKR) 1B10</span></div><div class="casAuthors">Endo, Satoshi; Hu, Dawei; Suyama, Miho; Matsunaga, Toshiyuki; Sugimoto, Kenji; Matsuya, Yuji; El-Kabbani, Ossama; Kuwata, Kazuo; Hara, Akira; Kitade, Yukio; Toyooka, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6378-6384</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inhibitors of a human member (AKR1B10) of the aldo-keto reductase superfamily are regarded as promising therapeutics for the treatment of cancer.  Recently, we have discovered (Z)-2-(4-methoxyphenylimino)-7-hydroxy-N-(pyridin-2-yl)-2H-chromene-3-carboxamide (1) as the potent competitive inhibitor using the virtual screening approach, and proposed its 4-methoxy group on the 2-phenylimino moiety as an essential structural prerequisite for the inhibition.  In this study, 18 derivs. of 1 were synthesized and their inhibitory potency against AKR1B10 evaluated.  Among them, 7-hydroxy-2-(4-methoxyphenylimino)-2H-chromene-3-carboxylic acid benzylamide (5n) was the most potent inhibitor showing a Ki value of 1.3 nM.  The structure-activity relationship of the derivs. indicated that the 7-hydroxyl group on the chromene ring, but not the 4-methoxy group, was absolutely required for inhibitory activity, The mol. docking of 5n in AKR1B10 and site-directed mutagenesis of the enzyme residues suggested that the hydrogen-bond interactions between the 7-hydroxyl group of 5n and the catalytic residues (Tyr49 and His111) of the enzyme, together with a Ï-stacking interaction of the benzylamide moiety of 5n with Trp220, are important for the potent inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj7CHzZirCtbVg90H21EOLACvtfcHk0lhwLUF1JkgJXg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsV2nu73M&md5=8b2ba23e95c0ef3b2beab844c457dadc</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.08.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.08.059%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DSuyama%26aufirst%3DM.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DSugimoto%26aufirst%3DK.%26aulast%3DMatsuya%26aufirst%3DY.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DKuwata%26aufirst%3DK.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DKitade%26aufirst%3DY.%26aulast%3DToyooka%26aufirst%3DN.%26atitle%3DSynthesis%2520and%2520Structure-Activity%2520Relationship%2520of%25202-Phenyliminochromene%2520Derivatives%2520as%2520Inhibitors%2520for%2520Aldo-Keto%2520Reductase%2520%2528AKR%2529%25201B10%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D6378%26epage%3D6384%26doi%3D10.1016%2Fj.bmc.2013.08.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiyama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takemura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikari, A.</span><span> </span><span class="NLM_article-title">Protective Roles of Aldo-Keto Reductase 1B10 and Autophagy against Toxicity Induced by <i>p</i>-Quinone Metabolites of <i>tert</i>-Butylhydroquinone in Lung Cancer A549 Cells</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">234</span><span class="NLM_x">, </span> <span class="NLM_fpage">282</span><span class="NLM_x">â</span> <span class="NLM_lpage">289</span><span class="refDoi">Â DOI: 10.1016/j.cbi.2014.09.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.cbi.2014.09.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=25289770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslehsbbO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=234&publication_year=2015&pages=282-289&author=S.+Endoauthor=A.+Nishiyamaauthor=M.+Suyamaauthor=M.+Takemuraauthor=M.+Sodaauthor=H.+Chenauthor=K.+Tajimaauthor=O.+El-Kabbaniauthor=Y.+Bunaiauthor=A.+Haraauthor=T.+Matsunagaauthor=A.+Ikari&title=Protective+Roles+of+Aldo-Keto+Reductase+1B10+and+Autophagy+against+Toxicity+Induced+by+p-Quinone+Metabolites+of+tert-Butylhydroquinone+in+Lung+Cancer+A549+Cells&doi=10.1016%2Fj.cbi.2014.09.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Protective roles of aldo-keto reductase 1B10 and autophagy against toxicity induced by p-quinone metabolites of tert-butylhydroquinone in lung cancer A549 cells</span></div><div class="casAuthors">Endo, Satoshi; Nishiyama, Ayako; Suyama, Miho; Takemura, Mayuko; Soda, Midori; Chen, Huayue; Tajima, Kazuo; El-Kabbani, Ossama; Bunai, Yasuo; Hara, Akira; Matsunaga, Toshiyuki; Ikari, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">234</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">282-289</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Tert-Butylhydroquinone (BHQ), an antioxidant used as a food additive, exhibits an anticancer effect at low doses, but is carcinogenic in rodents at high doses.  BHQ is metabolized into cytotoxic tert-butylquinone (TBQ), which is further converted to 6-tert-butyl-2,3-epoxy-4-hydroxy-5-cyclohexen-1-one (TBEH) through 6-tert-butyl-2,3-epoxy-4-benzoquinone (TBE).  Both TBQ and TBE are cytotoxic, but their toxic mechanisms have not been fully characterized.  In this study, we have investigated the toxic mechanisms of TBQ and TBE, and the defense system against the two p-quinones using lung cancer A549 cells.  TBQ and TBE, but not BHQ and TBEH, showed cytotoxicity to A549 cells.  Neither caspase-3 activation nor an increase in the expression of endoplasmic reticulum stress-assocg. target genes was obsd.  TBQ and TBE reacted with reduced glutathione, and significantly decreased the glutathione level in A549 cells, suggesting that the cytotoxicity of the p-quinones is caused by their high electrophilicity reacting with biomols.  The A549 cells treated with the p-quinones also showed increased levels of autophagic vacuoles and LC3-II protein, which are specific autophagy markers.  An autophagy inhibitor, 3-methyladenine (3MA), decreased the LC3-II prodn. by the p-quinones, but enhanced the cytotoxicity induced by TBQ and TBE, suggesting that autophagy contributes to alleviating the p-quinone-triggered cytotoxicity.  In addn., the TBE-induced cytotoxicity and autophagy activation in the cells were significantly suppressed by overexpression of aldo-keto reductase (AKR)1B10 that efficiently reduces TBE into TBEH, and were augmented by pretreatment with a potent AKR1B10 inhibitor, C1.  The effects of 3MA and C1 on the TBE-induced cytotoxicity were additive.  The data provides evidence for the first time that autophagy and AKR1B10 contribute to the defense system against the cytotoxicity caused by the electrophilic p-quinone metabolites of BHQ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpA-bYunP__9bVg90H21EOLACvtfcHk0lhwLUF1JkgJXg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslehsbbO&md5=a2a8d101138ff66c0382eba1e172f571</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2014.09.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2014.09.023%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DNishiyama%26aufirst%3DA.%26aulast%3DSuyama%26aufirst%3DM.%26aulast%3DTakemura%26aufirst%3DM.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DTajima%26aufirst%3DK.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DBunai%26aufirst%3DY.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DIkari%26aufirst%3DA.%26atitle%3DProtective%2520Roles%2520of%2520Aldo-Keto%2520Reductase%25201B10%2520and%2520Autophagy%2520against%2520Toxicity%2520Induced%2520by%2520p-Quinone%2520Metabolites%2520of%2520tert-Butylhydroquinone%2520in%2520Lung%2520Cancer%2520A549%2520Cells%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2015%26volume%3D234%26spage%3D282%26epage%3D289%26doi%3D10.1016%2Fj.cbi.2014.09.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Exposure to 9,10-Phenanthrenequinone Accelerates Malignant Progression of Lung Cancer Cells through Up-Regulation of Aldo-Keto Reductase 1B10</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">180</span><span class="NLM_x">â</span> <span class="NLM_lpage">189</span><span class="refDoi">Â DOI: 10.1016/j.taap.2014.04.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1016%2Fj.taap.2014.04.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=24813866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC2cXoslCmsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2014&pages=180-189&author=T.+Matsunagaauthor=Y.+Morikawaauthor=M.+Hagaauthor=S.+Endoauthor=M.+Sodaauthor=K.+Yamamuraauthor=O.+El-Kabbaniauthor=K.+Tajimaauthor=A.+Ikariauthor=A.+Hara&title=Exposure+to+9%2C10-Phenanthrenequinone+Accelerates+Malignant+Progression+of+Lung+Cancer+Cells+through+Up-Regulation+of+Aldo-Keto+Reductase+1B10&doi=10.1016%2Fj.taap.2014.04.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Exposure to 9,10-phenanthrenequinone accelerates malignant progression of lung cancer cells through up-regulation of aldo-keto reductase 1B10</span></div><div class="casAuthors">Matsunaga, Toshiyuki; Morikawa, Yoshifumi; Haga, Mariko; Endo, Satoshi; Soda, Midori; Yamamura, Keiko; El-Kabbani, Ossama; Tajima, Kazuo; Ikari, Akira; Hara, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">180-189</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Inhalation of 9,10-phenanthrenequinone (9,10-PQ), a major quinone in diesel exhaust, exerts fatal damage against a variety of cells involved in respiratory function.  Here, we show that treatment with high concns. of 9,10-PQ evokes apoptosis of lung cancer A549 cells through prodn. of reactive oxygen species (ROS).  In contrast, 9,10-PQ at its concns. of 2 and 5 Î¼M elevated the potentials for proliferation, invasion, metastasis and tumorigenesis, all of which were almost completely inhibited by addn. of an antioxidant N-acetyl-L-cysteine, inferring a crucial role of ROS in the overgrowth and malignant progression of lung cancer cells.  Comparison of mRNA expression levels of six aldo-keto reductases (AKRs) in the 9,10-PQ-treated cells advocated up-regulation of AKR1B10 as a major cause contributing to the lung cancer malignancy.  In support of this, the elevation of invasive, metastatic and tumorigenic activities in the 9,10-PQ-treated cells was significantly abolished by the addn. of a selective AKR1B10 inhibitor oleanolic acid.  Intriguingly, zymog. and real-time PCR analyses revealed remarkable increases in secretion and expression, resp., of matrix metalloproteinase 2 during the 9,10-PQ treatment, and suggested that the AKR1B10 up-regulation and resultant activation of mitogen-activated protein kinase cascade are predominant mechanisms underlying the metalloproteinase induction.  In addn., HPLC anal. and cytochrome c redn. assay in in vitro 9,10-PQ redn. by AKR1B10 demonstrated that the enzyme catalyzes redox-cycling of this quinone, by which ROS are produced.  Collectively, these results suggest that AKR1B10 is a key regulator involved in overgrowth and malignant progression of the lung cancer cells through ROS prodn. due to 9,10-PQ redox-cycling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYfQ6ZwQdsjrVg90H21EOLACvtfcHk0lhwLUF1JkgJXg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXoslCmsbY%253D&md5=8a75135338ed053f854c530d20035d69</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2014.04.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2014.04.024%26sid%3Dliteratum%253Aachs%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DMorikawa%26aufirst%3DY.%26aulast%3DHaga%26aufirst%3DM.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DYamamura%26aufirst%3DK.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DTajima%26aufirst%3DK.%26aulast%3DIkari%26aufirst%3DA.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DExposure%2520to%25209%252C10-Phenanthrenequinone%2520Accelerates%2520Malignant%2520Progression%2520of%2520Lung%2520Cancer%2520Cells%2520through%2520Up-Regulation%2520of%2520Aldo-Keto%2520Reductase%25201B10%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2014%26volume%3D278%26spage%3D180%26epage%3D189%26doi%3D10.1016%2Fj.taap.2014.04.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Usui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ukai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiho, T.</span><span> </span><span class="NLM_article-title">Growth Suppressing Activity for Endothelial Cells Induced from Macrophages by Carboxymethylated Curdlan</span> <span class="citation_source-journal">Biosci., Biotechnol., Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1924</span><span class="NLM_x">â</span> <span class="NLM_lpage">1925</span><span class="refDoi">Â DOI: 10.1271/bbb.61.1924</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1271%2Fbbb.61.1924" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1997&pages=1924-1925&author=S.+Usuiauthor=T.+Matsunagaauthor=S.+Ukaiauthor=T.+Kiho&title=Growth+Suppressing+Activity+for+Endothelial+Cells+Induced+from+Macrophages+by+Carboxymethylated+Curdlan&doi=10.1271%2Fbbb.61.1924"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1271%2Fbbb.61.1924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1271%252Fbbb.61.1924%26sid%3Dliteratum%253Aachs%26aulast%3DUsui%26aufirst%3DS.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DUkai%26aufirst%3DS.%26aulast%3DKiho%26aufirst%3DT.%26atitle%3DGrowth%2520Suppressing%2520Activity%2520for%2520Endothelial%2520Cells%2520Induced%2520from%2520Macrophages%2520by%2520Carboxymethylated%2520Curdlan%26jtitle%3DBiosci.%252C%2520Biotechnol.%252C%2520Biochem.%26date%3D1997%26volume%3D61%26spage%3D1924%26epage%3D1925%26doi%3D10.1271%2Fbbb.61.1924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Kato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwakami, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiki, I.</span><span> </span><span class="NLM_article-title">p38 Pathway as a Key Downstream Signal of Connective Tissue Growth Factor to Regulate Metastatic Potential in Non-Small-Cell Lung Cancer</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">1416</span><span class="NLM_x">â</span> <span class="NLM_lpage">1421</span><span class="refDoi">Â DOI: 10.1111/cas.13009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=10.1111%2Fcas.13009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=27403934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVegtrbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2016&pages=1416-1421&author=S.+Katoauthor=S.+Yokoyamaauthor=Y.+Hayakawaauthor=L.+Liauthor=Y.+Iwakamiauthor=H.+Sakuraiauthor=I.+Saiki&title=p38+Pathway+as+a+Key+Downstream+Signal+of+Connective+Tissue+Growth+Factor+to+Regulate+Metastatic+Potential+in+Non-Small-Cell+Lung+Cancer&doi=10.1111%2Fcas.13009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">P38 pathway as a key downstream signal of connective tissue growth factor to regulate metastatic potential in non-small-cell lung cancer</span></div><div class="casAuthors">Kato, Shinichiro; Yokoyama, Satoru; Hayakawa, Yoshihiro; Li, Luhui; Iwakami, Yusuke; Sakurai, Hiroaki; Saiki, Ikuo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1416-1421</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Although the secretory matricellular protein connective tissue growth factor (CTGF) has been reported to be related to lung cancer metastasis, the precise mechanism by which CTGF regulates lung cancer metastasis has not been elucidated.  In the present study, we show the mol. link between CTGF secretion and the p38 pathway in the invasive and metastatic potential of non-small-cell lung cancer (NSCLC).  Among three different human NSCLC cell lines (PC-14, A549, and PC-9), their in vitro invasiveness was inversely correlated with the level of CTGF secretion.  By supplementing or reducing CTGF secretion in NSCLC culture, dysregulation of the invasive and metastatic potential of NSCLC cell lines was largely compensated.  By focusing on the protein kinases that are known to be regulated by CTGF, we found that the p38 pathway is a key downstream signal of CTGF to regulate the metastatic potential of NSCLC.  Importantly, a neg. correlation between CTGF and phosphorylation status of p38 was identified in The Cancer Genome Atlas lung adenocarcinoma dataset.  In the context of the clin. importance of our findings, we showed that p38 inhibitor, SB203580, reduced the metastatic potential of NSCLC secreting low levels of CTGF.  Collectively, our present findings indicate that the CTGF/p38 axis is a novel therapeutic target of NSCLC metastasis, particularly NSCLC secreting low levels of CTGF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJk9GNwDz9xLVg90H21EOLACvtfcHk0ljPrryCGbhuzw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVegtrbJ&md5=ec1dc41761223c00e74ea991df1c66aa</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1111%2Fcas.13009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.13009%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DS.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DHayakawa%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DIwakami%26aufirst%3DY.%26aulast%3DSakurai%26aufirst%3DH.%26aulast%3DSaiki%26aufirst%3DI.%26atitle%3Dp38%2520Pathway%2520as%2520a%2520Key%2520Downstream%2520Signal%2520of%2520Connective%2520Tissue%2520Growth%2520Factor%2520to%2520Regulate%2520Metastatic%2520Potential%2520in%2520Non-Small-Cell%2520Lung%2520Cancer%26jtitle%3DCancer%2520Sci.%26date%3D2016%26volume%3D107%26spage%3D1416%26epage%3D1421%26doi%3D10.1111%2Fcas.13009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GQ0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GQ0','PDB','4GQ0'); return false;">PDB: 4GQ0</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i75"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00830">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_51160"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00830">10.1021/acs.jmedchem.7b00830</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Data of <b>4c</b>-binding modes in AKR1B10 and AKR1B1 and effect of alanine scanning on binding free energy for <b>4c</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00830/suppl_file/jm7b00830_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00830/suppl_file/jm7b00830_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00830/suppl_file/jm7b00830_si_001.pdf">jm7b00830_si_001.pdf (185.55 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00830/suppl_file/jm7b00830_si_002.csv">jm7b00830_si_002.csv (1.41 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00830&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-20%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00830%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00830" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677afb59b8e823b0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
